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Studies have demonstrated the immune system to be significantly more plastic than previously 
believed. Multiple external factors have been shown to influence the immune response including 
alterations to the host’s external environment and psychological status.  
This thesis details an investigation of this influence; exposing male CD1 mice to a two-week 
environmental enrichment paradigm then subjecting them to one of a range of inflammatory 
disease models chosen to assess a specific aspect of their immune function. 
 
Enriched animals were found to possess significantly higher numbers of circulating innate 
leukocytes compared to those animals housed in a standard lab environment.  
This leukocytosis was found to persist when animals were subject to a model of zymosan-
induced peritonitis, where enriched animals presented an enhanced neutrophil and macrophage 
influx into their peritoneal cavity. Similar results were observed in a model of sepsis induced by 
caecal ligation and puncture where enriched animals were also found possess an enhanced 
capacity for systemic bacterial clearance. Across both experiments no changes in inflammatory 
cytokine expression were observed between enriched and standard environment animals. 
Genomic and proteomic profiling supported these findings, revealing the increased expression 
of immune-modulatory genes associated with a heightened immune and moderated 
inflammatory response.  
Ex vivo analysis of leukocytes extracted from enriched animals showed they also possessed 
enhanced phagocytic function and an accompanying reduction in gene expression associated 
with heightened cytotoxic function.  
When subject to a model of persistent inflammation induced by sponge implantation, enriched 
animals again presented heightened leukocyte infiltration to the point of immune insult. This was 
accompanied with a reduction in the release of pro-inflammatory cytokines and the heightened 
expression of genes associated with a pro-resolving, wound healing phenotype. 
This study provides novel insights into the mechanisms by which environmental modulation may 
influence the immune response and of the potentially immune-protective influence of 




Table of Contents 
 INTRODUCTION ...................................................................................................... 20 
1.1 INFLAMMATION ........................................................................................................................... 20 
1.2 ACUTE INFLAMMATION ................................................................................................................ 21 
1.2.1 Stimuli for Acute Inflammation ...................................................................................... 21 
1.2.2 The Vascular Response ................................................................................................ 23 
1.2.3 The Cellular Response: ................................................................................................. 24 
1.2.4 Neutrophils .................................................................................................................... 25 
1.2.5 Monocytes ..................................................................................................................... 30 
1.2.6 Macrophages ................................................................................................................. 34 
1.2.7 Resolution of Inflammation ............................................................................................ 39 
1.2.8 Wound Healing .............................................................................................................. 43 
1.2.9 Chronic Inflammation .................................................................................................... 47 
1.3 MODELS OF INFLAMMATION ......................................................................................................... 49 
1.3.1 Zymosan Induced Peritonitis; A Model of Resolving, Localised Inflammation .............. 49 
1.3.2 Caecal Ligation and Puncture. ...................................................................................... 53 
1.3.3 Sponge Granuloma ....................................................................................................... 57 
1.4 ENVIRONMENTAL FACTORS INFLUENCING INFLAMMATION.............................................................. 63 
1.4.1 Enteric Microorganisms ................................................................................................. 63 
1.4.2 Genetics ........................................................................................................................ 64 
1.4.3 Ageing ........................................................................................................................... 64 
1.4.4 Diet ................................................................................................................................ 65 
1.4.5 Exercise ......................................................................................................................... 65 
1.4.6 Psychological Status ..................................................................................................... 68 
1.5 ENVIRONMENTAL ENRICHMENT.................................................................................................... 71 
1.5.1 Enrichment Methods ..................................................................................................... 72 
1.6 AIMS AND HYPOTHESIS ............................................................................................................... 77 
 METHODS ................................................................................................................ 79 
2.1 ANIMAL BREEDING AND HUSBANDRY ........................................................................................... 79 
10 
 
2.2 ENVIRONMENTAL ENRICHMENT.................................................................................................... 79 
2.3 BODY FAT AND MUSCLE ANALYSIS .............................................................................................. 83 
2.4 BLOOD ANALYSIS ....................................................................................................................... 83 
2.5 BONE MARROW CELL EXTRACTION ............................................................................................. 84 
2.6 ZYMOSAN INDUCED PERITONITIS ................................................................................................. 85 
2.7 PERITONEAL LAVAGE .................................................................................................................. 85 
2.8 CELL COUNT .............................................................................................................................. 86 
2.9 CYTOKINE ANALYSIS ................................................................................................................... 86 
2.10 FLOW CYTOMETRY – PROCEDURES AND ANALYSIS .................................................................... 87 
2.10.1 General Cell Staining Protocol for Flow Cytometry ..................................................... 87 
2.10.2 Cell Differentiation Markers Used ............................................................................... 87 
2.10.3 FACS Acquisition ........................................................................................................ 88 
2.11 ANIMAL BEHAVIOURAL ASSESSMENTS ....................................................................................... 89 
2.11.1 Open Field Test ........................................................................................................... 89 
2.11.2 Elevated Plus Maze ..................................................................................................... 90 
2.11.3 Light / Dark Box Test ................................................................................................... 91 
2.11.4 Serum Corticosterone Analysis ................................................................................... 91 
2.12 CAECAL LIGATION AND PUNCTURE ............................................................................................ 92 
2.12.1 CLP Procedure ............................................................................................................ 92 
2.12.2 Peritoneal Lavage and Cell Count .............................................................................. 93 
2.12.3 Bacterial Colony Count ................................................................................................ 93 
2.13 IMMUNE-MODULATORY GENE MICROARRAY ANALYSIS ............................................................... 94 
2.13.1 Whole Blood Total RNA Extraction for Micro-Array .................................................... 94 
2.13.2 Microarray Protocol ..................................................................................................... 94 
2.13.3 Microarray Data Analysis ............................................................................................ 95 
2.14 REAL TIME PCR ....................................................................................................................... 95 
2.15 NEUTROPHIL ACTIVATION .......................................................................................................... 96 
2.16 MACROPHAGE PHAGOCYTIC FUNCTION ..................................................................................... 96 
2.17 SPONGE GRANULOMA ............................................................................................................... 97 
2.17.1 Sponge Implantation Procedure .................................................................................. 97 
11 
 
2.17.2 Sponge Infiltrate Extraction and Analysis .................................................................... 97 
2.17.3 Flow Cytometric Leukocyte Profiling ........................................................................... 97 
2.17.4 Exudate Cytokine Profiling .......................................................................................... 98 
2.17.5 Granuloma Dispersal and Flow Cytometric Analysis .................................................. 98 
2.17.6 RT PCR Profiling of Granuloma Tissue ...................................................................... 98 
2.18 STATISTICAL ANALYSIS ............................................................................................................. 99 
2.19 EXPERIMENTAL DESIGN AND CONSIDERATION OF THE THREE RS ................................................ 99 
2.20 GENERAL EXPERIMENTAL SCHEMA .......................................................................................... 102 
 RESULTS ............................................................................................................... 103 
3.1 PHYSIOLOGICAL PARAMETERS .................................................................................................. 103 
3.1.1 Comparative Weight Gain Over Experimental Period ................................................. 103 
3.1.2 Comparative Nutritional Intake Over the Experimental Period ................................... 104 
3.1.3 Subcutaneous Fat Levels Following Enrichment ........................................................ 105 
3.2 INVESTIGATION OF ENRICHED MICE IN A BASAL IMMUNE STATE ................................................... 106 
3.2.1 Basal Immune State: Cellular Profile of the Peritoneal Cavity .................................... 106 
3.2.2 Basal Immune State: Peritoneal Cytokine Analysis .................................................... 108 
3.2.3 Basal Immune State: Blood Cellular Profile ................................................................ 108 
3.2.4 Basal Immune State: Bone Marrow Cellular Profile .................................................... 110 
3.3 ZYMOSAN INDUCED PERITONITIS: SIX HOUR TIME POINT ............................................................ 111 
3.3.1 ZIP 6: Cellular Profile of the Peritoneal Cavity ............................................................ 111 
3.3.2 ZIP 6: Peritoneal Cytokine Levels ............................................................................... 113 
3.3.3 ZIP 6: Blood Cellular Profile ........................................................................................ 114 
3.3.4 ZIP 6: Bone Marrow Cellular Profile ............................................................................ 116 
3.4 ZYMOSAN INDUCED PERITONITIS TWENTY-FOUR HOUR TIME POINT ............................................ 117 
3.4.1 ZIP 24: Cellular Profile of Peritoneal Lavage .............................................................. 117 
3.4.2 ZIP 24: Peritoneal Cytokine Levels ............................................................................. 119 
3.4.3 ZIP24: Blood Cellular Profile ....................................................................................... 120 
3.4.4 ZIP 24: Bone Marrow Cellular Profile .......................................................................... 122 
3.5 CAECAL LIGATION AND PUNCTURE ............................................................................................ 123 
3.5.1 CLP: Peritoneal Cell Profile ......................................................................................... 124 
12 
 
3.5.2 CLP: Peritoneal Cytokine Levels ................................................................................. 125 
3.5.3 CLP: Blood Cellular Profile .......................................................................................... 126 
3.5.4 Caecal Ligation and Puncture, Bacterial Colony Counts ............................................ 128 
3.6 GENETIC PROFILING OF WHOLE BLOOD FROM ENVIRONMENTALLY ENRICHED MICE ..................... 129 
3.6.1 Real Time PCR of Enriched vs Standard Mouse Whole Blood RNA .......................... 131 
3.6.2 Analysis of S100A8 and S100A9 Protein Expression ................................................. 132 
3.7 EX VIVO CELL ACTIVITY ASSAYS ................................................................................................ 134 
3.7.1 Neutrophil Activation ................................................................................................... 134 
3.7.2 Macrophage Phagocytosis .......................................................................................... 136 
3.7.3 RT PCR of Activated Macrophages ............................................................................ 137 
3.8 SPONGE GRANULOMA ............................................................................................................... 139 
3.8.1 Granuloma: Gross Anatomy ........................................................................................ 139 
3.8.2 Sponge Granuloma: Exudate Cellular Profiling .......................................................... 139 
3.8.3 Granuloma: Sponge Infiltrate Cytokine Analysis ......................................................... 143 
3.8.4 Granuloma: Granuloma Tissue, Cellular Profiling ....................................................... 144 
3.8.5 Granuloma: Granuloma Tissue, Genetic Profile ......................................................... 144 
3.9 BEHAVIOURAL ANALYSIS ........................................................................................................... 149 
3.9.1 Open Field Test ........................................................................................................... 149 
3.9.2 Light/Dark Box Test ..................................................................................................... 150 
3.9.3 Elevated Plus Maze ..................................................................................................... 151 
3.9.4 Circulating Corticosterone Levels ............................................................................... 152 
 DISCUSSION.......................................................................................................... 153 
4.1 ENRICHMENT AND LEUCOCYTOSIS ............................................................................................. 153 
4.2 ALTERED LEUKOCYTE RATIOS IN ENRICHED ANIMALS ................................................................. 156 
4.3 HEIGHTENED CELLULAR INFILTRATION ....................................................................................... 160 
4.4 THE CYTOKINE PROFILE OF ENRICHED ANIMALS ........................................................................ 162 
4.5 LEUKOCYTE ACTIVITY IN ENRICHED ANIMALS ............................................................................. 163 
4.6 GENE PROFILE OF ENRICHED ANIMALS ...................................................................................... 166 
4.6.1 Gene Expression in A Basal Immune State ................................................................ 166 
4.6.2 Gene Expression in The Granulomatous Tissues of Enriched Mice .......................... 169 
13 
 
4.7 THE BEHAVIOURAL PROFILE OF ENRICHED MICE ........................................................................ 172 
4.8 QUESTIONS, CHALLENGES, LIMITATIONS AND CONCLUSIONS ...................................................... 175 
 ONGOING RESEARCH ......................................................................................... 179 
5.1 INTRODUCTION, STRESS AND IMMUNE FUNCTION ....................................................................... 179 
5.2 METHODOLOGY. STRESS INDUCTION ......................................................................................... 183 
5.3 CURRENT RESULTS .................................................................................................................. 185 
5.3.1 Comparative Weight Gain ........................................................................................... 185 
5.3.2 Circulating Corticosterone Levels and Initial Behavioural Analysis ............................ 186 
5.3.3 Blood Profile of Chronically Restrained mice .............................................................. 187 
5.3.4 Zip6: Cellular Profile of the Peritoneal Cavity.............................................................. 188 
5.4 INITIAL POINTS OF DISCUSSION ................................................................................................. 190 
 FUTURE VISION ........................................... ERROR! BOOKMARK NOT DEFINED. 
 APPENDIX .............................................................................................................. 195 
7.1 VARIATIONS IN BLOOD AND BONE MARROW LEUKOCYTE POPULATIONS OVER THE TIMECOURSE 
OF ZYMOSAN INDUCED PERITONITIS ................................................................................................ 195 
7.2 FLOW CYTOMETRIC PROFILING OF SPONGE INFILTRATE LEUKOCYTES ......................................... 196 
7.3 CORTICOSTERONE READOUTS OVER SUCCESSIVE EXPERIMENTS ............................................... 197 
7.4 CONTINUED BEHAVIOURAL ANALYSIS; ETHOGRAMS ................................................................... 198 
7.5 GENES MEASURED IN RT-PCR PROFILING OF GRANULOMA TISSUE ........................................... 201 
7.6 PERITONEAL LEUKOCYTE PROFILE OF ANIMALS SUBJECT TO SIX HOURS ZYMOSAN PERITONITIS 
USING AN ENRICHED ENVIRONMENT WITH AND WITHOUT A RUNNING WHEEL .................................. 203 





Table of Figures 
Figure 1-1 The key processes and mediators governing inflammation and its resolution. ......... 43 
Figure 1-2 Mechanisms of leukocyte activation by zymosan. ..................................................... 50 
Figure 1-3 Order of leukocyte infiltration during zymosan induced peritonitis. ........................... 52 
Figure 1-4 Diagram of the caecal ligation and puncture procedure. ........................................... 55 
Figure 1-5 Time course of the foreign object granuloma response. ........................................... 60 
Figure 1-6 Methods of enriching the environment for rodents in captivity. ................................. 72 
Figure 2-1. Standard (left) vs Enriched (right) enclosures. ......................................................... 83 
Figure 2-2.Basic gating logic used in FACS analysis. ................................................................ 88 
Figure 2-3. Open field test........................................................................................................... 89 
Figure 2-4. Elevated plus maze. ................................................................................................. 90 
Figure 2-5. Light dark box. .......................................................................................................... 91 
Figure 2-6. CLP, ligated caecum 12 hours post procedure. ....................................................... 93 
Figure 2-7 Experimental procedures carried out and times each took to complete ................. 102 
Figure 3-1. Comparative weight change over time. .................................................................. 103 
Figure 3-2. Total food and water intake per cage group over enrichment period. .................... 104 
Figure 3-3. Comparative images of visceral fat pads from enriched versus standard environment 
mice. .......................................................................................................................................... 105 
Figure 3-4. Comparative weights of visceral fat pads taken from enriched and standard 
environment mice ...................................................................................................................... 105 
Figure 3-5. Peritoneal cell populations in enriched and standard environment mice. .............. 107 
Figure 3-6. Circulating blood cell populations in enriched and standard environment mice. ... 109 
Figure 3-7. Bone marrow cell population in mice from enriched and standard environments. . 110 
Figure 3-8. Peritoneal cell populations in enriched and standard environment mice following six 
hours of zymosan induced peritonitis. ....................................................................................... 112 
Figure 3-9. Comparative cytokine levels in the peritoneum of animals subject to six hours ZIP.
 .................................................................................................................................................. 113 
Figure 3-10. Circulating blood cell populations in enriched and standard environment mice 
following six hours of zymosan induced peritonitis. .................................................................. 115 
15 
 
Figure 3-11. Bone marrow cell populations in mice from enriched and standard environments 
following six hours of zymosan induced peritonitis. .................................................................. 116 
Figure 3-12. Peritoneal cell populations in enriched and standard environment mice following 24 
hours of zymosan induced peritonitis. ....................................................................................... 118 
Figure 3-13. Comparative cytokine levels in the peritoneum of animals subject to 24 hours ZIP
 .................................................................................................................................................. 119 
Figure 3-14. Circulating blood cell populations in enriched and standard environment mice 
following 24 hours of zymosan induced peritonitis. .................................................................. 121 
Figure 3-15. Tibial bone marrow cell population in mice from enriched and standard 
environments following 24 hours of zymosan induced peritonitis. ............................................ 122 
Figure 3-16. Peritoneal cell populations in enriched and standard environment mice following 12 
hours CLP. ................................................................................................................................ 124 
Figure 3-17. Comparative cytokine levels in the peritoneum of mice from and enriched or 
standard environment subject to 12hours CLP. ........................................................................ 125 
Figure 3-18. Circulating blood cell populations in mice from a standard or enriched environment 
subject to 12 hours of CLP. ....................................................................................................... 127 
Figure 3-19. Respective bacterial colony counts in (a) peritoneal lavage fluid and (b) blood 
populations of animals raised in an enriched or standard environment subject to 12 hours of 
CLP. .......................................................................................................................................... 128 
Figure 3-20. Microarray heatmap of blood RNA extracted from mice raised in an enriched vs 
standard lab environment.......................................................................................................... 129 
Figure 3-21. Real time PCR analysis of genes found to be differentially expressed in mice 
raised in an enriched vs standard environment. ....................................................................... 131 
Figure 3-22. Comparative expression of the individual dimers of calprotectin (S100A8 & 
S100A9) in animals housed in an enriched or standard lab environment. ............................... 133 
Figure 3-23. Comparative levels of CD11b and CCD62L expression in blood neutrophils 
extracted from mice housed in an enriched or standard environment. ..................................... 135 
Figure 3-24. Phagocytic capacity of biogel elicited macrophages extracted from animals housed 
in an enriched or standard environment ................................................................................... 136 
16 
 
Figure 3-25. Comparative expression of PTGS2 and NOS2 in LPS stimulated macrophages 
isolated from animals housed in an enriched or standard environment. .................................. 138 
Figure 3-26. Granulomatous tissue and sponge three days post implantation. ....................... 139 
Figure 3-27. Comparative total cell counts of the extracted infiltrate of sponges implanted in 
animals from an enriched or standard environment for 72 hours. ............................................ 140 
Figure 3-28. Flow cytometric analysis of cellular infiltrate taken from the extracted infiltrate of 
sponges implanted in animals from an enriched or standard environment for 72 hours. GR-1 vs 
F4/80 ......................................................................................................................................... 141 
Figure 3-29. Flow Cytometric analysis of cellular infiltrate taken from the extracted infiltrate of 
sponges implanted in animals from an enriched or standard environment for 72 hours. GR-1 vs 
Ly6b.2 ........................................................................................................................................ 142 
Figure 3-30.Comparative cytokine levels in the sponge infiltrate of animals from an enriched or 
standard environment subject to 72 hours of sponge implantation. ......................................... 143 
Figure 3-31. Weight and cellularity of granulomatous tissue extracted from animals from an 
enriched or standard environment subject to 72 hours of sponge implantation. ...................... 144 
Figure 3-32. Comparative real time PCR profiling array of RNA extracted from the 
granulomatous tissue of animals housed in a standard or enriched environment - 1. ............. 145 
Figure 3-33. Comparative real time PCR profiling array of RNA extracted from the 
granulomatous tissue of animals housed in a standard or enriched environment - 2. ............. 146 
Figure 3-34. Open field test on animals preceding and following two weeks housing in a 
standard or enriched environment ............................................................................................ 149 
Figure 3-35. Light Dark test analysis on animals preceding and following two weeks housing in 
a standard or enriched environment ......................................................................................... 150 
Figure 3-36. Elevated plus maze test analysis on animals following two weeks housing in a 
standard or enriched environment ............................................................................................ 151 
Figure 3-37. Relative corticosterone levels in the blood plasma of mice following two weeks in a 
standard or enriched environment. ........................................................................................... 152 
Figure 4-1. Alterations in leukocyte numbers and ratios across three cellular compartments 
following peritoneal administration of zymosan. ....................................................................... 158 
Figure 5-1.The immune regulatory influence of the nervous system. ....................................... 181 
17 
 
Figure 5-2. Experimental set up for chronic restraint stress. .................................................... 184 
Figure 5-3. Comparative weight change over time ................................................................... 185 
Figure 5-4. Corticosterone and light dark paradigm analysis of animals following two weeks in a 
standard or chronic stress environment. ................................................................................... 186 
Figure 5-5. Circulating blood cell populations in mice from and standard or chronic stress 
environment .............................................................................................................................. 187 
Figure 5-6. Peritoneal cell populations in chronic stress and standard environment mice 
following six hours of zymosan induced peritonitis ................................................................... 189 





Table of Tables 
Table 1 Key features of chronic and acute inflammation ............................................................ 21 
Table 2 Core types and constituents of neutrophil granules ....................................................... 28 
Table 3 Defining features of neutrophils ..................................................................................... 30 
Table 4 Defining features of monocytes ..................................................................................... 33 
Table 5 Defining features of macrophages ................................................................................. 38 
Table 6 Referenced doses of zymosan and resulting peritoneal leukocyte numbers ................ 53 
Table 7 Effects of environmental enrichment on cytokine levels and other immune parameters.
 .................................................................................................................................................... 78 
Table 8 Common enrichment techniques ................................................................................... 80 
Table 9 Differentially expressed genes in the blood RNA of mice raised in an enriched vs 
standard lab environment .......................................................................................................... 130 
Table 10 Differentially expressed genes in the granulomatous tissue of animals housed in an 





Appendix 1. Comparative cellularity in the (a) Bone marrow and (b) Blood of SE and EE mice 
following 6, 24 or 0 hours peritonitis (basal, no inflammation induced). ................................... 195 
Appendix 2. Granuloma infiltrate analysis one.......................................................................... 196 
Appendix 3. Granuloma infiltrate analysis two. ......................................................................... 196 
Appendix 4. Differential levels of corticosterone expression recorded over successive 
enrichment experiments. ........................................................................................................... 197 
Appendix 5. Further behavioural analysis of enriched animals. ............................................... 199 
Appendix 6 Complete list of genes measured in RT-PCR profiling of granuloma tissue ......... 201 
Appendix 7. Peritoneal leukocyte profile of animals subject to six hours zymosan peritonitis 





1.1 Inflammation  
Classically defined as a response to infection or physical injury and more recently described as 
a biological reaction to disrupted tissue homeostasis [Medzhitov, 2008], inflammation is an 
integral component of the immune response. Distinct from other homeostatic mechanisms in 
that damage to self is an unavoidable and indeed necessary part of the process, inflammation 
instigates and propagates a series of events culminating in the recruitment of blood derived 
factors including; plasma proteins, signalling factors and leukocytes that act together to 
neutralise the disrupting factor and repair perturbed tissue [Ashley et al., 2012].  
The characteristics of inflammation are alluded to by its name. First clinically described over two 
millennia ago by Aulus Cornelius Celsus (A Roman encyclopaedist and medical writer) the four 
cardinal signs of inflammation are; calore – heat, rubor – redness, tumor – swelling and dolore – 
pain [Celsus and Spencer, 1935]. This definition was later appended by the Greek physician 
Galen of Pergamon1 (AD 129 – c. 200/c. 216) with a fifth cardinal sign, function laesa – loss of 
function [Rather, 1971].  
Inflammation has a long evolutionary pedigree. Its action has been identified in the early stages 
of metazoan evolution, demonstrated by the typical inflammatory wound response presented by 
invertebrates such as starfish [Natoli et al., 2011]. Further, several of the key molecules (and 
molecular domains) involved in the inflammatory process have their lineage traced to the point 
of animal and vegetal cell divergence roughly two billion years ago [Kimbrell and Beutler, 2001]. 
An additional point of interest is the recent discovery that such inflammatory mediators and 
responses are evolving rapidly. Genes encoding scavenger receptors and chemo-attractants 
display an unusually high rate of deletions and duplications across species [Ponting, 2008]. This 
high rate of variance has been postulated to reflect the diversity of environmental challenges 
different animals are exposed to [Natoli et al., 2011]. 
                                                     
 
1 This attribution to Galen has been disputed, with medical historians variously attributing the 




With its deep and fluctuating lineage, it is perhaps unsurprising that both the aetiology and 
pathology of inflammation is highly variable. Multiple contexts such as the nature and intensity 
of stimuli and individual health status can affect the inflammatory process. Regardless the 
process of inflammation serves as the initiator and mediator of a variety of homeostatic 
processes, such as; pathogen and foreign body removal, wound healing and the isolation of 
irresolvable immune insults through the formation of granulomas. The foundation for each of 
these vital biological mechanisms is acute inflammation.  
 
1.2 Acute Inflammation  
Acute inflammation consists of a tightly regulated cascade of physiological and behavioural 
processes and coordinated immunological signalling molecules such as cytokines and 
chemokines. As summarised in Table 1 the defining features of acute inflammation are a rapid 
onset, accompanied by a notable local and systemic indications of the response (calore, dolore, 
rubor and tumor). The key cellular presence are neutrophils and overall damage is usually mild 
and rapidly repaired [Kumar et al., 2012].  
Table 1 Key features of chronic and acute inflammation 
Feature Acute Chronic 
Onset Rapid: Minutes or hours Slow: Days 
Key Cellular Infiltrate Neutrophils Monocytes/Macrophages & 
Lymphocytes 
Tissue damage, fibrosis Mild, self-limited Often severe and progressive 
Local and systemic signs Prominent Initially less prominent; subtle 
Table adapted from Robbins Basic Pathlogy, 9th Ed. [Kumar et al., 2012] 
 
1.2.1 Stimuli for Acute Inflammation  
Initiation of the inflammatory cascade is classically triggered by two key associated factors. 
Pathogen Associated Molecular Patterns (PAMPs) or Damage Associated Molecular Patterns 
(DAMPs) which are generated by the presence of pathogenic organisms in the host or tissue 
damage respectively. PAMPs are typically specific, conserved motifs of pathogen expressed 
molecules, such as the lipopolysaccharides (LPS) that form the outer membrane of gram 
negative bacteria or the double stranded RNA of specific viruses. DAMPs (or alarmins), are host 
derived molecules generated through cellular or tissue damage caused by necrosis, ischemia, 
trauma or infection. DAMPs are often intrinsic cell components, only released into the external 
environment through lysis or necrosis [Abbas et al., 2014, Murphy, 2011]. 
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More recently, a broader set of inflammation inducing stimuli has been put forward by Ruslan 
Medzhitov, roughly divided into two categories: ‘Exogenous inducers’ include the microbial 
PAMPS previously mentioned as well as allergens, foreign bodies and toxic compounds. The 
category ‘endogenous inducers’ includes a wide variety of cell, plasma and extracellular matrix 
derived factors all associated with dead, damaged or aberrant cells. This more inclusive set of 
stimuli reflects the hypothesis that inflammation is a response to disrupted homeostatic function 
as opposed to a specific attempt to clear infection [Medzhitov, 2008]. 
 
PAMPs and DAMPs are bound by Pattern Recognition Receptors (PRRs). PRRs are expressed 
by a broad spectrum of cell types including macrophages, dendritic and endothelial cells 
[Takeuchi and Akira, 2010]. PRR expression has been observed in multiple cellular 
compartments including the plasma membrane, endosomes, lysosomes and endolysosomes 
[Akira et al., 2006]. The apparent ubiquity of these receptor types is believed to be required for 
efficient ligand accessibility as well as maintenance of tolerance to self-molecules [Kawai and 
Akira, 2010]. Currently PRRs are divided into four families categorised by structural homology: 
C-type lectin receptors, nuclear oligomerisation receptors, RIG-1-like receptors and toll-like 
receptors (TLRs) [Kawai and Akira, 2010, Akira et al., 2006]. While each receptor typically binds  
a specific molecular pattern (e.g. TLR-4 binds LPS [Lu et al., 2008]) it is interesting to note that 
several are cross-reactive. TLR-9 is activated by binding to either bacterial DNA (a PAMP) or 
eukaryotic mitochondrial DNA (a DAMP). Mitochondria are popularly hypothesised to be the 
ancestors of prokaryotic organisms that entered an endosymbiotic relationship with a proto-
eukaryote cell roughly two billion years ago [Emelyanov, 2001]. Such DAMP-PAMP cross-
binding is believed indicative of the relationship between prokaria/eukaria evolution and the 
immune response [Calfee and Matthay, 2010]. 
 
Upon PAMP or DAMP binding PPRs stimulate the rapid release of preformed inflammatory 
mediators as well as upregulating transcription of genes involved in the inflammatory response. 
These genes encode numerous pro-inflammatory cytokines, chemokines, type-1 interferons, 
adhesion factors and matrix-metalloproteases (MMPs). Which act in concert to instigate 
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localised vascular and cellular changes, intended to address the offending damage, infection, or 
other disruptors of homeostasis [Murphy, 2011]. 
Following recognition of the appropriate stimuli, acute inflammation can be broadly divided in to 
two phases; vascular and cellular2. 
 
1.2.2 The Vascular Response 
During the initial stages of inflammation, affected tissues become reddened and swell, due to 
vasodilation increasing blood flow and oedema. The vascular events of the acute inflammatory 
response have two established mechanisms of initiation and involve three core processes. 
 
1.2.2.1 PAMP Mediated Immune Activation 
PAMP recognition by tissue resident or patrolling immune cells, most prominently mast cells and 
macrophages, stimulates release of various vasoactive molecules. Most notably histamines and 
bradykinins produced by degranulating mast cells and nitric oxide (NO) released by both 
macrophages and endothelial cells. Both molecules are potent vasodilators, increasing blood 
flow to local capillary beds. This net increase in blood causes the redness and heat typically 
associated with inflammation. In addition to vasodilation, histamine plays several other 
important roles in inflammation. It binds nociceptors heightening sensitivity to pain (the cause of 
inflammatory dolore) [Cannon et al., 2007]. Additionally histamine induces the permeabilisation 
of endothelial cells via phosphorylation induced separation of cell to cell (adherins) junctions. 
[Andriopoulou et al., 1999]. A consequence of this vascular permeation is the influx of fluid – 
rich in inflammatory factors - from the vessels into surrounding tissue. The osmotic pressure this 
exudate exerts generates the characteristic swelling of inflammation [Kumar et al., 2012]. 
 
                                                     
 
2 While typically presented as a canonical process for ease of description, the multipartite nature 
of inflammation and the fact many of its processes feedback on one another means it would 




1.2.2.2 Lipid Mediated Immune Activation 
Alternatively, or additionally damage to cellular membranes caused by trauma, infection (or 
inflammation) leads to the generation of multiple lipid inflammatory mediators. Membrane injury 
induces activation of lipid bilayer bound platelet activation factor (PAF) a potent inducer of 
vascular permeability, leukocyte activation and chemotaxis, degranulation and platelet 
aggregation [Zimmerman et al., 2002]. Following damage, or immune-activation arachidonic 
acids within the lipid bi-layer of leukocytes are converted into various prostaglandins, including 
prostacyclin - which induces vasodilation - and leukotriene factors which again elicit a range of 
inflammatory functions, most notably leukotrine-C4 which increases vascular permeability 
[Dahlen et al., 1981]. 
 
1.2.3  The Cellular Response: 
The culmination of the vascular response is an outpouring of protein rich exudate into the 
extracellular tissues producing an overall decrease in the rate of local blood flow and an 
increase in its viscosity. Together this leads to slowing and accumulation (or stasis) of cells in 
the inflamed area. Which in turn permits the movement (or margination) of leukocytes along the 
endothelium and into the inflamed tissue [Fedosov and Gompper, 2014].  
 
1.2.3.1 Extravasation 
Leukocyte recruitment to and extravasation into the site of injury can be divided into three steps: 
 
Margination and Rolling Adhesion. Cytokines; Interleukin-1 (IL-1) and Tumour Necrosis Factor 
alpha (TNF-α) generated by activated tissue-resident macrophages bind their concordant 
receptors on the endothelium , inducing surface expression of cellular adhesion molecules; E-
selectin and P-selectin, [Albelda et al., 1994, Abbas et al., 2014] Leukocytes (typically 
neutrophils initially) localised towards the site of inflammation by taxis along chemokine 
gradients interact with these adhesion molecules through corresponding receptors upon their 
surface, slowing the immune cell down. These interactions cause the cell to roll along the 
epithelial surface as weak molecular bonds between the adhesion molecules are made and 




Tight Adhesion and Transmigration. A second set of epithelial adhesion molecules, integrins, 
activated by the presence of inflammatory chemokines also bind the leukocyte. ICAM-1 
(Intercellular adhesion molecule-1) binds firmly to the leukocyte surface through interaction with 
L-selectin (CD62-L), an intercellular adhesion molecule found on the surface of multiple 
leukocyte populations locking it into place. Following immobilisation, the immune cell undergoes 
cytoskeletal re-arrangement, spreading out over the endothelia and extending pseudopodia into 
the gaps between cells. Transmigration occurs by binding a second integrin, PECAM-1 (Platelet 
endothelial cell adhesion molecule), the cell effectively using it to drag itself through the cell 
endothelium [Muller, 2013]. The process by which the leukocyte passes through the endothelial 
basement membrane remains a cause for debate, though it’s likely achieved through MMP 
mediated digestion of the membrane, physical force, or a combination of both [Sorokin, 2010]. 
 
Chemotaxis. Once within the tissue instersitium leukocytes migrate up chemotactic gradients to 
an inflammatory focus (differing cell types respond to specific chemotactic factors, these are 
listed in the proceeding sections), where they will carry out a variety of population specific 
effector functions.  
 
Inflammation is a nuanced process involving a diversity of different cell types whose presence 
and predominance depends on the initiator and duration of inflammation. However typically 
three leukocyte cell types lay at the foundation of the acute inflammatory process; neutrophils, 
monocytes and macrophages.  
 
1.2.4 Neutrophils  
Neutrophils are the most abundant leukocyte subset found within mammals, making up 
between 40-75% of circulating leukocytes depending on the animal [Mayadas et al., 2014]. 
They tend to have a rounded morphology (in circulation) and are readily identified by visible 




Neutrophils are generated within the bone marrow from myoblast stem cells primarily in 
response to granulocyte colony stimulating factor (G-CSF) which also controls their steady 
release into circulation [Borregaard, 2010]. The overall number of neutrophils within the body 
varies depending on their rate of production and egress from the bone marrow as well as their 
survival and clearance by other cells, during inflammation neutrophil production can increase 
rapidly [Borregaard, 2010]. 
 
Neutrophils are typically short lived cells, with the average life span in circulation for humans 
and mice reported between one to four days (depending on the method of observation), [Tak et 
al., 2013]. However due to their high numbers and constant presence in circulation they are 
typically the first leukocyte to encounter an inflammatory/immune activating stimuli. Neutrophils 
migrate towards sites of infection in response to a variety of chemoattractant factors, the most 
prominent of which are IL-8 (in mice referred to as keratinocyte chemoattractant (KC)) [Gerszten 
et al., 1999], IFN-γ, Leukotriene B4 (LTB4) and the compliment proteins C3a and C5a [Yadav et 
al., 2010]. Release of further neutrophils from the bone marrow is regulated by G-CSF and the 
chemokine, stromal cell-derived factor 1 (SDF1) (also known as C-X-C motif chemokine 12 
(CXCL12)) by activated immune and endothelial cells [Eash et al., 2009]. Cells then migrate to 
sites of inflammation up aforementioned chemokine gradients.  
 
Neutrophils serve as the primary effector cell during acute inflammation, normally reaching an 
inflammatory focus within minutes to hours of onset [Cash et al., 2009]. During this initial 
chemotactic response, interaction with chemokines, PAMPs, compliment proteins or bioactive 
lipids brings the neutrophil into a state of partial activation. Neutrophils are relatively 
unresponsive to a single inflammatory stimulus, however exposure to one primes the production 
of various cytokines, chemokines and cytotoxic factors allowing for a more rapid and efficient 
response once fully activated [Doerfler et al., 1989, Swain et al., 2002]. Following extravasation 
into inflamed tissues (described in 1.2.3) the neutrophil enters an environment with a high 
concentration of inflammatory stimuli and become fully activated, allowing the leukocytes to 




 Pathogen Killing by Neutrophils  
Phagocytosis 
A neutrophils’ primary method for neutralising an inflammatory instigator is by phagocytosis of 
pathogens and other foreign objects. Neutrophils and other phagocytes express PRR’s and 
opsonic receptors such as FcγRs and C-type lectin receptors, capable of binding various 
PAMPs (or the Fc/C3b motifs of opsonised objects). Upon binding cytoskeletal re-arrangements 
induce the engulfment and endocytosis of the bound object by the phagocytes [Segal et al., 
1980]. Once internalised this phagocytic vesicle is fused with preformed vesicles (referred to as 
granules) within the cells cytoplasm to form a phagosome. These granules contain various 
hydrolytic enzymes and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 
subunits that initiate destruction of the engulfed particles through generation of reactive oxygen 
species (ROS) and super oxide radicals, followed by proteasomal degradation [Vieira et al., 
2002] (Table 2). The primary generators of ROS are the enzymes myeloperoxidase (MPO) and 
inducible nitric oxide synthase (iNOS).  
 
MPO catalyses the formation of hypochlorous acid (HOCL) through reaction of chloride ions 
with hydrogen peroxide [Klebanoff, 2005, Williams, 2006]. HOCL has a potent microbicidal 
activity, when exposed to the acid Escherichia coli lose viability in less than 0.1 seconds [Rakita 
et al., 1990]. The means by which HOCL achieves this killing is a matter of study with current 
theories postulating the molecule; inhibits glucose oxidation (preventing respiration), depletes 
adenine nucleotides (inhibiting ATP metabolism), inhibits of DNA replication, or causes mass 
decarboxylation, deamination, or peroxidation of proteins and lipids (inducing structural 
breakdown) [Williams, 2006]. Regardless of its action, the presence of MPO is critical for host 
defence, demonstrated by the chronic granulomatous disease suffered by individuals lacking 
proper MPO function [Williams, 2006]. iNOS in turn catalyses the generation of nitric oxide, a 
short lived free radical that reacts with DNA, lipids causing damage through oxidation. iNOS 





Neutrophils also secrete a variety of other proteinases and antimicrobial peptides by release of 
their granules into the extracellular milieu [Faurschou and Borregaard, 2003]. Neutrophils 
possess discrete sets of granules, each containing a different compliment of immune mediator’s 
dependent on the inflammatory microenvironment and their overall level of inflammation (Table 
2).  





More recently neutrophils have been discovered to possess a third mechanism of microbial 
clearance; the extracellular release of web like structures capable of immobilising and killing 
bacteria. Comprised of fibres of chromatin studded with granule-derived antimicrobial peptides 
and enzymes such as neutrophil elastase and MPO, these Neutrophil Extracellular Traps 
(NETs) are observed to be released following neutrophil activation [Brinkmann et al., 2004].  
NETs function by trapping and aggregating pathogens within an adhesive matrix of chromatin 
and exposing them to a variety of highly concentrated antimicrobial peptides and enzymes. In 
addition to MPO and serine proteases NETs also contain high levels of cathelicidin (which 
destroys lipoprotein membranes of microbes) and lactoferrin (which sequesters free iron, an 
essential substrate required for bacterial growth) [Papayannopoulos and Zychlinsky, 2009]. 
The process of NET release, (or NETosis) is a distinct form of cell death in which the breakdown 
of both nuclear and granule membranes results in the release of decondensed chromatin and 
granule constituents into the extracellular space. NETosed neutrophils are distinct from other 
apoptotic cells lacking the markers on their cell surface that signal and coordinate their 
phagocytosis. As a result the lysed neutrophil and accompanying NET remains in the 
extracellular space for a protracted period of time before the chromatin matrix that forms the 
majority of the NET structure is disassembled by nucleases [Fuchs et al., 2007]. NETosis is 
induced by a variety of inflammatory mediators (e.g. KC,TNF-α, compliment immune 
complexes) and PAMPs from a wide range of bacteria, fungi, and protozoa [Byrd et al., 2013]. 
The stimuli that promote NETosis as opposed to apoptosis are not yet fully elucidated. 
However, similar to other immune effector functions, the scale of NETosis likely varies with the 
inflammatory micro-environment the neutrophil acts within [Mayadas et al., 2014]. 
 
Throughout the inflammatory process neutrophils also release various cytokines, chemokines, 
chemotactic factors and other inflammatory mediators that perpetuate inflammation until its 
source is neutralised, (Table 3) [Borregaard, 2010]. Of these several of the granule proteins 
released by neutrophils (most prominently azurocidin and cathelicidin) induce the chemotaxis, 
adhesion and recruitment of monocytes to a site of inflammation [Soehnlein et al., 2009], while 
MIP-2 serves as a potent chemotactic factor for macrophages. In this manner neutrophils both 
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limit the spread of microbial infection and prepare the way for the recruitment and action of 
further effector cells [Soehnlein et al., 2009, Mayadas et al., 2014]. 
  
Table 3 Defining features of neutrophils  







Morphology Rounded, uniform, cells 12-20µm in diameter. Granular cytoplasm. 
Nucleus subdivided into 2-5 lobes 
Origin Generated from myoblast stem cells in the bone marrow 
Function in 
Inflammation 
Rapidly migrate towards site of inflammation attacking micro-
organisms via: phagocytosis, degranulation (release of soluble and 
generation of neutrophil extracellular traps (NETs). 
Key mediators of 
activation/ 
chemotaxis 
Keratinocyte chemoattractant (KC), (in humans -interleukin-8 MIP-2  
(macrophage inflammatory peotion 2) .IL-8 (interleukin 8, interferon 
gamma (IFN-γ), C3a, C5a, Leukotriene B4 and Tumour necrosis 




TNF-α. Matrix metalloproteinases (MMPs) 2,8,9 &12, KC, MIP-2 
Key markers Gr-1, CD11b , CD31 
References [Borregaard, 2010, Kim et al., 2010, Lacy et al., 2015, Mayadas et 
al., 2014, Rose et al., 2012] 
 
1.2.5 Monocytes  
Monocytes are large granulated leukocytes with a variably uniform or amoeboid shape, typified 
by a unilobed, ellipsoidal (or ‘bean shaped’) nucleus. They typically form 5-10% of the 
circulating leukocyte population in mice and humans [Nichols et al., 1971] (Table 4).  
 
Like neutrophils, mouse monocytes originate from the bone marrow from precursor stem cells – 
monoblasts and in mice differentiate into two primary monocyte subsets distinguished by their 
31 
 
expression of the cell surface lymphoid marker, lymphocyte antigen six complex (Ly6C). 
Monocyte populations expressing high levels of Ly6C are pro-inflammatory in function and 
rapidly recruited to sites of infection and inflammation [Serbina et al., 2008]. A second 
population expressing low levels of Ly6C have been observed to play a more defensive role, 
patrolling the vascular endothelium and contributing to tissue repair [Geissmann et al., 2003]. 
While distinct, it should be noted that these two populations are not mutually exclusive with 
studies suggesting that Ly6Chigh monocytes may differentiate into their Ly6Clow counterparts in 
the absence of inflammation [Shi and Pamer, 2011]. 
 
Like neutrophils monocytes are recruited out of the bone marrow to a point of inflammation by 
specific chemokines. CC-chemokine ligand 2 (CCL2, also known as Monocyte chemotactic 
protein one, MCP1) and CC-chemokine ligand 7 (CCL7, also known as Monocyte chemotactic 
protein 3, MCP3) are the two key factors known to mediate inflammatory monocyte recruitment, 
both binding to CC-chemokine receptor 2 (CCR2) [Tsou et al., 2007]. CCL2 is produced by 
most nucleated cell types, either constitutively or following induction by oxidative stress, 
cytokines, or growth factors involved in inflammation [Tsou et al., 2007]. CCL7 is also produced 
by multiple cell types in response to bacterial infection [Jia et al., 2008]. While the specific roles 
of these two chemokines in monocyte recruitment is unclear (they may have overlapping, 
sequential or parallel effects) it has been demonstrated that deletion of either mcp1 or mcp3 
results in a roughly 40-50% decrease in monocyte recruitment during infection and inflammation 
[Jia et al., 2008]. 
 
Recruitment of Ly6Chigh inflammatory monocytes to a site of inflammation is mediated by two 
key receptors; CCR1 and CCR5. Both are capable or binding a wide variety of chemokines 
most pertinently CCL3 (also known as MIP1α) and CCL5 (also known as regulated on 
activation, normal T-cell expressed and secreted, RANTES) [Kaufmann et al., 2001]. While both 
receptors support monocyte chemotaxis towards CCL5, transmigration assays have established 
each have further specific functions. CCR1 has been shown to mediate monocyte arrest while 
CCR5 supports the process of ‘spreading’ across the endothelial surface, two actions that 
constitute the initial steps of monocyte extravasation into inflamed tissues [Weber et al., 2001].  
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Ly6Clow monocytes are also dependent in part on the receptors and affiliate ligands listed 
above. However their comparative expression of CCL2 is lower than that of their Ly6Chigh 
counterparts [Auffray et al., 2009]. This characteristic that has been suggested to contribute to 
Ly6Clow cells slower recruitment to a site of inflammation  than Ly6Chigh [Shi and Pamer, 2011]. 
Ly6Clow cells respond to an additional ligand, CX3C-chemokine ligand1 (CX3CL1; also known 
as fractalkine), a membrane-bound chemokine expressed predominantly in the spleen [Auffray 
et al., 2007]. Deletion of CX3CR1 was demonstrated to diminish patrolling by Ly6Clow 
monocytes and reduce their overall survival under both steady-state and inflammatory 
conditions [Auffray et al., 2009].  
 
Monocyte recruitment follows the same core process as that of neutrophils (rolling adhesion and 
transmigration). Mouse monocytes express L-selectin (also known as CD62L), P-selectin 
glycoprotein ligand-1 (PSGL1), macrophage receptor 1 (MAC1, also known as integrin αMβ2), 
platelet endothelial cell adhesion molecule (PECAM1) lymphocyte function-associated antigen 1 
(LFA1; also known as αLβ2 integrin), and very late antigen 4 (VLA4; also known as integrin 
α4β1), all of which contribute to leukocyte adhesion and migration [Ley et al., 2007]. Recent 
studies have also highlighted a specific role for neutrophils in chaperoning the recruitment of 
monocytes from circulation [Wantha et al., 2013]. During inflammation neutrophils that have 
entered inflamed tissues release cathelicidin a small antimicrobial peptide that binds the luminal 
surface of the arterial endothelium. Inflammatory monocytes are able to bind cathelicidin via 
formyl peptide receptor 2 (FPR2). This interaction activates MAC1 and VLA4 allowing 
endothelial adhesion through binding of ICAM1 and VCAM1 respectively [Wantha et al., 2013] 
Upon entry to a site of immune activity monocytes are capable of performing a range of 
antimicrobial and homeostatic functions. They possess a large array of scavenger receptors 
capable of recognising and inducing phagocytosis of microorganisms, potentially toxic 
compounds and dying cells [Serbina et al., 2008]. Like neutrophils they also secrete a variety of 
effector molecules involved in inflammation and the wider immune response such as reactive 
oxygen species, nitric oxide, type one interferons, IL-1β and TNF-α [Serbina et al., 2008]. 
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Perhaps the most prominent role for monocytes during inflammation is of an accessory cell 
linking the primary, innate phase of the response to secondary more adaptive responses. This 
is achieved primarily through their conditional differentiation into macrophages. 
 










Morphology Large, variable shaped cells 15-20µm, granular, unilobed ‘bean 
shaped nucleus 
Origin Bone marrow, monoblast stem cells  





Tissue patrolling and repair  
Key mediators of 
activation/ chemotaxis 




TNF-α, IL-1β, ROS IL-10 
Key markers CD11b+ CD115+ Ly6Chigh CD11b+ CD115+ Ly6CLow 







Macrophages are large, mono-nucleate leukocytes with a diverse morphology dependent on 
their position within the body (Table 5). The capacity of macrophages to specialise their function 
to a particular microenvironment makes them a highly heterogeneous cell population taking on 
different names according to their tissue location. Despite this variety of macrophage classes 
each carries out the same key functions: Overseeing tissue development and remodelling, 
surveying and enacting tissue homeostasis (through phagocytosis of apoptotic or senescent 
cells and reshaping tissue structure), and arbitrating the immune response to pathogens by 
perpetuation or resolution of the inflammatory response [Italiani and Boraschi, 2015]. We will 
focus on this final role. 
 
As mentioned previously the origins and ontogeny of macrophage subsets in mice and humans 
remain a subject of study and debate. Up until recently monocytes were regarded as the 
systemic reservoir for the generation and renewal of tissue resident macrophages (and dendritic 
cells) [van Furth and Cohn, 1968]. However, growing evidence has discovered multiple 
macrophage subpopulations are derived independently of monocytes, with three independent 
points of origin identified in mice. The first source being the yolk sac in the murine embryo, 
which gives rise to progenitor cells that seed tissues with macrophages expressing high levels 
of marker F4/80. Later in the development of the foetus, generation of such tissue resident 
F4/80high macrophages shifts to the foetal liver (so far only confirmed to contribute to skin 
resident macrophages otherwise known as Langerhans cells) [Epelman et al., 2014]. 
  
Development of macrophages from both these sources is dependent on the cytokines; colony 
stimulating factor one (CSF-1) and IL-34 [Ma et al., 2012]. The third (or classical) source is the 
bone marrow which gives rise to the formation of monocyte derived F4/80low macrophages 
[Geissmann et al., 2010] through stimulation with CSF-1 under steady state conditions and 
granulocyte macrophage colony stimulating factor (GMCSF) during inflammation [Burgess and 
35 
 
Metcalf, 1980]. Such F4/80low cells are capable of migrating into tissue where they become 
F4/80high tissue resident macrophages and or TNF/iNOS-producing dendritic cells (TIP DCs) 3. 
In steady state conditions tissue resident macrophages (here-on resident macrophages) 
proliferate at low levels. This proliferation increases strongly following macrophage depletion or 
inflammation [Hashimoto et al., 2013]. During the early stages of the inflammatory response the 
rapid influx of neutrophils and monocytes is accompanied by a concomitant and radical loss of 
resident macrophages. The reasons behind this phenomena – referred to as the “the 
macrophage disappearance reaction”-; tissue adherence, emigration or apoptosis, remain 
uncertain. Though it has been hypothesised that these cells may emigrate into lymph nodes and 
stimulate lymphocyte responses [Barth et al., 1995]. This deficit in macrophages is rapidly filled 
by infiltrating monocytes that ultimately differentiate into tissue resident macrophages [Auffray et 
al., 2007].  
 
Once inside tissue such monocyte derived macrophages (MDMs) are capable of responding to 
cues in the microenvironment (e.g. cytokines, cell fragments, PAMPs) to determine whether 
they should contribute to the continuation of the inflammatory response or its resolution [Lech et 
al., 2012]. These two functional phenotypes are referred to as M1 and M2 type macrophages 
respectively. M1 macrophages function in a primarily antimicrobial, killing or inhibitory capacity 
and are characterised by the ability to metabolise the amino acid arginine into free radical nitric 
oxide, which as previously mentioned is a powerful effector molecule with microbicidal activity 
[Mills, 2012]. M2 macrophages act to promote inflammatory resolution and healing, they are 
capable of metabolising arginine into ornithine, which promotes cell proliferation and repair 
through polyamine and collagen synthesis, as well as fibrosis [Mills, 2012, Pesce et al., 2009].  
In vitro studies of rapidly infiltrating MDMs show they are activated towards an M1 phenotype by 
pathogen associated molecules such as LPS or pro-inflammatory cytokines such as TNF-α or 
                                                     
 
3 The differences between monocyte derived TIP-DC’s and tissue resident macrophages are 
highly blurred. The original functions that distinguished DC’s from macrophages (naive T-cell 
stimulation for the former and cytotoxicity for the latter) have recently been found to be 
performed by both cell subsets. There is also currently no known cell surface marker that is not 
shared between them. As such it seems these two populations are likely to be one and the 
same. At least, from a functional perspective. [Ferenbach and Hughes [2008], Italiani and 
Boraschi, 2015].  
36 
 
IFN-γ (this will typically be the environment they enter into during inflammation) [Ginhoux and 
Jung, 2014]. In addition to phagocytosing pathogens and releasing ROS and NO, M1 
macrophages release inflammatory cytokines IL-1β, TNF-α and IL-6, polarising a Th1 type 
lymphocyte response. Conversely M2 polarization has been observed in response to Th2 type 
cytokines IL-4 and IL-13 and other anti-inflammatory mediators such as IL-10, tumour growth 
factor beta (TGF-β) and glucocorticoids [Rőszer, 2015]. M2 Macrophages release IL-10 and 
express high levels of scavenger, mannose, and galactose-type receptors [Weisser et al., 
2013]. These macrophages participate in; Th2 polarising responses, dampening inflammation, 
tissue remodelling and angiogenesis [Rőszer, 2015]. During the progression of inflammation, a 
switch from an M1 to M2 type response is indicative of movement to a resolution, or repair stage 
of the immune process [Ortega‐Gómez et al., 2013].  
 
The mechanism of this switch from M1 to M2 responses is currently a matter of study, with the 
question raised as to whether M1 and M2 macrophages are truly distinct subpopulations, or the 
same cells that shift from one phenotype to another in response to the microenvironment 
signals [Crane et al., 2014, Guilliams et al., 2014]. 
A popular hypothesis is that Ly6Chigh monocytes and/or monocyte-derived macrophages in the 
tissue become M1 macrophages, while Ly6Clow monocytes and/or tissue-resident macrophages 
become M2 macrophages. While elegant, this theory has been disputed, with in vitro 
observations of the trans-differentiation from Ly6Chigh M1 cells to Ly6Clow M2 cells [Arnold et al., 
2007, Crane et al., 2014].  
 
A second hypothesis suggests that monocytes recruited into tissues at sequential time points 
will encounter varying microenvironments, polarising them towards M1 during early phases and 
M2 in late phases [Crane et al., 2014]. Accordingly in this scenario cytokines and other such 
signals play a key role in determining the different functional phenotypes of macrophages. Such 
a hypotheses would make Ly6Chigh monocytes more likely to take on a M1 phenotype due to 
their rapid migrating into tissues during the initial phase of an inflammatory response. 
A third hypothesis puts forward that polarized macrophage populations can switch from one to 
the other in response to changing environmental conditions. In vitro studies have demonstrated 
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M1 macrophages are capable of converting into M2 macrophages and vice versa through 
exposure in culture to IFN-γ, IL-12 and LPS or IL-4, or IL-10 [Mylonas et al., 2009, Stout et al., 
2005]. 
 
Accordingly, it is likely that the M1/M2 macrophage phenotype paradigm is an artificial one, 
serving as a means of conceptualising a continuum of diverse functional states and overlapping 
roles between these cells. Accordingly, M1 and M2 activation states should not be regarded as 
mutually exclusive functional states but the extremes of a single scale. In light of the reflexivity 
and adaptability of immune cells involved in the inflammatory process it stands that different 
inflammatory inducers will activate different cellular responses. These are well established in 










Morphology Large, variably shaped cells 15-20µm, granular, unilobed nucleus 
Subpopulation Tissue resident Monocyte derived 
Origin Foetal yolk sack/ liver Bone marrow, monocytes 
Key marker F4/80 High F4/80 Negative  





Inflammatory resolution, tissue 
repair. Fungal or helminth 
infection 
Key mediators of 
activation/ 
chemotaxis 
IFN-gamma LPS GM-CSF 
 




TNF IL-1 beta IL-6 IL-12 IL-23 IL-10 TGF-beta IL-1ra 
Key markers MHCII, CD40, CD80, CD25, 
CD127. CXCL9, CXCL10, 
CXCL11, NOS2 
 
MHCII, CD206, CD209, Dectin 
1. Mrc1, tgm2, Fizz1, Ym1/2, 
Arg1 






1.2.7 Resolution of Inflammation 
For many years resolution was essentially considered the cessation of inflammation, a passive 
process associated with the fading of inflammatory stimuli, dilution of chemokine and cytokine 
gradients and the prevention of any further leukocyte recruitment. 
 
However, more recent research has demonstrated resolution to be both an active and dynamic 
process, facilitated by a variety of mediators that specifically act to; (i) counteract inflammatory 
cytokine and chemokine signalling, (ii) inhibit blood leukocyte adherence and extrvasation, (iii) 
promote leukocyte apoptosis and clearance of these apoptotic cells, (iv) promote macrophage 
reprogramming to an anti-inflammatory ‘pro-resolving’ phenotype [Sugimoto et al., 2016] (Figure 
1-1). 
 
Again it should be noted that resolution is not a self-contained phase in the progression of the 
host immune response. Many of the pro-resolving pathways that come to the fore during 
resolution are initially activated during acute inflammation, additionally leukocytes involved in 
the active phase of inflammation undergo a functional transition in order to contribute to the 
process of resolution and wound healing [Serhan and Savill, 2005]. As such resolution should 
be regarded as an overlapping and contiguous process to inflammation (and wound healing), 
with - as it has been put “the beginning programming the end” [Serhan and Savill, 2005]. With 
this concept in mind it seems fitting that neutrophils – the prime instigators of the inflammatory 
response are also one of the primary initial players in the process of its resolution. 
 
1.2.7.1 Chemokine Moderation and Neutrophil Cessation  
As previously discussed a successful inflammatory response is dependent on neutrophil 
recruitment to the point of immune insult (1.2.3). Abrogation of such an influx is a key initial pre-
requisite for inflammatory resolution and is believed to be brought about through the reduction 
and inhibition of chemotactic gradients by chemokine sequestration and/or proteolytic cleavage 




Classically associated with remodelling of the extra-cellular matrix (ECM) MMPs have been 
demonstrated to regulate the immune response through modulating the activity of various 
bioactive molecules such as TNF-α [Tam et al., 2004], α-defensin [Wilson et al., 1999], and 
mannose binding lectin [Butler et al., 2002]. Further and most saliently such MMPs have been 
reported to act upon inflammatory chemokines. Macrophage specific MMP-12 has been 
demonstrated to cleave CXC chemokines, removing the ELR (glutamic acid-leucine-arginine) 
motif, that is vital for receptor binding [Dean et al., 2008]. MMP directed chemokine cleavage 
has also been shown to block function of neutrophil and monocyte specific CC-chemokines, for 
example MMP cleaved CCl-7 is still able to bind its cognate receptors (CCR1,2 and 3) but is 
unable to elicit downstream signalling effectively transforming the once chemotactic factor into 
an inhibitor [Bonecchi et al., 2004]. 
 
Chemokines can also be recognised by a family of proteins referred to as atypical chemokine 
receptors (ACKRs) (previously termed decoys, scavenger receptors or chemokine binding 
proteins). Present on the surface of cells and free floating, binding of a chemokine to its 
respective ACKR fails to induce a migratory response due to the inability of ACKRs to initiate 
the requisite G-protein coupled signalling pathways [Nibbs and Graham, 2013]. As such, 
ACKRs sequester chemokines from the environment blocking both their dispersal and function. 
A key member of this ACKR family involved in neutrophil regulation is Duffy antigen receptor for 
chemokines (DARC). Predominantly expressed by endothelial cells at sites of inflammation and 
leukocyte extravasation DARC is able to sequester both CC and CXC pro-inflammatory 
cytokines, restricting neutrophil influx [Bonecchi et al., 2004].  
 
Additionally, such decoy receptors can also be generated from classical chemokine receptors. 
For example, in the context of acute murine peritonitis, release of IL-10 has been shown to 
inhibit downregulation of CCR5, while also blocking activation of the receptor once bound by its 




1.2.7.2 The Role of Neutrophils in Resolution 
While the cessation of neutrophil movement is a key step in the process of resolution, recent 
discoveries have highlighted the important role these cells play in the attenuation of 
inflammation. For example, the proteases neutrophils release are capable of degrading pro-
inflammatory cytokines such as IL-β and TNF-α but not IL-10 [Van Der Meer et al., 2009]. 
Further, a recent paper suggests that at high densities NETs may be able to build aggregates 
capable of trapping chemokines and other inflammatory mediators and degrade them again 
through the action of neutrophil released serine proteases. However, as yet this phenomenon 
has only been reported in vitro [Schauer et al., 2014].  
 
An additional, novel pre-resolving mechanism focused around neutrophils involves generation 
and release of membrane-bound compartments referred to as microvesicles. Studies have 
revealed these microvesicles to contain a variety of anti-inflammatory and pro-resolving 
mediators the most significant of which being annexin A1 (ANXA1) [Dalli et al., 2008]. Able to 
interact with other cells via its micro-vesicle delivery system ANXA1 interacts with formyl peptide 
receptor 2 (FPR2) to reduce leukocyte adhesion and migration as well as promoting neutrophil 
apoptosis and clearance of dead cells [Gastardelo et al., 2009, Perretti et al., 1996]. 
 
1.2.7.3 Apoptosis and Efferocytosis  
Following the abortion of migration any remaining neutrophils within the now resolving site of 
inflammation typically apoptose and are cleared by macrophages via efferocytosis. Apoptotic 
leukocytes induce their own clearance through secretion of factors that attract phagocytic cells, 
(such factors include; lysophosphatidylcholine (LPC) [Lauber et al., 2003], sphingosine 1-
phosphate (S1P) [Gude et al., 2008] and fractalkine (Cx3CL1) [Truman et al., 2008]) and 
expression of surface markers (such as ANXA1 derived peptide fragments [Blume et al., 2012] 
and phosphatidylserine (PS) [Ravichandran, 2011]) that permit identification and also ease 




1.2.7.4 A Functional Macrophage Switch Initiates the Return To Normal Homeostasis  
Following efferocytosis of apoptotic cells, macrophages undergo a functional switch from a pro 
to anti-inflammatory phenotype. This switch is typified by the increased release of TGF-β, IL-10 
and T-cell membrane protein 4 (TIM4), each key mediators of inflammatory cell clearance and 
tissue homeostasis [Fadok et al., 1998]. These macrophages also switch to an arginine based 
metabolism (previously mentioned in 1.2.6) promoting synthesis of pro-resolutionary lipid 
mediators including lipoxins, and resolvins [Serhan et al., 2008]. Of these lipoxins one of the 
best characterised is lipoxin A4 (LXA4) which has been shown to stimulate phagocytic activity 
independently of the release of pro-inflammatory mediators as well as inhibiting neutrophil entry 
to tissues while promoting monocyte migration [Maddox et al., 1997]. Resolvin E1 has in turn 
been demonstrated to interact with monocytes, macrophages and dendritic cells, moderating 
their activation by TNF-α and hence serving as an anti-inflammatory signalling molecule [Arita et 
al., 2007]. 
 
1.2.7.5 The Role of Suppressor Cells in Resolution  
While neutrophils and macrophages have typically been regarded as the dominant cell types 
involved in the process of resolution recent evidence suggests that myeloid derived suppressor 
cells (MDSC) also play an important role though production of arginase-1 (ARG1) and inducible 
nitric oxidase synthase (iNOS) both of which initiates the release of NO and ROS involved in 
programmed cells death and several other immunosuppressive mechanisms [Ribechini et al., 
2010]. 
 
T-regulatory cells (T-regs), a subset of CD4+ T-cells have been shown to support resolution 
through release of TGF-β and IL-10, their presence appears especially important in the context 
of extended or chronic periods of inflammation [Ortega‐Gómez et al., 2013]. 
Following on from (and overlapping) resolution comes the process of prolonged tissue 
remodelling and recovery of functionality lost during the detrimental process of inflammation that 




Figure 1-1 The key processes and mediators governing inflammation and its resolution. During the 
intial phase of inflammation release of various inflammatory factors promotes leukocyte; 
accumulation, survival and differentiation at the site of inflammation. Upon activation, neutrophils 
release microparticles containing pro-resolving mediators that limit granulocyte ingress activate 
various pro-resolutionary pathways. As the inflammatory responce progresses further processes 
prepare the environment for the onset of resolution via; remidiation of chemokine gradients, 
activation of feedback loops limiting pro-inflammatory and upregulating anti-inflammatory 
cytokines and cessation of neutrophil influx. Acetylcholine (ACh) and Annexin-1 (AnxA1) released 
early in inflammation play a key role in mediating this switch. Further resolutionionary mediators 
downregulate survival pathways and activate apoptosis of granulocytes, promting the release of 
further pro-resolving mediators that upon effercytosis of apoptotic cells promote differentiation of 
M2- type macrophages. These macrophages mediate the re-establishment of tissue homeostasis. 
Figure adapted from [Sugimoto et al., 2016]  
 
1.2.8 Wound Healing 
Like the inflammatory response it proceeds, wound healing is a complex multifaceted process 
the mechanistics of which are influenced by a myriad of factors. While a comprehensive review 
of wound healing goes beyond the scope of this thesis, a brief overview is provided in the 
context of its overlap with the inflammatory process. 
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Wound healing is stratified into a series of overlapping and intercalated phases determined by 
the cell lineages and physiological responses involved. As with the process of inflammation and 
resolution exact determination of these phases is a subject of debate. Typically wound healing 
is divided into four phases: the immediate response, inflammatory response and proliferatory, 
migratory and resolutionary phase 
 
1.2.8.1 The Immediate Response 
One of the earliest responses to injury originates from damage caused to local blood vessels. 
To prevent local haemorrhage a clot of insoluble fibrin fibres formed by activated and 
aggregated platelets is generated within minutes of vascular injury. In addition to patching the 
gap in the blood vessel the clot acts as an initial scaffold onto which various growth factors can 
bind and effector cells infiltrate into [Nurden et al., 2007]. Platelets themselves serve as a 
source for these growth and chemotactic factors including; platelet derived growth factor 
(PDGF), CXCL4, vascular endothelial growth factor (VEGF), RANTES and TGF-β [Bahou and 
Gnatenko, 2004, Chai and Tarnawski, 2002]. Each prompting various aspects of the healing 
response. 
 
In addition to platelet derived factors the clotted blood contains a variety of interleukins, 
chemokines, colony stimulating factors, tumour necrosis factors α and β and IFN-γ which 
contribute to the induction and release of serum response factor (SRF) by surrounding cells. 
SRF is a master transcription factor that activates multiple genes known to contribute to the 
healing response [Chai and Tarnawski, 2002].  
 
1.2.8.2 The Inflammatory Response  
The inflammatory response has been described in detail previously (1.2). Although the issue of 
whether the presence of inflammatory cells is essential for wound healing remains a matter of 
research, it is clear that these cell populations have a strong influence on other cells within the 
wound and surrounding tissue. The expression profile of neutrophils recruited to sites of healing 
suggest they may influence several aspects of repair, such as the breakdown of the initially 
45 
 
formed fibrin clot, promotion of angiogenesis and the process of re-epithelialisation [Theilgaard-
Mönch et al., 2004].  
 
Monocyte derived macrophages are also regarded as playing a key role in wound healing, 
present throughout the repair process M2 macrophages have been shown to express a variety 
of anti-inflammatory, pro-angiogenic factors as well as multiple matrix metallopeptidases 
required for tissue remodelling [Deonarine et al., 2007].  
 
1.2.8.3 Angiogenesis and Lymphogenisis 
Integral to successful wound repair angiogenesis involves the formation of capillaries from 
around the wound edge, followed by the infiltration into the site of damage. Typically, a 
microvascular network will viably permeate the wound several days post injury, this network 
provides nutrition and oxygen to growing tissues supporting the generation of a more 
sophisticated wound healing scaffold referred to as granulation tissue [Tonnesen et al., 2000]. 
Angiogenesis is a stringently regulated process mediated by a plethora of growth factors, the 
most important of which being vascular endothelial growth factor (VEGF). While far less studied 
than angiogenesis, lymphogenisis (repair and re-generation of lymph vessels) is also believed 
to be mediated under the tight regulation of multiple factors, some overlapping those of 
angiogenesis and some unique, such as; podoplanin VEGF-C, hyaluronic acid and ephrin-B2 
[Stacker et al., 2014]. 
 
1.2.8.4 Proliferation (Migration and Contraction) 
The clot (and/or scab depending on the location of the wound) that forms during the immediate 
response serves as a temporary means for restoring the function of skin or subdermal tissue as 
a protective barrier. During this phase of the healing process this scab retracts in sync with the 
regeneration of tissue lost during the injury. Re-epithelization of a wound is achieved though the 
migration and proliferation of keratinocytes in the region of the wound [Matoltsy and Viziam, 
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1970]4. Keratinocytes are able to migrate through collagen and fibronectin that constitute the 
scab via production of a variety of MMPs [Pilcher et al., 1999] and physically pulling themselves 
through the matrix using a series of actin mediated cytoplasmic projections in a process referred 
to as ‘keratinocyte crawling’ [Mitchison and Cramer, 1996]. In this way keratinocytes are able to 
bore a pathway to the interface of scab and viable tissue and proliferate. 
 
In addition to the epidermis the underlying dermis undergoes a separate healing process. 
Fibroblast cells surrounding the site of the wound initially respond by generating a matrix of 
actin bundles referred to as stress fibres which are capable of facilitating some limited 
connective tissue contraction [Hinz, 2007]. Around these fibres further fibroblasts are driven to 
differentiate into smooth muscle myofibrils (myofibrilblasts) through the action of growth factors 
such as TGF-β, and mechanical stress [Hinz, 2007]. Together these wound fibroblasts and 
myofibrilblasts knit the wound closed and facilitate the synthesis and position of collagen fibres, 
the primary constituent of scar tissue.  
 
1.2.8.5 Resolution 
In this final and sometimes un-ending phase of repair the wounded tissue attempts to restore 
full functionality and normal appearance. Migrating and proliferating keratinocytes at the 
wound’s edge eventually meet one another, cease proliferation and re-stratify (the means by 
which this stop phase is regulated is still under study, the Wnt pathway appears integral 
[Cooper et al., 2004]). In order for complete healing to occur epidermal appendages such as 
hair follicles and sebaceous glands need to regenerate. This regeneration often fails to happen 
in excessive scar tissue although it has been shown that inflammation at the site of the wound 
may help promote this regrowth process (again through Wnt signalling [Ito et al., 2007]) [Osaka 
et al., 2007]. During this phase vasculature within the scar tissue becomes more defined and 
diffuse to form a more functional network, and dense sections of the ECM may be remodelled to 
restore normal architecture. 
                                                     
 
4 It is currently unknown whether these cells initially migrate from other parts of the body or 
are generated in situ. It has been postulated that stem cells resident in the epidermis and at 
the base of hair follicles may be the source of these cells [Eming et al., 2014]. 
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The inflammatory response to wound healing also resolves once healing is complete. This 
appears to be mediated by a number of factors shown to be active in the resolutionary phase of 
inflammation such as resolvins [Schwab et al., 2007] and annexins [Perretti and Gavins, 2003] 
(Figure 1-1). Neutrophils are cleared from the site typically through apoptosis and phagocytosis 
by macrophages [Haslett, 1992]. Macrophages in turn are thought to de-activate through a 
combination of anti-inflammatory and resolutionary factors, such as galectins and 
glucocorticosteroids. Upon which they may migrate out of the tissue, become phagocytosed by 
other macrophages or revert into tissue resident cells [Ma et al., 2003].  
 
While this process initiates within hours of injury the time required for complete healing is highly 
variable and dependent on multiple factors such as; wound size, source of injury, age and 
health. Imperfect regulation of wound resolution can result in hyper-proliferation of various cells, 
chronic inflammation and consequential excessive tissue formation all of which contribute to a 
range of pathologies. Imperfect wound healing and persistent wounds have become a leading 
cause of morbidity and mortality in the western world fuelled in part by the increasingly aged 
population and a growing risk of nosocomial infection with antibiotic resistant bacteria [Stacker 
et al., 2014]. 
 
1.2.9 Chronic Inflammation 
If the underlying cause cannot be resolved the inflammatory process enters into a long term, 
chronic phase. Chronic inflammation retains many of the features of acute; increased blood 
flow, vascular permeability and cellular influx. However, the composition of this influx changes. 
In place of short lived neutrophils chronic inflammation is typified by a predominance of 
monocytes, macrophages and lymphocytes [Abbas et al., 2014] (Table 1 Key features of 
chronic and acute inflammation) which have a lifespan of months or even years dependent on 
subtype [Takahashi, 2001]. The presence of such cells in a continually activated pro-
inflammatory state leads to the constitutive generation of multiple cytokines, enzymes, growth 
factors and metabolites that cause both tissue injury and fibrosis (the thickening or scarring of 
connective tissue) [Mosser, 2003]. It is this persistent cycle of cellular influx, tissue damage and 
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remodelling that generates the pathologies commonly associated with inflammatory disease, 




1.3 Models of Inflammation  
1.3.1 Zymosan Induced Peritonitis; A Model of Resolving, Localised Inflammation 
Injection of pathogens and other irritants into the peritoneal cavity has been a recognised model 
for studying the inflammatory immune response for well over a century [Brown, 1995]. As the 
largest naturally occurring serosal space in the vertebrate body and also located close to the 
skin surface, the peritoneal cavity serves as both an easy target for the administration of 
immune-activating reagents and as an efficient reservoir for the collection of cells and soluble 
effectors released into it. 
 
A large variety of immune-activating molecules, compounds and organisms have been used 
over the years to induce peritonitis (e.g. IL-1 [Song et al., 2013], LPS [Steinmüller et al., 2006] 
and live E.coli [Wells and Johnstone, 1907]). Each instigating its own variation of the 
inflammatory response. One of the most widely used effectors is zymosan, an insoluble glucan 
polysaccharide derived from the cell surface of the yeast Saccharomyces cerevisiae. Initially 
used over thirty years ago [Doherty et al., 1985] and to date, still regularly employed [Monroe et 
al., 2016] zymosan’s popularity as reagent stems from its ease of preparation and capacity to 
induce a consistent, self-resolving model of sterile inflammation [Rao et al., 1994, Perretti et al., 
1992].  
 
1.3.1.1 Mechanism of Action 
Produced through boiling, trypsin treatment and drying (or lyophilisation) of S.cerevisiae, 
zymosan is administered in the form of homogenised particles suspended in a endotoxin free 
medium (typically PBS or sterile water). Phagocytes such as monocytes, macrophages and 
dendritic cells have been shown to express a variety of receptors such as the mannose, 
complement [Underhill, 2003] and β-glucan receptors - most significantly the beta glucan 
receptor dectin-1 [Brown et al., 2002] that mediate their recognition and internalisation of 
zymosan particles (Figure 1-2).  
 
Further inflammatory responses to zymosan are initiated through binding with the heterodimeric 
complex of toll-like receptors 2 and 6 [Underhill et al., 1999]. Activation of TLR2/6 elicits the 
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activation of transcription factor NF-κB through a Myeloid differentiation primary response 88 
protein (MYD88) dependent pathway, leading to the generation of multiple pro-inflammatory 
mediators, such as IL-6, CCL2 and KC [Underhill et al., 1999] (Figure 1-2). 
 
Figure 1-2 Mechanisms of leukocyte activation by zymosan. Binding of zymosan (and other β-
glucans) by the dectin-1 receptor triggers phagocytosis of its bound ligand and the recruitment 
and activation of Src followed by Syk tyrosine kinases in the cytoplasm. Syk, in turn, induces the 
CARD9-Bcl10-Malt1 immune signalling complex leading to the production of reactive oxygen 
species (ROS), activation of NF-κB and subsequent release of pro-inflammatory cytokines. 
Zymosan can also be bound by the TLR 6/2 receptor complex resulting in activation of signalling 
protein MyD88 which in turn initiates formation of the IRAK-IRAK4-TRAF6 signalling complex 
which also up-regulates transcription of NF-κB. Syk -Spleen tyrosine kinase, Src - Proto-oncogene 
tyrosine-protein kinase Src, TRAF - TNF receptor associated factor, IRAK - interleukin-1 receptor-
associated kinase, CARD - Caspase recruitment domain-containing protein, Bcl - B-cell 
lymphoma/leukaemia protein, MALT - Mucosa-associated lymphoid tissue lymphoma translocation 




1.3.1.2 Advantages and Limitations of ZIP  
ZIP’s key advantages stem from its capacity to induce a relatively consistent mild to moderate 
inflammatory response that both induces and resolves rapidly. Zymosan has also been shown 
to produce all the core indicators of acute inflammation (pain, leukocyte infiltration and synthesis 
of inflammatory mediators) in addition to producing directly analogous results when used in vitro 
upon isolated macrophages [Taylor et al., 2002, Doherty et al., 1985]. Injection into a serosal 
cavity as opposed to an artificially created one such as an air pouch allows the natural ingress 
and egress of leukocytes to and from the inflammatory site via draining lymph nodes and the 
release of quantifiable levels of inflammatory mediators [Bellingan et al., 1996]. Further, the 
well-established understanding of the events that occur during the model make peritonitis a 
practical choice for initial investigation into the effects of any immunological/physiological 
modulator of the inflammatory response (Figure 1-3). 
 
While this model is relatively simple and easily reproducible from a technical standpoint, it does 
require some practical skill at administering intra-peritoneal injections quickly and consistently. 
Poor injection technique can lead to leakage of zymosan out of the peritoneal cavity or 
accidental administration of the regent subcutaneously or inguinaly. Additionally, the high level 
of vasculature surrounding the peritoneal cavity makes contamination with blood (through 
needle rupture) a high risk without good injection technique. In both these instances the affected 
animal will have to be excluded from the study [Cash et al., 2009].  
 
Further it should be noted application of a single antigenic component of a complete pathogen 
will ultimately generate an artificial response, while ZIP is largely regarded as a powerful and 
robust model of inflammation it is still only a model. Additionally, as zymosan is an insoluble 





1.3.1.3 Timecourse of ZIP 
Intraperitoneal (i.p) injection of zymosan particles elicits a pattern of leukocyte recruitment 
following that of a typical inflammatory response. Neutrophils are the first readily identifiable 
cells to enter the peritoneal cavity reaching detectable levels roughly one to two hours post 
injection, peaking at four to six hours following which numbers begin to fall [Cash et al., 2009]. 
Monocytes enter the peritoneal cavity roughly four to six hours post injection peaking at around 
24-hours. At this point monocyte numbers begin to drop, likely due to a combination of, death, 
migration out of tissues and differentiation into macrophages [Cash et al., 2009]. 
 
1.3.1.4 Dose Dependant Effects of Zymosan Administration.  
The immune response elicited by zymosan is highly dose dependent, with low doses reported to 
induce a moderate self-resolving inflammatory reaction while higher doses produce a more 
intense response that takes a significantly longer time to resolve. Quantities of zymosan 
injected in studies range across the literature from 10 µg to as much as 1mg per mouse and 
produce a correspondingly wide range of cellular responses (Table 6). With this variation in 
dose some concerns have been raised as to whether administration of higher levels of zymosan 
generate a truly ‘resolving’ or realistic inflammatory response. It is suggested that high doses at 
(e.g. 1mg per cavity) induce an excessive and potentially dysregulated inflammatory response 
Figure 1-3 Order of leukocyte infiltration during zymosan induced peritonitis.with a low to 
moderate dose of zymosan (10 - 500µg) Neutrophils are reported to enter the peritoneal cavity 
within 1-2 hours of injection. Monocytes typically follow at around the four hour time point with 




typified by mast cell activation and heightened production of CCL5 and KC, culminating in a 
huge cellular infiltrate into the peritoneum and an inflammatory response that may never truly 
resolve [Cash et al., 2009]. Accordingly, care should be taken when using this model to choose 
a dose of zymosan that meets the needs of the phenomena being investigated. 
 
Table 6 Referenced doses of zymosan and resulting peritoneal leukocyte numbers 
Study Dose of zymosan  Leukocyte numbers at 
four to six hours (x106) 
[Cash et al., 2009] 10µg 2-2.5 
[Rajakariar et al., 2008] 100 mg 3-7 
[Bian et al., 2012] 0.5mg 5-13 
[Kolaczkowska et al., 2008] 1 mg 16-18 
[Ajuebor et al., 1998] 1 mg 8-12 
 
1.3.2 Caecal Ligation and Puncture.  
While ZIP portrays the effects a mild to moderate, self-resolving inflammatory response caecal 
ligation and puncture (CLP) is an attempt to model the uncontrolled inflammatory reaction 
caused by sepsis. 
 
1.3.2.1 Dynamics of Sepsis 
Sepsis is an acute, systemic reaction to inflammatory activators produced by microbial infection. 
This infection is typically bacterial but can also be induced by viruses, fungi and eukaryotic 
parasites. Sepsis progresses in two primary phases, an initial hyper-inflammatory phase; 
characterised by hyperthermia and leucocytosis, followed by a hypo-inflammatory phase; 
characterised by hypothermia and leukopenia [Nguyen and Smith, 2007]. 
During the hyper-inflammatory phase large numbers of; pro-inflammatory leukocytes, mediators 
(such as cytokines) and secondary mediators (such as enzymes and ROS) are realised in rapid 
succession in to circulation. The primary inflammatory cytokines detected during this phase of 
sepsis are; TNF-α, IL-1, IL-6, IL-12, IFN-γ, and macrophage migration inhibitory factor (MIF) 
[Kelly-Scumpia et al., 2010, Matsukawa et al., 1999, Riedemann et al., 2003, Ward and 
Bosmann, 2012, Weighardt et al., 2006]. This exacerbated release of pro-inflammatory 
cytokines has been termed a ‘cytokine storm’ [Aikawa, 1996]. Reponses to this cytokine release 
include the activation and chemotaxis of leukocytes, enhanced phagocytic and cytotoxic activity, 
vascular endothelial injury with accompanying oedema, synthesis of acute phase proteins by 
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the liver and systemic activation of the coagulation and complement systems [Nguyen and 
Smith, 2007]. More recent research has revealed that concomitant to this pro-inflammatory burst 
is a near simultaneous release of anti-inflammatory cytokines, including IL-10, transforming 
growth factor (TGF)-β, and IL-4, likely produced as part of a feedback response attempting to 
restore immunological equilibrium [Junger et al., 1996].  
 
Following this acute hyper-inflammatory response comes a prolonged anti or hypo-inflammatory 
state typified by the inhibition of multiple leukocyte signalling pathways involved in cell 
chemotaxis, proliferation and survival [Junger et al., 1996, Muenzer et al., 2010]. This leads to 
the rapid apoptosis of lymphocytes and dendritic cells, effectively paralysing the adaptive and 
exhausting innate immune responses [Hotchkiss and Nicholson, 2006]. This shut down of both 
arms of the immune response renders the sufferer immunocompromised and at high risk of 
mortality through secondary infection.  
 
1.3.2.2 CLP as a Means of Modelling Sepsis 
Due to its complex, multi-faceted nature, sepsis is challenging to model in experimental 
animals. One of the most extensively used means to study sepsis over the past thirty years has 
been the caecal ligation and puncture (CLP) method, which is regarded by many to provide the 
best representation available of the complexity of human sepsis [Dejager et al., 2011]. CLP 
consists of three core physiological insults: Tissue trauma caused by laprodectimy, necrosis 
and inflammation caused by ligation of the caecum and infection caused by leakage of intestinal 
microbial into the peritoneal cavity and eventually bloodstream (Figure 1-4). It is this leakage 
that induces the inflammatory response in mice, culminating in septic shock. First signs of 
sepsis (lethargy, fever, piloerection, diarrhoea, huddling, and malaise) are typically observable 
in animals 6-12 hours following surgical procedure. Over the following 12-24 hours these 
symptoms become more severe until animals are unable to move and exhibit a dramatic 
decrease in body temperature indicative of the hypo-inflammatory phase of the disease 
[Toscano et al., 2011]. At this point (if not before) animals should be sacrificed to avoid 






Figure 1-4 Diagram of the caecal ligation and puncture procedure. CLP is induced by the isolation, 
ligation and puncture of the caecum directly below the ileocaecal valve. The further up the caecum 
the ligation is performed and the size and number of punctures determine the severity of the 
disease model. Sham operations are performed by isolation of the caecum without ligation and 
puncture.  
 
1.3.2.3 Advantages and Limitations of CLP 
CLP has several distinct advantages over other models of sepsis. Unlike other procedures that 
introduce cultured colonies of bacteria into an animal, CLP utilises enteric bacteria that originate 
from the host, mimicking the injury that typically leads to sepsis in humans. This mimicry is 
further enhanced by the polymicrobial nature of the immune insult introduced. Supporting this 
the systemic cytokine profile found in sepsis is very similar to that found in human patients. It is 
also a relatively simple procedure compared to other models of sepsis such as colon acendens 
stent peritonitis (CASP) which requires surgical introduction of a stent into the caecum [Dejager 
et al., 2011]. Further, as with the ZIP model of peritonitis a variety of cells and soluble analytes 
can be easily retrieved from the peritoneal lavage and blood of an animal in order to analyse the 
progression of the inflammatory response.  
 
Despite this relative simplicity, one of the key drawbacks of the CLP model is the variability of 
the results it produces due to differences in experimental procedures across labs. The outcome 
of CLP has been found to be highly dependent on a number of variables during the operation: 
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(i) The fraction of caecum ligated and according amount of necrosis incurred [Ayala et al., 
2000], (ii) the size and number of punctures performed on the caecum and the amount of 
pressure exerted when extruding faecal material [Singleton and Wischmeyer, 2003], (iii) the size 
of the abdominal incision made, (iv) anaesthesia used, (v) age, sex and strain of the animal 
used, (vi) the point in the animal’s diurnal cycle in which the procedure was performed, (vii) 
general heterogeneity of immune responses – this is especially evident when using outbred 
animals [Wichterman et al., 1980, Baker et al., 1983, Dejager et al., 2011].  
 
Despite these drawbacks CLP remains – in balance – the simplest and most realistic means of 
modelling sepsis in mice, it also serves as an effective way of investigating the immune 
response in the context of an overwhelming inflammatory and microbial challenge.  
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1.3.3 Sponge Granuloma 
The primary goal of the immune response is the removal of any non-self-objects or molecules 
from the body and the preparation of the affected tissue for regrowth and repair. However, 
circumstances in which an immune insult cannot be removed – either due to its size or 
recalcitrance to immune effector functions – results in a unique chronic immune state termed 
granulomatous inflammation or, the foreign body reaction [Strauch and Rubenstein, 1984]. In 
such a reaction offending objects are surrounded with a wall of leukocytes, predominately made 
up of macrophages that eventually fuse to form a fibrotic capsule referred to as a granuloma. 
The purpose of this structure is to isolate the antigen from the rest of the body, facilitating its 
eradication and preventing further dissemination [Strauch and Rubenstein, 1984]. 
Such foreign body granulomas have been well studied in a clinical context where they are often 
produced in response to implanted devices (such as pace makers or artificial hips), sutures or 
other foreign objects that find themselves embedded beneath the skin [Souza et al., 1986].  
 
1.3.3.1 The Foreign Body Response  
The foreign body reaction begins in a similar manner to a classic inflammatory immune reaction. 
Upon entering the body foreign objects will almost immediately acquire a coat of plasma 
proteins (including  albumin, fibrinogen, complement, fibronectin, vitronectin and γ-globulin 
[Karsenty and Park, 1995, Majchrzycki et al., 2015] in addition to inducing localised oedema 
through the physical trauma of entry. Such oedema induces leukocyte recruitment from 
circulation to the site of injury and their subsequent activation through interaction with the 
proteins adsorbed to the surface of the foreign object, most particularly those that form part of 
the complement pathway [Tono-Oka et al., 1996].  
 
Such binding and activation induces an acute inflammatory response analogous to that 
previously described, typified by the mass influx of acute phase effector cells such as 
neutrophils as well as mast cells to the site of injury. Depending on the nature of the object and 
injury caused [McQuibban et al., 2000] this response is followed several days later by the 
hallmarks of a chronic inflammatory response characterised by the presence of lymphocytes 
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and plasma cells at the site of injury, as well as the perpetuation of macrophages and 
monocytes [Strauch and Rubenstein, 1984].  
 
Unable to phagocytose the offending object macrophages bound to the object’s surface will 
eventually begin to fuse with one another, merging their cytoplasm to form aggregates referred 
to as foreign body giant cells (FBGCs). Macrophage fusion is a highly orchestrated process, the 
exact molecular mechanisms of which have not yet been fully characterised [Klopfleisch, 2016]. 
However, it is known that essential to initiation of this fusion is the presence of the anti-
inflammatory cytokine IL-4 [Jia et al., 1996] and its functional homologue IL-13 [Babic et al., 
1999]. Binding of these cytokines by macrophages has been observed to upregulate mannose 
receptor expression by these cells, facilitating macrophage interaction and membrane fusion 
through a process comparable to phagocytosis [Hicklin and Ellis, 2005]. It is interesting to note 
that FBGC formation also appears to rely on the presence of CCL2, with CCL2-null mice 
presenting a high reduction in the level of cell fusion in response to implantation of biomaterial 
[Assinder et al., 2009]. The fact granuloma initiating events requires a combination of both pro 
and anti-inflammatory mediators demonstrates the unique immune scenario this response is 
generated by. If possible FBGCs continue to fuse and multiply until they uniformly cover the 
object they have adhered to. This effectively seals the object off from the rest of the host, 
generating an isolated environment between its surface and the FBGC membrane. In a process 
termed ‘frustrated phagocytosis’, FBGCs are then able to release multiple effector molecules 
into the environment targeted at destroying the foreign object. These include reactive oxygen 
intermediates (ROIs, oxygen free radicals), degradative enzymes, and acid [Opdenakker et al., 
2001].  
Much like the macrophages they derive from FBGCs are capable of secreting a range of 
growth, angiogenic and matrix remodelling factors that regulate the process of tissue 
remodelling and wound healing [Kundu and Patil, 2006]. Concomitant to the formation of 
FBGCs, macrophages and developing FBGCs release multiple chemotactic factors such as 
Platelet derived growth factor (PDGF) and LTB4 which promote migration of fibroblasts to the 
site of immune activation [Kundu and Patil, 2006]. Upon arrival fibroblasts are activated and 
deposit multiple (ECM) proteins (predominantly collagens) across the surface of the foreign 
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object and the FBGCs that surround it [Yokota et al., 2000]. The fibrinogen produced by these 
cells correspondingly incudes macrophages and FBGCs to produce further bone and 
angiogenic factors [Ramaswamy and Hemler, 1990]. This process of encapsulation, occurring 
over a period of weeks further isolates the foreign object from the rest of the host environment. 
While this physical separation ensures the object itself can no longer directly damage the host, 
the capsule - now a fibrotic ball of scar tissue - risks being detrimental in itself. Often lacking 
vasculature, the capsule becomes impermeable to cells, slowing healing or preventing its 





Figure 1-5 Time course of the foreign object granuloma response. Immediately following the contact of a foreign object with host plasma it becomes coated 
with a layer of host proteins. Concomitantly neutrophils enter the site of the foreign body and respond by releasing cytokines, chemokines, reactive oxygen 
species and other enzymes. Over the course of days, the released neutrophil products recruit circulating monocytes to the site of inflammation which in turn 
differentiate into macrophages that bind to the surface of the foreign object via the adsorbed plasma protein. In case where the foreign object is too large to 
be phagocytosed, macrophages will begin to fuse together forming foreign body giant cells (FBGCs) around the surface of the object. At the same time both 
macrophages and FBGCs release a variety of mediators that attract fibroblasts. Upon arrival fibroblasts release large quantities of collagen, over time 




1.3.3.2 Sponge Implantation as a Model of the Healing and Foreign Body Response  
Owing to its fairly regular occurrence in surgical settings and relationship with the process of 
wound healing, multiple models of the foreign body/wound healing response have devised for 
use in experimental animals. Of these one of the most extensively used are dead space 
models, which use artificial, porous implants inserted within an animal to study tissue healing 
and formation as well as the effects of bio-active substances in the wound. Perhaps the most 
popular and well established model of this type is the sponge implantation model in which one 
or more sponge disks (typically polyvinyl alcohol - PV(A) are implanted under the skin for a set 
period of time and the resultant changes in tissue and cellular physiology and biology assessed 
[Hynes, 1992, Mosser and Zhang, 2008].  
 
1.3.3.3 Advantages and Limitations of the Sponge Implantation Model 
The sponge implantation model possesses a number of advantages over other models of its 
type. Unlike other materials commonly inserted (e.g. wire meshes) the mechanical properties of 
PVA sponge (i.e. sponge like) make it very easy to implant and remove with the minimal level of 
injury to the test animal. The porous nature of these sponges also allows them to capture a 
range of cells and effector molecules that infiltrate from the surrounding tissues, this sponge 
infiltrate can be readily recovered and analysed ex vivo. Alternatively, the sponge can also be 
sectioned for histological analysis. Additionally, sponges can also be impregnated with a variety 
of compounds  that may modulate the wound healing or inflammatory response [Chin et al., 
2013, Carpenter and Cohen, 1990] For example injection of carrageenan into the sponge 
immediately following implantation elicits a chronic, irresolvable inflammatory response 
culminating in granuloma formation [Yarden and Schlessinger, 1987]. Sponges can also be 
cannulated permitting repeat sampling of the wound healing/inflammatory microenvironment at 
successive time points [Smith et al., 2005]. Such additions make this model a highly versatile 
one. 
 
PVA sponge implantation is also a comparatively rapid means of modelling the foreign body 
tissue response with inflammation observable within hours of implantation, giant cell formation 
and angiogenesis detectable within mice within 4-14 days and fibrosis within 14-21 days 
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(dependent on what the sponge was impregnated with) [Chauhan et al., 1993, Chin et al., 
2013]. 
 
As with the ZIP model, classification of various cell subsets detected within the sponge infiltrate 
can provide an insight into the current phase of the inflammatory/foreign body response within 
an animal [Chin et al., 2013, Qian et al., 2011]. Additionally quantification of various cytokines 
present within the sponge exudate can be used to determine the biological conditions within the 
sponge [Al-Alwan et al., 2013]. The granulomatous tissue itself can also be harvested from 
sacrificed animals and subject to a variety of analyses ranging from gross histology, to RNA 
microarray analysis. 
 
Many of the shortcomings of the sponge implantation model mirror that of CLP, namely that 
variations in surgical procedure cause corresponding variation in the animal’s response to the 
implanted sponge. Factors such as the size and dimensions of the sponge, process by which 
the sponge was sterilised, sponge porosity (which alters on a batch by batch basis ), distance of 
the sponge from the site of incision, location of the sponge and means by which the sponge was 
impregnated have all been shown to affect host responses [Opdenakker et al., 1993, Chin et al., 
2013, Chauhan et al., 1993]. Accordingly, consistent surgical technique and avoidance of 
varying the batches of sponge used are vital for consistent data.  
 
It should also be observed that the sponge implantation model is somewhat unique in that it is a 
near complete imitation of the process it is often used to model – the traumatic implantation of a 




1.4 Environmental Factors Influencing Inflammation 
Influences of inflammatory state are considered both heterogeneous and multifactorial, 
determined through interaction of both genetic and environmental factors [Jenerowicz et al., 
2012, Danese et al., 2004, Kelishadi et al., 2009]. This diversity of influences means 
inflammatory disorders often possess aetiologies so complex as to be undefinable [Scott et al., 
2004, Vodovotz, 2006]. Regardless, multiple lines of research have identified several key 
inflammatory modulators.  
 
1.4.1 Enteric Microorganisms  
At the time of writing, the interplay between the immune system and commensal microbiota is a 
popular field of scientific research. Differential populations of bacteria have been attributed with 
both instigating and preventing inflammatory responses. Studies of individuals suffering 
inflammatory bowel diseases have found significantly higher proportions of Enterobacteriaceae 
and Bacteroides bacterial species residing in patient intestines compared to healthy individuals. 
Known to elicit a strong inflammatory immune response these bacteria have been implicated in 
exacerbating and potentially causing symptoms of the disease. Various bacteria have been 
implicated in potentiating or instigating; ulcerative colitis, colorectal cancer, Crohn’s disease, 
liver disease and multiple allergic type diseases all through exacerbation of the inflammatory 
response [Wang et al., 2007, Kleessen et al., 2002]. 
 
Conversely, several studies have identified bacterial strains that appear to have a neutralising 
effect on gut inflammation. Of these the most studied are strains of Lactobacillus and 
Bifidobacterium [Isolauri et al., 1991, O’Mahony et al., 2005, Saavedra et al., 1994]. Several 
methods by which these bacteria prevent inflammation have been suggested: (i) The 
outcompeting or destruction of inflammation-aggravating bacterial strains; (ii) Enhancing the 
barrier between the GI tract and circulatory system, reducing efflux of inflammatory molecules; 
(iii) Direct interaction and nullification of the inflammation driving components of the host 





Numerous studies have established that specific immunological traits and phenotypes are 
heritable, many of which have distinct effects on inflammation [Mcdevitt and Benacerraf, 1969]. 
Arguably the archetypical immuno-genetic determinant is the human lymphocyte antigen (HLA) 
system. A series of genes located on chromosome six that (amongst numerous other functions) 
determine immune cell-surface antigen-presenting proteins. Differing alleles of HLA genes (HLA 
types) have been connected to varying immune responses, including graft rejection, 
inflammation and risk of autoimmune disease [Thorsby, 1997, Abbas et al., 2014]. More 
recently a comprehensive immunophenotyping study analysing 78,000 immune traits in 669 
female twins identified 23 individual genetic variants within 13 independent loci. Suggesting 
genetic regulation of the immune and inflammatory response to be both diffuse and wide 
ranging [Roederer et al., 2015]. Correspondingly research has demonstrated significant 
variation in cytokine responses, wound healing, recovery time, and development of autoimmune 
disease across various mouse strains [Kigerl et al., 2006, Ma et al., 2006, Sethi et al., 2004, Shi 
et al., 1997]5.  
 
While the influence of genetics over the immune inflammatory response is undisputed, the scale 
of this influence remains a subject of debate. In a 2015 study using 210 identical twins scientists 
at Stanford University suggest human immune variation is primarily driven by non-heritable 
influences. Immune parameters were shown to become increasingly divergent between twin 
pairs with age. A single non-heritable factor was demonstrated to alter more than 50% of the 
cell subsets and serum proteins investigated [Brodin et al., 2015]. 
 
1.4.3 Ageing 
Multiple studies have demonstrated that ageing in both humans and experimental animals is 
characterised by a state of chronic, low-grade inflammation. A phenomenon popularly referred 
to as ‘inflammaging’ [Franceschi et al., 2007]. Inflammaging is characterised by persistent, 
                                                     
 
5 As a corollary, ‘strain specific differences’ are a commonly cited reason for experimental 
variation within animal studies [Murphy et al., 2003]. 
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heightened levels of pro-inflammatory cytokines (IL-6, IL-15, IL-8, IL-1 ) [Franceschi et al., 2005, 
Giacconi et al., 2004, Wikby et al., 2006, Zanni et al., 2003, Hobbs et al., 1993] and other 
inflammatory indicators such as coagulatory factors, heat shock proteins and C-Reactive 
Protein (CRP) [Assunção et al., 2012, Coppola et al., 2003]. Expression of these inflammatory 
factors is often associated with the process of immunosenesenece or immune-dysregulation in 
the elderly and is regarded as a strong predictor of morbidity and mortality [Schmaltz et al., 
2005]. However, it should be noted that several studies of human centenarians have 
demonstrated that such a phenotype is not always indicative of failing health [Franceschi et al., 
2007]. 
 
1.4.4 Diet  
The increasing prevalence of chronic inflammatory disorders across the western world has 
stimulated multiple lines of research into the relationships between dietary habits and 
inflammatory indices. Commonly linked to increased risk of cardiac and inflammatory disease 
trans-unsaturated fatty acid (TFA) consumption has been positively correlated with increased 
circulating markers of inflammation [Lopez-Garcia et al., 2005, Mozaffarian et al., 2004]. 
Conversely numerous human studies have identified an inverse association between levels of 
circulating inflammatory markers and consumption of ω-3 fatty polyunsaturated fatty acids (ω-3 
PUFAs) [Micallef et al., 2009, He et al., 2009]. Further, diets high in fibrous foods such as fruits, 
vegetables and unprocessed grain also show an inverse correlation with inflammatory markers 
[Holt et al., 2009]. Whereas those high in processed and red meats show the reverse [Fung et 
al., 2005]. As a corollary diets high in fruits, vegetables and ω-3 PUFAs, such as the traditional 
‘Mediterranean’ and ‘Japanese’ diets are typically associated with decreased morbidity, 
mortality and inflammatory disease burden [Sofi et al., 2008]. Again a diet high in TFAs, 
processed foods and low in fibre (loosely termed the ‘Western diet’) presents the converse 
[Cordain et al., 2005, Tikellis et al., 2008].  
 
1.4.5 Exercise 
The immunomodulatory effects of physical exercise are well studied (if not yet fully elucidated) 
with an abundance of evidence correlating regular exercise with a decreased risk of developing 
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numerous chronic diseases each of which has excessive or dysregulated inflammation as part 
of their aetiology [Booth et al., 2012]. 
The influences of physical activity on the immune system are at least in part, indirect. Caused 
by the increased energy expenditure it places upon the body. An inactive lifestyle typically leads 
to the accumulation of adipose tissue in mammals. With an excess in adipose tissue comes an 
accompanying infiltration and accumulation of leukocytes, persistent release of cytokines and 
the development of low grade chronic inflammation [Beavers et al., 2010]. While a discussion of 
the inflammatory effects of obesity or heightened adiposity goes beyond the scope of this thesis 
it is noted that a higher level of body fat in mice and humans typically correlates with a higher 
risk of inflammatory disease [Beavers et al., 2010].  
 
More recently it has been recognised that acute exercise can also actively regulate the 
inflammatory response by inducing the release of immunomodulatory mediators from skeletal 
muscle. Such myokines - as they have been termed - are released upon muscular contraction 
and exert a diversity of effects, some occurring locally within muscle while others act distally 
upon other organs and tissues throughout the body. Multiple immune-active factors are 
released from muscle during exercise, including; IL-1 receptor antagonist (IL-1rα), IL-10 and IL-
6 [So et al., 2014]. Of these the most well characterised is IL-6, this focus has stemmed from 
the observation that IL-6 displays the most marked response to exercise stimuli while also 
possessing a range of immune effector functions [Petersen and Pedersen, 2005]. 
During acute exercise muscle contraction stimulates the release of IL-6 from skeletal muscle, 
increasing levels of the cytokine in circulation by up to 100-fold depending on the intensity and 
duration of the exercise [Leggate et al., 2010]. Skeletal muscle derived IL-6s’ (SM-IL-6) role in 
exercise appears to be as a regulator of energy metabolism, serving to augment glucose 
release from the liver and fatty acid release from adipose tissue in order to provide sufficient 
fuel to meet increased metabolic demand [Pedersen, 2012].  
 
Skeletal muscle is unique in being able to release IL-6 independently of TNF-α, instead being 
stimulated by the increased intracellular calcium levels that accompany increased muscle 
contraction. In turn, SM-IL-6 effector function appears unique. In contrast to leukocyte or 
67 
 
adipose produced IL-6, SM-IL-6 is predominantly anti-inflammatory in function, purportedly 
triggering an anti-inflammatory signalling cascade through antagonistic inhibition of TNF-α and 
IL-1β [Petersen and Pedersen, 2005]. Further, SM-IL-6 release has been demonstrated to 
induce the release of the anti-inflammatory cytokine IL-10 [Starkie et al., 2003]. Additionally, 
exercise induces an acute anti-inflammatory effect by stimulating production of adrenaline and 
cortisol (production of these hormones is believed to be enhanced by IL-6). Both of these 
signalling molecules, released by the sympathetic nervous system, have been shown to limit 
production of inflammatory cytokines in monocytes, neutrophils and macrophages [Fischer, 
2006]. 
Acute exercise is also known to influence leukocyte trafficking and function. The nature of these 
alterations are very much dependent on the nature and duration of the exercise. At a systemic 
level exercise stimulates bone marrow haematopoiesis transiently increasing circulating 
numbers of blood cells and neutrophils [Smith et al., 1996]. Transient increases in levels of 
inflammatory monocytes have been observed after  single, acute bouts of intense exercise in 
both mice and humans [Gleeson et al., 2011], followed by a rapid return to baseline numbers in 
the hours following the activity. In addition studies have reported increases in neutrophil priming 
and phagocytic activity following short bouts of intense exercise [Smith et al., 1996, Giraldo et 
al., 2009].  
However, regular exercise appears to reduce the overall proportion of inflammatory monocytes 
in circulation at resting state [Timmerman et al., 2008] and subjection of mice to a high intensity 
exercise regimen has been observed to increase circulating numbers of T-Regulatory cells 
[Wang et al., 2012]. Several studies have also demonstrated that inflammatory cytokine 
production by monocytes and Th1 but not Th2 T-cells is inhibited following regular bouts of 
intense exercise [Starkie et al., 2000]. 
 
Further studies in mice and humans have shown that the anti-inflammatory effects of repeat 
high intensity exercise can become so pronounced as to be immunosuppressive, rendering 
athletes and mice subject to high intensity running programs more susceptible to infection 




Mechanisms for this biphasic pro or anti-inflammatory response to moderate and intensive 
exercise regimens are still being elucidated. However, one recent line of study has 
demonstrated that acute exercise downregulates expression of TLRs 2 and 4 in male humans 
and mice [Oliveira and Gleeson, 2010]. A later study also found an accompanying reduction in 
TLR associated monocyte activation factors (MHC II, CD80, CD86) [Lancaster et al., 2005]. This 
downregulation in TLRs was found to be cumulative over successive exercise bouts and may 
highlight one potential mechanism by which exercise induces an anti-inflammatory influence 
over the host immune response [Lancaster et al., 2005]. 
 
1.4.6 Psychological Status 
1.4.6.1 Negative Mood States 
A growing body of human and animal studies suggest an interplay between emotional and 
immunological status. Of this research the majority of work has been directed at the negative 
mood states of stress, anxiety and depression. Multiple lines of evidence suggest that anxiety 
can induce a pro-inflammatory response in humans and animals. Several cohort studies on 
stressed or anxious individuals have revealed elevated levels of pro-inflammatory mediators; 
CRP, IL-6, TNF-α and heightened white blood cell counts [Duivis et al., 2013, Pitsavos et al., 
2006, Vogelzangs et al., 2013]. Further studies have identified stress to be a significant 
instigating or exacerbating factor in multiple inflammatory disorders including: IBD [Mawdsley 
and Rampton, 2005]; dermatitis [Arndt et al., 2008]; rheumatoid arthritis (RA)[Parker et al., 
1995] and asthma [Wright et al., 1998]. Persistent pyscho-social stress appears to have a 
diminishing or deregulating effect on the inflammatory response. In a study comparing rates of 
wound healing among students, recovery time during the stressful exam period was on average 
three days slower than during summer vacation. This reduction was accompanied with a 
reported 68% increase in inflammatory IL-β production [Marucha et al., 1998].  
 
In addition, over a third of patients suffering major depressive disorder (MDD) exhibit elevated 
levels of IL-6, TNF-α and CRP when compared to non-depressed patients. These elevated 
levels occur in the absence of physical illness or infection [Dinan, 2009, Dowlati et al., 2010, 
Raison and Miller, 2011, Dantzer et al., 2008]. In turn individuals suffering depression are at 
69 
 
greater risk of suffering disorders with a strong inflammatory aetiology such as atherosclerosis 
and heart disease [Duivis et al., 2014]. It is interesting to note that these patient often present a 
depressed cellular and humoral response to infection [Fortes et al., 2002],  an overall immune 
state with parallels to the immunosenescence observed in ‘inflammaging’.  
 
Research from animal models of mood and behaviour has helped to further elucidate the 
relationship between negative emotional states and inflammation. Studies using the repeat 
social defeat (RSD) behavioural paradigm (a model of social stress in which mice are 
recurrently attacked and defeated in their home cage by an aggressive conspecific animal) have 
revealed acute stress to correlate with heightened numbers of myeloid cells (monocytes and 
granulocytes) in blood circulation [Wohleb et al., 2015]. In turn this increased cycling of myeloid 
cells in the context of psychological stress has been associated with the development of an 
inflammatory Ly6Chigh monocyte phenotype in mice [Engler et al., 2004, Powell et al., 2013] 
(and a synonymous CD14+/CD16− phenotype in human cells [Heidt et al., 2014]).  
 
Accompanying these cellular changes one paper reports the upregulation of inflammatory gene 
expression in the leukocyte transcriptome [Powell et al., 2013]. Additional studies combining the 
maternal separation of rat pups (another established stress induction paradigm [Lehmann et al., 
1999]) with an OVA-induced model of asthma revealed separated rats present a notably more 
severe inflammatory response compared to control animals [Kruschinski et al., 2008] 
 
1.4.6.2 Stress Mitigation and Positive Mood States  
Recent estimates by the World Health Organization suggest that by 2030 depression and stress 
related syndromes will be the most debilitating and widespread health disorders on the planet, 
closely followed by auto-immune disease and allergy [Mathers et al., 2008]. Such figures have 
initiated a huge growth in research directed at investigating the effects stress mitigating 
therapies have on immune state. A study of 50 individuals revealed  participants to have lower 
circulating levels of IL-6 following six weeks of training in compassion meditation, compared to 
the control group [Pace et al., 2009]. In a further study 49 participants were subject to the Trier 
Social Stress Test (TSST) (an experimental paradigm intended to induce stress), after which a 
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local, inflammatory response was induced in each patient’s forearm and the resultant exudate 
extracted. Following this the participants underwent an eight-week regimen of mindfulness-
based meditation at the end of which they were subjected to the same TSST and inflammation 
paradigm once again. Analysis revealed significantly lower levels of inflammatory cytokines IL-8 
and TNF-α in the exudates of participants following the eight weeks meditation in addition to 
lower circulating cortisol levels [Rosenkranz et al., 2013].  
 
More recently several lines of research have begun investigating the influence positive mood 
states may have on the inflammatory response. Studies have shown that laughing therapy (in 
which at its most simple subjects are made to watch humorous films) upregulates the 
expression of genes involved in the NK cell inflammatory immune response, such as granzymes 
H and B, perforin, cathepsin and granulysin [Hayashi and Murakami, 2009, Hayashi et al., 
2007]. Similar effects on NK cells have been described in investigations where laughter was 
also shown to significantly decrease levels of circulating pro-inflammatory cytokines in patients 
suffering rheumatoid arthritis [Matsuzaki et al., 2006].  
 
Research modelling the influence of positive emotion on the inflammatory immune state in 
animals is currently limited. Perhaps due to the questions raised around equivalence of animal-
human psychology. Nevertheless, one aspect of animal welfare that has shown a small but 





1.5 Environmental Enrichment 
Environmental enrichment (EE) or behavioural enrichment is an umbrella term for a large range 
of practises and principles that seek to enhance the quality of life for captive animals by 
providing environmental stimuli that improve both their physical and psychological wellbeing. 
Generally the goal of environmental enrichment is to encourage ‘normal’/’natural’ species 
specific behaviour while reducing or preventing abnormal behaviours such as stereotypies (e.g. 
pacing or excessive grooming) [Young, 2003]. 
 
The practise of EE has been commonplace in the care of captive animals for close to a century 
[Mellen and Sevenich MacPhee, 2001], however its use on lab animals only became 
established in the late 1960’s [Mellen and Sevenich MacPhee, 2001]. While its purpose in zoos 
and similar establishments focuses solely on improving the welfare of the animals, for 
researchers EE began primarily as an experimental variable in exploring the relationship 
between an organism’s neurological makeup and its external environment [Hutchinson et al., 
2005]. Initial work in the field focused on the behavioural effects of enrichment, demonstrating 
its capacity to enhance cognition and memory in a series of learning based tasks [de Jong et 
al., 2000]. Later studies further revealed the effects of EE at a cellular level, identifying its 
effects on gene expression [Rampon et al., 2000a], neuronal development [Kempermann et al., 
1997] and synaptic plasticity [Nakamura et al., 1999]. Additional studies have discovered that 
EE is able to mitigate or facilitate repair of neurological damage caused by chemical exposure 
[Guilarte et al., 2003], physical trauma [Xerri and Zennou-Azogui, 2003] and neurodegenerative 
disease [Jankowsky et al., 2005]. 
 
While the majority of EE paradigms use rodents for research a number of other animals such 
as; birds [Reed et al., 1993], rabbits [Olson et al., 2006], pigs [Beattie et al., 2000], primates 
[Schneider et al., 1991] and spiders [Bengston et al., 2014] have also been used in EE 
experiments. 
Parallel EE treatment paradigms can be found in clinical studies. While not operationally similar 
such treatments provide a degree of mental and physical stimulation comparable to that of 
rodent EE studies. Such treatments include learning of complex tasks, an active social lifestyle 
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[Wright et al., 1998], cognitive (‘brain’) training exercises [Valenzuela and Sachdev, 2009], 
sensory enhancement (e.g. listening to music) [Núnez et al., 2002], food supplementation [Holt 
et al., 2009] and physical exercise [Siedlik et al., 2015]. These treatments have been shown to 
produce comparable results to rodent studies, improving cognition and memory suggesting a 
similar mechanism of action for both humans and animals. 
 
1.5.1 Enrichment Methods 
While the vast majority of studies have focused on the neurological effects of EE a small 
number of papers have begun identifying the modulating effects of EE on the immune system 
utilising a variety of enrichment techniques: Across each of these studies the specific method of 
EE varies considerably using one or a combination of methods summarised in Figure 1-6 below. 
 
Figure 1-6 Methods of enriching the environment for rodents in captivity. EE for rodents in captivity 
can be achieved by providing them with social contact (pair, group, permanent, temporary), 
physical activity using running wheel, new larger and complex enclosures, novel objects and 
accessories, sensory stimulations (visual, auditory, and olfactory), and better nutrition. 
 
1.5.1.1 Novel Objects 
Experimental animal’s environments can be enriched by inclusion of various novel structures 
(e.g. mazes, shelters, tubes and additional floors) and accessories (ropes, ladders, chews, 
ramps, wheels.) To stimulate their attention and engagement with their housing environment. A 
study on aged rodents housed in an environment enriched with novel objects revealed a 
significant increase in IL-2 and TNF-α release from leukocytes extracted from the peritoneum of 
enriched animals. The authors suggested this increased cytokine release could compensate for 

















































this study has been questioned. Unlike other EE studies of its kind where the novel objects 
placed within the environment remained unchanged, this study altered the objects used every 
48 hours. It has been suggested that rapid and regular interference with their environment 
would serve as a source of stress for the mice, confounding the results obtained [Singhal et al., 
2014]. 
 
In a further study mice that spent four months in a novel object and physically enriched 
environment displayed a significant reduction in brain IL-β, IL-6 and TNF-α, following infection 
with the influenza type A, when compared to animals housed in a standard environment 
[Jurgens and Johnson, 2012]. However, it should be noted the study was unable to determine 
whether the primary source of these immune alterations came from the novel objects, increased 
physical activity or a combination of the two. 
 
Adolescent rats born of mothers’ subject to restraint stress showed a comparative increase in 
IL-2 and reduction in IL-1β production by activated splenocytes, when housed in the presence 
of novel objects one-week post birth. The same animals also showed a heightened resistance 
to the immune-suppressive effects of cyclophosphamide when compared to rats born of 
stressed pregnancies but housed in a standard environment [Laviola et al., 2004]. Without the 
addition of a non-stressed, non-enriched control in this study it is difficult to establish the extent 
of EE’s influence on the immune response. Regardless these initial results do provide support 
to the concept that EE by novel objects may contribute to better immune homeostasis.  
 
1.5.1.2 Physical Exercise 
As previously discussed (1.4.5) multiple studies have reported physical exercise (PE) to have 
anti-inflammatory effects, most especially in the context of diseases and metabolic disorders 
associated with chronic low-grade systemic inflammation. Regular voluntary exercise is 
generally regarded as one of the most consistent means of enhancing the welfare and 
environment of both humans and captive animals, correspondingly it is the most well studied 




1.5.1.3 Social Enrichment 
Social housing of captive animals is a typical component of most animal research units and 
scientific studies for reasons of welfare and economy. Mice are characteristically social animals 
with studies demonstrating that male mice prefer to sleep in close proximity to familiar mice [van 
Loo et al., 2001] while mice denied social contact show increased anxiety, depression like 
behaviour and aggression when reintegrated with other animals [Ma et al., 2011]. 
Behavioural studies of laboratory rodents have revealed their stratification into two key 
populations within a housed group: ‘subordinate’ and ‘dominant’, each with separate 
behavioural, physiological and immunological profiles [Bartolomucci, 2007]. Submissive 
animals, especially those of low social rank have been reported to show signs of 
immunosuppression with a reduction in splenocyte and lymphocyte proliferation, serum 
antibodies and increased levels of circulating IL-4 and IL-10 [Fleshner et al., 1989, 
Bartolomucci, 2007]. In a further study two hours of social confrontation led to increased 
numbers of granulocytes and an accompanying decrease in lymphocyte numbers and elevated 
CD4/CD8 and T-cell/B-cell ratio in defeated animals [Stefanski and Engler, 1998]. Suggesting 
that immunosuppression in subordinate animals is caused by the impairment of both humoral 
and cellular immunity, possibly as a result of prolonged stress. Concomitant to these results 
dominant male rodents typically show better immune function compared to other members of 
their cage group while also showing reduced indicators of sickness behaviour when subject to 
immune challenge [Bartolomucci et al., 2001]. The development of such social hierarchies 
poses a serious risk of confounding any results obtained from EE paradigms the core goal of 
which is typically to enhance as opposed to impoverish an animal’s external environment6. 
However, it has been reported that mice housed together following the stress of social defeat 
show improvements in behaviour significantly more rapidly than animals placed in isolation [de 
Jong et al., 2005]. A similar study in rats revealed that social housing after social defeat 
reverses the reduction in heart rate, temperature and locomotor activity caused by the 
                                                     
 
6 It could be argued here – and in other incidences where enrichment practises risk increased 
aggression between captive animals – that such behaviour is typical behaviour within all social 
groups and as such constitutes the ‘natural’ behaviours that enrichment regimens seek to 
evoke. This of course begs the question, how much aggression is too much? 
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experience [Ruis et al., 1999]. Further it has been shown that when housed together, 
undisturbed for a long enough period of time incidences of inter-group fighting among mice 
typically fall to very low levels, most especially if the animals were weaned together [Gurfein et 
al., 2012b]. Accordingly, while conflict is a definite risk factor when socially housing 
experimental animals, provided this conflict is kept to a minimum; such social enrichment is 
likely to be of benefit to them. 
 
1.5.1.4 Sensory Enrichment 
The effects of sensory enrichment on the function of sensory organs (visual, auditory, touch and 
olfactory) and brain activity has been the subject of much study and review in the field of 
behavioural biology and captive animal research [Wells, 2009]. To date no studies have 
specifically investigated the immunomodulatory influence of sensory stimulation in the context of 
environmental enrichment. However, studies have established that various sensory stimuli can 
alter immune function. C57/BL6 mice subject to daily stroking for a period of eight days 
demonstrated a significant nonspecific increase in thymic and splenic T-cells numbers 
compared to un-stroked animals [Major et al., 2015]. Enhancement of systemic T-cell 
proliferation has also been observed in response to visible light passing through the eye and 
hitting the skin [Roberts, 2000]. Randomised trials which subjected adult participants to a slide 
show portraying images of disease or a series of neutral, control images revealed that the visual 
perception of disease symptoms is capable of stimulating heightened release of IL-6 into 
circulation [Schaller et al., 2010]. 
 
Several studies report the influence of auditory stimulation on the immune system. Rats played 
music for five hours a day, for a period of eight days were shown to present an enhanced 
immune and anti-tumour response compared to control animals and rats subject to auditory 
stress [Núnez et al., 2002]. Human studies utilising age and gender matched human volunteers 
has shown that group drumming therapy may enhance cellular immunity by increasing 
lymphocyte activated NK cell activity [Bittman et al., 2001]. Again the question may be asked if it 
is the actual process of drumming causing these immune alterations or a neuro-endocrine 
response to a novel social situation.  
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Immune mechanisms associated with olfactory stimulation used as an enrichment technique are 
yet to be studied. However a known relationship exists between olfaction and immunity, with 
predator odour known to stimulate the Hypothalamic pituitary adrenal (HPA) axis and 
proceeding immune responses in rodents [Strous and Shoenfeld, 2006]. Instinctual responses 
to many smells are demonstrated to be mediated by the MHC region of the mammalian genome 
[Singh et al., 1987]. Accordingly, it seems logical to assume that the olfactory environment 
humans and animals reside in will have some influence (direct or indirect) on their immune 
status.  
 
1.5.1.5 Nutritional Enrichment 
While some researchers have advocated the use of food as a means to enrich a captive 
animals’ environment [Sherwin, 2007a, Brown, 2009], in an experimental setting the behavioural 
and physiological alterations a variation in diet can cause pose a high risk of confounding the 
effects of the enrichment itself, a brief overview of the effect of diet on inflammatory state is 




1.6 Aims and Hypothesis 
Currently research investigating the modulating effect EE may have upon the immune response 
remains in its infancy. A review of those studies that have been carried out (Table 7) presents 
enriched rodents as possessing heightened innate leukocyte activity coupled with reduced 
levels of circulating inflammatory cytokines and lymphocytes. Such an unusual immune profile 
would appear likely to promote an equally unique inflammatory response. However, as of yet no 
direct research has investigated the effects of environmental enrichment on classical 




Enrichment of a mouse’s captive environment will have a distinct and experimentally 
observable influence on that animal’s inflammatory immune response. 
 
Aims: 
1. To establish a practicable and reproducible enrichment methodology that evokes an 
altered behavioural and physiological response in mice. 
2. To observe any immune alterations enrichment may cause by subjecting animals to 
established models of disease that evoke specific aspects of the inflammatory 
response. 
3. To investigate any specific cellular/molecular immune alterations enrichment may 
cause. 
4. To determine from the results obtained whether environmental enrichment is of benefit 
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2.1 Animal Breeding and Husbandry 
Adult male CD1 mice (acquired at six weeks old, 15-20g body weight) were obtained from 
Charles River UK ltd. Animals were kept under standard conditions: in individually ventilated 
enclosures, food and water provided ad libitum, 12-hour light-dark cycle. All animals were 
allowed a seven-day acclimatisation period before any experimental procedure was performed 
upon them. All experiments were approved and performed under the guidelines of the Ethical 
Committee for the Use of Animals, Bart’s and The London School of Medicine and Home Office 
Regulations [Act 1986]. PPL 70/8714. PIL-30/9411. 
 
2.2 Environmental Enrichment 
Environmental enrichment (EE) consists of a variety of different principles and methodologies. 
As can be seen in Table 8 both the recommended forms of enrichment and practised 
enrichment protocols vary widely across labs and institutions. As an example in one study 
researchers regularly changed their experimental cage environment as part of their EE protocol. 
“Rearrangement of toys, tunnels, and wheels was carried out 3–4 times per week to maintain 
novelty” [Jurgens and Johnson 2012]. Conversely other groups would regard this practise as a 
definitive way of inducing persistent ‘non-natural’ stressors into a mouse group. “The cage 
environment was left unaltered throughout the course to minimise animal stress” [Van de 
Weerd, Baumans et al. 1994, Baumans 2005, Willner 2005]. 
 
While the issues around this lack of methodological consistency and the variability of results 
have been acknowledged [Toth, Kregel et al. 2011] and attempts have been made to generate 
a EE ‘standard operating procedure’ [Sztainberg and Chen 2010], as of yet no single approved 
method has been agreed upon. 
In an attempt to devise an enrichment protocol that would provide both a consistent and 
measurable psychological and physiological (and ergo immunological) effect, a review was 
carried out to determine the most consistent EE techniques in use. Table 8 lists those 
techniques. The most common, effective and practicable cage additions and procedures used 




Table 8 Common enrichment techniques 
  
Type Action Study 
 
Social Forming cage groups with weanlings that know each other   [Sherwin, 2002, Sztainberg and Chen, 2010] 
Same sex groups set up before puberty  [Sherwin, 2007b] 
Avoidance of changing, removing members of social cage groups  [Sztainberg and Chen, 2010] 
Human/Animal Systematic, gentle, daily handling  [NSWAARRP, 2004, van de Weerd and 
Baumans, 1995] 
‘Gentling’ – mouse is stroked and allowed to explore hand  [NSWAARRP, 2004] 
Allow animals to become used to procedures, involve positive reinforcement  [Hubrecht et al., 1993] 
Food Scatter or hide food to encourage foraging  [Gurfein et al., 2012a, Sztainberg and Chen, 
2010, van de Weerd and Baumans, 1995] 
Scatter seed on top of the pelleted food. Animals learn to manipulate the pellets to access the 
seeds that fall through. Delivery of the seed is random, but foraging is controlled by the mouse 
[Hutchinson et al., 2005] 
Provision of hard-shelled nuts (e.g. walnuts, hazelnuts, macadamia nuts), encouraging physical 
effort to obtain food 
[Hutchinson et al., 2005] 




Inclusion of dividers in cage (provision for thigmotaxis).  [NSWAARRP, 2004, Boyd and Love, 1995, 
Committee, 2004, Sherwin, 2002, Sztainberg 
and Chen, 2010, van de Weerd and 
Baumans, 1995] 
Enlarge the floor space by providing levels within the cage or by providing items to climb on or 
exercise in 
[Sherwin, 2007b, van de Weerd and 
Baumans, 1995] 
Use of a solid bottomed cage (as opposed to a mesh or grate) [Committee, 2004, Sherwin, 2002, Sherwin, 
2007b] 
Provision of a running wheel  [Gurfein et al., 2012a, Sherwin, 2007a, 
Sztainberg and Chen, 2010] 
Provision of toys – ropes, ladders, balls, chews  [Hutchinson et al., 2005, Sztainberg and 
Chen, 2010, Smith and Hargaden, 2001] 
White, opaque cage walls  [Sherwin, 2007a] 
Opaque (or transparent red) nest box, with gaps to allow olfaction  [Sherwin, 2007a] 
Provision of multiple exits in any enclosed space [Gurfein et al., 2012a] 
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Type Action Study 
Olfactory 
Stimulation 
Male aggression often follows box cleaning through disruption of scent marking. 
Placing nesting material from dirty box into clean may reduce this.  
[van Loo et al., 2001] 
Avoid presence of strong scents, or predator scents in mouse  
enclosure  
[Sherwin, 2002] 




Minimise or attempt to block out extraneous noise in mouse enclosure, be aware of 
potential for high frequency noise through electrical equipment. 
Ensure correct day night cycle for mice  
[Sherwin, 2007b, Sherwin, 2002] 
Provision of nesting material – preferably shredded paper  [NSWAARRP, 2004, Sherwin, 2007a, Sherwin, 2002, 
Sztainberg and Chen, 2010] 
Provision of nesting boxes [Gurfein et al., 2012a] 
Provide substrate specifically for defecation – preferably wood shavings or sawdust  [Sherwin, 2007b] 
Provision of a thick layer of substrate to encourage digging  [Sherwin, 2007b, Sherwin, 2002] 
Provision of objects to chew and climb  
 
[Hutchinson et al., 2005, Smith and Hargaden, 2001, 
Sztainberg and Chen, 2010] 
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The devised enrichment protocol was as follows: 
Same sex, male, CD1 mice aged six weeks and weaned together were given one week to 
acclimatise to the environment of the animal unit in a standard enclosure used in the unit. Such 
an enclosure consisted of a 36x20x14cm (523 square cm) cage (Allentown) cage, roughly a 
1cm depth of woodchip bedding and roughly 25g of nesting material. Six animals were housed 
per enclosure. At the end of the week each enclosure group was either placed in a new 
standard enclosure and designated a standard environment (SE) group or placed in an 
enrichment enclosure and designated as an environmentally enriched (EE) group. 
Enrichment enclosures were 50x38x21cm (1355 square cm, Allentown) (Figure 2-1) and 
included:  
• One wheel, (silent spinner,Kaytee) 
• One nest house, (Puzzle playground, Superpet) 
• One tunnel  
• One chew block  
• Ample nesting material (50g) 
• Woodchip bedding to a 5cm depth. 
 
Mice from both groups were cleaned out once a week. While cleaning occurred enriched mice 
were allowed to remain inside their nest house to minimise disturbance 7.  Roughly 20% of 
soiled bedding was left in the enrichment cage. After cleaning all apparatus was replaced 
exactly as found. Prior to cleaning/handling/weighing etc. Mice were allowed a period of roughly 
ten minutes to acclimatise to the presence of the researcher. No other researchers were 
allowed to handle the mice.  
  
                                                     
 
7 Upon introduction to the enrichment enclosure, mouse groups would not always choose the 
nest house as their primary nesting site. This was likely due to the structure being an 
unfamiliar - and ergo abject - object for these typically neo-phobic animals. It was discovered 
that placing nesting material from their previous enclosure inside the nest house ensured the 




2.3 Body Fat and Muscle Analysis 
Following enrichment sacrificed animals were subject to a laparotomy and had their visceral fat 
pads excised and stored in neutral buffered formalin (NBF). In addition, the left leg of each 
animal was removed and stored in NBF.  
 
2.4 Blood Analysis 
Following terminal anaesthesia through isoflurane inhalation blood samples were taken from 
mice via cardiac puncture. In this procedure a 1ml syringe, with a ¼ inch 25G needle, pre-filled 
with 150µl of a 3% solution of sodium citrate was inserted into the ventricle of the heart via the 
left side of the chest, between the ribs. Application of gentle negative pressure via-the syringe 
allowed for recovery of between 0.25-1ml of blood dependent on the size of the mouse the 
strength of its heart beat. Following blood collection mice were sacrificed via CO2 exposure.  
 
Isolated blood was then subject to haematological analysis using a IDEXX ProCyte Dx® 
Haematology Analyser. A tool that utilises laser based flow cytometry, optical fluorescence and 
measurement of impedance to laminar flow to produce a readout of relative numbers and 
percentages of monocytes, lymphocytes, neutrophils and eosinophils and erythrocytes as well 
as large range of other circulating blood factors. 
 
Figure 2-1. Standard (left) vs Enriched (right) enclosures. 
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2.5 Bone Marrow Cell Extraction  
Complete legs (without skin) were removed from sacrificed mice and stored in RPMI media 
(GIBCO/Invitrogen) + 30% EtOH at 4°C. When ready for processing (a maximum of four hours 
post sacrifice) a leg was removed from the media using tweezers, muscle and connective 
tissues was carefully pared off the tibia using a scalpel until the bone was completely exposed, 
while still being connected to the femur and the foot. Following this the fibula was dissected 
from the tibia by placing the scalpel between the two bones at the top of the foot paw and 
drawing it up past the knee joint. If performed correctly this allowed the patella to be carefully 
peeled from the top of the tibia, cleanly separating the two leg bones and helping ensure a 
consistent amount of bone was removed from each animal. The foot was then removed from 
the bottom of the tibia using surgical scissors. Bending of the foot back toward the tibia allowed 
easier location of the region where cartilage connects the two bone sets. Placing surgical 
scissors at the apex of this bend and careful manipulation to ensure the blade passes through 
the regions of least resistance helped ensure consistency in the amount of bone tissue acquired 
for extraction. Using a gauze, the base of the tibia was gently polished to remove any adhering 
tissue and then cut ~1mm from the tip with surgical scissors to expose the marrow at both ends. 
The basal end of the tibia was then gripped gently using locking forceps and held over a small 
(4cm diameter) bacterial culture plate, with the wider part of the bone facing down. A 2.5ml 
syringe with a 10mm 26G needle, prefilled with 2ml of sterile PBS (phosphate buffered saline) + 
3mM EDTA was inserted into the opening at the narrow end of the tibia and gently pushed 
roughly 5mm deep using a screwing motion. Gentle pressure was used to flush the PBS EDTA 
solution through the bone, releasing its contents into the culture plate below. Successful 
clearance of the bone was identified by a colour shift from pink to white across the tibia’s length.  
The collected cell solution was taken from the plate using a Pasteur pipette and moved to a 
15ml falcon tube. The plate was washed with an additional 1ml of PBS EDTA which was also 
added to the tube. The collate was then centrifuged (1500 RPM, 5 minutes, 4°C). The resulting 




2.6 Zymosan Induced Peritonitis 
Zymosan induced peritonitis (ZIP) is an experimental model that uses application of the 
eponymous yeast cell wall derived polysaccharide to induce an acute inflammatory response in 
the peritoneal cavity of a test animal. In our procedure male CD1 mice from both the EE and SE 
groups were injected intraperitoneally (ip) with 500µl of PBS containing 0.5mg of zymosan-A 
(Sigma-Aldrich). Using a 500µl, 29G mycojector insulin syringe (Terumo). Following injection 
animals were observed for sickness behaviour indicative of peritoneal inflammation (lethargy, 
piloerection, closed eyes). If any animals had displayed sickness symptoms in excess of the 
observed norms for ZIP (respiratory issues, nasal discharge, vocalisation) they would have 
immediately been culled by a schedule one procedure. Mice were then left for either 6 or 24 
hours, following which they were sacrificed.  
 
2.7 Peritoneal Lavage  
Placed on their back mice were sprayed liberally with 70% EtOH focused around the abdominal 
area. Using scissors, a small cut was made in the abdominal skin of the animal just below the 
diaphragm. The fur either side of the incision was then held firmly and pulled towards the cranial 
and caudal ends of the mouse, revealing the hypodermis. Using forceps, a region of the 
peritoneum roughly 10mm below the diaphragm was lifted up and away from the abdominal 
organs and used as the injection point for 2.5ml of PBS+3mM EDTA at 4°C. (Injection carried 
out using a 2.5ml syringe fitted with a ½ inch 25G needle). The abdominal cavity of the mouse 
was gently massaged to ensure suspension of the peritoneal cells within. Again using forceps to 
lift the peritoneum at its centre point a small lateral incision was made into the cavity using 
surgical scissors. Through this cut was inserted the tip of a Pasteur pipette which was used to 
draw the lavage fluid out of the peritoneal cavity. On average around 2ml of fluid was recovered. 
Samples were then centrifuged (1500 RPM, 5 minutes, 4°C), the supernatant was retained and 
stored at -80°C. The resultant pellet was reconstituted in 1ml of PBD-3mm EDTA and kept on 
ice in preparation for further analysis.  
On occasion the lavage taken from animals would be contaminated with blood, likely a result of 
the cardiac puncture they had previously received or inadvertent damage to the organs/tissues 




2.8 Cell Count 
Both bone marrow and peritoneal cell counts were carried out using a haemocytometer 
(Improved Neubauer). Prior to counting samples were diluted to a factor that permitted 
visualisation of between 10-100 cells per quadrant of the haemocytometer. In the case of 
peritoneal cells this necessitated a 10x dilution for the six-hour time point and a 15x for 24 
hours. For bone marrow a 25-50x dilution was required. 
 
Following dilution 10µl of cell suspension was added to a further 10µl of trypan blue. 10µl of this 
mix was pipetted between the haemocytometer and cover-slip. Viewed at 20x magnification 
under a light microscope cells in four, 4x4 quadrants were counted row by row. Dead cells, 
evidenced by trypan blue infiltrate into the nucleus were not counted.  
The total cell count per ml (and per mouse) was calculated as:  
 
Cell count x 104 (depth of haemocytometer well) x Dilution factor / four 
 
2.9 Cytokine Analysis 
Cytokine analysis was carried using a Luminex®- BioPlex Pro® Assay (Life Technologies). A 
bead based multiplex assay used to quantify levels of KC, IL-1β, TNF-α, IL-6 and MCP-1 in 
peritoneal lavage fluid. The protocol was carried out in accordance to the manufacturer’s 
guidelines (Invitrogen Manual LCH0001). Briefly, cytokine specific, antibody coated beads were 
vortexed and added across a 96 well plate. The plate was then inserted into a magnetic cradle 
that retained the magnetic beads within the plate wells while allowing them to be stringently 
washed. 50µl of analyte (diluted 20x) was added to the wells including appropriate, blanks, 
standards and controls. The plate was then sealed, shaken at 1100rpm for 30 seconds before 
being incubated for 30minutes while shaken at 300rpm. Following three further wash cycles 
streptavidin was added to each well and the plate was subject to the same process of shaking, 
incubation and washing once again. 100µl of assay buffer was then added to each well before 






2.10 Flow Cytometry – Procedures and Analysis  
2.10.1 General Cell Staining Protocol for Flow Cytometry 
Re-suspended peritoneal cell samples were transferred to a series of micro-test tubes (starlabs) 
fixed into a round bottomed 96 well plate. A small aliquot (50-200µl dependent on the number of 
stains carried out) was taken from each sample and added to a single tube for use in control 
stains. The tubes were then centrifuged at 1500rpm (or equivalent) 4°C for five minutes. 
Maximum acceleration and deceleration. The tubes were then emptied with care taken not to 
dislodge the pelleted cells and 100µl of Anti-mouse FCGRII/III (Clone 2.4G2) blocking antibody 
(BD Biosciences) 500x diluted was used to re-suspend each pellet. Samples were then left to 
incubate for a minimum of ten minutes at 4°C. Following another cycle of centrifugation and 
removal of supernatant the cell pellets were re-suspended in 100ul of (fluorescence activated 
cell sorting) FACS buffer and stained with the appropriate antibody mix (listed below). Following 
a minimum of 30 minutes incubation (in darkness 4°C) each sample was fixed by addition of 
100µl 10% paraformaldehyde (PFA) and made up to 400µl with FACS buffer in preparation for 
analysis. If analysis wasn’t carried out immediately samples were wrapped in foil and stored at 
4°C to reduce photophore degradation. 
 
2.10.2 Cell Differentiation Markers Used 
GR-1 (RB6-8C5) clone, eBioscience), also known as the myeloid differentiation antigen GR-1 
is expressed by cells of the myeloid lineage in a developmentally regulated manner in the bone 
marrow. Monocytes express GR-1 transiently during bone marrow development, its presence is 
also found on peripheral neutrophils making it a commonly used marker for these populations. 
[Daley, Thomay et al. 2008, Wang, Bair et al. 2012]. 
 
F4/80 (BM8 clone eEioscience) antigen is expressed at high levels on the surface of various 
macrophages: Kupffer cells, splenic red pulp macrophages, microglia, gut lamina propria, and 
Langerhans cells in the skin. F4/80 is also expressed in the macrophages of the connective 
tissue, heart, kidney, reproductive, and neuroendocrine systems [Leenen, de Bruijn et al. 1994]. 
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Ly-6B.2 (7/4 clone eBioscience) expressed on neutrophils, inflammatory monocytes and some 
activated macrophages high levels of expression are also seen in bone marrow, spleen, lung 
and lymph nodes [Rosas, Thomas et al. 2010]. 
 
2.10.3 FACS Acquisition   
FACS acquisition was carried out using a BD LSRFortessa II™. 20,000 events were acquired 
per sample (where possible). For each staining experiment a forward versus side scatter plot 
(FSC-SSC) was initially gated to remove all events at the extremes of each axis, FSC-Area 
versus FSC height plots were also used in order to exclude irregular shaped material and cell 
aggregates from the final data set (Figure 2-2). Single stain controls were used both for 
compensation and to determine relative marker expression levels (positive, negative. Low, 
high). Posthumous analysis was carried out using the FlowJo™ software package. Cell 
population counts within a cavity (bone or peritoneum) were calculated by multiplying: 
 
Percentage cell in a given gate x total cell count = Relative number of gated cells in cavity 
  
 
Figure 2-2.Basic gating logic used in FACS analysis. (a) SSC-FSC gating, (b) Differential gating of 
F4/80hi, GR-1- populations, demarcated as macrophages and F4/80- GR-1hi populations demarcated 
as neutrophils. (c) Differential gating of GR-1hi, Ly6B.2+ populations demarcated as neutrophils and 
GR-1+, Ly6B.2+ populations demarcated as activated/inflammatory monocytes. Gating logic based 





2.11 Animal Behavioural Assessments 
2.11.1 Open Field Test 
The open field test (OFT) is an ethologically based paradigm that provides objective measures 
of exploratory behaviour as well as a useful initial screen for anxiety-related behaviour in 
rodents. The apparatus used consisted of a white PVC arena (50cm × 30cm × 20cm) divided 
into 15, 10cm ×10cm squares. The three central squares were designated the “centre” region. 
Experimental animals were placed in the bottom left corner square (respective to the 
experimenter), facing the wall and observed and filmed for three minutes. The walls and floor of 
the arena were thoroughly cleaned between each trial using 70% ethanol and then dried. In 
order to ensure parity test subjects were alternated between SE and EE groups (e.g. mouse S 
(standard) 1 was recorded first, followed by E (enriched) 1, then S2, E2 etc). This test was 
performed in accordance to a published methodology previously used by the lab [Gallo et al., 
2014].  
 
Three key parameters were recorded: The total number of squares crossed (delineated by all 
four paws in a square); total number of rears (defined as both front paws off the ground, 
excluding grooming) and the number of centre crossings.  
Following observation and tabulation, the integrity of results was verified via blind analysis of 
recordings by another member of the lab. 
 
 
Figure 2-3. Open field test.  Anxiety-like and exploratory behaviour are tested through observation 
of the number of: Times the mouse rears (pictured), squares it crosses in total and the number of 
centre squares crossed in a three-minute period.  
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2.11.2 Elevated Plus Maze 
A widely used test of measuring anxiety like behaviour in mice, the elevated plus maze (EPM) 
utilises the natural aversion of mice to open and elevated areas. The apparatus consisted of a 
50cm x 50cm cross shaped platform, set 50cm above the floor. Two arms of the maze were 
walled on both sides while the other two were left open.  At the test’s onset animals were placed 
at the junction of the open and closed arms, facing the open arm opposite to the experimenter 
and recorded for five minutes. The walls and floor of the maze were thoroughly cleaned 
between each trial using 70% ethanol and then dried. In order to ensure parity test subjects 
were alternated between SE and EE groups (e.g. mouse S (standard) 1 was recorded first, 
followed by E (enriched) 1, then S2, E2 etc). This test was performed in accordance to a 
previously published methodology [Walf and Frye 2007]. 
 
Five variables were measured: The number of entries made by the rodent onto the open and 
closed arms; the time spent on the open arm and closed arm and latency to enter the closed 
arm. Following observation and tabulation, the integrity of results was verified via blind analysis 
of recordings by another member of the lab.  
 
Figure 2-4. Elevated plus maze. Anxiety-like and exploratory behaviour are tested through 
observation of the number of: entries made by the rodent onto the open and closed arms the time 





2.11.3  Light / Dark Box Test 
This test uses rodent preference for darkened areas and corresponding adversity to illuminated 
ones as a means of observing relative levels of anxiety like behaviour. The test apparatus 
consisted of a 45cm × 20cm ×21cm box, divided into two distinct compartments: One third (15 
cm long) painted black, with a black lid on top. The remainder of the box was painted white and 
open at the top. A 2.5cm × 2.5 cm opening connected the two compartments. One wall of the 
light compartment was formed of transparent Perspex to enable observation. The averseness of 
this compartment was enhanced by illumination from a 50 Watt lamp positioned perpendicular 
to the centre of the box floor. At the test’s onset each animal was placed in the light 
compartment, facing away from the opening and recorded for five minutes. The walls and floor 
of the box were thoroughly cleaned between each trial using 70% ethanol and then dried. In 
order to ensure parity test subjects were alternated between SE and EE groups (e.g. mouse S 
(standard) 1 was recorded first, followed by E (enriched) 1, then S2, E2 etc). This test was 
performed in accordance to a published methodology previously used by the lab [Gallo, Rattazzi 
et al. 2014]. 
Three dependent variables were measured: The time spent in the light area: latency to cross to 
the dark area (delineated by all four paws in) and the total number of transitions between 
compartments. Following observation and tabulation, the integrity of results was verified via 
blind analysis of recordings by another member of the lab.  
 
Figure 2-5. Light dark box. Anxiety-like and exploratory behaviour are tested through observation 
of the time spent in the light area: latency to cross to the dark area and the total number of 
transitions between compartments. 
 
2.11.4  Serum Corticosterone Analysis 
Levels of the stress associated glucocorticoid present in the plasma of EE and SE mice were 
measured using a commercial kit (Corticosterone EIA kit, Enzo Life Sciences) as per 
manufacturer’s instructions. Briefly, plasma samples were isolated from citrulated blood by 
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centrifugation for ten minutes at 2,000x g using a refrigerated centrifuge.  Samples were diluted 
1 in 10 and run in duplicate with a 1.5% steroid displacement buffer on a pre-treated 96 well 
plate. Assay plates included a corticosterone spiked control well and an eight-point standard 
curve produced by serial dilution of a kit-provided, 200,000 pg mL−1 corticosterone standard, 
plates were read at a 405 nM wavelength. Concentrations of samples were calculated by 
plotting the concentration of standards against their corresponding absorbance value, adding a 
line of best fit to these data points and determining the equation for the line. Multiplying the 
values obtained by the absorption values obtained for each sample produced the corresponding 
concentration of corticosterone. 
 
2.12 Caecal Ligation and Puncture  
Caecal ligation and puncture (CLP) is a commonly used animal model of sepsis, (a state of 
intense, systemic inflammation normally instigated by infection). As the name suggests the CLP 
model consists of perforation of the caecum allowing release of faecal matter into the peritoneal 
cavity. Generating an acute, poly-microbial induced immune response. 
 
2.12.1 CLP Procedure  
Mice were anaesthetised by i.p injection (1ml syringe 26G needle) of a solution of 1:1 ketamine 
(75mg/kg. Vetoquinol) and xylazine (15mg/kg. Bayer). Following confirmation of complete 
anaesthesia by paw pinch animals had their abdomen; shaved, swabbed with 70% EtOH and 
placed upon a sterile drape. A 1-2cm midline laparotomy was performed in order to expose the 
caecum and adjoining intestine. The caecum was then ligated using 4.0 silk sutures 
(PROLENE, Ethicon) just below the ileo-caecal valve. The caecum was then pierced through 
twice with a 19G needle at a distance of ~0.5mm from its distal end. Such a distance is reported 
to induce a mid to low grade severity of sepsis [Toscano, Ganea et al. 2011]. Gentle pressure 
was applied to the caecum in order to extrude a small quantity of faecal matter from the sites of 
puncture. The caecum was then returned to the peritoneal cavity and the peritoneum closed 
with 4.0 silk sutures. In turn the skin was then sutured closed. Animals were placed on a heat 
pad and resuscitated by subcutaneous injection of pre-warmed 0.9% saline solution using a 
25G needle. The mice were left to recover from their anaesthesia in an incubation chamber. 
Recovery time took between 20-60 minutes. Animals were then returned to their cages where 
93 
 
free access to food and water (and hydrogel) was provided. Following 12 hours, each animal 
was clinically scored for severity of illness and subject to terminal anaesthesia, followed by 
further processing. 
 
Figure 2-6. CLP, ligated caecum 12 hours post procedure. 
  
2.12.2 Peritoneal Lavage and Cell Count 
Lavage and cell count was carried out in the same manner as previously described (2.8), with 
the modification that the laparotomy and peritoneal lavage was carried out through the left side 
of the mouse, in order to prevent rupture of the sutured peritoneum. 
 
2.12.3 Bacterial Colony Count 
Isolated blood and PLF from each animal was subject to a 10-fold serial dilution in sterile PBS 
down to 10-6. 100µl of each sample dilution (10-1 to 10-6) was streaked across one quarter of a 
nutrient broth (nb) agar plate (10cm diameter, 1cm depth) divided into four equal sections. 
Sterile conditions were maintained throughout this process. Following seeding, the plates were 
incubated at 37°C for 24 hours. Following incubation, a count of the bacterial colonies growing 
on each plate was carried out. Colony forming units (CFU) per ml were calculated by selecting 
the PLF or blood dilution that provided the most accurately quantifiable number of colonies for 
each sample (i.e. visible colonies were present but not so many that one colony could not be 
distinguished from another) and multiplying: 
CFU/ml = Colony count x Dilution factor x ten 
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2.13 Immune-Modulatory Gene Microarray Analysis 
2.13.1 Whole Blood Total RNA Extraction for Micro-Array 
Blood isolated through cardiac puncture was immediately placed in RNAprotect Animal Blood 
Tubes (Qiagen) which contain reagents that lyse blood cells while stabilising intracellular RNA 
to preserve the gene expression profile. 
RNA was then extracted using an RNeasy Animal Blood RNA Mini Kit (Qiagen) adhering to the 
manufacturer’s instructions (RNeasy Handbook 06/2012). Briefly, blood samples were washed 
and pelleted by centrifugation then re-suspended in a buffered solution of proteinase K. 
Following digestion of contaminant proteins the samples were homogenised by centrifugation 
through a polymer matrix and the eluted sample mixed with 90% ethanol to optimise RNA 
binding conditions. Samples were then centrifuged through a silica membrane binding the freed 
RNA. The bound RNA was subject to DNAase digestion to remove DNA contamination and 
then underwent multiple cycles of washing before being eluted in 30µl of RNA free water. 
Quality checking of each RNA sample was carried out by spectrophotometric analysis using a 
Nandrop (ND-1000. Thermo-Scientific) and microfluidic analysis via Agilent 2100 Bioanalyser 
(Agilent Technologies). Bioanlyser analysis was carried out by the QMUL Barts and the London 
Genome Centre. Extracted RNA samples were aliquated into two tubes and stored at -80°C in 
preparation for microarray analysis. 
 
2.13.2 Microarray Protocol 
Purified RNA was sent the University College London Genomics facility for processing and 
microarray analysis. The following procedures and protocols were performed and provided by 
Dr Mark Kristiansen (Application Specialist, UCL Genomics. London). 
Up to 500ng of total RNA was processed and labelled using the Ambion® WT Expression Kit as 
outlined in the manufacturer's instructions. Briefly, sense strand cDNA was prepared from total 
RNA ready for fragmentation and labelling using the Genechip ® WT Terminal Labelling Kit. 
Labelled samples were hybridised on Affymetrix GeneChip Mouse Gene v2.0ST arrays for 16 
hours at 45°C with constant rotation. (Detailed protocols can be found in the Affymetrix WT 
Terminal Labelling and Hybridisation User Manual edition 5.) Subsequent washing and 
scanning of the arrays was performed on an Affymetrix GeneChip Fluidics station 450 and 
GCS3000 Affymetrix scanner respectively according to the manufacturer’s recommendations. 
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The resulting CEL files were used for downstream analysis. Quality control (QC) of the datasets 
obtained from the scanned Affymetrix arrays was performed using Expression Console 
software. 
 
2.13.3  Microarray Data Analysis 
Pathway and statistical analysis was carried out by Dr Masahiro Ono (Faculty of Natural 
Sciences, Department of Life Sciences. Imperial College. London). Relevant genes were filtered 
by excluding those without an Entrez ID and those with low expression levels less than 100 by 
non-logged value. T-statistics were applied across the data set using the Bioconductor package 
Limma, and differentially expressed genes were identified by p<0.05 (non-adjusted p-value) and 
fold change > 2. 
 
2.14  Real Time PCR  
Total RNA was purified from the blood of mice (extracted via cardiac puncture) using an 
RNeasy Protect Animal Blood System (Qiagen) using the same procedure stated in 2.13.1. 
Extracted RNA was reverse transcribed using 2 μg oligo (dT)15 primer, 10U AMV reverse 
transcriptase, 40U RNase inhibitor (all from Promega Corporation, Madison, WI, USA) and 
1.25 mM of each dNTP (Bioline, London, UK) for 45 minutes at 42 °C. The real-time polymerase 
chain reaction was carried out using power a SYBR GREEN master mix (Thermofisher 
scientific) and QuantiTect primers (Qiagen). Cycling conditions were set according to the 
manufacturer’s instructions. The sequence-specific fluorescent signal was detected by 7900HT 
Fast Real-Time PCR System (Applied Biosystems, Warrington, Cheshire, UK). CT values for 
each gene were normalized relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
and then used to calculate expression levels. We used the comparative Ct method to measure 
the gene transcription in samples. Results are expressed as relative units based on calculation 





2.15 Neutrophil Activation  
Activation assays and analysis were carried out using the same protocols stipulated in [Cooper, 
Norling et al. 2008, Headland, Jones et al. 2014]. Briefly, blood samples were separated into 
five aliquots and treated respectively with TNF-α (50 ng/ml), Platelet activating factor (PAF) 
(10−9M) for 15 or 30 minutes at 37°C, or left unstimulated. Samples were washed and stained 
for the presence of GR-1 APC (RB6-8C5 clone), CD11b FITC (M1/M70 clone) and L-Selectin 
(CD62L) PE (Mel-14 clone) on ice for 45 minutes (all antibodies were purchased from, 
eBioscience). Each sample was lysed and fixed using an Immuno-lyze™ reagent kit (Beckman 
Coulter). Neutrophils were gated according to forward/side scatter characteristics and positive 
expression of Gr-1 and CD11b. CD11b expression was recorded as units of fluorescence where 
the median fluorescence intensity for 10,000 cells was measured in the FL1 green channel 
(548nm). In the case of CD11b antibody, the red FL2 channel was used (590nm). Samples 
were analysed by a BD LSRFortessa II™ with post hoc analysis carried out using FlowJoTM 7.0 
software (Tree Star, Ashland, OR, USA, Oregon Corporation). 
 
2.16  Macrophage Phagocytic Function 
The following procedure was based on that of [Montero-Melendez et al., 2015]. Animals were 
injected i.p with 0.5ml of a 4% solution of biogel P-100 Bio-Rad) and left undisturbed for four 
days. Animals were then sacrificed and subject to peritoneal lavage with 10ml of PBS. Collected 
cells were washed twice then re-suspended in complete RPMI-1640 media (Sigma-Aldrich). 
Isolated cells were confirmed as macrophages via microscopic analysis then counted and 
seeded at 0.2x106 cells per well in 200µl of warm complete RMPI on a 96 well, black walled, 
clear bottomed plate (Grenier one) and allowed to adhere for two hours at 37˚C (5% CO2). 
Macrophages were then stimulated with BODIPY 576/589 (Invitrogen) conjugated, lyophilised 
E.coli (sigma) added at a final concentration of 1mg/ml to each well. Following one-hour cell 
activity was halted and any non-phagocytosed E.coli removed by washing three times with cold 




2.17  Sponge Granuloma 
2.17.1  Sponge Implantation Procedure  
The following procedure was based upon that of [Luvone et al., 1994] Mice were deeply 
anaesthetised by i.p injection of a 1:1 solution of ketamine (75mg/kg; Vetoquinol) and xylazine 
(15mg/kg; Bayer). The dorsal hair of each animal was shaved and the skin sterilised with 70% 
ethanol. A roughly 1cm incision was made just below the midline of the back and a small (~2 x 
2cm) subcutaneous pouch formed using artery forceps. A sterilised by autoclave) 0.5 x 1 x 2cm 
polyether–polyurethane sponge was implanted into the pouch and then injected with 100µl of a 
0.1% solution of carrageenan. The cavity was then sutured closed (4.0, Ethicon Ltd, U.K.) and 
the animals placed in a recovery chamber until fully conscious.  
72 hours following surgery animals were sacrificed by Co2. The granulomatous tissue and 
sponge was then carefully excised from each animal with surgical scissors. Following 
separation of the sponge from the tissue encasing it each granuloma was weighed and then 
split in two, 1 half was immediately used for cellular analysis and the other stored in RNAlater 
for later use.  
 
2.17.2 Sponge Infiltrate Extraction and Analysis 
To examine the content of each of the excised sponges, each sponge was hooked onto a 
sterilised paperclip, which was in turn attached to rim of a falcon tube and centrifuged at 
1500rpm for five minutes to extract the fluid it contained. The recovered fluid was centrifuged 
again (1500rpm for five minutes) and the resulting pellet re-suspended in 1ml of sterile PBS and 
the supernatant kept for cytokine profiling. Following quantification by haemocytometer, the 
isolated cells were subject to flow cytometric leukocyte profiling. 
 
2.17.3 Flow Cytometric Leukocyte Profiling  
Cell samples were each stained in 100μl of FACS buffer (PBS containing 5% FCS and 0.02% 
NaN2) containing CD16/CD32 FcIIR blocking antibody (clone 93; eBioscience, Wembley, UK) 
for 30 min at 4°C. Thereafter cells were stained with the following FITC or PE-conjugated 
antibodies (eBioscience, Wembley, UK):  GR-1 (clone RB6-8C5), F4/80 (clone BM8) and 
Ly6B.2 (clone 7/4). Cells were labelled with the appropriate concentration of conjugated 
antibodies for 40 minutes at 4 °C then washed and analysed. In all experiments, stained cells 
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were acquired with an LSR FORTESSA flow cytometer (becton Dickinson) post hoc analysis 
was carried out using FlowJoTM 7.0 software (Tree Star, Ashland, OR, USA, Oregon 
Corporation). 
 
2.17.4 Exudate Cytokine Profiling 
Quantification of cytokines keratinocyte chemoattractant (KC), interleukin 10 (IL-10), 
macrophage inflammatory protein-one alpha (MIP1-α) and tumour necrosis factor alpha (TNF-
α), within the exudate supernatant was performed using a Bio-Plex mouse cytokine assay (Bio-
Rad, Hercules, CA, USA) according to the manufacturer’s directions. Measurements were 
carried out using a Luminex Bio-Plex 200 system (Bio-Rad) and then analysed with Bio-Plex 
Manager 6.1 software (Bio-Rad). 
 
2.17.5 Granuloma Dispersal and Flow Cytometric Analysis 
Granuloma samples were finely minced using a scalpel blade and added to a 0.1% solution of 
collagenase (Sigma-Aldrich) in HBSS (GIBCO) and incubated while swirling at 37oC for 60-90 
minutess until a uniform suspension was formed. The solution was then passed through a 
150µm strainer and pelleted by centrifugation (1800rpm, 5 minutes). The resulting pellet was re-
suspended in 2ml of a 0.5% solution of pronase-A (Sigma Aldrich) in HBSS and incubated while 
swirling at 37oC for roughly 30 minutes until the preparation was predominately a suspension of 
single cells. Following washing and re-pelleting the cells were counted by haemocytometer.  
 
2.17.6 RT PCR Profiling of Granuloma Tissue 
Granuloma tissue was homogenised using a Precellys24 homogeniser (Precellys) and total 
RNA extracted using an RNeasy mini kit (Qiagen) according to the manufacturer’s protocol. 
Extracted RNA was reverse transcribed using 2 μg oligo (dT)15 primer, 10U AMV reverse 
transcriptase, 40U RNase inhibitor (all from Promega Corporation, Madison, WI, US(A) and 
1.25 mM each dNTP (bioline, London, UK) for 45 minutes at 42 °C. Following quality assurance 
and quantification by nanodrop (Thermo Scientific) samples were analysed for gene expression 




2.18 Statistical Analysis 
According to the nature of the data obtained a two tailed t-test, or ANOVA (one or two-way) was 
performed. Time course observations were analysed with multiple t-tests and the Holm-Sidak 
post-hoc test. Behavioural data was analysed via non parametric analysis using the Mann 
Whitney U test. All statistical analysis was performed using GraphPad PRISM software (V6.0) 
with the exception of microarray analysis which was carried out as stated in 2.13.3 using the 
software package LIMMA (bioconductor). 
 
2.19 Experimental Design and Consideration of the Three Rs 
Owing to the explorative nature of the research carried out and the wide variability of results 
obtained in previous studies investigating the influence of enrichment on the immune response 
(and in our own pilot studies), it proved very difficult to make any reliable assumptions about 
effect size when planning for the group sizes to be used in each experiment. 
 
In order to work out a suitable sample size we used a cruder (but still effective) resource 
equation calculation (or E equation). 
According to this method a value “E” is measured, with E equal to the total number of animals 
used in an experiment minus the total number of experimental groups [Charan and Kantharia, 
2013]. 
The E value should lie between 10 and 20. If E is equal to or less than 10 then adding more 
animals will increase the chance of getting more significant result. If E exceeds 20 then adding 
more animals should not increase the chance of getting significant results. 
 
Originally treatment groups of 10 mice were planned with two groups; enriched environment 
and standard environment  
Therefore, E= (10 mice x 2 groups) – 2                E=18. 
  
The same number of mice per group has been used for previous enrichment experiments 




Previous experience of the experimental models performed in this thesis suggested a high 
likelihood that some of the animals would become unsuitable for data collection due to 
experimental error (e.g. through presence of blood in peritoneal lavage during ZIP and CLP or 
removal of sutures in the sponge granuloma model). It was accordingly decided to add a further 
two mice per group to account for this error, producing a final total of 12 in all.  
 
Efforts were made to ensure this project ascribed to the guidelines provided by the NC3Rs 
(National Centre for Replacement, Refinement and Reduction of Animals in Research) for the 
requirements for good rodent housing and husbandry [NC3Rs, 2017]. Owing to the nature and 
purpose of this study the housing conditions for the standard lab enclosure group conformed to 
the normal set up used for mice in the facility this study was carried out in. These conditions in 
turn followed the basic housing requirements stipulated by the NC3Rs.  
These included: 
• The housing of animals in stable, compatible groups - Staff took into account; sex, age, 
reproductive condition, familiarity, prior group housing experience when grouping the 
animals. Special care was taken to assess for signs of excessive fighting among groups 
in the enriched cages.  
• The use of enclosures designed to cause minimum disturbance to the animals 
• The provision of enough space for exercise and normal behaviour (e.g. grooming and 
pandiculation).  
• The provision of basic environmental enrichment (nesting material) to help reduce the 
risk of social stress and aggression and allow the animals to fulfil some of their species-
specific behaviours. 
• Gentle and frequent handling from early in life.  
 
Housing conditions in the enriched environment group (See section 2.2 for a detailed 
description) were designed using previous research supported by the NC3Rs as means of 




Throughout the course of each study carried out all animals were subject to regular 
assessments of their welfare status (every second day). These checks were verified by staff at 
the animal unit and (on three separate occasions) visits by a home office inspector. 
 
In order to minimise animal numbers efforts were made to generate as much data as possible 
from each animal used, these included: 
• Taking weight, food/water intake and adiposity measurements from every animal. 
• Taking blood (serum and plasma), PLF and bone marrow samples from every animal in 
order to obtain data on multiple aspects of their biological status. 
• Pre-emptive storage of these samples as well as further organs and tissues in 
preparation for any further analysis that may need to be carried out. 
• Where possible, subjecting animals to batteries of tests (e.g. behavioural) to reduce the 
need for repetition. 
• Performing pilots of each procedure with one to two animals in order to refine 




2.20 General Experimental Schema 
All experiments followed the same basic program. Following receipt mice were allocated into SE 
or EE cage groups and allowed one week to acclimatise to the lab environment (day -7 to 0). 
Following which they spent two weeks in an enrichment or standard enclosure (Days 0 – 14). 
Animals were then subject to either a battery of behavioural tests or one model of inflammation, 




Acclimatisation Day -7 
Enrichment Days 0-14 
All Behavioural Assessments 3 hours 
Zymosan induced peritonitis 6 hours 6 hours 
Caecal ligation and puncture 12 hours 
Zymosan induced peritonitis 24 hours 24 hours 
Sponge granuloma  72 hours 
Environmental Modulation 
Behavioural/ Immune assessment (only one protocol used per experiment)  
Experiment Ends  




N.B Unless otherwise specified all results displayed are representative of one data set chosen 
from three repeat experiment.s 
 
3.1 Physiological Parameters 
We recorded the basic physiological parameters (weight, nutritional intake, fat content) of all 
experimental animals. This data served as a simple, initial means of identifying any gross 
changes in animal physiology and immune state.  
 
3.1.1 Comparative Weight Gain Over Experimental Period  
Over the course of the 14-day enrichment period animals in the environmentally enriched (EE) 
group demonstrated a significantly slower weight gain than those from the standard 
environment (SE) (Figure 3-1). At the end of the two weeks SE animals had gained on average 
one gram of additional weight compared to EE. This pattern of weight change was observable in 
every experiment these parameters were measured (ten experiments in total.) 
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Figure 3-1. Comparative weight change over time. 24 Mice per group, N=12 experiments. Statistical 
significance determined using multiple t-test analysis, results were normalised using the Holm-





3.1.2 Comparative Nutritional Intake Over the Experimental Period 
Animals from both groups maintained roughly the same intake of food (average 27g of chow 
consumed per cage group, per day). Enriched animals trended towards a higher overall water 
intake (average SE, 29ml and EE, 35ml of water per group, per day.) (Figure 3-2). In the three 
separate experiments that were assessed, food intake remained remarkably consistent across 
test groups and successive days of measurement. The only point in which this trend was 
perturbed was at the onset of the enrichment period when both groups were moved into new 
cages. Here food intake would be consistently lower than average at time point one (day one) 
and higher at time point two (day three). This transient anorexia followed by polyphagia likely 
indicates the transition from a state of neo-phobia followed by habituation as these animals 
habituate to a new environment [Misslin et al., 1982].  
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Figure 3-2. Total food and water intake per cage group over enrichment period. Results shown are 
an average of the two cages used for each experimental group N=3 experiments, each with 24 mice 




3.1.3 Subcutaneous Fat Levels Following Enrichment 
In order to determine the source of this variance in weight change, levels of subcutaneous fat 
were assessed between groups. The overall weight and size of visceral fat pads excised from 
animals was consistently lower in EE compared to SE groups (Figure 3-3, Figure 3-4). 
Comparatively reduced levels of adiposity were observed throughout the bodies of enriched 
animals (data not shown). 
 
Figure 3-3. Comparative images of visceral fat pads from enriched versus standard environment 
mice. 
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Figure 3-4. Comparative weights of visceral fat pads taken from enriched and standard 
environment mice . **p<0.005, t-test. N=1 experiments, 24 mice per group. 
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3.2 Investigation of Enriched Mice in a Basal Immune State  
Continuing our investigation of the influence of environmental enrichment on murine biology we 
moved on to focus on its effect on the immune response. As part of this three primary cellular 
compartments were investigated for signs of immune activity: Bone marrow; the point of origin 
for most innate immune cells. Blood; the primary route of transit for these cells and the 
peritoneal cavity; a large serosal space that we chose to use as a focus for inflammation. To 
determine whether enrichment had any physiological effects on mice in a basal, non-immune 
activated state we initially chose to investigate enriched mice untreated with any inflammagen 
or immune-active compound.  
 
3.2.1 Basal Immune State: Cellular Profile of the Peritoneal Cavity  
The peritoneum is a large membrane bound and fluid filled cavity found in all mammals, housing 
the liver, spleen, gastro-intestinal tract and other viscera. Previous studies have identified a 
variety of immune cells are resident within the peritoneal cavity, including unique macrophage 
subsets and B-cells [Ray and Dittel, 2010].  
 
Microscopic analysis of lavage fluid extracted from the peritoneal cavity of EE and SE mice 
revealed the majority of isolated cells to possess a morphology associated with that of 
monocytes and non-activated macrophages (large size, agranulated, indented nucleus). A cell 
count of the lavage revealed no differences in overall cell number between EE and SE mice 
(Figure 3-5a). FACS analysis of this PLF identified a small but distinct population of F4/80 
expressing cells in both animal groups, identified previously as peritoneal resident macrophages 
[Davies et al., 2013], no comparative differences in the number of these cells were found 
(Figure 3-5b). Additional staining for granulocytic (GR-1) and monocytic (Ly6b.2) markers 




Figure 3-5. Peritoneal cell populations in enriched and standard environment mice. (a) Overall 
peritoneal cell count (b) FACS plot and respective count of high F4/80 expressing cells, attributed 
as macrophages (c) double negative FACS plot of GR-1 (granulocyte) and Ly6B.2 (monocyte) 
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3.2.2 Basal Immune State: Peritoneal Cytokine Analysis  
Analysis of the extracted PLF by Luminex assay found the presence of inflammatory cytokines 
in the peritoneal cavity to be below detectable limits (10pg/ml). Such results would be expected 
for an animal in a basal, non-immune activated state. 
 
3.2.3 Basal Immune State: Blood Cellular Profile  
Analysis of extracted cardiac blood (using an IDEXX Haematology Analyser) identified no 
difference in total circulating leukocytes or individual leukocyte populations (neutrophils, 
lymphocytes or monocytes) between EE and SE groups (Figure 3-6a and b). However, a 
significant difference in the relative proportions of circulating cell types was observed, with the 
blood of EE mice consistently possessing a higher percentage (~10%) of neutrophils and a 
correspondingly lower percentage (~10%) of lymphocytes when compared to the SE group 
(Figure 3-6c). Overall lymphocytes were found to be the largest leukocyte population circulating 
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Figure 3-6. Circulating blood cell populations in enriched and standard environment mice. (a) 
Total blood leukocyte count b) Individual leukocyte population counts (c) Relative percentages of 




3.2.4 Basal Immune State: Bone Marrow Cellular Profile   
Microscopic investigation of viable cells extracted from the tibia of EE and SE animals revealed 
a complex mixture of leukocytes and erythrocytes at various stages of development. While 
some mature leukocytes could be identified (e.g. neutrophils, erythrocytes), the transitory stage 
of development most of the cells were within, made distinction between populations difficult. A 
total count of the extracted tibial cells revealed enriched mice possessed a significantly higher 
cell number in their bone marrow (Figure 3-7a) compared to those from SE. In an effort to 
further delineate cell populations within the bone marrow staining for the 
granulocytic/neutrophilic markers GR-1 and CD11b was carried out.  No significant differences 
were identified between groups for cells expressing these markers (Figure 3-7b). As with the 
microscopic analysis it was noted that populations appeared to be in a transitionary 
developmental state with plots presenting a continuum of cells with increasing expression of 
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Figure 3-7. Bone marrow cell population in mice from enriched and standard environments. (a) 
Total tibial myelocytes and leukocytes. (b) FACS plot and respective count of GR-1 (granulocyte) 
CD11b (monocyte lineage) positive cells. *p<0.05, t-test. Representative of N=3 experiments, 24 
mice per group. 
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3.3 Zymosan Induced Peritonitis: Six Hour Time Point 
We next chose to examine the effects of environmental enrichment on leukocyte recruitment 
utilising an experimental model of zymosan induced peritonitis (ZIP). Two time points were 
chosen in which to sacrifice and analyse treated animals. Each time point corresponded to 
established peaks of innate leukocyte recruitment: Six hours – typified by high numbers of 
neutrophils and 24 hours – typified by a peak influx of monocytes [Cash et al., 2009]. 
  
3.3.1 ZIP 6: Cellular Profile of the Peritoneal Cavity  
Following enrichment and six hours of ZIP analysis of peritoneal lavage revealed a significantly 
higher number of cells in the peritoneum of EE animals (Figure 3-8a). Concordant with the 
established time-course of ZIP overall numbers of cells were roughly tenfold higher across both 
groups when compared to animals that had received no inflammagen [Cash et al., 2009]. 
Microscopic study revealed a large number of these cells to possess a granular cytoplasm and 
a tri-lobed nucleus, a morphology typically associated with neutrophils. Flow cytometric analysis 
confirmed this observation, identifying the dominant cell population in both animal groups to be 
GR1hi, F4/80-, ascribed as neutrophils (Figure 3-8b). Smaller populations of GR1hi, Ly6B.2+ cells 
- attributed as monocytes - were also found (Figure 3-8c). With both sets of markers EE animals 
typically displayed a higher proportion of positively expressing cell populations compared to SE 
(~10-20%) more neutrophil marker expression and ~1-4% more monocyte marker expression. 
For both neutrophil and monocyte populations a significantly higher number (~50%) of cells 
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Figure 3-8. Peritoneal cell populations in enriched and standard environment mice following six 
hours of zymosan induced peritonitis. (a) Overall peritoneal cell count. (b) FACS plot and 
respective count of F4/80-  GR1hi expressing cells attributed as neutrophils (Quadrant 3). (c) FACS 
plot and respective count of a GR-1hi, Ly6B.2+ cell population attributed as monocytes. *p<0.05 
(**p<0.005), t-test. Representative of N=3 experiments, 24 mice per experiment. 
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3.3.2 ZIP 6: Peritoneal Cytokine Levels 
Further analysis of the extracted PLF identified heightened levels of pro-inflammatory cytokines 
in the peritoneal cavity of mice from both groups. These levels were concordant with those 
found in previous studies using ZIP [Cash et al., 2009]. While no significant differences in 
peritoneal cytokine levels were found between groups (potentially due to the sample number 
used) a concurrent trend for reduced IL-6 and KC in enriched mice was observed across all 
three repeat experiments (Figure 3-9).  
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Figure 3-9. Comparative cytokine levels in the peritoneum of animals subject to six hours ZIP. 
Comparative levels of (Reading top to bottom left to right): Interleukin six, keratinocyte 
chemoattractant, macrophage chemoattractant protein 1 and tumour necrosis factor alpha. 
Results representative of N=3 experiments, 10 mice per experiment. 
114 
 
3.3.3 ZIP 6: Blood Cellular Profile 
As with the basal readouts blood analysis identified no differences in overall numbers of blood 
leukocytes between the two experimental groups (Figure 3-10a). Overall numbers of neutrophils 
were found to have increased roughly twofold across both groups with corresponding decreases 
in circulating lymphocytes and to a lesser extent: monocytes (Figure 3-10b). However, in 
contrast to the basal results (3.2.3) circulating lymphocyte numbers were significantly lower in 
EE animals (~25%) compared to SE and a strong trend was found across all repeat 
experiments for a higher number of neutrophils (Figure 3-10b). Analysis of relative proportions 
of leukocytes in circulation revealed an overall increase in the percentage of circulating 
neutrophils in both animal groups. Such a state is typically associated with an active innate 
immune response [Liu et al., 2016]. However, within this state of neutrophilia the variation in 
circulating immune cell proportions identified in the previous basal experiments was amplified. 
EE mice presented a significantly higher relative percentage of neutrophils (and correspondingly 
lower percentage lymphocytes in circulation compared to SE mice). Numbers and proportions of 
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Figure 3-10. Circulating blood cell populations in enriched and standard environment mice 
following six hours of zymosan induced peritonitis. (a) Total blood leukocyte count (b) Individual 
leukocyte population counts (c) Relative percentages of individual leukocyte populations. *p<0.005 
(**p<0.005), t-test. Representative of N=4 experiments, 24 mice per experiment. 
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3.3.4 ZIP 6: Bone Marrow Cellular Profile 
Interested to determine the source of this neutrophil influx into the peritoneum and blood 
circulation we profiled the point of origin for these leukocytes, the bone marrow. Following six 
hours of ZIP overall cell numbers in the bone marrow were roughly three times lower in both 
groups compared to basal data (3.2.4) (Appendix 1) such decreases in bone marrow population 
have been reported as occurring transiently during inflammatory challenge in previous studies 
[Bian et al., 2012]. No significant difference in cell counts were found between EE and SE 
animals although a trend for higher cell numbers in the enriched animals was identified across 
all four experiments (Figure 3 10a). Again a non-significant trend for higher GR1+, CD11b+ cell 
numbers was identified in the EE group (Figure 3 10b).  
 
Figure 3-11. Bone marrow cell populations in mice from enriched and standard environments 
following six hours of zymosan induced peritonitis. (a) Total tibial myelocytes and leukocytes. 
(b) FACS plot and respective count of GR-1 (granulocyte) CD11b (monocyte lineage) positive 
cells. N=4 experiments, 24 mice per experiment. 
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3.4 Zymosan Induced Peritonitis Twenty-Four Hour Time Point  
 
3.4.1 ZIP 24: Cellular Profile of Peritoneal Lavage  
The 24 hour time point of ZIP is typically associated with a transition from a neutrophil focused 
to a more monocyte/macrophage led immune response [Ajuebor et al., 1998]. Microscopic 
analysis of lavage fluid extracted at this point supported these findings with cells of a 
monocyte/macrophage type morphology identified among the neutrophils that dominated the 
peritoneal lavage at the earlier six hour time point (3.3.1). Enriched animals still possessed a 
significantly higher number of cells (~20%) compared to those of the standard group (Figure 
3-12a). Concordant with the six hour time point FACS analysis identified higher numbers of GR-
1hi, F4/80- neutrophils and GR-1hi, Ly6B.2+ monocytes in the enriched group (Figure 3-12b&c). 
In contrast to the six-hour time point, monocytes now formed a larger proportion of the overall 
peritoneal population (24 hours ~20% 6 hours <5%) (Figure 3-12b). An additional F4/80hi GR-1- 
population was also identified and ascribed as monocyte derived macrophages (Cash, White et 






Figure 3-12. Peritoneal cell populations in enriched and standard 
environment mice following 24 hours of zymosan induced 
peritonitis. (a) Overall peritoneal cell count (b) FACS plot and 
respective count of a GR-1hi, Ly6B.2+ cell population attributed 
as monocytes. (c) FACS plot and respective counts of F4/80- GR-
1hi expressing cells attributed as neutrophils and F4/80hi GR-1- 
cells, attributed as macrophages. *p<0.005 (**p<0.005), t-test. 
Representative of N=4 experiments, 24 mice per experiment. 
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3.4.2 ZIP 24: Peritoneal Cytokine Levels 
 Analysis of the extracted PLF identified levels of IL-6, KC and MCP-1 had fallen strongly in both 
groups when compared to readouts taken from the six hour time point (3.3.2). TNF-α levels 
remained roughly consistent. Again, while no significant differences in peritoneal cytokine levels 
were found between groups a concurrent trend for reduced IL-6 and TNF-α and increased KC 
and MCP-1 were observed across both repeat experiments (Figure 3-13).  
 
  










S ta n d a rd E n r ic h e d











S ta n d a rd E n r ic h e d










S ta n d a rd E n r ic h e d









S ta n d a rd E n r ic h e d
Figure 3-13. Comparative cytokine levels in the peritoneum of animals subject to 24 hours ZIP. 
Comparative levels of (reading top to bottom left to right): Interleukin six, keratinocyte 
chemoattractant, macrophage chemoattractant protein 1 and tumour necrosis factor alpha. 
Results representative of N=2 experiments, 10 mice per experiment (third repeat experiment failed 
to yield any data). 
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3.4.3 ZIP24: Blood Cellular Profile 
Concordant with basal and ZIP six hour analysis no difference in overall numbers of blood 
leukocytes were identified between the two mouse groups (Figure 3-14a). Mice from the 
enriched group presented a significantly higher overall number of circuiting neutrophils (~25%) 
compared to SE animals and a correspondingly lower number of circulating lymphocytes 
(~15%) (Figure 3-14b).  
 
Analysis of relative proportions of leukocytes in circulation revealed that across both groups the 
overall percentage of neutrophils had dropped by roughly 20% in comparison to results 
obtained at the six hour time point (3.3.3). Relative lymphocyte populations had increased 
correspondingly. Despite this shift, enriched animals still maintained a significantly higher 
proportion of neutrophils (20%) and lower proportion (15%) of lymphocytes in circulation 





Figure 3-14. Circulating blood cell populations in enriched and standard environment mice 
following 24 hours of zymosan induced peritonitis. (a) Total blood leukocyte count (b) Individual 
leukocyte population counts (c) Relative percentages of individual leukocyte populations. 
*p<0.005 (**p<0.005), t-test. Representative of N=3 experiments, 24 mice per experiment. 
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3.4.4 ZIP 24: Bone Marrow Cellular Profile  
 
Following 24 hours of ZIP overall cell numbers in the bone marrow had recovered to near basal 
levels in both groups (3.2.4), transient neutropenia followed by rapid neutrophil re-population 
such as this has been reported in previous studies [Chervenick et al., 1968] with no significant 
difference in cell counts (Figure 3-15a). GR-1+, CD11b+ populations had returned to an 
expression profile similar to that found in basal analysis (3.2.1), accounting for roughly one third 
of the cells in both groups with no significant difference in numbers (Figure 3-15b). 
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Figure 3-15. Tibial bone marrow cell population in mice from enriched and standard environments 
following 24 hours of zymosan induced peritonitis. (a) Total tibial myelocytes and leukocytes. (b) 
Scatter plot and respective calculated counts of GR-1 (granulocyte) CD11b (monocyte lineage) 
positive cells. Representative of N=2 experiments, 24 mice per experiment.
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3.5 Caecal Ligation and Puncture 
 
Having established that housing in an enriched environment influences the cellular response to 
an exogenously administered inflammagen we moved on to explore how enriched animals 
would respond to a more complex live bacterial model of inflammatory insult. Accordingly, we 
chose to employ a mouse model of endogenous bacterial sepsis induced by caecal ligation and 
puncture (CLP). CLP induces a diffuse polymicrobial sepsis originating in the peritoneal cavity 
and disseminating into circulation usually within hours of the procedure. While CLP is almost 
invariably fatal to the subject [Dejager et al., 2011], assessment of immunological parameters 
prior to onset of death provides a valuable means of identifying the strength and direction of the 




3.5.1 CLP: Peritoneal Cell Profile 
Similar to ZIP, CLP induces a rapid and acute inflammatory peritonitis, characterised by an 
influx of innate immune leukocytes into the peritoneal cavity [Dejager et al., 2011]. Twelve hours 
following the induction of CLP a count of the extracted PLF presented a dramatically heightened 
number of cells in the peritoneum of both experimental groups compared to baseline data 
(3.2.1) with microscopic analysis suggesting a large number of these cells to be granulocytic. 
Comparative cell counts revealed EE mice to possess a significantly higher cell number 
compared to SE animals (Figure 3-16a). Flow cytometric analysis revealed a corresponding 
trend (non-significant) for a heightened number of GR-1hi F4/80- neutrophils in the peritoneal 
cavity of EE animals (Figure 3-16b).  
 
Figure 3-16. Peritoneal cell populations in enriched and standard environment mice following 12 
hours CLP. (a) Peritoneal cell count of mice from standard and enriched environments subject to 
12 hours of CLP.b) Representative FACS profiles of F4/80 vs GR-1 expressing cells and 
comparative plots of total peritoneal populations of GR-1hi F4/80- neutrophils  in SE and EE mice 
*p<0.005 (**p<0.005), t-test. Representative of N=2 experiments, 24 mice per experiment. 
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3.5.2 CLP: Peritoneal Cytokine Levels 
Analysis of extracted PLF (Figure 3-17) and serum (data not shown) identified heightened levels 
of pro-inflammatory cytokines in both groups. Levels were notably higher than those found at 
the six hour time point for ZIP, suggesting a far more severe inflammatory response. No 
significant difference was found in relative levels of cytokine expression between groups. 
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Figure 3-17. Comparative cytokine levels in the peritoneum of mice from and enriched or standard 
environment subject to 12hours CLP.. Comparative levels of (reading top to bottom left to right): 
Interluekin six, keratinocyte chemoattractant, macrophage inflammatory protein-2 and macrophage 




3.5.3 CLP: Blood Cellular Profile 
Blood profiling revealed that both animal groups presented a notably reduced number of 
circulating leukocytes compared to basal results (3.2.3) (Figure 3-18a). Such a drop in blood 
leukocytes has been previously reported as a symptom of early stage sepsis [Nguyen and 
Smith, 2007]. No differences in comparative numbers of total blood leukocytes were found 
(Figure 3-18a). Significantly higher numbers of circulating lymphocytes and monocytes were 
identified in EE animals with a concurrent trend towards lower neutrophil numbers when 
compared to SE mice (Figure 3-18b). 
 
A similar pattern was found in analysis of relative proportions of leukocytes within blood, with a 
significantly highly percentage of monocytes found in EE animals and a corresponding trend 
towards increased lymphocytes and reduced neutrophils compared to SE mice (Figure 3-18c). 
For both groups neutrophils were the dominant leukocyte population in circulation (~40-50%) 
(Figure 3-18c). This contrasts to animal in a basal state which typically presented a proportion 





Figure 3-18. Circulating blood cell populations in mice from a standard or enriched environment 
subject to 12 hours of CLP. (a) Total blood leukocyte count (b) Individual leukocyte population 
counts (c) Relative percentages of individual leukocyte populations. *p<0.005 (**p<0.005), t-test. 
Representative of N=2 experiments, 24 mice per experiment. 
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3.5.4 Caecal Ligation and Puncture, Bacterial Colony Counts 
In order assess of the overall bacterial load of animals subject to CLP, serially diluted samples 
of extracted blood and PLF were seeded on agar plates and incubated overnight. The following 
day resulting bacterial colonies found upon the plates were quantified. Colony counts of the PLF 
showed a trend (non-significant) for a lower overall bacterial count in the peritoneal cavity of 
enriched animals (Figure 3-19a). Colony counts from blood samples were significantly lower in 
EE compared to SE mice (Figure 3-19b). Suggesting enriched animals possess a reduced 
number of bacterium in blood circulation at this 12 hour time point compared to those housed in 
a standard lab environment.  
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Figure 3-19. Respective bacterial colony counts in (a) peritoneal lavage fluid and (b) blood 
populations of animals raised in an enriched or standard environment subject to 12 hours of CLP. 
Values represented a colony forming units per ml. *p<0.005 (**p<0.005), t-test. Representative of 




3.6 Genetic Profiling of Whole Blood from Environmentally Enriched 
Mice 
Aiming to identify potential mechanisms responsible for the altered cellular immune response in 
enriched mice we compared the genetic fingerprints of whole blood taken from EE and SE 
animals in a basal immune state. Using fold change (FC) >2 or <0.5 and non-adjusted p-value 
<0.05, of the 34,760 probes present on the chip, eight genes were identified as upregulated and 
five genes downregulated (Figure 3-20), listed in Table 9. 
 
Figure 3-20. Microarray heatmap of blood RNA extracted from mice raised in an enriched vs 
standard lab environment. Gene expression across the blood of three mice per experimental 




Table 9 Differentially expressed genes in the blood RNA of mice raised in an enriched vs standard lab environment 
Gene Codes Function (when known) Immune relevance (if any) 
Down regulated genes in enriched animals 
Psmf1 Proteasome inhibitor PI31 subunit Potentially inhibits the activation of the 
proteasome by the 11S and 19S 
regulators [Li et al., 2014] 
 Inhibit MHCI peptide processing 
S100a13 S100 calcium-binding protein A13 Involved in Regulation of Fibroblast 
Growth Factor-1 and p40 
Synaptotagmin-1 Release in Vitro 
[Carreira et al., 1998] 
Implicated in the TH17 differentiation pathway [Nimmo et 
al., 2012]. Upregulated in response to bacterial activation 
of neutrophils [McLachlan et al., 2004]. Promotes 
expression of IL1-α from fibroblast and monocyte cell 
lines[Mandinova et al., 2003] 
Trim10 Tripartite motif containing 10 Erythroid cell terminal differentiation 
[Blaybel et al., 2008] 
- 
Urod  Uroporphyrinogen decarboxylase Key enzyme in heme synthesis 
pathway [De Verneuil et al., 1983] 
- 
Snx15  Sorting nexin-15 Transport protein – implicated in furin 
localisation [Phillips et al., 2001] 
- 
Up regulated genes in enriched animals 
Rnu2-10  U2 small nuclear RNA 10 - - 
Sirpb1 Signal-regulatory protein beta 1 
(SRPb1) 
Glycoprotein receptor that recruits and 
signals via the tyrosine phosphatases 
SHP-1 and SHP-2 [Alblas et al., 2005]. 
Macrophage NO production via JAK/STAT [Alblas et al., 
2005]. Integrin-Mediated Monocyte Adhesion, Trans-
endothelial Migration and Phagocytosis[Liu et al., 2008] 
Pcp4l1  Purkinje cell protein 4 like 1 expressed in specific domains of the 
developing brain [Bulfone et al., 2004] 
- 
Rhoj  Rho-related GTP-binding protein Focal adhesion molecule disassembly 
and angiogenesis[Wilson et al., 2014, 
Kim et al., 2014] 
Upregulated in response to bacterial infection in zebrafish 
[Salas-Vidal et al., 2005] 
Gm5150 predicted gene - - 
S100a9  S100 calcium-binding protein 
A9,migration inhibitory factor-
related protein 14 (MRP14), 
Calgranulin B 
-Binds S100A8 below to form the 
neutrophil associated molecule 
calprotectin 
Promotes leukocyte recruitment, neutrophil and 
macrophage accumulation, macrophage cytokine 
production, and SMC proliferation[Croce et al., 2009] 
S100a8  Calgranulin A Binds S100A9 above to form 
calprotectin neutrophil molecule 
Regulator of innate inflammation [Ehrchen et al., 2009] 
leukocyte, (neutrophil) trafficking[Kerkhoff et al., 1998] 
implicated in colitis [Røseth et al., 1997] 
Chil1  Chitinase-3-like protein 1 
(CHI3L1) 
A member of the family of mammalian 
chitinase-like enzymes. Has no direct 
enzymatic function 
Secreted by activated macrophages and neutrophils, 
upregulated during inflammation and the TH2 response 




3.6.1 Real Time PCR of Enriched vs Standard Mouse Whole Blood RNA 
A literature search was performed for each identified gene and four of particular immunological 
interest (s100a8, s100a9, chil1, srpb1) were selected for further study. In order to confirm the 
heightened expression reported by the microarray, real time PCR was carried out using primers 
specific for each of the four genes. A significantly higher level of expression (~1.5- 2 fold) for 
three of the selected genes (relative to housekeeping gene GADPH) was identified in EE mice 
compared to SE (Figure 3-21). 
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Figure 3-21. Real time PCR analysis of genes found to be differentially expressed in mice raised in 
an enriched vs standard environment. From top left: SRPb1 – Signal Regulatory Protein Beta One 
Alpha, Chil-1 – Chitinase like protein one, S100A8 – Calgranulin A, S100A9 – Calgranulin B. 




3.6.2  Analysis of S100A8 and S100A9 Protein Expression  
We then assessed whether this heightened immunomodulatory gene expression program was 
evident at the translational level. We elected to focus on the protein products of genes S100A8 
and S100A9 named calgranulin A and B respectively. In addition to having individual 
modulatory functions calgranulin A and B are able to form the heterodimeric complex 
calprotectin that possesses further, distinct antimicrobial properties. Both calprotectin and its 
constituents are of current interest to clinical research, primarily for their involvement in the 
regulation of colitis and sepsis [Ehrchen et al., 2009]. For this reason and in light of the 
commercial availability of reliable antibodies specific to these proteins we chose to focus upon 
them for protein analysis. Measuring levels of these two proteins in the PLF (Figure 3-22a), 
blood plasma (Figure 3-22b) and total cell lysate (Figure 3-22c) of EE or SE animals subject to 
no inflammatory insult revealed significantly higher levels of these two soluble mediators in EE 
animals. Levels of freely circulating calgranulin A in the PLF and serum of SE mice were so low 
as to be undetectable, with calgranulin B being found at detectable – but comparatively very low 
levels in each sample. Both proteins were found at more substantial levels within the cell lysate 
of SE mice, though still significantly lower compared to samples taken from EE animals (Figure 
3-22c). This would suggest that calgranulin A and B is both being produced at higher levels in 
enriched animals and (unlike SE mice) – both these proteins are being actively released into the 
blood stream.  
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Figure 3-22. Comparative expression of the individual dimers of calprotectin (S100A8 & S100A9) in 
animals housed in an enriched or standard lab environment. Protein content in: (a) Peritoneal 
lavage. (b) Blood serum. (c) Blood pellet lysate. Samples were taken from enriched (EE) and 
standard environment mice (SE) subject to no additional immune modulation. *p<0.005 





3.7 Ex vivo Cell Activity Assays  
Having observed its effects at a systemic and genetic level we next chose to investigate if 
environmental enrichment exerts an influence on the activity of individual leukocytes ex vivo. 
We chose to focus on two cell populations shown to be active in the data acquired from ZIP and 
CLP; neutrophils and macrophages. Each was subject to a series of assays designed to 
determine their overall level of immune activation and function.    
 
3.7.1 Neutrophil Activation  
Samples of blood neutrophils from EE and SE animals were stimulated with the leukocyte 
activating molecules; platelet activating factor (PAF) or Tumour necrosis factor alpha (TNF-α) 
for 15 or 30 minutes. Following stimulation, the cell populations were analysed for the 
expression of activation markers CD11b and CD62L. A quantitative increase in the former and 
decrease of the latter (shedding) is considered indicative of a state of activation [Cooper et al., 
2008]. For each stimuli and respective readout cells from both EE and SE mice demonstrated 
increased expression of CD11b and shedding of CD62L. However, no significant differences 
(calculated by 2-way ANOVA) were identified in the relative change of expression between both 




Figure 3-23. Comparative levels of CD11b and CCD62L expression in blood neutrophils extracted 
from mice housed in an enriched or standard environment. Following stimulation with a TNF-α (50 
ng/ml), b Platelet activating factor (PAF) (10−9M) for 15 or 30 minutes. Values are presented as 
individual data points ±s.e.m. of six mice N=2 experiments. Significance calculated (none found) by 
two-way ANOVA (P < 0.05). 
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3.7.2 Macrophage Phagocytosis 
Biogel elicited macrophages isolated from the peritoneal cavity of EE and SE and animals had 
their capacity for phagocytosis assessed by culture with BODIPY-conjugated E.coli (dried). 
Macrophages isolated from enriched mice were found to phagocytose a significantly higher 
quantity of bacteria over the course of the one hour incubation period than those from animals 
housed in a standard lab enclosure (Figure 3-24). 
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Figure 3-24. Phagocytic capacity of biogel elicited macrophages extracted from animals housed in 
an enriched or standard environment . Comparative levels of BODIPY linked E.coli phagocytosed 




3.7.3 RT PCR of Activated Macrophages 
In order to further investigate the activity of EE macrophages. Isolated cells were stimulated 
with 1 or 10 ng of LPS. The isolated RNA from stimulated cells was subject to RT-PCR to detect 
expression of two key markers of macrophage activation: PTSG2 which codes for 
Prostaglandin-endoperoxide synthase 2 (also known as cyclooxygenase-2 – COX-2), an 
enzyme responsible for the generation of the prostaglandin family of inflammatory mediators. 
NOS-2, which codes for nitric oxides synthase 2 (iNOS), an enzyme that heightens macrophage 
cytotoxic function by catalysing the generation of nitric oxide. EE macrophages were found to 
express lower levels of both genes compared to those isolated from SE animals. These lower 
expression levels were found to be significant for PTGS2 following stimulation with 1ng of LPS 





Figure 3-25. Comparative expression of PTGS2 and NOS2 in LPS stimulated macrophages isolated 
from animals housed in an enriched or standard environment. (a) Relative PTGS2 expression 
following overnight stimulation with 0, 1 or 10 ng of LPS. (b) Relative NOS2 expression following 
overnight stimulation with 0, 1 or 10 ng of LPS. *p<0.005, t-test. Representative of N=1 experiments, 
24 mice per experiment. 
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3.8 Sponge granuloma  
Having investigated the effects of enrichment in the context of an isolated immune activating 
ligand and a live pathogenic challenge we decided to investigate the influence of EE in the 
context of a persistent inflammatory challenge leading to granuloma formation. 
 
3.8.1 Granuloma: Gross Anatomy  
Focusing on the transitionary point between the acute and chronic/resolutionary phases of 
inflammation [Anderson et al., 2008] animals were sacrificed three days following sponge 
implantation. Post mortem analysis revealed the sponges to be surrounded by a layer of solid 
tissue showing some initial signs of angiogenesis (Figure 3-26). At this early stage of the 
granulation response no signs of fibrosis were identified.  
 
 
Figure 3-26. Granulomatous tissue and sponge three days post implantation. 
 
3.8.2  Sponge Granuloma: Exudate Cellular Profiling 
Due to its positioning at the foci of the granuloma response and capacity to retain infiltrated cell 
and soluble factors the contents of the excised sponges provide a useful picture of the 
immediate inflammatory environment of a granuloma. Sponge infiltrate was extracted by 
centrifugation. A cell count revealed no significant differences in total cell numbers between EE 





Figure 3-27. Comparative total cell counts of the extracted infiltrate of sponges implanted in 
animals from an enriched or standard environment for 72 hours. Representative of N=3 
experiments, 24 mice per experiment.  
 
Further analysis of isolated exudate cell by flow cytometry revealed the presence of two distinct 
but linked populations of GR-1 expressing cells GR-1high and GR-1+ (Figure 3-28a). No 
difference in relative numbers of GR-1hi cells or total GR-1 expression was found between 
groups. However, enriched animals possessed a significantly higher number of GR-1+ cells 
(Figure 3-28b). Back gating of these populations (Appendix 3) identified both to be of roughly 
the same size (determined by forward scatter characteristics) but of differing internal complexity 
(determined by side scatter characteristics). GR-1hi cell exhibited a high level of SSC, 
suggesting them to be granulocytic. In contrast GR-1+ cells possessed a comparatively low 
SSC. 
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Figure 3-28. Flow cytometric analysis of cellular infiltrate taken from the extracted infiltrate of 
sponges implanted in animals from an enriched or standard environment for 72 hours. GR-1 vs 
F4/80 (a) Population stratification into GR-1-, GR-1+ and GR-1-hi cells. (b) Comparative cell counts 
of GR1 positive and high populations, individually and combined. *p<0.005, t-test. Representative 
of N=3 experiments, 24 mice per experiment. 
142 
 
In an attempt to further delineate the components of this GR-1+ population, sponge infiltrate 
cells were also stratified by expression of Ly6b.2 vs GR-1. Analysis revealed a small population 
(3-10%) of Ly6b.2hi GR1-1+ cells, ascribed as inflammatory monocytes within both mouse 
groups. Back gating of these cells placed them in the low SSC group described in the previous 
section (Appendix 2). This cell population was found to be significantly higher in enriched 
animals (Figure 3 29). 
Figure 3-29. Flow Cytometric analysis of cellular infiltrate taken from the extracted infiltrate of 
sponges implanted in animals from an enriched or standard environment for 72 hours. GR-1 vs 
Ly6b.2 (a) Population stratification into Ly6b.2+ Gr-1hi and GR-1+ Ly6b.2hi populations. (b) Relative 
population numbers of GR-1+ Ly6b.2hi cells *p<0.005, t-test. Representative of N=3 experiments, 24 
mice per experiment. 
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3.8.3  Granuloma: Sponge Infiltrate Cytokine Analysis 
We further investigated the immune milieu within the granuloma by quantifying the presence of 
key inflammatory cytokines; keratinocyte chemoattractant (KC), tumour necrosis factor alpha 
(TNF-α), macrophage inflammatory protein 1 alpha (MIP-1α) and anti-inflammatory cytokine 
Interleukin 10 (IL-10) within the sponge infiltrate. With the exception of IL-10, significantly lower 
levels of pro-inflammatory, chemotactic cytokines were found in the sponge infiltrate of enriched 
mice. (Figure 3-30). 
 
Figure 3-30.Comparative cytokine levels in the sponge infiltrate of animals from an enriched or 
standard environment subject to 72 hours of sponge implantation. Comparative levels of (reading 
top to bottom left to right): Keratinocyte chemoattractant, interleukin 10, macrophage inflammatory 
protein-one alpha and tumour necrosis factor alpha. *p<0.05 (**p<0.005, ***p<0.0005). Figure 
representitive of N=3 experiments, 24 mice per experiment.  
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3.8.4 Granuloma: Granuloma Tissue, Cellular Profiling 
We moved on to analyse the granulomatous tissue itself. Superficial investigation revealed no 
differences in the weight or gross appearance between the excised tissue of EE and SE mice 
(Figure 3-31a). However, once dispersed a significantly higher cell count was revealed in the 
tissue of enriched animals (Figure 3-31b). This significance persisted after calculating cellularity 
relative to the weight of granuloma tissue recovered (Figure 3-31 
c). Due to the nature of the tissue dispersal process we were unable to perform flow cytometric 
analysis on the granuloma cells. In order to gain some insight into their biological state genetic 
profiling was carried out instead. 
 
3.8.5 Granuloma: Granuloma Tissue, Genetic Profile 
Interested to discover whether the altered cellular and cytokine profile in EE animals was 
modulated at the transcriptional level we analysed extracted granuloma tissues for the relative 
expression of a panel of 84 genes involved in inflammation, immunity and tissue repair. In this 
initial profiling only those genes that were at least 1000 times more highly expressed when 
compared to expression from the other group were selected for further investigation (Figure 
3-32 and Figure 3-33).  The genes identified suggested an expression pattern that favoured 
leukocyte mobilisation and chemotaxis in SE and tissue remodelling and repair in EE mice 
(Table 10). 
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Figure 3-31. Weight and cellularity of granulomatous tissue extracted from animals from an 
enriched or standard environment subject to 72 hours of sponge implantation. From left to right 
figures detail; gross granuloma weights for each experimental group, total cell count recorded for 
each dispersed granuloma, granuloma cell counts relative to the weight of granulomatous tissue 





R T  P C R  G e n e  A r ra y  1



























































































































































































1 0 0 0
2 0 0 0
3 0 0 0
4 0 0 0
5 0 0 0
1 0 0 0 0
1 5 0 0 0
2 0 0 0 0
2 5 0 0 0 C o n tro l
E n r ic h e d
Figure 3-32. Comparative real time PCR profiling array of RNA extracted from the granulomatous tissue of animals housed in a standard or enriched 
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Figure 3-33. Comparative real time PCR profiling array of RNA extracted from the granulomatous tissue of animals housed in a standard or enriched 
environment - 2. Expression detailed relative to that of house keeping gene GADPH  A full list of the genes profiled can be found in Appendix 6. One animal 
used per goup. 
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Table 10 Differentially expressed genes in the granulomatous tissue of animals housed in an enriched or standard environment ;72 hours post implantation 
Symbol Gene Role Reference 
  Orange = Upregulated in enriched mice  
  Blue = Downregulated in enriched mice  
Acta2 Actin, alpha 2, smooth 
muscle  
Alpha actins are a family of proteins involved in cell motility, structure and integrity, 
forming key constituent of the contractile apparatus. 
Alpha-smooth muscle actin (α-SMA) is commonly used as a marker of 
myofibroblast formation 
[Strauch and Rubenstein, 1984] 
Ccl12 Chemokine (C-C motif) 
ligand 12 
Also known as monocyte chemotactic protein 5 (MCP-5). CCL12 specifically 
attracts eosinophils, monocytes and lymphocytes 
[Jia et al., 1996] 
Ccl7 Chemokine (C-C motif) 
ligand 7 
A monocyte chemotactic factor and regulator of macrophage function. CCL7 has 
been shown to interact with MMP2.9 (see below) 
[McQuibban et al., 2000] 
Col14a1 Collagen, type XIV, alpha 
1 
Interacts with the collagen fibril surface. Involved in the regulation of fibrillogenesis 
(collagen fibre formation)  
[Tono-Oka et al., 1996] 
Col1a1 Collagen, type I, alpha 1 The major component of type I collagen, the fibrillar collagen found in most 
connective tissues, including cartilage 
[Majchrzycki et al., 2015] 
Col1a2 Collagen, type I, alpha 2 Forms one of the chains for type I collagen, the fibrillar collagen found in most 
connective tissues 
[Karsenty and Park, 1995] 
Csf3 Colony stimulating factor 3 
(granulocyte) 
Stimulates bone marrow production of granulocytes and stem cells and their 
release into the bloodstream. Regulates the survival, differentiation, and function of 
neutrophil precursors and mature neutrophils 
[Souza et al., 1986] 
Ctsk Cathepsin K Catabolises elastin, collagen, and gelatin allowing the breakdown of bone and 
cartilage. Expression is stimulated by inflammatory cytokines released after tissue 
injury 
[Inaoka et al., 1995] 
Ctsl Cathepsin L A lysosomal cysteine protease that plays a major role in intracellular protein 
catabolism. Its substrates include collagen and elastin, as well as alpha-1 protease 
inhibitor, a major controlling element of neutrophil elastase activity 
[Chauhan et al., 1993] 
Cxcl3 Chemokine (C-X-C motif) 
ligand 3 
A monocyte migration and adhesion factor  [Smith et al., 2005] 
Egf Epidermal growth factor Stimulates cellular proliferation, differentiation and survival. A key soluble factor in 
the wound healing process 
[Carpenter and Cohen, 1990] 
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Symbol Gene Role Reference 
Egfr Epidermal growth factor 
receptor 
 A cell-surface receptor for members of the epidermal growth factor family (see 
above) 
[Yarden and Schlessinger, 1987] 
Il10 Interleukin 10 A key anti-inflammatory cytokine, downregulates the expression of Th-1 cytokines, 
MHC class II antigens and co-stimulatory molecules on macrophages. It also 
enhances B-cell proliferation and antibody production 
[Mosser and Zhang, 2008] 
Itga1 Integrin alpha 1 Forms part of the surface receptor for collagen and laminin. This receptor is 
involved in cell-cell adhesion and may play a role in inflammation and fibrosis 
 [Gardner et al., 1999] 
Itgav Integrin alpha V Receptor for multiple components of the cell matrix  [Bauer et al., 1993] 
Itgb1 Integrin beta 1 (fibronectin 
receptor beta) 
Primarily links the actin cytoskeleton with the extracellular matrix. Integrin beta 1 is 
further involved in cell adhesion and interaction in multiple processes including: 
embryogenesis, haemostasis, tissue repair and the immune response 
[Hynes, 1992] 
Itgb5 Integrin beta 5 A receptor for fibronectin, plays a role in binding together components of the 
extracellular matrix 
[Ramaswamy and Hemler, 1990] 
Mif Macrophage migration 
inhibitory factor 
Aids regulating macrophage function in host defence through suppression of the 
anti-inflammatory effects of glucocorticoids 
[Yokota et al., 2000] 
Mmp2 Matrix metallopeptidase 2 Degrades type IV collagen, (the major structural component of basement 
membranes). MMP2 plays a role in tissue reorganisation, regulation of 
vascularization and the inflammatory response 
[Kundu and Patil, 2006] 
Mmp9 Matrix metallopeptidase 9 Degrades type IV and V collagens and other extracellular matrix proteins, MMP9 
plays several important functions within neutrophil action, angiogenesis and wound 
repair 
[Opdenakker et al., 2001] 
Plaur Plasminogen activator, 
urokinase receptor 
Part of the plasminogen activation system, which is involved in tissue 
reorganisation events such as mammary gland involution and wound healing 
 [Kjøller, 2002] 
Tagln Transgelin A shape change sensitive actin-binding protein and early marker of smooth muscle 
differentiation 
[Assinder et al., 2009] 
Vegfa Vascular endothelial 
growth factor A 
A pluripotent protein involved with: mediating increased vascular permeability, 
inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell 
migration and inhibiting apoptosis 
[Hicklin and Ellis, 2005] 
Wisp1 WNT1 inducible signalling 
pathway protein 1 
Part of the WNT signalling pathway, regulates multiple cellular functions, including 
adhesion, migration, proliferation, differentiation, and survival 





3.9 Behavioural Analysis  
In order to investigate the potential behavioural effects of enrichment, mouse groups were 
subject to a battery of behavioural tests designed to ascertain if the altered housing paradigm 
caused observable changes in the animal’s anxiety like behaviour. 
 
3.9.1 Open Field Test  
The open field test revealed that over the course of the two week enrichment period enriched 
animals show a small but significant decrease in the overall number of squares crossed over 
the test period. Suggesting a potential reduction on overall exploratory activity (Figure 3-34). No 
significant differences were identified in the number of centre crossings or number of rears 
between each group, though a trend for a reduced number of overall rears by enriched animals 
was identified in each experiment. 
 
Figure 3-34. Open field test on animals preceding and following two weeks housing in a standard 
or enriched environment . From left to right total number of: Squares crossed, rears and centre 
crosses. Experiments representative of N=3 experiments, 12 mice per experiment. P<0.05, Mann-
Witney test.  
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3.9.2 Light/Dark Box Test 
While no observable differences were noted for overall time spent in light or the number of 
transitions between zones, light dark box test analysis presented a significantly higher crossing 
latency in animals subject to the enrichment program (Figure 3-35). Again suggesting a reduced 
willingness for exploratory activity and potentially heightened anxiety like behaviour in enriched 
animals. 
 
Figure 3-35. Light Dark test analysis on animals preceding and following two weeks housing in a 
standard or enriched environment. From left to right: Time spent in light, crossing latency, 
transitions from light to dark region. Figures representative of N=3 experiments, 12 mice per 
experiment. P<0.05, paired t test. 
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3.9.3 Elevated Plus Maze 
Elevated plus maze analysis produced no significant differences between groups for each 
parameter investigated, however as with the previous two behavioural tests a trend was 





Figure 3-36. Elevated plus maze test analysis on animals following two weeks housing in a 
standard or enriched environment. From left to right: Number of open arm entries, total time spent 
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3.9.4 Circulating Corticosterone Levels  
Levels of the stress associated immune regulatory hormone corticosterone were also analysed 
in the blood serum of EE and SE animals. While no significant alterations in overall 
corticosterone levels were found between EE and SE groups ( 
 
 
Figure 3-37), a consistent trend for intra-enclosure variation was identified (Appendix 4). 







Figure 3-37. Relative corticosterone levels in the blood plasma of mice following two weeks in a 
standard or enriched environment. Figure representative of N=3 experiments, 12 mice per 
experiment. 
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 Discussion  
This study sought to assess whether defined alterations to an animal’s housing conditions could 
have a modulating effect on its immune response. The experimental paradigm of environmental 
enrichment (EE) was used alongside established models of inflammatory disease to explore 
these potential modulating effects and investigate the possible underpinning cellular and 
molecular mechanisms behind them.  
Our results show that two weeks environmental enrichment invokes a significant alteration in 
the immune response of male CD1 mice: 
• Enhancing circulating leukocyte numbers and myelopoiesis 
• Increasing leukocyte infiltration to foci of inflammation while maintaining circulating 
inflammatory mediators at comparably safe levels 
• Enhancing macrophage phagocytosis (but not neutrophil activation) while moderating 
oxidative burst 
• Enhancing cellular clearance of bacteria in a model of polymicrobial sepsis 
• Inducing the upregulation of circulating immune-protective factors at a basal state 
• Instigating a genetic program geared towards tissue remodelling and wound repair  
Together these results present the picture of environmental enrichment promoting a potentially 
more efficient and immune-protective phenotype in mice. This raises two key questions: How 
are such changes brought about? and what are the implications of such enviro-immune 
influences in an experimental and clinical context?  
 
4.1 Enrichment and Leucocytosis 
Perhaps the most prevalent finding in across all the models used in this study was the 
consistently higher number of leukocytes – most predominantly granulocytes – identified in 
animals subject to environmental enrichment. Analysis of tibial bone marrow suggested that this 
tissue was the likely source of these cells with significantly higher numbers of granulocytic cells 
found in EE animals compared to those animals housed in a standard environment (SE).  
As EE mice have access to both a running wheel and a larger overall enclosure space, one 
explanation for this amplified cell number is the increased level of physical exercise they may 
perform compared to SE animals. Multiple studies have reported heighted haematopoiesis in 
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response to increased physical exercise in mice [Baker et al., 2011] and humans [Morici et al., 
2005, Rehman et al., 2004]. Further, short term exercise has been shown to promote the 
release of granulocytic factors G-CSF, GM-CSF, M-CSF, IL-8 and MCP-1 [Suzuki et al., 2002].  
The similarities between such previous studies and the data acquired in this one make it 
tempting to ascribe the alterations in bone marrow and blood leukocyte numbers solely to the 
increased physical activity EE animals likely perform. However, it should be noted that studies 
have found a high variation in leucocytosis in response to exercise, dependent on multiple 
factors including the nature and duration of the physical activity itself and the metabolic status of 
the individuals undertaking the exercise. In both mice and humans acute exercise bouts are 
typically correlated with an augmented inflammatory state, while prolonged physical activity 
appears immunosuppressive, inhibiting both lymphocyte and granulocyte function [Smith et al., 
1992].  
 
Personal observations of the enrichment enclosures suggested a high level of inter-group 
variation in wheel use. With typically only one or sometimes two animals running on the wheel 
for the majority of the time observed. Studies carried out by Vargas-Pérez et al have identified 
the same behaviours, suggesting that dominance hierarchies within cage groups determine 
resource distribution, with dominant mice running on wheels placed within the cage significantly 
more than subordinate animals [Vargas-Pérez et al., 2009]. Accordingly, it is probable that 
levels of physical exercise within enrichment cages vary greatly between enriched animals and 
so it could logically be assumed that corresponding levels of leucocytosis would be equally 
variable as well. While there is certainly a relatively high level of variation in leukocyte counts 
taken from EE animals it can be seen that while leukocyte values are often significantly different 
between EE and SE groups the level of spread between values remains more or less consistent 
between them. This suggests that while wheel running may be a contributing factor to 
heightened haematopoiesis in EE mice it is not the sole one. Preliminary investigations into the 
effects of housing mice in enrichment cages without an exercise wheel present lends support to 
this hypothesis, revealing that mice from such cages still display a higher leukocyte count than 
SE animals (Appendix 7) Further, while these animals possess lower leukocyte numbers than 
EE animals housed with a wheel the values presented for them have a notably smaller spread. 
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Raising the possibility that inclusion of a wheel in mouse enclosures may indeed increase 
variability of results.  
 
It was also observed that enriched animals presented a consistently lower overall level of 
adiposity than SE animals while maintaining the same average food intake. Suggesting an 
higher overall level of metabolic activity in enriched animals. Concordant results has been 
observed in previous enrichment studies [Grippo et al., 2014, Slater and Cao, 2015] with 
researchers suggesting that housing in a socially enriched environment induces an increase in 
levels of metabolically thermogenic brown fat [Cao et al., 2011, During et al., 2015]. Enriched 
animals in our study were observed to be considerably more physically active than their 
comparatively sedentary SE counterparts, continually exploring and moving around their 
enclosure when awake (Appendix 5). This increased activity is the probable cause of their 
reduced adiposity and another potential contributor to increased haematopoiesis and circulating 
granulocytes in EE animals.  
 
Increased levels of adiposity are in fact also correlated with higher levels of circulating 
leukocytes [Reyes et al., 2015, Johannsen et al., 2008]. However, this increase is typically 
associated with the physically detrimental state of chronic low grade inflammation as opposed 
to the observed immune-protective effects of regular physical exercise. Obesity and a sedentary 
lifestyle have been linked with increases in circulating inflammatory mediators and pro-
inflammatory leukocyte subsets in both mice [Vieira et al., 2009] and humans [Lira et al., 2010] 
and with this a correspondingly higher risk of disease associated with a dysregulated 
inflammatory response [Lumeng and Saltiel, 2011]. Of interest, obesity has also been correlated 
with an exacerbation of sepsis induced inflammation and vascular dysfunction in mice 
[Vachharajani et al., 2005] as well as a reduced capacity for wound healing in both clinical 
[Wilson and Clark, 2004] and animal studies [Seitz et al., 2011].  
 
While the effects of adiposity and sedentarism (exemplified by animals housed in a standard lab 
environment) on circulating leukocyte numbers does not appear as pronounced as those of 
housing in an enriched environment this influence does raise the question as to whether 
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animals housed in a standard lab environment – typically used as the control group in a large 
number of scientific experiments serve a realistic representation of an organism in a ‘normal’ 
immune state.  
One challenge of trying to discern whether the leukogenic effects of environmental enrichment 
are effected solely by physical activity or other factors is that the large majority of experimental 
setups used to investigate enrichment on lab animals (or captive animals in zoos) inherently 
promote increased physical activity as part of their design (be this directly through use of wheels 
or treadmills or indirectly through increased cage size). One exception to this experimental 
paradigm is in enrichment studies performed on animals used as livestock. The financial 
impetus on the livestock industry typically leads to research on improving animal welfare 
focusing on methods to improve an animal’s environment without increasing the floor space of 
the enclosure. In one study laying hens were housed in standard commercial steel battery 
cages, augmented with a perch, sandbox and polypropene string ‘pecking’ bunches. Following 
17 weeks, birds in enriched cages were revealed to possess significantly higher levels of 
circulating heterophils (the avian analogue of neutrophils) compared to those birds housed in a 
standard unadorned cage, as well as heightened leukocyte activity [Matur et al., 2016]. In a 
further study juvenile crayfish housed in enriched tanks displayed higher levels of circulating 
cells in their haemolymph (the invertebrate equivalent of blood) compared to those housed in 
‘unadorned tanks’ [Ayub et al., 2011]. Weaning piglets subject to social enrichment have also 
been found to increase their circulating neutrophil to lymphocyte ratio, however it is uncertain 
whether this effect is transitory or not [Puppe et al., 1997]. 
 
4.2 Altered Leukocyte Ratios in Enriched Animals 
Analysis of blood leukocyte populations of mice in a basal, non-immune-activated state 
revealed EE animals to possess a significantly higher proportion of neutrophils in blood 
circulation compared to SE. This trend was amplified following six hours of ZIP with neutrophils 
becoming the dominant leukocyte population in the blood of EE mice. This neutrophilic trend 
persisted up to 24 hours post zymosan injection, where a heightened proportion of neutrophils 
was found in EE animals despite lymphocytes returning as the overall dominant blood leukocyte 
population (Figure 4-1). While no previous studies investigating the immune-modulatory effect 
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of enrichment on rodents have identified concordant increases in circulating neutrophil 
numbers8, several have observed decreases in blood lymphocyte populations following 
enrichment [Kaufman et al., 1994, Hutchinson et al., 2012, Arranz et al., 2010]. As can be seen 
in the results of this thesis and previous studies a decrease in blood lymphocyte population is 
often accompanied with a con-commitant increase in neutrophils [Doeing et al., 2003].  
                                                     
 








Corresponding to the increased neutrophil to lymphocyte ratio identified in the blood of EE mice 
circulating neutrophil [McCarthy and Dale, 1988] and NK [Nieman et al., 1990] concentrations have 
been shown to increase during and persist following repeat bouts of moderate exercise. Circulating 
lymphocyte concentrations initially increase during exercise and then drop to below pre-exercise levels 
for several hours or days following physical activity depending on the intensity of the exercise program 
[Fry et al., 1992, Nielsen and Pedersen, 1997, Smith et al., 1992]. This peak and trough of lymphocyte 
numbers has been attributed to their rapid tracking out of the lymphatic system and into blood 
circulation during physical activity and their corresponding succession by granulocyte populations 
during recovery [Fry et al., 1992]. Again, for the reasons previously stated, while physical activity is 
likely a contributing factor to the results observed in our study, it is unlikely to be the sole reason for 
the altered leukocyte ratios observed.  
 
Increased neutrophil to lymphocyte count ratios (NLCR) are a common prognostic marker of blood 
stream infection [Liu et al., 2016] and has found growing use as an indicator of underlying low level 
systemic inflammation other chronic inflammatory disease states [Ahbap et al., 2016, van Wolfswinkel 
et al., 2013, Meng et al., 2016]. In our blood profiling of animals subject to CLP we found reduced cell 
numbers typically associated with the instigation of the hypo-inflammatory phase of sepsis - 
leukopenia and lymphopenia [Nguyen and Smith, 2007]. However, in EE mice, the severity of this 
lymphopenia was reduced with enriched animals maintaining higher overall population of lymphocytes 
and monocytes compared to SE mice. Studies in both mice [Bommhardt et al., 2004, Hotchkiss et al., 
1999] and humans [Okashah et al., 2014] have demonstrated that elevated lymphocyte numbers are 
correlated with improved survival rates in studies of sepsis. It is interesting to note that the blood 
profile of EE animals in CLP is the reverse of that found in those subject to ZIP with the former 
presenting higher lymphocyte numbers relative to SE mice and the latter higher neutrophils, again this 
could be attributed to our study animals being in a state of immune-stimulation in ZIP and imminent (if 




4.3 Heightened Cellular Infiltration  
Another feature of the EE-evoked cellular response was an enhanced level of cellular infiltration at the 
point of inflammatory insult (e.g. the peritoneum in ZIP and CLP and surrounding the sponge in 
sponge granuloma). Recent studies investigating the effects of enrichment on a model of dextran 
sulphate sodium (DSS) induced inflammatory colitis also reported increased neutrophil infiltration as 
feature of the EE-immune response. This heightened cellular response was observed to increase the 
severity of symptoms in enriched animals suggesting enrichment aggravated the disease. However, in 
the same study the author reported EE had no effect on the cellular inflammatory response to a model 
of Iodoacetamide (IAA) induced gastritis. Suggesting that the effects of EE on the inflammatory 
response vary depending on the region an inflammatory response occurs [Reichmann et al., 2013]. It 
should be noted that this particular study specifically investigated the effects of EE on the immune 
response of animals that had been subject to water avoidance stress (WAS), a behavioural paradigm 
designed to induce an acute state of psychological stress that, as will be later discussed is known to 
have an acute modulatory influence on the immune response.  
 
In a further study where EE and environmentally impoverished (EI) 9 mice were subject to a model of 
Piry virus induced encephalitis, enriched animals were found to display higher T-cell infiltration into the 
central nervous system (CNS). Accompanying this enhanced infiltration EE mice presented a more 
rapid resolution of infection and a reduced level of overall tissue damage compared to EI reared 
animals [De Sousa et al., 2011]. Additional studies carried out by Kipnis et al have identified that EE 
can spontaneously induce recruitment of T-cells into the brain without any inflammatory insult [Ziv et 
al., 2006]. While these two studies focus upon different leukocyte subsets than this thesis (and also a 
region of the body typically regarded as immune-privileged) they still lend some support to the concept 
that EE may positively influence leukocyte trafficking and infiltration.  
 
Intraperitoneal injection of zymosan induces a rapid accumulation of PMNs into the peritoneal cavity. 
This immune response presents a consistent time course, made up of an initial influx of neutrophils 2-
10 hours post injection followed by the later arrival of monocytes and monocyte-derived macrophages 
                                                     
 
9 It is interesting to note that what is classed as an ‘environmentally impoverished’ enclosure in this 
study is essentially the standard environment enclosure used in all the experiments discussed in this 
thesis (and throughout the five separate animal units I have worked in).  
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at 10-25 hours [Getting et al., 1997, Cash et al., 2009]. It was due to these well-established leukocyte 
dynamics that ZIP was chosen to assess the rate and dynamics of the acute inflammatory response in 
EE animals.  
 
Differential analysis of the cell populations in EE revealed elevated numbers of neutrophils and 
monocytes compared to SE animals at six hours after challenge. Correspondingly, significantly higher 
numbers of peritoneal macrophages were found in enriched animals 24 hours post injection. The 
initially higher influx of neutrophils into the EE animal mirrored the higher proportion we observed in 
circulation in basal conditions. This raises question as to whether these increased cell numbers are 
simply a result of the correspondingly higher levels of myeloid derived cell in the bone marrow and 
blood of EE mice or potentially due to an increased speed of egress to the site of inflammation. The 
observation that circulating monocyte numbers remained the same in EE and SE mice while monocyte 
and macrophage (which likely derived from infiltrating monocytes) numbers in the peritoneal cavity 
were heightened lends some support to this hypothesis. Additionally a previous study which subjected 
mice to enrichment for up to 18 weeks revealed isolated leukocytes to exhibit heightened proliferation 
and chemotaxis indicating a common mode of effect for enrichment [Arranz et al., 2010]. 
 
It is also interesting to note that at 24 hours the most significantly heightened leukocyte population in 
the EE mouse peritoneal cavity, (as a number and a proportion of the total cell count) are 
macrophages. Macrophage influx is typically associated with a more advanced stage of the 
inflammatory immune response, mediating the shift past the acute phase onto resolution or chronic 
inflammation [Italiani and Boraschi, 2015]. This raises the possibility that enriched animals not only 
experience a heightened cellular inflammatory response but a more rapid one also.  
 
EE animals subject to 12 hours of CLP also demonstrated a significantly higher cellular influx of 
neutrophils into the peritoneal cavity than SE mice. These cells were identified to be predominantly 
neutrophils. This heightened leukocyte presence during the transitionary point between the hyper and 
hypo-inflammatory phase of the sepsis response is likely a key contributing factor in the reduced 
bacterial counts identified in enriched animals. Consistent with this finding previous studies have 
shown that diminished innate leukocyte activity and/or numbers are associated with a high mortality 
rate in sepsis [Brown et al., 2006, Alves-Filho et al., 2008]. Congruently, supply of the neutrophil 
attractants CXCL1 and CXCL2 into the peritoneal cavity after inducing polymicrobial sepsis enhances 
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both neutrophil recruitment and clearance of bacteria, as well as improving survival [Craciun et al., 
2010].  
Granulocyte and monocyte influx was also found to be enhanced in animals subject to a carrageenan-
sponge implantation model of wound healing and granuloma. As with the pathologies emulated by 
other models in this thesis, heightened neutrophil influx has been shown to promote improved wound 
healing in previous studies [Devalaraja et al., 2000]. However, it should be noted that efficient cellular 
profiling proved challenging in this particular model. We were unable to perform direct flow cytometric 
analysis on the granuloma tissues we excised. This was due to our methodology of proteinase 
induced cell dispersal having the side effect of cleaving expressed surface receptors from the 
leukocyte cell surface. Preventing binding by marker antibodies. In turn cells extracted from the 
implanted sponges typically displayed high levels of apoptosis likely diminishing the accuracy of the 
data we obtained from them. Future studies would need to devise more effective means of isolating 
and profiling individual leukocytes with granulomatous tissue or otherwise use alternative 
methodologies such as histology or fluorescence microscopy.  
 
4.4 The Cytokine Profile of Enriched Animals 
The consensus of previous studies is that environmental enrichment elicits a reduction in circulating 
pro-inflammatory cytokines IL-6 [Jurgens and Johnson, 2012, McQuaid et al., 2013] , IL-1β [Jurgens 
and Johnson, 2012, McQuaid et al., 2013, Williamson et al., 2012] TNF-α [Jurgens and Johnson, 
2012, Williamson et al., 2012] and IFN-γ [Marashi et al., 2003]. While promoting increased expression 
of anti-inflammatory lymphoproliferative IL-2 [Arranz et al., 2010, Laviola et al., 2004, Marashi et al., 
2003] and IL-10 [Marashi et al., 2003]. 
 
Analysis of an established panel of four cytokines involved in the progression of ZIP identified no 
significant differences in inflammatory cytokine levels in the peritoneum of EE and SE animals at both 
six and 24 hour time points. It is possible that the concentration of zymosan administered in these 
experiments (0.5mg per mouse) was so high as to cause an exacerbated inflammatory response, with 
cytokines released at such high levels that more subtle variations in their concentration would become 
indistinguishable [Cash et al., 2009]. However, fluctuations in these cytokine’s overall levels over the 
two time points were found to match that of previous studies [Cash et al., 2009], elevated at the 6 hour 
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time point and falling towards normal homeostatic levels at 24 hours, suggesting that cytokine 
expression in these animals follows a comparatively normal homeostatic response. 
Correspondingly no significant differences in expression between EE and SE mice were identified in 
the panel of chemotactic factors and pro-inflammatory cytokines chosen to investigate mice subject to 
CLP.(Though as with the ZIP the cytokine levels observed were concordant with previous studies 
employing this model [Huber-Lang et al., 2014]). This finding suggests a unique scenario in which EE 
animals present an intensified cellular response without an accompanying increase in pro-
inflammatory cytokines.  
 
One could speculate that the increase in circulating anti-inflammatory mediators reported in previous 
EE studies may serve to balance or mitigate detrimental levels of inflammatory cytokines that 
infiltrating inflammatory leukocytes typically release. One study lends some support to this concept 
reporting that EE promotes an anti-inflammatory phenotype in brain microglia through adiponectin 
dependent suppression of TNF-α release [Chabry et al., 2015].  
 
In contrast to ZIP and CLP significant differences were found in the cytokine levels of EE and SE mice 
subject to sponge granuloma. Significantly lower levels of pro-inflammatory KC, MIP-1α and TNF-α 
were identified in the sponge infiltrate of enriched mice, while levels of anti-inflammatory IL-10 
remained the same between SE and EE groups. A reduction in pro-inflammatory factors and presence 
of anti-inflammatory cytokines such as IL-10 is typically associated with the shift of the immune 
response into a resolving or reparative phase [Eming et al., 2014, Ortega‐Gómez et al., 2013]. Viewed 
together these cytokine readouts suggest that environmental enrichment may support the mediation of 
pro-inflammatory signalling factors without incurring detrimental immunosuppressive effects on the 
cellular response.  
 
4.5 Leukocyte Activity in Enriched Animals 
Having established EE increased cell quantity, we moved on to investigate if it also effected cell 
quality. Neutrophil selectins (L, E and P) are vital components in the process of the cell’s extravasation 
into tissues. Interaction of selectins with their composite ligands expressed by both leukocytes and 
activated endothelial cells causes the slowdown of flowing leukocytes facilitating their entrance into 
inflamed tissues. Unlike E- and P-selectins, the cellular mechanisms involved in the regulation of L-
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selectin (CD62-L) expression are not fully defined [Gómez-Gaviro et al., 2000]. Regardless L-selectin 
is constitutively expressed on the cell surface of neutrophils and has been shown to be enzymatically 
cleaved and shed simultaneously with the cell’s activation [Gómez-Gaviro et al., 2000] 
Conversely, CD11b, an integrin also involved in leukocyte adhesion and migration during the 
inflammatory response is shown to be upregulated on the surface of neutrophils following activation 
[Fortunati et al., 2009]. Accordingly, measurement of the relative expression levels of these two 
markers is a popular means of assessing a neutrophil’s rate and state of activation ex vivo.  
Stimulation of blood neutrophils with activating factors PAF and LPS induced an overall decrease in L-
selectin and increase in CD11b expression in both EE and SE neutrophils at levels concordant with 
those reported in previous studies [Cooper et al., 2008]. No differences in expression or shedding 
were found between EE and SE groups suggesting that EE does not influence the dynamics of 
neutrophil extravasation. However, such receptor expression assays can only be regarded as 
indicators of leukocyte activity. In further studies, specific chemotaxis and endocytosis assays (such 
as flow chamber assays or intravital microscopy) would provide a more comprehensive means of 
establishing the effects of EE on neutrophil activity10. 
 
Phagocytosis is the eponymous effector function of macrophages and an essential component of the 
immune response to infectious organisms, inflammatory resolution, wound healing and general tissue 
homeostasis [Ginhoux and Jung, 2014]. Previous enrichment studies carried out on female CD1 mice 
have identified that macrophages isolated from EE animals proved more efficient at phagocytosing 
latex beads when compared to control animals [Arranz et al., 2010]. Enhanced phagocytosis of 
opsonized latex-coated beads by peripheral blood neutrophils has also been reported in beagles 
subject to a two year long enrichment regimen [Hall et al., 2006]. This thesis’ results support these 
findings, observing that macrophages isolated from enriched animals are significantly more effective at 
phagocytosing E.coli than those from SE mice. However, it should be noted that the previous two 
papers cited only found results when analysing cells isolated from aged animals. The study by Arranz 
et al, in fact found no differences in phagocytosis when studying adult mice (44 weeks) observing 
improved macrophage function (with increasing significance) only at successively older ages (69 and 
92 weeks) [Arranz et al., 2010]. The mice used in our studies were between 9-10 weeks old when 
                                                     
 
10 We had planned to investigate the chemotaxis and extravasation of EE leukocytes using intravital 
microscopy. Unfortunately, loss of the necessary equipment prevented this avenue of research.  
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studied, an age regarded to correspond with the early phase of adulthood in the mouse lifecycle [Dutta 
and Sengupta, 2016]. This disparity in results could possibly be attributed to gender differences in the 
mice used for each study, research has established that phagocytic responses in male and female 
mice differ (with female mice macrophages typically being regarded as the more effective phagocytes) 
[Scotland et al., 2011]. Additionally, differences in methodology (e.g. use of opsonised beads vs 
lyophilised bacteria) could also account for these differences. Regardless, these studies raise an 
interesting observation found in previous neurological studies utilising EE. Namely that the protective 
physiological influence of enrichment becomes increasingly pronounced with age. A potentially 
constructive line of continued research would be to apply the methods employed in this thesis to mice 
at a range of ages (and both genders). 
 
The enzymes PTGS2 (responsible for the generation of prostaglandins) and iNOS (which is one of 
three enzymes that generate nitric oxide from the amino acid L-arginine) are both released by 
macrophages and their heightened expression is typically associated with an activated, pro-
inflammatory phenotype [Martinez and Gordon, 2014]. While both integral to proper homeostatic 
responses, excessive production of these enzymes and their respective products has been associated 
with a variety of pathologies including cancer [Howe, 2007], chronic inflammation [Hugo et al., 2015] 
and reduced mortality in sepsis [Hollenberg et al., 2000]. 
 
Previous enrichment studies have reported increased reactive oxygen species (ROS) production by 
macrophages isolated from aged mice stimulated with phorbol myristate acetate (PMA) [Arranz et al., 
2010]. These results seemingly conflict with our findings which suggest iNOS gene expression is 
reduced in EE animals following stimulation with LPS. The age of the animals used and 
methodological variations may explain these disparate results: In the same study EE mice responses 
to LPS were found to be age dependent. NK cells extracted from older enriched animals presenting an 
exacerbated release of inflammatory TNF-α in response to LPS stimulation while cells from younger 
animals displayed a reduced response compared to the control. As the animals used in our study were 
considerably younger than those used by Arranz et al it is possible that the reduced expression of 
iNOS observed in EE macrophages is a reflection of this age dependent anti-inflammatory response. 
Corroborating this hypothesis studies in humans [Gomez et al., 2005] and mice [Godbout et al., 2005] 




Expression of ptgs2 was also found to be reduced following stimulation of EE macrophages with LPS. 
To date no immunological studies have specifically assessed prostaglandin associated gene 
production in the context of enrichment. However, neurological studies have found that EE leads to 
the downregulation of PTGS2 and a further downstream enzyme in the prostaglandin synthesis 
pathway; prostaglandin D2 Synthase PTGDS [Hüttenrauch et al., 2016]. Conversely, a further study 
found evidence that enrichment indirectly enhanced ptgs2 gene expression in the brain through 
inhibition of a microRNA found to in turn inhibit expression of a range of genes including ptgs2 [Vallès 
et al., 2014], suggesting the possibility of differential cellular responses to enrichment in circulation 
and the CNS. Further analyses of leukocyte prostaglandin release (through an ELISA or similar 
immune-assay) or oxidative burst activity (through myeloperoxidase or cytochrome-C based assays) 
would provide a better understanding of the potential alterations in effector function in enriched 
leukocytes.  
 
4.6  Gene Profile of Enriched Animals 
4.6.1 Gene Expression in A Basal Immune State 
To date no studies have attempted to profile the immune-genotype of an EE animal. To this end we 
took a hypothesis driven approach performing microarray analysis of RNA extracted from whole blood 
of EE and SE animals. Most of the genes identified by the array had a specific metabolic or immune 
regulatory function. Of these, four stood out for their role in inflammation: Chil1 (Chitinase 3 like 
protein 1, CHI3L1, YKL-40), Signal regulatory protein beta 1(SRPB1), S100A8 and S100A9 (S100 
calcium-binding protein 8 and 9). Saliently a trend was found among each of these genes for 
heterogeneous immunomodulatory properties, promoting an efficient but moderated inflammatory 
response.  
 
CHI3L1, is a member of the family of mammalian chitinase-like enzymes. Produced by a wide variety 
of cells including neutrophils [Volck et al., 1997], macrophages [Rehli et al., 2003], fibroblasts and 
endothelial cells [Malinda et al., 1999] clinical studies typically present CHI3L1 as an acute phase 
inflammatory protein, with heightened circulating levels detected in patients suffering rheumatoid 
arthritis [Hua and Recklies, 2004], sepsis [Kornblit et al., 2013] and inflammatory bowel disease 
[Kamba et al., 2013]. Supporting this CHI3L1 secretion is increased by leukocytes upon stimulation by 
IFN-γ [Kzhyshkowska et al., 2006] and IL-6 [Nielsen et al., 2011]. Of note CHI3L1 has also been 
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shown to downregulate cellular responses to the same cytokines [Hua and Recklies, 2004] and 
promote release of TGF-β. Suggesting that CHI3L1 may be part of a regulatory mechanism to mediate 
the inflammatory response. 
 
While the exact physiological role of CHI3L1 is under ongoing research, studies have demonstrated its 
involvement in a range of immunological processes, including; apoptosis [Lee et al., 2009], 
opsonisation [Johansen, 2006], M2 macrophage differentiation [He et al., 2013], dendritic cell 
activation [Lee et al., 2011], mitogen-activated protein kinase (MAPK) and Akt signalling [Chen et al., 
2011] as well as tissue remodelling and angiogenesis [Francescone et al., 2011]. Additionally a study 
has found that CHI3L1 is able to augment macrophage bacterial killing by inhibiting macrophage 
apoptosis while simultaneously enhancing host tolerance by supressing inflammasome activation 
[Cruz et al., 2012]. A set of functions that corresponds with the enhanced macrophage activity and 
moderated release of soluble inflammatory mediators found in our studies. Of interest a recent study 
has suggested that circulating levels of CHI3L1 decrease in response to acute exercise [Mygind et al., 
2016]. 
 
Also up regulated was SRPB1, a glycoprotein receptor expressed on human monocytes, 
granulocytes, macrophages and microglial cells [Seiffert et al., 2001]. Like CH3L1, SIRPB1 has been 
shown to upregulate phagocytic function, with stimulation of the receptor on murine macrophages 
enhancing their engulfment of latex beads [Hayashi et al., 2004]. Further studies of SIRPB1 
expression on mouse microglial cells have revealed that ligation of the receptor not only upregulates 
microglial phagocytosis of neuronal debris (through re-organisation of the actin cytoskeleton) but also 
inhibited lipopolysaccharide-induced stimulation of TNF-α and NOS2 (Gaikwad, Larionov et al. 2009). 
It is tempting to speculate that the action of this protein and the heightened expression of its gene in 
enriched mice lends further credence to our observation of enhanced phagocytosis and reduced iNOS 
expression in EE macrophages. A further study has revealed that SRPB1 binding also upregulates 
neutrophil transendothelial migration [Liu et al., 2008], raising one possible explanation for the 
heightened leukocyte influx we observed in our CLP and ZIP models.  
 
S100A8 and S100A9 together form the protein complex calprotectin, a molecule found to be highly 
abundant in myeloid cells, with neutrophils expressing the highest content (calculated to be ~30% of 
total cytosolic proteins [Sugimoto et al., 2016]). Released by leukocytes upon activation at sites of 
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infection, calprotectin exerts a direct antimicrobial action by sequestration of the essential bacterial 
nutrients manganese and zinc [Stříž and Trebichavský, 2004]. In addition, calprotectin stimulates the 
innate immune system through activation of RAGE and TLR4, resulting in downstream NF-κB 
activation and secretion of pro-inflammatory cytokines, TNF-α and IL-17 [Riva et al., 2012, Vogl et al., 
2007]. 
Individually the S100A8 and A9 proteins have also been found to act as powerful regulators of the 
innate immune response, promoting neutrophil and macrophage accumulation, cytokine production, 
and smooth muscle cell proliferation [Croce et al., 2009, Kerkhoff et al., 1998]. S100A9 deficient 
neutrophils exhibited a reduced secretion of cytokines (e.g. TNF-α and MCP-1) in response to LPS 
stimulation while inflammatory cytokine production in dendritic cells was exacerbated by S100A8 
deficiency [Averill et al., 2011]. 
 
These immune stimulating properties have led many researchers to suggest that calprotectin is an 
acutely pro-inflammatory protein. This idea is supported by calprotectin’s use as a biomarker for 
inflammatory disease, most especially intestinal inflammation [Konikoff and Denson, 2006] and sepsis 
[Decembrino et al., 2015]. However, a number of studies have described an anti-inflammatory and 
immune-protective role for calprotectin (and its constituent proteins). Calprotectin deficiency has been 
correlated with increased risk of developing chronic, non-healing wounds [Trøstrup et al., 2011]. It has 
also been demonstrated to have markedly anti-inflammatory and tissue-protective effects in a model of 
adjuvant-induced arthritis in rats [Brun et al., 1995]. Further, calprotectin suppressed NF-κB 
expression and pro-inflammatory cytokine release in a mouse model of autoimmune myocarditis 
[Otsuka et al., 2009]. Pharmacological blockade of calprotectin has correspondingly been found to 
exacerbate T-cell activation and cardiac allograft rejection [Shimizu et al., 2011]. 
 
Pharmacological administration of S100A8 to mice at the onset of a model of LPS induced sepsis has 
been reported to significantly increase survival rates, reducing tissue damage, inflammation, and 
oxidative injuries to major organ systems (Sun, Lu et al. 2013). Of note (following a trend displayed by 
SRPB1 and CHI3L1) calprotectin has been shown to inhibit the oxidative metabolism of LPS-activated 
PMNs in vitro, which has been postulated to help reduce the oxidative organ injury that follows septic 




The seemingly disparate biological functions observed for calprotectin and its subunits suggest that 
their effects might be concentration dependent or modulated by the cellular and biochemical 
composition of the local tissue environment [Schiopu and Cotoi, 2013]. 
In light of its current interest to clinical research and the commercial availability of reliable antibodies 
specific to the protein we elected to focus on S100A8 and S100A9 for proteomic analysis. The 
differences in levels of the gene protein products (calgranulin A and B) between experimental groups 
were striking, with circulating and peritoneal levels of both proteins found to be almost non-existent in 
SE animals while freely detectable in enriched mice. The presence of the proteins in the cell lysate of 
both mouse groups suggested that while calgranulin A and B is actively synthesised in EE and SE 
animals, only EE leukocytes are constitutively releasing it into circulation. It is interesting to note that if 
subject to clinical analysis these heightened levels of calprotectin in enriched mice would be regarded 
as indicative of a hyper-inflammatory or disease state, an assumption that does not correspond with 
the results acquired in our study. Again, it is tempting to speculate that the increased levels of 
calprotectin protein (and possibly CHI3L1 and SRPB1) are bestowing an immune-protective 
phenotype upon enriched animals. 
 
4.6.2 Gene Expression in The Granulomatous Tissues of Enriched Mice 
Sponge implantation induced granuloma is a unique disease model encompassing various aspects of 
the acute inflammatory, chronic inflammatory and wound healing response. We initially chose this 
model to investigate how EE would modulate the host response to a persistent, irresolvable immune 
insult. Consistent with previous models we found this response to be typified by an enhanced cellular 
infiltrate at the point of inflammation and a moderated release of inflammatory mediators. However, in 
light of several studies that have correlated EE to improved wound healing [Detillion et al., 2004, Ernst 
et al., 2006, Vitalo et al., 2012] we became interested to learn if our own enriched animals presented 
any alteration in both their inflammatory and wound healing response. 
 
A 72 hour endpoint was chosen for this model to allow us to explore the cellular and molecular 
immune environment of EE mice at a transitionary point between the acute and chronic/resolutionary 
phases of inflammation [Anderson et al., 2008]. As previously mentioned the cytokine readouts and 
cell types identified in the sponge infiltrate suggested the granuloma may have been proceeding more 
quickly in enriched mice. As we were unable to specifically investigate the cellular content of the 
granuloma tissue itself we chose instead to compare patterns of gene expression between EE and SE 
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groups. One benefit this avenue of investigation afforded was that the gene expression identified not 
only gave insight into the homeostatic state of the granuloma but also allowed some prediction of how 
the immune response in these tissues may progress. 
 
The largest group of upregulated genes that we observed in EE animals coded for the core structural 
components of endothelial tissue.  
These included:  
Three collagens: (1α1, 1α2 and 14α1): Primarily released by fibroblasts, collagens form the major 
constituent of connective tissues such as cartilage as well as being abundant in other fibrous tissues 
such as tendons, bone and muscle [Sherman et al., 2015]. It is a vital resource in the wound healing 
process not only serving as the raw material for many tissues but also assisting: chemotaxis of 
fibroblasts and leukocytes to the wound site, aiding the generation of haemostatic plugs and serving 
as a matrix for the deposition of further tissue [Sherman et al., 2015]. 
Actin alpha 2: A component of smooth muscle and a marker indicating the differentiation of fibroblasts 
into smooth muscle cells [Strauch and Rubenstein, 1984] 
Transgellin: A shape change sensitive protein reported to bind actin and aid in the formation of actin 
stress fibres (which provide a provisional level of contractility in healing wounds [Hinz, 2007]) and 
smooth muscle [Assinder et al., 2009].  
Three Integrins: (α5, β1 and β5): A class of transmembrane protein involved in the adhesion of cells to 
one another and the extracellular matrix, integrins can be regarded as the mortar (and collagen the 
bricks) that holds mammalian tissues together [Hynes, 1992]. Previous neurological studies in mice 
have also reported upregulation of integrin gene expression in the brain following 14 days of 
environmental enrichment [Rampon et al., 2000a]. 
 
The second largest group of upregulated genes were found to code for two families of enzymes 
involved in tissue remodelling and immune regulation:  
 
Two matrix metallopeptidases: (MMPs, 2 and 9): Both able to degrade various collagens, these MMPs 
are known to play important roles in tissue reorganisation, repair and angiogenesis [Kundu and Patil, 
2006]. Of particular interest MMP9 has been shown to be actively released by neutrophils and act as a 
neutrophil chemotactic factor [Opdenakker et al., 2001]. A recent study has also reported that rats 
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show a significant upregulation of hippocampal MMP9 protein when subject to EE at a young age 
[Cao et al., 2014].  
Two cathepsins: (K and L): Cysteine proteases that catabolise elastin, collagen, and gelatine allowing 
the breakdown of bone and cartilage, cathepsins are released by neutrophils and macrophages 
[Chauhan et al., 1993, Inaoka et al., 1995]. 
 
Several downstream regulators of the previously listed genes were also upregulated in EE mice. Each 
pluripotent regulators of tissue remodelling and repair: 
Epidermal growth factor (EGF) and its receptor (EGFR): known to stimulate fibroblast and keratinocyte 
proliferation and induce both cells to secrete collagenases (such as cathepsins and MMPs) to degrade 
the matrix during the remodelling phase [Carpenter and Cohen, 1990]. 
Plasminogen activator urokinase receptor (PLAUR): A component of the plasminogen activation 
system, an enzymatic cascade involved in the control of fibrin degradation, matrix turnover and cell 
invasion. Again neurological studies have demonstrated that EE upregulates plasminogen activation in 
the hippocampus of adult mice [Horii-Hayashi et al., 2011] 
WNT Inducible signalling pathway protein 1 (WNT1): Part of the eponymous WNT signalling pathway, 
regulates multiple cellular functions, including adhesion, migration, proliferation, differentiation and 
survival (Babic, Chen et al. 1999). 
Vascular endothelial growth factor A (VEGFA): A pluripotent protein involved with mediating; 
increased vascular permeability, inducing angiogenesis, vasculogenesis endothelial cell growth, 
promoting cell; migration, and inhibiting apoptosis [Hicklin and Ellis, 2005]. Multiple studies have 
demonstrated increased circulating levels of VEGF in mice and rats following environmental 
enrichment paradigms with several suggesting that enhanced VEGF expression is one of the key 
mechanisms by which EE conveys its neuroprotective and reparative properties [Fares et al., 2013, 
Goshen et al., 2009, Ortuzar et al., 2013] .This hypothesis has been supported by the finding that 
inhibition of VEGF activity blocks the neuro-regenerative properties of enrichment [Cao et al., 2004].  
 
Concordant with the cytokine data obtained for the sponge granuloma model the IL-10 gene was also 
found to be upregulated in EE mice. Increased levels of IL-10 are typically associated with the 
cessation of inflammation and a shift to a later, resolution focused stage of the immune response 
[Sugimoto et al., 2016]. Lending additional explanation to the increased leukocyte numbers found 
within the granulomatous tissue of EE mice, expression of colony stimulating factor three (also known 
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as granulocyte-colony stimulating factor, G-CSF) was also found to be upregulated. G-CSF has been 
shown to stimulate bone marrow production of granulocytes and stem cells and promote their release 
into the bloodstream, it also modulates the survival, differentiation and function of neutrophil 
precursors and mature neutrophils [Roberts, 2005]. 
 
While the results of this gene array only serve as a peripheral analysis of the potential immune state of 
EE mouse granuloma tissue, it gives a strong indication that enriched animals present an altered 
immune-regulatory gene program geared towards cellular regrowth and repair. However, whether this 
program would result in an improved granulomatous response or increased fibrosis and chronic 
inflammation remains to be seen.  
 
4.7 The Behavioural Profile of Enriched Mice  
As a large number of studies have correlated environmental enrichment with a variety of neurological 
and behavioural changes. We were interested to investigate how EE altered the behaviour of our own 
mice. Investigations of circulating corticosterone levels proved challenging with levels of the hormone 
found to vary considerably between experiments and groups (Appendix 4). These variations occurred 
despite measures to keep the measurement protocol as consistent as possible; taking blood samples 
at the same time of day to avoid circadian variation in cortisol levels [Chung et al., 2011]. Performing 
the collection one cage at a time in an isolated room to minimise the effect of transport stress on the 
mice and performing the EIA assay as constantly as possible.  
 
Previous studies present an equally wide spread in the corticosterone levels observed in EE animals 
with some higher than those from a standard environment  [Benaroya‐Milshtein et al., 2004] some 
lower [McQuaid et al., 2013], and some displaying no change at all [Jain et al., 2013]. While this 
disparity of results has been attributed to variations in EE protocols, mouse strain or gender 
[Hutchinson et al., 2012] other researchers have suggested that corticosterone release is triggered too 
readily in response to a variety of minor physiological and psychological stressors (e.g. loud noises, 
unusual odours, light) to be used as a reliable measure of mouse behavioural status [Bielohuby et al., 
2012]. It is possible that unforeseen and unpreventable events occurring in the animal unit our mice 
were housed in (e.g. fire alarms, entrance of cleaning staff etc.) could account for the inter-cage and 
intergroup variation seen in our results. 
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Our behavioural tests provided more constant results, suggesting that EE animals develop a small but 
significant reduction in exploratory activity by the end of the enrichment period. Such a reduction in 
activity is typically associated with a heightened state of anxiety.  
 
Again previous research reports a high level in variation in the behavioural change EE induced, with 
studies utilising the same behavioural paradigms as ours respectively presenting EE as; anxiogenic 
[Rampon et al., 2000b], anxiolytic [Benaroya‐Milshtein et al., 2004], or causing no change in anxiety at 
all [Wolfer et al., 2004]11. 
 
Many of these variations have also been attributed to disparities in methodology, mouse strain and 
gender used for EE experiments [van de Weerd et al., 1994]. Male mice in particular have been 
reported to demonstrate significantly higher levels of aggression in enriched cages compared to those 
of a standard environment [Wolfer et al., 2004]. Increased bouts of fighting were regularly observed in 
our enrichment cages as were typical displays of dominance behaviour (such as grooming, barbering 
and territorial marking) and submissive behaviour (avoidance, crouch response, submissive upright 
posture) [Malatynska and Knapp, 2005]. The increased complexity of social dynamics in EE cages 
could very likely account for the heightened anxiety related behaviour observed in our animals, raising 
the possibility that EE may influence the murine immune response by placing animals under an 
increased burden of psychological stress. 
 
The effect of psychological stress on the immune system has been a subject of growing study for the 
past 20 years [Okimura et al., 1986]. Psychosocial status has been shown to strongly influence 
leukocyte numbers with several studies correlating stress to increased circulation of neutrophils and 
                                                     
 
11 It should be noted that use of behavioural assessors such as these is not without its controversy. 
Many researchers argue that activities that constitute anxiety like behaviour in one; species, strain, 
gender, environment are not contiguous with anxiety like behaviour in another [Bourin and Hascoët, 
2003, Crawley, 1985].  
A further personal (and hence subjective) observation: After spending several hundred hours in the 
company of enriched mice, I found their behaviour when interacting with; each other, their 
environment and myself to be far more active and engaged compared to animals from a standard 
environment (Appendix 5). Enriched animals – at the risk of anthropomorphising – seemed more 
interested in their environment, and standard animals correspondingly, more apathetic. Such apathy, 
within the paradigm of the light dark box, open field test and elevated plus maze would be classified as 
a low state of anxiety (and accordingly present EE animals as comparatively more anxious). To me 
this seems a misleading assessment of these animal’s behaviour. However, I am not a behavioural 
biologist and accept the established wisdom of these long used behavioural assessors. 
174 
 
monocytes [Wohleb et al., 2015, Swan and Hickman, 2014]. Stress has further been shown to induce 
myelopoiesis, upregulate cell effector activity and promote the release of numerous 
immunomodulatory factors [Viswanathan and Dhabhar, 2005, Fuertig et al., 2015], results that parallel 
many of our own. These findings have more recently led to some ecologists and behavioural biologists 
advocating leukocyte numbers and ratios as a biomarker for stress in animals, although the reliability 
of such readout is contested [Swan and Hickman, 2014]. 
 
Many of these studies have focused on the immune-destabilising effects of chronic or persistent 
stress. Which have been demonstrated to include leukocyte suppression, dysfunction and a chronic 
inflammatory phenotype [Padgett et al., 1998, Zhang et al., 2008, Glaser and Kiecolt-Glaser, 2005]. 
However, an emerging body of research has turned its attention to the effects of mild or sub-acute 
stress on psychology, neurology and the immune response. 
 
Such studies have found mild stress elicits a number of beneficial effects on the central nervous 
system, such as reduced anxiety levels [Benaroya‐Milshtein et al., 2004, Rampon et al., 2000b] 
enhanced memory, modulation and upregulation of neurogenesis [Kempermann et al., 1997] neural 
plasticity [Sale et al., 2009] and most saliently; improved recovery from brain injury and cerebral 
disorders [Laviola et al., 2004, Kovesdi et al., 2011]. This phenomena has been termed eustress (eu – 
good, Greek) [Le Fevre et al., 2003] or inoculation stress [Crofton et al., 2015]. Studies of eustress 
have associated beneficial immuo-protective effects with parallels to our own; enhancing leukocyte 
numbers, cellular effector function and promoting a immune protective, immune-moderated phenotype 
[Dhabhar, 2000, Dhabhar et al., 2012, Berk et al., 2001]. 
 
Such findings present the possibility that environmental enrichment serves as a means of generating 
eustress in experimental animal and that this stress in turn may contribute to the immune alterations 
we see in EE animals. This raises many questions for further research, such as; as what point does 
eustress simply become ‘stress’? And would this shift from a positive to negative stress state produce 
an accompanying alteration in immunity? Initial attempts to answer these questions are made in the 




4.8 Questions, Challenges, Limitations and Conclusions 
Perhaps the biggest issue within this of this body of research originates from the methodology itself. 
As discussed in Hutchinson et al., 2005 and throughout this thesis EE studies display a huge variation 
in their methodologies and an accompanying large disparity in the results they produce. While 
attempts at standardising the EE methodology have been made [Gurfein et al., 2012a] variation 
persists. In addition, the effects of enrichment on mice have been demonstrated to depend on the 
strain and sex of the animals used, further complicating the search for a single enrichment strategy 
that can be used effectively for all animals, [Coutellier and Würbel, 2009, Fitchett et al., 2005, Lin et 
al., 2011, Touma et al., 2003, Wood et al., 2010]. A consequence of this variation is that that several 
authors have come to regard EE as a confounding variable and accordingly a methodology that 
should be avoided [Hutchinson et al., 2012]. 
 
A possible source of this issue is that as a concept environmental enrichment is ambiguous; its 
underlying purpose defined by the nature of the research performed and the field it is focused within. 
For example, in the field of zoo and captive animal studies, where the practise of EE was originally 
conceived, EE’s goal is to improve the psychological and physical welfare of animals with an 
emphasis on mitigating aggressive or stereotypical behaviours. For livestock research however, 
welfare is regarded as something of a bi-product of attempts to improve the economy of generating 
meat, dairy or any other animal products. Neurobiologists typically consider EE as a means of 
modelling a sensorially and psychologically stimulating environment, seeking to interpret how such 
external stimuli effect animal and human neurobiological processes. Immunology currently seems to 
lack a definite purpose behind its use of EE, with some studies describing it as a means of improving 
welfare [Marashi et al., 2004], inducing stress [Cao et al., 2011], promoting physical exercise 
[Benaroya-Milshtein et al., 2007], or often giving no reason at all other than that it has been shown to 
effect immunology in previous literature [Reichmann et al., 2013].  
 
In creating my own EE protocol my goal, (similar to that of neurobiology) was to attempt to generate 
an environment that evokes the complex physical and psychosocial events that occur in the lives of 
non-captive, wild animals and the organisms whose biology we so often try to emulate in scientific 
studies; humans. A secondary goal was to keep my enrichment set up as simple and reproducible as 
possible (use of enrichment items typically already available in animal units and of enclosures 
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compatible with the rack system most animal units employ) with the intention that proceeding research 
will utilise it again. It is my hope that with further study the purpose of EE in immunology research will 
become more clarified and its methodologies accordingly more consistent. 
 
Increased variability in results will inherently be a component of techniques such as EE. When you 
increase the complexity of any system you increase the number of outputs it can produce. 
Nevertheless, patterns of consistency were found in my results, that have been reproduced by other 
members of my lab. Suggesting that such consistency is not an impossibility. 
 
It is also hard to ignore the overlap that lays between EE and physical enrichment. Many of the results 
of EE can be attributed to the effects of physical exercise alone. However, as mentioned previously, 
studies utilising environmental enrichment without the inclusion of apparatus that invoke overt physical 
exercise has been shown to have significant effect on the immune response [Arranz et al., 2010, De 
Sousa et al., 2011, Marashi et al., 2003]. Further, in one study that demonstrated EE limited the 
growth of pancreatic tumours, it was found that separating the EE methodology utilized into its 
individual parts greatly lessened its anti-tumorigenic properties: 
 
“Each single component of EE (inanimate stimulation, social stimulation or physical exercise) was not 
profound enough to achieve comparative anti-tumor effects as EE.”[Li et al., 2015]. 
 
My own data, though preliminary supports these findings (appendix 7). It also interesting to note that 
experiments in which groups of mice were subject to equal bouts of forced or voluntary exercise in the 
context of an experimental model of Alzheimer’s disease showed strong differences in their 
physiological responses, with the voluntary group presenting a greater reduction in disease symptoms 
than the forced [Yuede et al., 2009]. This would suggest that there is at the very least a psycho-
neurological component in the influence of exercise on the immune system (and logically for EE 
paradigms as well). Nevertheless, without a more thorough dissection of PE from EE, it is difficult to 
categorically say what the root causes of these immunological effects are. 
 
While the results our study clearly demonstrate that environmental enrichment increases leukocyte 
cellularity and infiltration to a site of inflammation, our data can currently only strongly suggest that this 
results in a more rapid and efficient immune response or inflammatory resolution. It is difficult to be 
177 
 
certain of this effect without allowing the models we chose to continue to completion (i.e. the end of 
inflammation, complete granuloma formation, or the death/survival of the mouse). This was not 
possible in the models we employed due to the constraints of our project licence. However, in further 
studies more moderate, resolving models of inflammation could be used to investigate the process of 
EE, such as those modelling atopic dermatitis or scratch wound assays.  
 
Further this study elected to focus upon three specific inflammatory cell types to investigate the 
immunomodulatory effects of EE; neutrophils, monocytes and macrophages. These cells were chosen 
for their vital role in the instigation and progression of inflammation and also because the majority of 
other studies on EE and the immune response have – following on from neurological studies – 
focused on lymphoid leukocyte subsets. However, there are many other leukocyte populations that 
play a key role in the models we have used (such as dendritic cells and eosinophils for ZIP and 
sponge granuloma) that should be studied for a more complete picture of the EE effect. As an 
addendum to this, a more complete flow cytometric cellular profile could be pursued. Which, for 
example could seek to determine relative levels of pro or anti-inflammatory macrophage 
subpopulations elected in the EE-immune response12.  
 
A final limitation of this study (one that only became truly apparent in its latter stages) is that though 
the data we have obtained presents a relatively detailed picture of the effects of environmental 
enrichment on the murine inflammatory response. It provides little incite as to its cause. While some 
speculation can be made as to the relationship between the effects of enrichment on the 
psychological, neurological and immunological state of an animal, none of the data generated in this 
study can provide a definite connection between them.  
 
Nevertheless, this study has demonstrated that enrichment does have a tangible effect on immune 
homeostasis. 
The fact that our external environment evokes such a strong biological response is not a surprising 
one. The immune response is, after all one of an interconnected series of homeostatic systems 
designed to respond to alterations in both our internal and external environment [Medzhitov, 2008]. 
                                                     
 
12 Preliminary attempts were made to further dissect infiltrating monocyte populations in ZIP, utilising 
differential Ly6C, F4/80, CD11b and MHCII staining. The results (not shown) proved inconclusive.  
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However, this study and others of its kind serve to remind the researcher of the huge variability of 
immunological and clinical outcomes that varied living conditions can generate. With this in mind and 
the fact that the ultimate purpose of most animal experimentation is to emulate human biological 
responses as accurately as possible; it seems that the housing environment experimental animals are 
kept within should be a chief point of consideration in experimental design. 
 
While the results of this study and others like it are framed in such a way as to suggest that 
environmentally enriched animals posses an improved immune capacity it is equally possible to 
suggest the obverse; that animals housed in a standard lab environment have diminished immune 
function. Currently the standard environment most experimental animals are housed within are 
considered by many researchers to be impoverished; lacking in adequate psychological, social or 
physical stimulation [Balcombe, 2010, Balcombe, 2006, Benefiel et al., 2005, De Sousa et al., 2011]. 
As a result animals housed in standard laboratory conditions are demonstrated to be relatively 
overweight, insulin resistant, hypertensive and more likely to experience premature death than their 
wild counterparts13 [Martin et al., 2010]. 
 
“The standard laboratory mouse lives what might be considered a "couch potato" existence… They 
are kept comfortable with an endless supply of food and water and a few potential playmates. But they 
don't have much of anything to do.” [Cao et al., 2011]. 
 
As such it could be argued that protocols such as environmental enrichment increase the biological 
relevance of captive environments for experimental purposes [Newberry, 1995].  
Taking a wider view of the implications of this research further consideration should be made of the 
influence of the psychosocial (not just the physical) environment on human immune responses in a 
clinical context. There is strong evidence that patient-specific immune states before surgery are highly 
correlated with recovery [Fragiadakis et al., 2015] and in turn that these immune states are often 
strongly influenced by the environment they live within [Brod et al., 2014b]. Enrichment procedures 
such as the one used in this study could be used as a means of stratifying the potential effects of 
environment on patient immune outcomes and personalising treatment regimens accordingly. 
                                                     
 
13 Excluding, one presumes the risk of mortality from predation wild animals experience. 
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 Ongoing Research  
5.1 Introduction, Stress and Immune Function  
The concept of a palpable relationship between psychological and physiological states is an ancient 
one. As far back as the second century AD roman physician Galen (Aelius Galenus) hypothesised that 
a “balance of the passions of the soul” was fundamental to good physical health going on to 
distinguish between disease states induced by organic and emotional means [James, 1997]. Such 
theories have pervaded western medicine for much of recorded history. Up until the late nineteenth 
century intense emotional states and responses (such as grief, anger and anxiety) were still 
considered a leading cause of human morbidity and mortality. More recently, in light of modern 
analytical techniques this field has received a resurgence in interest. In 1975 seminal studies by 
Robert Ader and Nicholas Cohen observed that rats fed the immunosuppressive drug 
cyclophosphamide in a liquid solution containing saccharin would later (after recovery) display the 
same immunosuppression after being fed saccharin solution alone. The authors suggested this 
provided early proof of a neurological effect (psychological conditioning) influencing the immune 
response [Ader and Cohen, 1975]. Later studies  would go on to identify the presence of neuropeptide 
specific receptors (for signalling molecules such as calcitonin gene-related peptide, secretoneurin, 
vasoactive intestinal peptide (VIP), and substance P (SP) [Kaneider et al., 2003]) on the surface of 
leukocytes and direct innervation of immune organs such as the thymus and spleen [Ruff et al., 1985]. 
These findings and others led to the initiation of the interdisciplinary field of psychoneuroimmunology 
(PNI). Perhaps the greatest contribution made by this burgeoning field so far is through its 
investigations of the influence of psychological stress on the immune response. 
 
Stress is a nebulous term, its connotation varying across the fields (and individuals) that study it. 
Dhabar and McEwin provide an integrated definition of the term suggesting stress is a: 
 
“Constellation of events, consisting of a stimulus (stressor), that precipitates a reaction in the brain 
(stress perception) that activates physiological fight or flight systems in the body (stress response).” 
[Dhabhar and Mcewen, 1997]. 
 
Stress has been shown to elicit biological responses through a variety of neurological and 
endocrinological mechanisms, many of which have not yet been fully elucidated. However, central to 
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the stress response is set of interconnected regions in the brain referred to as the hypothalamic 
pituitary adrenal (HPA) axis. Immediately following a perceived stressor, the hypothalamus releases 
corticotrophin releasing hormone (CRH). CRH in turn stimulates the pituitary gland to secrete 
adrenocorticotropic hormone (ACTH), which correspondingly stimulates the adrenal cortex to secrete 
glucocorticoids (in humans, the primary glucocorticoid is cortisol, in mice corticosterone). Activation of 
the hypothalamus also activates the sympathetic nervous system (SNS), which in turn stimulates the 
adrenal gland (specifically the adrenal medulla) to secrete further hormones; epinephrine (also known 
as adrenalin) and norepinephrine. These hormones heighten metabolic activity and are responsible for 
the feelings of anxiety that proceed stress [Barnes, 2010]. Additional studies have shown that some 
time following activation of the HPA and SNS, stress also activates the parasympathetic nervous 
system (PNS) inducing release of acetylcholine, a pluripotent neurotransmitter that (broadly speaking) 
counteracts the effects of cortisol and adrenaline returning the body to a resting – non stressed – state 
[Lehrner et al., 2016]. 
 
Each of these stress induced hormones (cortisol, adrenalin and acetylcholine) have been shown to 
exert specific immune-modulatory effects; inhibiting release of a variety of inflammatory mediators and 
promoting a tolerogenic or anergic leukocyte state (Figure 5-1). This has led many researchers to 
suggest that psychological stress is acutely immunosuppressive in effect [Pruett et al., 1993, 




Figure 5-1.The immune regulatory influence of the nervous system. The central nervous system (CNS) 
mediates the release of various immune influencing glucocorticoids via activation of a series of 
connected regions within the brain referred to as the hypothalamic–pituitary–adrenal axis. Research 
suggests the CNS to be primarily immune-suppressive in action, inhibiting production of pro-
inflammatory cytokines, chemotactic factors and limiting migration and activation in several immune cell 
types.[Barnes, 2010, Moser et al., 1995, van Oosten et al., 2010, Wingett et al., 1996] Additionally the CNS 
elicits differential immune effects dependent on cell type and stage of development, inducing the 
expansion and migration of immature dendritic cells while seemingly promoting a tolerogenic phenotype 
in their mature counterparts [Moser et al., 1995, Roca et al., 2007]. Although less studied, several papers 
have demonstrated that the sympathetic nervous system is able to modulate immune activity through 
production of epinephrine and norepinephrine promoting a T helper type 2 (Th2) and Th17 phenotype in 
in T-cells and dendritic cells, respectively [Kim and Jones, 2010, Panina-Bordignon et al., 1997]. Produced 
by the parasympathetic nervous system, acetylcholine has been shown to interact directly with multiple 
immune cell subsets through expression of acetylcholine receptors, leading to suppression of a number 
of pro-inflammatory pathways in macrophages and other immune cells. [Borovikova et al., 2000, de Jonge 
et al., 2005, Yoshikawa et al., 2006] Abbreviations: IFN-γ, interferon-γ; IL-17, interleukin-17; NF-κB, nuclear 
factor-κB; STAT, signal transducer and activator of transcription; Th1, T helper type 1; TNF, tumour 




Numerous studies have revealed that subjection to chronic or persistent stress (repeated stress 
exposures over the course of weeks or months) has a dysregulating or suppressive effect on the 
immune system. In human and animal studies, chronic stress has been shown to inhibit: leukocyte 
proliferation [Jiang et al., 1990, Bartrop et al., 1977] antibody production [Fleshner et al., 1989, 
Edwards and Dean, 1977], NK cell activity [Irwin et al., 1990, Bartrop et al., 1977, Rosenne et al., 
2014], Lymphocyte function, macrophages function [Brown and Zwilling, 1994, Bonneau et al., 1991, 
Bobel et al., 2015], and the overall humoral immune response [Kelley et al., 1982, Weiner 3rd et al., 
2012]. 
 
Corresponding to these studies, chronic stress has been linked with a number of pathologies 
associated with immune dysfunction such as cancer [Antoni et al., 2006], improper wound healing 
[Padgett et al., 1998] and age related acceleration of immuno-senescence [Epel et al., 2004]. 
Interestingly and in accordance with its purported immune-suppressive effects, chronic stress has 
been shown to reduce the severity of symptoms in murine models of type II collagen-induced arthritis 
[Rogers et al., 1980] and experimental autoimmune encephalomyelitis (EAE) [Griffin et al., 1993]. 
 
However, as mentioned in the main body of this thesis, acute stress (short-term, intermittent) has 
conversely been shown to have an activating effect on the immune/inflammatory response. Short-term 
stress promotes an initial increase and subsequent decrease in blood lymphocyte and monocyte 
numbers and an accompanying increase in blood neutrophil numbers [Dhabhar et al., 2012]. It has 
further been demonstrated to enhance leukocyte infiltration into tissues, and upregulate their effector 
activity [Dhabhar and McEwen, 1996]. This effect is postulated to be driven in part by upregulation of 
the inflammatory cytokines, IFN-γ, TNF-α, MCP-1, IL-1β and IL-6 [Viswanathan et al., 2005, Dhabhar 
and Viswanathan, 2005]. 
 
In contrast to chronic stress, acute stress has been shown to improve anti-tumour activity [Dhabhar et 
al., 2010]. While correspondingly increasing the severity of symptoms in experimental arthritis [Cutolo 
and Straub, 2007] and EAE [Franklin et al., 1988]. 
 
The seemingly bi-phasic effects of stress are currently a subject of ongoing research, however its 
effects hint of the presence of a biological feedback mechanism. Supporting this, low-dose 
corticosterone or epinephrine administration has been found to significantly heighten the inflammatory 
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immune response, while high-doses of corticosterone are found to be potently anti-inflammatory in 
effect [Dhabhar and McEwen, 1999]. This suggests that released stress hormones are immune-
activating at physiological/acute concentrations and immune suppressive at  pharmacologic 
concentrations [Dhabhar, 2014]. 
 
Such findings raise several questions in light of our own data on EE animals, which according to our 
behavioural analysis are likely in a state of heightened psychological stress. The immune phenotype 
of EE mice; increased leukocyte numbers, heightened infiltration and activity coupled with a 
moderated inflammatory cytokine release would appear to sit somewhere between that of chronically 
and acutely stressed animals: A unique and possibly advantageous physiological state to be in. 
In an attempt to begin dissecting the effects of varying form of stress on the immune response and 
contrast them with previously observed results, we have begun a series of experiments subjecting 
CD1 mice to the same battery of inflammatory immune models previously described, in the context of 
an environment of chronic psychological stress. The initial findings follow. 
 
5.2 Methodology. Stress Induction 
With the exception of the stress induction procedure, methodologies used in the proceeding 
experiments were the same as those stated in chapter two. Briefly, 24 age matched male CD1 mice 
were housed in cages groups of six in a standard lab enclosure set up. Following one week of 
acclimatisation animals were separated into standard environment (SE) and chronic stress 
environments (12 mice per experimental group). 
 
Animals in the chronic stress group were subject to two hours of chronic restraint stress for each day 
of the experimental period. In accordance with established procedures [Roper et al., 2010, Lin et al., 
2013] stress was induced by placing animals in 50ml falcon tubes with air and tail holes cut at each 
end and securing them in place for two hours. Animals were continually observed over the stress 
period to ensure they experienced no physical harm and were each checked for signs of injury once 




Figure 5-2. Experimental set up for chronic restraint stress. 
 
At the end of the experimental period animals were either subject to behavioural tests or six hours 




5.3 Current Results 
5.3.1 Comparative Weight Gain 
Over the course of the 14 day experimental period animals subject to a high stress environment 
demonstrated a significantly reduced weight gain than those from the standard environment, with 
weight gain being observed to plateau for restrained animals at day 10. At the end of the two weeks 
SE animals had gained on average two grams of additional weight compared to restrained. 
 
Figure 5-3. Comparative weight change over time. 24 Mice per group, N=3 experiments. Statistical 
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5.3.2 Circulating Corticosterone Levels and Initial Behavioural Analysis 
At the end of the two week experimental period significantly higher levels of circulating corticosterone 
were recorded in animal’s subject to restraint stress (Figure 5-4a). Corresponding to these findings 
restrained mice were observed to display significantly heightened anxiety like behaviour, 
demonstrated through a significant reduction in the overall time spent in light and transitions across 





Figure 5-4. Corticosterone and light dark paradigm analysis of animals following two weeks in a 
standard or chronic stress environment. (a) Comparative levels of blood corticosterone 
representative of N=2 experiments. (b) Results of light dark box behavioural paradigm, from left to 
right: Time spent in light, crossing latency, transitions from light to dark region. *p<0.005 
(***p<0.0005), t-test.  Figures representative of N=1 experiments, 24 mice per experiment.  
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5.3.3 Blood Profile of Chronically Restrained mice 
In contrast to animals housed in an enriched environment, stressed animals in a basal immune state 
showed no significant differences in overall leukocyte numbers or relative proportions of leukocyte 
population in blood. 
Figure 5-5. Circulating blood cell populations in mice from and standard or chronic stress environment. 
(a) Total blood leukocyte count (b) Individual leukocyte population counts (c) Relative percentages of 
individual leukocyte populations.t-test. Representative of N=2 experiments, 24 mice per experiment. 
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5.3.4 Zip6: Cellular Profile of the Peritoneal Cavity 
Following two weeks of chronic stress and six hours ZIP, analysis of peritoneal lavage revealed 
significant differences between stressed and standard environment animals. In a reversal of the 
results obtained from enriched animals stressed mice displayed a significantly lower level of leukocyte 
infiltration into the peritoneal cavity compared to SE. 
Flow cytometric analysis revealed the major source of this depleted infiltration to be to be GR1hi, 
F4/80-, expressing cells ascribed as neutrophils, with numbers on average half of that found in SE 
animals. Smaller but significant reductions were also observed for GR1hi, Ly6B.2+ cells suggesting a 





Figure 5-6. Peritoneal cell populations in chronic stress and standard environment mice following six 
hours of zymosan induced peritonitis. (a) Overall peritoneal cell count. (b) FACS plot and respective 
count of F4/80- GR1hi expressing cells attributed as neutrophils (Quadrant 3). (c) FACS plot and respective 
count of a Gr1hi, Ly6B.2+ cell population attributed as monocytes. *p<0.05 (**p<0.005), t-test. 







5.4 Initial Points of Discussion  
These results present the initial findings of a planned series of experiments aimed at comparing and 
contrasting the differential effects of stress on the inflammatory immune response. While only 
preliminary these findings suggest that the immune modulating effects of the stress incurred by 
environmental enrichment are very different to that of chronic stress. 
 
In order to confirm that our animals were indeed under an increased burden of stress we initially 
subjected them to behavioural analysis and assessed circulating levels of corticosterone. In 
accordance with previous studies chronic restraint stress invoked a significant increase in blood 
corticosterone [Kant et al., 1987, Shutt et al., 1988, Gong et al., 2015] and a highly significant increase 
in anxiety like behaviour [Bourin and Hascoët, 2003, Mineur et al., 2006]. These results contrast to 
those found in our study of EE animals which were observed to display variable levels of 
corticosterone and a lower level of anxiety like behaviour compared to restrained animals. This would 
suggest that although enriched animals are likely to be under some form of stress, its duration and 
intensity is less than that of animals subject to chronic restraint. 
 
Restrained animals were also found to present drastically reduced levels of weight gain compared to 
SE animals. Studies on mice have observed variable changes in food consumption in response to 
stress. With some reporting anorexia [Hosoi et al., 2016, Jeong et al., 2013] and others increased 
weight gain [Zhang et al., 2014]. Regardless, these results – when viewed in light the data obtained for 
ZIP – would suggest that reduced adiposity is not a primary contributing factor to the improved cellular 
response EE mice present. 
 
In contrast to other studies of its type, chronic stress was found to have no significant influence on 
circulating blood leukocyte populations [Dhabhar and Mcewen, 1997]. However, a significantly 
impaired cellular responses was observed following administration of zymosan to restrained animals. 
Reduced or inhibited cellular responses are a frequently reported effect of chronic stress, with several 
studies implicating heightened circulating levels of immuno-suppressive corticosteroid hormones as 




A key source to this reduced cell influx was found to be neutrophils. When contrasted to the results 
obtained in our analysis of EE animals one could hypothesise that the cause of this reduction might be 
reduced granulopoeisis in the bone marrow. Indeed reduced myelopoiesis is one of a number of 
immunosuppressive effects attributed to elevated corticosterone levels [Garvy et al., 1993]. 
At this date we plan to subject chronically stressed animals to a more complete biological and 
immunological analysis including; cytokine analysis and a full timecourse for ZIP. Complimentary 
experiments are also planned to investigate the effects of acute non-persistent stress on the murine 
immune response. 
It has been proposed that an optimum level of stress may exist, a point in which an individual is 
suitably stimulated (psychologically and physiologically) by their environment without being 
overwhelmed by it [Le Fevre et al., 2006]. Identification of such a zone of ‘optimal stress’, would 
certainly be a great interest to researchers, clinical practitioners and the public. 
It is hoped that with this data and more comprehensive behavioural/neuro-endocrinological analysis 
we may be able to identify where environmental enrichment sits on the currently developing spectrum 
of stress induced immune responses (Figure 5-7). 
 
 











 Afterword  
A great deal of research within my lab and across many other groups is invested in exploring 
mechanisms that favour or contribute to a more effective immune response and a faster return to a 
functional homeostatic state. The results of this study provide a new14 outlook on the potential 
mechanisms that may facilitate this re-establishment of equilibrium, suggesting that alterations to an 
individual’s external environment (and the improvement or reduction in wellbeing that may cause) can 
alter both the mode and magnitude of the host immune response.  
While environmental enrichment appears to have a tangible effect on the immune response, deeper 
analysis will be required to ascertain if its effects could be of benefit in the context of disease and 
more specially disease recovery. In order to derive a practical benefit from these findings concerted 
research efforts should be made to correlate and stratify clinical and animal studies with one another. 
Environmental enrichment has already been demonstrated to improve rodent wound healing in 
response to physical trauma [Xerri and Zennou-Azogui, 2003] and comparable clinical studies have 
revealed interventions designed to improve the mental wellbeing of patients leads to a marked 
improvement in overall health [Diener and Chan, 2011] and reduced expression of genes associated 
with chronic systemic and cellular inflammation [Irwin et al., 2015]. Longitudinal and cross sectional 
studies are beginning to correlate discrete elements of human life (at the social, psychological and 
physical level) with alterations in inflammatory gene and biomarker expression [Cole et al., 2007].It 
would interesting (though ambitious) to attempt to reproduce specific aspects of social, home and 
hospital ward environments in experimental animal enclosures, in order to investigate how such 
elements may influence murine biology and compare these results to those found in human subjects.  
As a corollary, the results of this study are in line with a growing body of literature demonstrating the 
need to investigate immune responses (and disorders) as dynamic multifaceted systems. Attempts to 
regulate these systems effectively must account for different factors such as living conditions and 
psycho-social status [Beura et al., 2016]. 
                                                     
 
14 Perhaps ‘renewed’ might be the more appropriate term. The concept that our external environment 
may influence our internal, is an ancient one.  
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A common question posed when presenting the findings of this study is “can environmental 
enrichment serve as a viable treatment for human immune disease or as a prophylactic against 
microbial or inflammatory disease?” The honest answer to this question is currently “No”. The results 
we have obtained cannot be easily translated from mice to humans. Most humans live in an 
environment significantly more dynamic and sensorially diverse than that of an ‘enriched’ mouse 
enclosure. Further, the emotional complexity of humans is such that it is often very difficult to 
categorically define what would be considered an ‘enrichment’ to their environment. Consider for 
example the differing ways introverted and extroverted personality types may respond to a novel 
social situation, for one it could be a stimulating and engaging experience while for the other a 
potentially detrimental stressor15.  
Put explicitly this studies’ results find that enriching the living conditions of male CD1 mice modulates 
the expression of a specific set of immune genes that may promote an improved innate cellular 
response both in the animals and humans. Providing this can be verified, one might use such genes to 
identify and stratify patients at risk of developing septicaemia or other inflammatory pathologies. 
Accordingly, a far-reaching ambition for this study could be to pharmacologically modulate the immune 
genes we have identified to therapeutically treat high-risk patients.  
Perhaps the most convincing finding to emerge from this thesis is that we cannot consider biological 
systems such as experimental animals or indeed human beings in all their diversity as ‘fixed’ in their 
immune response. Both mice and humans actively respond to alterations in their living conditions, 
changing multiple aspects of their behaviour and biology to accommodate variations in their 
environment. Such dynamic adjustments to an altering external and internal environment are often 
termed allostasis or homeorhesis [Verburg-van Kemenade et al., 2017].  
The ultimate purpose of animal experimentation is to emulate human physiological responses as 
accurately as possible. With the results of this study and others in mind, it is clear that a consideration 
of the environment we house such animals in [French et al., 2009] and its parallels to human living 
conditions [Beura et al., 2016] should be an important part of experimental design. 
                                                     
 
15 Note that our understanding of the emotional world experimental animals inhabit remains in its 
infancy. It is quite possible that personality types such as ‘introverted’ and ‘extroverted’ exist in mice 
and accordingly it should be remembered that our current classification of what constitutes an 
‘enriching element’ in a mouse environment is potentially as crude a designation than any one might 
attempt to apply to human enrichment. 
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As corollary of this it is my opinion that the conditions we house many experimental animals under 
both fail to adequately illustrate the complex biological systems we wish them to emulate and are in 
fact often physically and psychologically impoverishing for the animal in question. It is my hope that 
future research and policy around animal research takes these factors into consideration and my 
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7.1 Variations In Blood And Bone Marrow Leukocyte Populations Over 
The Timecourse Of Zymosan Induced Peritonitis 
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Appendix 1. Comparative cellularity in the (a) Bone marrow and (b) Blood of SE and EE mice following 6, 
24 or 0 hours peritonitis (basal, no inflammation induced). Values are presented as individual data points 
±s.e.m. of 12 mice for each group at each time point. Charts are representative of N=3 experiments. 













Appendix 2. Granuloma infiltrate analysis one (a) Two distinct populations of GR1 expressing cells were 
identified and gated. GR1+ = gate 1. GR1high= gate 2. (b) Back-gating of these populations revealed 
differential scatter profiles. The Gr1+ gate (b1) was found to contain two populations with a roughly 
consistent SSc (internal complexity) but variable FSc (size). The scatter profile of the higher FSc 
population is typically associated with that of monocytes. The GR1high gate (b2) was found to contain a 































Appendix 3. Granuloma infiltrate analysis two. (a) GR1 vs Ly6B.2 staining of recovered sponge infiltrate 
cells revealed a forked cell population. (b) Switching to a contour plot allowed easier demarcation of two 
primary populations expressing varying levels of GR1 and Ly6b.2,(c). (d) back gating of population d1 
(GR1high,Ly6b.2+) revealed an FSc vs SSc profile corresponding to that of neutrophils (as well as gated 
population 2 (GR1high) identified in the F4/80 vs GR1 plot (Appendix 2). Back gating of population d2 
(GR1+,Ly6b.2high) revealed an FSc vs SSc profile corresponding to that of monocytes (as well as gated 















7.3 Corticosterone Readouts Over Successive Experiments 
 
Appendix 4. Differential levels of corticosterone expression recorded over successive enrichment 





7.4 Continued Behavioural Analysis; Ethograms 
 
An ethogram is a catalogue of stereotypical behaviours or actions exhibited by a particular species of 
animal. These behaviours are broken up into discrete acts or postures referred to as action patterns, 
which can be used as score-able units for (semi) quantitative analysis of animal behaviour [Sluyter et 
al., 2013]  
 
Mouse ethograms have typically been used in the field of behavioural genetics to link specific 
behaviours to the influence of one or more genes [Sluyter et al., 2013]. However there has been some 
use of this technique to study the effects of environment enrichment [Marashi et al., 2003, van de 
Weerd et al., 1998, van Loo et al., 2004]. Interested to see how the behaviour of the EE mice used in 
this study may have altered compared to SE mice I subjected them to my own preliminary ethogram 
analysis, based upon action patterns used in previous papers utilising an enriched environment 
[Marashi et al., 2003, van de Weerd et al., 1998, van Loo et al., 2004].  
 
Protocol Two groups of six male CD1 mice (enriched, non enriched) were removed from their 
standard enclosures and placed in an empty cage. These mice were recorded with a digital camera for 
30 minutes and a tally of the actions of these animals was made and later corroborated by another 
member of the lab. 
 
Results Tallying and comparing the number of individual actions performed by the two mouse groups 
revealed a trend towards higher levels of social activity (Appendix 5a) and a higher level of overall 
activity in enriched animals (Appendix 5a & b). It was of interest to note that ten minutes following 
return to their respective cages the standard group had settled down to sleep while the enriched group 







Appendix 5. Further behavioural analysis of enriched animals. (a) Comparative ethogram of EE and SE 
group interaction with cage environment. (b) Comparative ethogram of EE and SE group interaction with 
one another. N=1 experiment, 12 mice per experiment (six per group). (c) Comparative photographs of EE 
and SE mice 10 minutes post ethogram experiment.  
 
E n v ir o n m e n ta l In te ra c tio n








R e a r in g
D a s h in g
D ig g in g
E s c a p e



























E n v iro n m e n ta l.  n = 3








R e a r in g
D a s h in g
D ig g in g
E s c a p e

























Ultimately we chose not to continue this line of analysis as it would have become highly labour 
intensive to produce data of viable quality for publication. However, it did provide some useful insights 




7.5 Genes Measured In RT-PCR Profiling Of Granuloma Tissue 
Appendix 6 Complete list of genes measured in RT-PCR profiling of granuloma tissue 
UniGene GenBank Symbol Gene 
Mm.213025 NM_007392 Acta2 Actin, alpha 2, smooth muscle, aorta 
Mm.686 NM_009608 Actc1 Actin, alpha, cardiac muscle 1 
Mm.309336 NM_009640 Angpt1 Angiopoietin 1 
Mm.867 NM_011331 Ccl12 Chemokine (C-C motif) ligand 12 
Mm.341574 NM_013654 Ccl7 Chemokine (C-C motif) ligand 7 
Mm.4861 NM_011616 Cd40lg CD40 ligand 
Mm.35605 NM_009864 Cdh1 Cadherin 1 
Mm.297859 NM_181277 Col14a1 Collagen, type XIV, alpha 1 
Mm.277735 NM_007742 Col1a1 Collagen, type I, alpha 1 
Mm.277792 NM_007743 Col1a2 Collagen, type I, alpha 2 
Mm.249555 NM_009930 Col3a1 Collagen, type III, alpha 1 
Mm.738 NM_009931 Col4a1 Collagen, type IV, alpha 1 
Mm.389135 NM_007734 Col4a3 Collagen, type IV, alpha 3 
Mm.7281 NM_015734 Col5a1 Collagen, type V, alpha 1 
Mm.10299 NM_007737 Col5a2 Collagen, type V, alpha 2 
Mm.334994 NM_016919 Col5a3 Collagen, type V, alpha 3 
Mm.4922 NM_009969 Csf2 Colony stimulating factor 2 (granulocyte-macrophage) 
Mm.1238 NM_009971 Csf3 Colony stimulating factor 3 (granulocyte) 
Mm.390287 NM_010217 Ctgf Connective tissue growth factor 
Mm.291928 NM_007614 Ctnnb1 Catenin (cadherin associated protein), beta 1 
Mm.4858 NM_007800 Ctsg Cathepsin G 
Mm.272085 NM_007802 Ctsk Cathepsin K 
Mm.930 NM_009984 Ctsl Cathepsin L 
Mm.21013 NM_008176 Cxcl1 Chemokine (C-X-C motif) ligand 1 
Mm.131723 NM_019494 Cxcl11 Chemokine (C-X-C motif) ligand 11 
Mm.244289 NM_203320 Cxcl3 Chemokine (C-X-C motif) ligand 3 
Mm.4660 NM_009141 Cxcl5 Chemokine (C-X-C motif) ligand 5 
Mm.252481 NM_010113 Egf Epidermal growth factor 
Mm.8534 NM_007912 Egfr Epidermal growth factor receptor 
Mm.235105 NM_028784 F13a1 Coagulation factor XIII, A1 subunit 
Mm.273188 NM_010171 F3 Coagulation factor III 
Mm.88793 NM_010196 Fga Fibrinogen alpha chain 
Mm.317323 NM_008002 Fgf10 Fibroblast growth factor 10 
Mm.473689 NM_008006 Fgf2 Fibroblast growth factor 2 
Mm.330557 NM_008008 Fgf7 Fibroblast growth factor 7 
Mm.289681 NM_010415 Hbegf Heparin-binding EGF-like growth factor 
Mm.267078 NM_010427 Hgf Hepatocyte growth factor 
Mm.240327 NM_008337 Ifng Interferon gamma 
Mm.268521 NM_010512 Igf1 Insulin-like growth factor 1 
Mm.874 NM_010548 Il-10 Interleukin- 10 
Mm.222830 NM_008361 Il-1b Interleukin 1 beta 
Mm.14190 NM_008366 Il-2 Interleukin-2 
Mm.276360 NM_021283 Il-4 Interleukin-4 
202 
 
Mm.1019 NM_031168 Il-6 Interleukin-6 
Mm.4364 NM_010560 Il-6st Interleukin 6 signal transducer 
Mm.482186 NM_001033228 Itga1 Integrin alpha 1 
Mm.5007 NM_008396 Itga2 Integrin alpha 2 
Mm.57035 NM_013565 Itga3 Integrin alpha 3 
Mm.31903 NM_010576 Itga4 Integrin alpha 4 
Mm.16234 NM_010577 Itga5 Integrin alpha 5 (fibronectin receptor alpha) 
Mm.225096 NM_008397 Itga6 Integrin alpha 6 
Mm.227 NM_008402 Itgav Integrin alpha V 
Mm.263396 NM_010578 Itgb1 Integrin beta 1 (fibronectin receptor beta) 
Mm.87150 NM_016780 Itgb3 Integrin beta 3 
Mm.6424 NM_010580 Itgb5 Integrin beta 5 
Mm.98193 NM_021359 Itgb6 Integrin beta 6 
Mm.196581 NM_011949 Mapk1 Mitogen-activated protein kinase 1 
Mm.8385 NM_011952 Mapk3 Mitogen-activated protein kinase 3 
Mm.2326 NM_010798 Mif Macrophage migration inhibitory factor 
Mm.156952 NM_032006 Mmp1a Matrix metallopeptidase 1a (interstitial collagenase) 
Mm.29564 NM_008610 Mmp2 Matrix metallopeptidase 2 
Mm.4825 NM_010810 Mmp7 Matrix metallopeptidase 7 
Mm.4406 NM_013599 Mmp9 Matrix metallopeptidase 9 
Mm.2675 NM_008808 Pdgfa Platelet derived growth factor, alpha 
Mm.154660 NM_008872 Plat Plasminogen activator, tissue 
Mm.4183 NM_008873 Plau Plasminogen activator, urokinase 
Mm.1359 NM_011113 Plaur Plasminogen activator, urokinase receptor 
Mm.971 NM_008877 Plg Plasminogen 
Mm.245395 NM_008960 Pten Phosphatase and tensin homolog 
Mm.292547 NM_011198 Ptgs2 Prostaglandin-endoperoxide synthase 2 
Mm.292510 NM_009007 Rac1 RAS-related C3 botulinum substrate 1 
Mm.757 NM_016802 Rhoa Ras homolog gene family, member A 
Mm.250422 NM_008871 Serpine1 
Serine (or cysteine) peptidase inhibitor, clade E, member 
1 
Mm.249934 NM_011486 Stat3 Signal transducer and activator of transcription 3 
Mm.283283 NM_011526 Tagln Transgelin 
Mm.137222 NM_031199 Tgfa Transforming growth factor alpha 
Mm.248380 NM_011577 Tgfb1 Transforming growth factor, beta 1 
Mm.200775 NM_011578 Tgfbr3 Transforming growth factor, beta receptor III 
Mm.8245 NM_011593 Timp1 Tissue inhibitor of metalloproteinase 1 
Mm.1293 NM_013693 Tnf Tumor necrosis factor 
Mm.282184 NM_009505 Vegfa Vascular endothelial growth factor A 
Mm.3667 NM_011707 Vtn Vitronectin 
Mm.10222 NM_018865 Wisp1 WNT1 inducible signaling pathway protein 1 
Mm.287544 NM_009524 Wnt5a Wingless-related MMTV integration site 5A 
Mm.328431 NM_007393 Actb Actin, beta 
Mm.163 NM_009735 B2m Beta-2 microglobulin 
Mm.343110 NM_008084 Gapdh Glyceraldehyde-3-phosphate dehydrogenase 
Mm.3317 NM_010368 Gusb Glucuronidase, beta 




7.6 Peritoneal Leukocyte Profile of Animals Subject To Six Hours 
Zymosan Peritonitis Using An Enriched Environment With And Without A 




Appendix 7. Peritoneal leukocyte profile of animals subject to six hours zymosan peritonitis using an 





ABBAS, A. K., LICHTMAN, A. H. & PILLAI, S. 2014. Cellular and Molecular Immunology: with 
STUDENT CONSULT Online Access, Elsevier Health Sciences. 
ADER, R. & COHEN, N. 1975. Behaviorally conditioned immunosuppression. Psychosomatic 
Medicine, 37, 333-340. 
AHBAP, E., SAKACI, T., KARA, E., SAHUTOGLU, T., KOC, Y., BASTURK, T., SEVINC, M., AKGOL, 
C., KAYALAR, A. O. & UCAR, Z. A. 2016. Neutrophil-to-lymphocyte ratio and platelet-
tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clinical 
nephrology, 85, 199-208. 
AIKAWA, N. 1996. Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome 
associated with surgical insults. Nihon Geka Gakkai Zasshi, 97, 771-777. 
AJUEBOR, M. N., FLOWER, R. J., HANNON, R., CHRISTIE, M., BOWERS, K., VERITY, A. & 
PERRETTI, M. 1998. Endogenous monocyte chemoattractant protein-1 recruits monocytes in 
the zymosan peritonitis model. Journal of leukocyte biology, 63, 108-116. 
AKIRA, S., UEMATSU, S. & TAKEUCHI, O. 2006. Pathogen recognition and innate immunity. Cell, 
124, 783-801. 
AL-ALWAN, L. A., CHANG, Y., MOGAS, A., HALAYKO, A. J., BAGLOLE, C. J., MARTIN, J. G., 
ROUSSEAU, S., EIDELMAN, D. H. & HAMID, Q. 2013. Differential roles of CXCL2 and 
CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell 
migration. The Journal of Immunology, 191, 2731-2741. 
ALBELDA, S. M., SMITH, C. W. & WARD, P. 1994. Adhesion molecules and inflammatory injury. The 
FASEB Journal, 8, 504-512. 
ALBLAS, J., HONING, H., DE LAVALETTE, C. R., BROWN, M. H., DIJKSTRA, C. D. & VAN DEN 
BERG, T. K. 2005. Signal regulatory protein α ligation induces macrophage nitric oxide 
production through JAK/STAT-and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-
dependent pathways. Molecular and cellular biology, 25, 7181-7192. 
ALVES-FILHO, J. C., DE FREITAS, A., SPILLER, F., SOUTO, F. O. & CUNHA, F. Q. 2008. The role 
of neutrophils in severe sepsis. Shock, 30, 3-9. 
ANDERSON, J. M., RODRIGUEZ, A. & CHANG, D. T. Foreign body reaction to biomaterials.  
Seminars in immunology, 2008. Elsevier, 86-100. 
ANDRIOPOULOU, P., NAVARRO, P., ZANETTI, A., LAMPUGNANI, M. G. & DEJANA, E. 1999. 
Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. 
Arteriosclerosis, thrombosis, and vascular biology, 19, 2286-2297. 
ANTONI, M. H., LUTGENDORF, S. K., COLE, S. W., DHABHAR, F. S., SEPHTON, S. E., 
MCDONALD, P. G., STEFANEK, M. & SOOD, A. K. 2006. The influence of bio-behavioural 
factors on tumour biology: pathways and mechanisms. Nature Reviews Cancer, 6, 240-248. 
ARITA, M., OHIRA, T., SUN, Y.-P., ELANGOVAN, S., CHIANG, N. & SERHAN, C. N. 2007. Resolvin 
E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate 
inflammation. The Journal of Immunology, 178, 3912-3917. 
ARNDT, J., SMITH, N. & TAUSK, F. 2008. Stress and atopic dermatitis. Current allergy and asthma 
reports, 8, 312-317. 
ARNOLD, L., HENRY, A., PORON, F., BABA-AMER, Y., VAN ROOIJEN, N., PLONQUET, A., 
GHERARDI, R. K. & CHAZAUD, B. 2007. Inflammatory monocytes recruited after skeletal 
muscle injury switch into antiinflammatory macrophages to support myogenesis. The Journal 
of experimental medicine, 204, 1057-1069. 
ARRANZ, L., DE CASTRO, N. M., BAEZA, I., MATÉ, I., VIVEROS, M. P. & DE LA FUENTE, M. 2010. 
Environmental enrichment improves age-related immune system impairment: long-term 
exposure since adulthood increases life span in mice. Rejuvenation research, 13, 415-428. 
ASHLEY, N. T., WEIL, Z. M. & NELSON, R. J. 2012. Inflammation: mechanisms, costs, and natural 
variation. Annual Review of Ecology, Evolution, and Systematics, 43, 385-406. 
ASSINDER, S. J., STANTON, J.-A. L. & PRASAD, P. D. 2009. Transgelin: an actin-binding protein 
and tumour suppressor. The international journal of biochemistry & cell biology, 41, 482-486. 
ASSUNÇÃO, L., ELOI-SANTOS, S. & PEIXOTO, S. 2012. High sensitivity C-reactive protein 
distribution in the elderly: the Bambui Cohort Study, Brazil. Brazilian Journal of Medical and 
Biological Research, 45, 1284-1286. 
AUFFRAY, C., FOGG, D., GARFA, M., ELAIN, G., JOIN-LAMBERT, O., KAYAL, S., SARNACKI, S., 
CUMANO, A., LAUVAU, G. & GEISSMANN, F. 2007. Monitoring of blood vessels and tissues 
by a population of monocytes with patrolling behavior. Science, 317, 666-670. 
AUFFRAY, C., FOGG, D. K., NARNI-MANCINELLI, E., SENECHAL, B., TROUILLET, C., 
SAEDERUP, N., LEEMPUT, J., BIGOT, K., CAMPISI, L. & ABITBOL, M. 2009. CX3CR1+ 
205 
 
CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their 
response to inflammation. The Journal of experimental medicine, 206, 595-606. 
AVERILL, M. M., BARNHART, S., BECKER, L., LI, X., HEINECKE, J. W., LEBOEUF, R. C., 
HAMERMAN, J. A., SORG, C., KERKHOFF, C. & BORNFELDT, K. E. 2011. S100A9 
Differentially Modifies Phenotypic States of Neutrophils, Macrophages, and Dendritic Cells 
Implications for Atherosclerosis and Adipose Tissue Inflammation. Circulation, 123, 1216-
1226. 
AYALA, A., SONG, G. Y., CHUNG, C.-S., REDMOND, K. M. & CHAUDRY, I. H. 2000. Immune 
depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Critical 
care medicine, 28, 2949-2955. 
AYUB, N., BENTON, J. L., ZHANG, Y. & BELTZ, B. S. 2011. Environmental enrichment influences 
neuronal stem cells in the adult crayfish brain. Developmental neurobiology, 71, 351-361. 
BABIC, A. M., CHEN, C.-C. & LAU, L. F. 1999. Fisp12/mouse connective tissue growth factor 
mediates endothelial cell adhesion and migration through integrin αvβ3, promotes endothelial 
cell survival, and induces angiogenesis in vivo. Molecular and cellular biology, 19, 2958-2966. 
BAHOU, W. F. & GNATENKO, D. V. Platelet transcriptome: the application of microarray analysis to 
platelets.  Seminars in thrombosis and hemostasis, 2004. Copyright© 2004 by Thieme 
Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA., 473-484. 
BAKER, C. C., CHAUDRY, I. H., GAINES, H. O. & BAUE, A. E. 1983. Evaluation of factors affecting 
mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery, 94, 331-
335. 
BAKER, J., DE LISIO, M. & PARISE, G. 2011. Endurance exercise training promotes medullary 
hematopoiesis. The FASEB Journal, 25, 4348-4357. 
BALCOMBE, J. 2010. Laboratory rodent welfare: Thinking outside the cage. Journal of Applied Animal 
Welfare Science, 13, 77-88. 
BALCOMBE, J. P. 2006. Laboratory environments and rodents' behavioural needs: a review. 
Laboratory animals, 40, 217-235. 
BARNES, P. J. 2010. Mechanisms and resistance in glucocorticoid control of inflammation. The 
Journal of steroid biochemistry and molecular biology, 120, 76-85. 
BARTH, M., HENDRZAK, J., MELNICOFF, M. & MORAHAN, P. 1995. Review of the macrophage 
disappearance reaction. Journal of leukocyte biology, 57, 361-367. 
BARTOLOMUCCI, A. 2007. Social stress, immune functions and disease in rodents. Frontiers in 
neuroendocrinology, 28, 28-49. 
BARTOLOMUCCI, A., PALANZA, P., GASPANI, L., LIMIROLI, E., PANERAI, A. E., CERESINI, G., 
POLI, M. D. & PARMIGIANI, S. 2001. Social status in mice: behavioral, endocrine and 
immune changes are context dependent. Physiology & behavior, 73, 401-410. 
BARTON, B. A., SCHRECK, C. B. & BARTON, L. D. 1987. Effects of chronic cortisol administration 
and daily acute stress on growth, physiological conditions, and stress responses in juvenile 
rainbow trout. Dis. Aquat. Org, 2, 173-185. 
BARTROP, R., LAZARUS, L., LUCKHURST, E., KILOH, L. G. & PENNY, R. 1977. Depressed 
lymphocyte function after bereavement. The Lancet, 309, 834-836. 
BAUER, J. S., VARNER, J., SCHREINER, C., KORNBERG, L., NICHOLAS, R. & JULIANO, R. L. 
1993. Functional role of the cytoplasmic domain of the integrin alpha 5 subunit. The Journal of 
Cell Biology, 122, 209-221. 
BEATTIE, V., O’CONNELL, N. & MOSS, B. 2000. Influence of environmental enrichment on the 
behaviour, performance and meat quality of domestic pigs. Livestock production science, 65, 
71-79. 
BEAVERS, K. M., BRINKLEY, T. E. & NICKLAS, B. J. 2010. Effect of exercise training on chronic 
inflammation. Clinica chimica acta, 411, 785-793. 
BELLINGAN, G. J., CALDWELL, H., HOWIE, S., DRANSFIELD, I. & HASLETT, C. 1996. In vivo fate 
of the inflammatory macrophage during the resolution of inflammation: inflammatory 
macrophages do not die locally, but emigrate to the draining lymph nodes. The Journal of 
Immunology, 157, 2577-2585. 
BENAROYA-MILSHTEIN, N., APTER, A., YANIV, I., KUKULANSKY, T., RAZ, N., HABERMAN, Y., 
HALPERT, H., PICK, C. G. & HOLLANDER, N. 2007. Environmental enrichment augments 
the efficacy of idiotype vaccination for B-cell lymphoma. Journal of immunotherapy, 30, 517-
522. 
BENAROYA‐MILSHTEIN, N., HOLLANDER, N., APTER, A., KUKULANSKY, T., RAZ, N., WILF, A., 
YANIV, I. & PICK, C. 2004. Environmental enrichment in mice decreases anxiety, attenuates 
stress responses and enhances natural killer cell activity. European Journal of Neuroscience, 
20, 1341-1347. 
BENEFIEL, A. C., DONG, W. K. & GREENOUGH, W. T. 2005. Mandatory “enriched” housing of 
laboratory animals: the need for evidence-based evaluation. ILAR Journal, 46, 95-105. 
206 
 
BENGSTON, S. E., PRUITT, J. N. & RIECHERT, S. E. 2014. Differences in environmental enrichment 
generate contrasting behavioural syndromes in a basal spider lineage. Animal Behaviour, 93, 
105-110. 
BERK, L. S., FELTEN, D. L., TAN, S. A., BITTMAN, B. B. & WESTENGARD, J. 2001. Modulation of 
neuroimmune parameters during the eustress of humor-associated mirthful laughter. 
Alternative therapies in health and medicine, 7, 62-76. 
BEURA, L. K., HAMILTON, S. E., BI, K., SCHENKEL, J. M., ODUMADE, O. A., CASEY, K. A., 
THOMPSON, E. A., FRASER, K. A., ROSATO, P. C., FILALI-MOUHIM, A., SEKALY, R. P., 
JENKINS, M. K., VEZYS, V., HAINING, W. N., JAMESON, S. C. & MASOPUST, D. 2016. 
Normalizing the environment recapitulates adult human immune traits in laboratory mice. 
Nature, 532, 512-6. 
BIAN, Z., GUO, Y., HA, B., ZEN, K. & LIU, Y. 2012. Regulation of the inflammatory response: 
enhancing neutrophil infiltration under chronic inflammatory conditions. The Journal of 
Immunology, 188, 844-853. 
BIELOHUBY, M., POPP, S. & BIDLINGMAIER, M. 2012. A guide for measurement of circulating 
metabolic hormones in rodents: Pitfalls during the pre-analytical phase. Molecular metabolism, 
1, 47-60. 
BITTMAN, B. B., BERK, L. S., FELTEN, D. L. & WESTENGARD, J. 2001. Composite effects of group 
drumming music therapy on modulation of neuroendocrine-immune parameters in normal 
subjects. Alternative therapies in health and medicine, 7, 38. 
BLAYBEL, R., THÉOLEYRE, O., DOUABLIN, A. & BAKLOUTI, F. 2008. Downregulation of the Spi-
1/PU. 1 oncogene induces the expression of TRIM10/HERF1, a key factor required for 
terminal erythroid cell differentiation and survival. Cell research, 18, 834-845. 
BLUME, K. E., SOEROES, S., KEPPELER, H., STEVANOVIC, S., KRETSCHMER, D., 
RAUTENBERG, M., WESSELBORG, S. & LAUBER, K. 2012. Cleavage of annexin A1 by 
ADAM10 during secondary necrosis generates a monocytic “find-me” signal. The Journal of 
Immunology, 188, 135-145. 
BOBEL, J., DI-LERNIA, M., ABBOTT, J., LONG, M. & WARREN, L. 2015. 43 Influence of oat β-glucan 
on neutrophil function and lymphocyte subsets in response to stress. Journal of Equine 
Veterinary Science, 35, 402. 
BOMMHARDT, U., CHANG, K. C., SWANSON, P. E., WAGNER, T. H., TINSLEY, K. W., KARL, I. E. 
& HOTCHKISS, R. S. 2004. Akt decreases lymphocyte apoptosis and improves survival in 
sepsis. The Journal of Immunology, 172, 7583-7591. 
BONECCHI, R., LOCATI, M., GALLIERA, E., VULCANO, M., SIRONI, M., FRA, A. M., GOBBI, M., 
VECCHI, A., SOZZANI, S. & HARIBABU, B. 2004. Differential recognition and scavenging of 
native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC 
chemokine ligand 22) by the D6 decoy receptor. The Journal of Immunology, 172, 4972-4976. 
BONNEAU, R. H., SHERIDAN, J. F., FENG, N. & GLASER, R. 1991. Stress-induced effects on cell-
mediated innate and adaptive memory components of the murine immune response to herpes 
simplex virus infection. Brain, behavior, and immunity, 5, 274-295. 
BOOTH, F. W., ROBERTS, C. K. & LAYE, M. J. 2012. Lack of exercise is a major cause of chronic 
diseases. Comprehensive Physiology. 
BOROVIKOVA, L. V., IVANOVA, S., NARDI, D., ZHANG, M., YANG, H., OMBRELLINO, M. & 
TRACEY, K. J. 2000. Role of vagus nerve signaling in CNI-1493-mediated suppression of 
acute inflammation. Autonomic Neuroscience, 85, 141-147. 
BORREGAARD, N. 2010. Neutrophils, from marrow to microbes. Immunity, 33, 657-670. 
BOURIN, M. & HASCOËT, M. 2003. The mouse light/dark box test. European journal of 
pharmacology, 463, 55-65. 
BOYD, J. & LOVE, J. 1995. The effects of dividers on the nesting sites of mice. Frontiers in Laboratory 
Animal Science, 2. 
BRINKMANN, V., REICHARD, U., GOOSMANN, C., FAULER, B., UHLEMANN, Y., WEISS, D. S., 
WEINRAUCH, Y. & ZYCHLINSKY, A. 2004. Neutrophil extracellular traps kill bacteria. 
science, 303, 1532-1535. 
BROD, S., RATTAZZI, L., PIRAS, G. & D'ACQUISTO, F. 2014a. ‘As above, so below’examining the 
interplay between emotion and the immune system. Immunology, 143, 311-318. 
BROD, S., RATTAZZI, L., PIRAS, G. & D'ACQUISTO, F. 2014b. “As above, so below” Examining the 
interplay between emotion and the Immune System. Immunology, n/a-n/a. 
BRODIN, P., JOJIC, V., GAO, T., BHATTACHARYA, S., ANGEL, C. J. L., FURMAN, D., SHEN-ORR, 
S., DEKKER, C. L., SWAN, G. E. & BUTTE, A. J. 2015. Variation in the Human Immune 
System Is Largely Driven by Non-Heritable Influences. Cell, 160, 37-47. 




BROWN, D. H. & ZWILLING, B. S. 1994. Activation of the hypothalamic-pituitary-adrenal axis 
differentially affects the anti-mycobacterial activity of macrophages from BCG-resistant and 
susceptible mice. Journal of neuroimmunology, 53, 181-187. 
BROWN, G. D., TAYLOR, P. R., REID, D. M., WILLMENT, J. A., WILLIAMS, D. L., MARTINEZ-
POMARES, L., WONG, S. Y. & GORDON, S. 2002. Dectin-1 is a major β-glucan receptor on 
macrophages. The Journal of experimental medicine, 196, 407-412. 
BROWN, H. 1995. Ilya Mechnikov and his studies on comparative inflammation. Experimental Biology 
and Medicine, 209, 99-101. 
BROWN, K., BRAIN, S., PEARSON, J., EDGEWORTH, J., LEWIS, S. & TREACHER, D. 2006. 
Neutrophils in development of multiple organ failure in sepsis. The Lancet, 368, 157-169. 
BRUN, J. G., HÅLAND, G., HAGA, H. J., FAGERHOL, M. K. & JONSSON, R. 1995. Effects of 
calprotectin in avridine‐induced arthritis. Apmis, 103, 233-240. 
BULFONE, A., CACCIOPPOLI, C., PARDINI, C., FAEDO, A., MARTINEZ, S. & BANFI, S. 2004. 
Pcp4l1, a novel gene encoding a Pcp4-like polypeptide, is expressed in specific domains of 
the developing brain. Gene expression patterns, 4, 297-301. 
BURGESS, A. W. & METCALF, D. 1980. The nature and action of granulocyte-macrophage colony 
stimulating factors. Blood, 56, 947-958. 
BUTCHER, S. K., KILLAMPALLI, V., LASCELLES, D., WANG, K., ALPAR, E. K. & LORD, J. M. 2005. 
Raised cortisol: DHEAS ratios in the elderly after injury: potential impact upon neutrophil 
function and immunity. Aging cell, 4, 319-324. 
BUTLER, G. S., SIM, D., TAM, E., DEVINE, D. & OVERALL, C. M. 2002. Mannose-binding Lectin 
(MBL) Mutants Are Susceptible to Matrix Metalloproteinase Proteolysis POTENTIAL ROLE IN 
HUMAN MBL DEFICIENCY. Journal of Biological Chemistry, 277, 17511-17519. 
BYRD, A. S., O’BRIEN, X. M., JOHNSON, C. M., LAVIGNE, L. M. & REICHNER, J. S. 2013. An 
extracellular matrix–based mechanism of rapid neutrophil extracellular trap formation in 
response to Candida albicans. The Journal of Immunology, 190, 4136-4148. 
CALFEE, C. S. & MATTHAY, M. A. 2010. Clinical immunology: Culprits with evolutionary ties. Nature, 
464, 41-42. 
CANNON, K. E., CHAZOT, P. L., HANN, V., SHENTON, F., HOUGH, L. B. & RICE, F. L. 2007. 
Immunohistochemical localization of histamine H 3 receptors in rodent skin, dorsal root 
ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets. Pain, 129, 
76-92. 
CAO, L., CHOI, E. Y., LIU, X., MARTIN, A., WANG, C., XU, X. & DURING, M. J. 2011. White to brown 
fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-
adipocyte axis. Cell metabolism, 14, 324-338. 
CAO, L., JIAO, X., ZUZGA, D. S., LIU, Y., FONG, D. M., YOUNG, D. & DURING, M. J. 2004. VEGF 
links hippocampal activity with neurogenesis, learning and memory. Nature genetics, 36, 827-
835. 
CAO, W., DUAN, J., WANG, X., ZHONG, X., HU, Z., HUANG, F., WANG, H., ZHANG, J., LI, F. & 
ZHANG, J. 2014. Early enriched environment induces an increased conversion of proBDNF to 
BDNF in the adult rat's hippocampus. Behavioural brain research, 265, 76-83. 
CARPENTER, G. & COHEN, S. 1990. Epidermal growth factor. J Biol Chem, 265, 7709-7712. 
CARREIRA, C. M., LAVALLEE, T. M., TARANTINI, F., JACKSON, A., LATHROP, J. T., HAMPTON, 
B., BURGESS, W. H. & MACIAG, T. 1998. S100A13 is involved in the regulation of fibroblast 
growth factor-1 and p40 synaptotagmin-1 release in vitro. Journal of Biological Chemistry, 
273, 22224-22231. 
CASH, J. L., WHITE, G. E. & GREAVES, D. R. 2009. Zymosan‐Induced Peritonitis as a Simple 
Experimental System for the Study of Inflammation. Methods in enzymology, 461, 379-396. 
CELSUS, A. C. & SPENCER, W. G. 1935. De Medicina. With an English Translation by WG Spencer, 
London; Harvard University Press: Cambridge, Mass. 
CHABRY, J., NICOLAS, S., CAZARETH, J., MURRIS, E., GUYON, A., GLAICHENHAUS, N., 
HEURTEAUX, C. & PETIT-PAITEL, A. 2015. Enriched environment decreases microglia and 
brain macrophages inflammatory phenotypes through adiponectin-dependent mechanisms: 
relevance to depressive-like behavior. Brain, behavior, and immunity, 50, 275-287. 
CHAI, J. & TARNAWSKI, A. 2002. Serum response factor: discovery, biochemistry, biological roles 
and implications for tissue injury healing. Journal of physiology and pharmacology: an official 
journal of the Polish Physiological Society, 53. 
CHARAN, J. & KANTHARIA, N. 2013. How to calculate sample size in animal studies? Journal of 
Pharmacology and Pharmacotherapeutics, 4, 303. 
CHAUHAN, S. S., POPESCU, N., RAY, D., FLEISCHMANN, R., GOTTESMAN, M. & TROEN, B. 
1993. Cloning, genomic organization, and chromosomal localization of human cathepsin L. 
Journal of Biological Chemistry, 268, 1039-1045. 
208 
 
CHEN, C.-C., LLADO, V., EURICH, K., TRAN, H. T. & MIZOGUCHI, E. 2011. Carbohydrate-binding 
motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in 
colonic epithelial cells. Clinical Immunology, 140, 268-275. 
CHERVENICK, P., BOGGS, D., MARSH, J., CARTWRIGHT, G. & WINTROBE, M. 1968. Quantitative 
studies of blood and bone marrow neutrophils in normal mice. 
CHIN, Y. K.-Y., HEADEY, S. J., MOHANTY, B., PATIL, R., MCEWAN, P. A., SWARBRICK, J. D., 
MULHERN, T. D., EMSLEY, J., SIMPSON, J. S. & SCANLON, M. J. 2013. The structure of 
integrin α1I domain in complex with a collagen-mimetic peptide. Journal of Biological 
Chemistry, 288, 36796-36809. 
CHUNG, S., SON, G. H. & KIM, K. 2011. Circadian rhythm of adrenal glucocorticoid: its regulation and 
clinical implications. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1812, 
581-591. 
COMMITTEE, A. R. A. 2004. Enrichment Strategies for Rodents in the Laboratory. In: HEALTH, N. I. 
O. (ed.). United States. 
COOPER, D., NORLING, L. V. & PERRETTI, M. 2008. Novel insights into the inhibitory effects of 
Galectin-1 on neutrophil recruitment under flow. Journal of leukocyte biology, 83, 1459-1466. 
COOPER, L., JOHNSON, C., BURSLEM, F. & MARTIN, P. 2004. Wound healing and inflammation 
genes revealed by array analysis of'macrophageless' PU. 1 null mice. Genome biology, 6, 1. 
COPPOLA, R., MARI, D., LATTUADA, A. & FRANCESCHI, C. 2003. Von Willebrand factor in Italian 
centenarians. Haematologica, 88, 39-43. 
CORDAIN, L., EATON, S. B., SEBASTIAN, A., MANN, N., LINDEBERG, S., WATKINS, B. A., 
O’KEEFE, J. H. & BRAND-MILLER, J. 2005. Origins and evolution of the Western diet: health 
implications for the 21st century. The American journal of clinical nutrition, 81, 341-354. 
COUTELLIER, L. & WÜRBEL, H. 2009. Early environmental cues affect object recognition memory in 
adult female but not male C57BL/6 mice. Behavioural brain research, 203, 312-315. 
CRACIUN, F. L., SCHULLER, E. R. & REMICK, D. G. 2010. Early enhanced local neutrophil 
recruitment in peritonitis-induced sepsis improves bacterial clearance and survival. The 
Journal of Immunology, 185, 6930-6938. 
CRANE, M. J., DALEY, J. M., VAN HOUTTE, O., BRANCATO, S. K., HENRY JR, W. L. & ALBINA, J. 
E. 2014. The monocyte to macrophage transition in the murine sterile wound. PloS one, 9, 
e86660. 
CRAWLEY, J. N. 1985. Exploratory behavior models of anxiety in mice. Neuroscience & Biobehavioral 
Reviews, 9, 37-44. 
CROCE, K., GAO, H., WANG, Y., MOOROKA, T., SAKUMA, M., SHI, C., SUKHOVA, G., PACKARD, 
R. R. S., HOGG, N., LIBBY, P. & SIMON, D. I. 2009. MRP-8/14 is Critical for the Biological 
Response to Vascular Injury. Circulation, 120, 427-436. 
CROFTON, E. J., ZHANG, Y. & GREEN, T. A. 2015. Inoculation stress hypothesis of environmental 
enrichment. Neuroscience & Biobehavioral Reviews, 49, 19-31. 
CRUZ, C. S. D., LIU, W., HE, C. H., JACOBY, A., GORNITZKY, A., MA, B., FLAVELL, R., LEE, C. G. 
& ELIAS, J. A. 2012. Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and 
augments host tolerance to lung antibacterial responses. Cell host & microbe, 12, 34-46. 
CUTOLO, M. & STRAUB, R. H. 2007. Stress as a risk factor in the pathogenesis of rheumatoid 
arthritis. Neuroimmunomodulation, 13, 277-282. 
D'AMICO, G., FRASCAROLI, G., BIANCHI, G., TRANSIDICO, P., DONI, A., VECCHI, A., SOZZANI, 
S., ALLAVENA, P. & MANTOVANI, A. 2000. Uncoupling of inflammatory chemokine receptors 
by IL-10: generation of functional decoys. Nature immunology, 1, 387-391. 
DAHLEN, S.-E., BJÖRK, J., HEDQVIST, P., ARFORS, K.-E., HAMMARSTRÖM, S., LINDGREN, J.-A. 
& SAMUELSSON, B. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in 
postcapillary venules: in vivo effects with relevance to the acute inflammatory response. 
Proceedings of the National Academy of Sciences, 78, 3887-3891. 
DALLI, J., NORLING, L. V., RENSHAW, D., COOPER, D., LEUNG, K.-Y. & PERRETTI, M. 2008. 
Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. 
Blood, 112, 2512-2519. 
DANESE, S., SANS, M. & FIOCCHI, C. 2004. Inflammatory bowel disease: the role of environmental 
factors. Autoimmunity Reviews, 3, 394-400. 
DANTZER, R., O'CONNOR, J. C., FREUND, G. G., JOHNSON, R. W. & KELLEY, K. W. 2008. From 
inflammation to sickness and depression: when the immune system subjugates the brain. 
Nature reviews neuroscience, 9, 46-56. 
DAVIES, L. C., ROSAS, M., JENKINS, S. J., LIAO, C.-T., SCURR, M. J., BROMBACHER, F., 
FRASER, D. J., ALLEN, J. E., JONES, S. A. & TAYLOR, P. R. 2013. Distinct bone marrow-
derived and tissue-resident macrophage lineages proliferate at key stages during 
inflammation. Nature communications, 4, 1886. 
209 
 
DE JONG, I. C., PRELLE, I. T., VAN DE BURGWAL, J. A., LAMBOOIJ, E., KORTE, S. M., 
BLOKHUIS, H. J. & KOOLHAAS, J. M. 2000. Effects of environmental enrichment on 
behavioral responses to novelty, learning, and memory, and the circadian rhythm in cortisol in 
growing pigs. Physiology & behavior, 68, 571-578. 
DE JONG, J. G., VAN DER VEGT, B. J., BUWALDA, B. & KOOLHAAS, J. M. 2005. Social 
environment determines the long-term effects of social defeat. Physiology & behavior, 84, 87-
95. 
DE JONGE, W. J., VAN DER ZANDEN, E. P., THE, F. O., BIJLSMA, M. F., VAN WESTERLOO, D. J., 
BENNINK, R. J., BERTHOUD, H.-R., UEMATSU, S., AKIRA, S. & VAN DEN WIJNGAARD, R. 
M. 2005. Stimulation of the vagus nerve attenuates macrophage activation by activating the 
Jak2-STAT3 signaling pathway. Nature immunology, 6, 844-851. 
DE SOUSA, A. A., REIS, R., BENTO-TORRES, J., TRÉVIA, N., DE ALMEIDA LINS, N. A., PASSOS, 
A., SANTOS, Z., DINIZ, J. A. P., DA COSTA VASCONCELOS, P. F. & CUNNINGHAM, C. 
2011. Influence of enriched environment on viral encephalitis outcomes: behavioral and 
neuropathological changes in albino Swiss mice. PloS one, 6, e15597. 
DE VERNEUIL, H., SASSA, S. & KAPPAS, A. 1983. Purification and properties of uroporphyrinogen 
decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential 
decarboxylations of uroporphyrinogens I and III. Journal of Biological Chemistry, 258, 2454-
2460. 
DEAN, R. A., COX, J. H., BELLAC, C. L., DOUCET, A., STARR, A. E. & OVERALL, C. M. 2008. 
Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC 
chemokines and generates CCL2,-7,-8, and-13 antagonists: potential role of the macrophage 
in terminating polymorphonuclear leukocyte influx. Blood, 112, 3455-3464. 
DECEMBRINO, L., DE AMICI, M., POZZI, M., DE SILVESTRI, A. & STRONATI, M. 2015. Serum 
Calprotectin: A Potential Biomarker for Neonatal Sepsis. Journal of immunology research, 
2015. 
DEJAGER, L., PINHEIRO, I., DEJONCKHEERE, E. & LIBERT, C. 2011. Cecal ligation and puncture: 
the gold standard model for polymicrobial sepsis? Trends in microbiology, 19, 198-208. 
DEONARINE, K., PANELLI, M. C., STASHOWER, M. E., JIN, P., SMITH, K., SLADE, H. B., 
NORWOOD, C., WANG, E., MARINCOLA, F. M. & STRONCEK, D. F. 2007. Gene expression 
profiling of cutaneous wound healing. Journal of translational medicine, 5, 1. 
DETILLION, C. E., CRAFT, T. K., GLASPER, E. R., PRENDERGAST, B. J. & DEVRIES, A. C. 2004. 
Social facilitation of wound healing. Psychoneuroendocrinology, 29, 1004-1011. 
DEVALARAJA, R. M., NANNEY, L. B., QIAN, Q., DU, J., YU, Y., DEVALARAJA, M. N. & RICHMOND, 
A. 2000. Delayed wound healing in CXCR2 knockout mice. Journal of Investigative 
Dermatology, 115, 234-244. 
DHABHAR, F. S. 2000. Acute stress enhances while chronic stress suppresses skin immunity: the role 
of stress hormones and leukocyte trafficking. Annals of the New York Academy of Sciences, 
917, 876-893. 
DHABHAR, F. S. 2014. Effects of stress on immune function: the good, the bad, and the beautiful. 
Immunologic research, 58, 193-210. 
DHABHAR, F. S., MALARKEY, W. B., NERI, E. & MCEWEN, B. S. 2012. Stress-induced redistribution 
of immune cells—From barracks to boulevards to battlefields: A tale of three hormones–Curt 
Richter Award Winner. Psychoneuroendocrinology, 37, 1345-1368. 
DHABHAR, F. S. & MCEWEN, B. S. 1996. Stress-induced enhancement of antigen-specific cell-
mediated immunity. The Journal of Immunology, 156, 2608-2615. 
DHABHAR, F. S. & MCEWEN, B. S. 1997. Acute stress enhances while chronic stress suppresses 
cell-mediated immunityin vivo: A potential role for leukocyte trafficking. Brain, behavior, and 
immunity, 11, 286-306. 
DHABHAR, F. S. & MCEWEN, B. S. 1999. Enhancing versus suppressive effects of stress hormones 
on skin immune function. Proceedings of the National Academy of Sciences, 96, 1059-1064. 
DHABHAR, F. S., SAUL, A. N., DAUGHERTY, C., HOLMES, T. H., BOULEY, D. M. & OBERYSZYN, 
T. M. 2010. Short-term stress enhances cellular immunity and increases early resistance to 
squamous cell carcinoma. Brain, behavior, and immunity, 24, 127-137. 
DHABHAR, F. S. & VISWANATHAN, K. 2005. Short-term stress experienced at time of immunization 
induces a long-lasting increase in immunologic memory. American Journal of Physiology-
Regulatory, Integrative and Comparative Physiology, 289, R738-R744. 
DIENER, E. & CHAN, M. Y. 2011. Happy people live longer: Subjective well‐being contributes to 
health and longevity. Applied Psychology: Health and Well‐Being, 3, 1-43. 
DINAN, T. G. 2009. Inflammatory markers in depression. Current opinion in psychiatry, 22, 32-36. 
210 
 
DOEING, D. C., BOROWICZ, J. L. & CROCKETT, E. T. 2003. Gender dimorphism in differential 
peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein 
puncture methods. BMC clinical pathology, 3, 1. 
DOERFLER, M. E., DANNER, R. L., SHELHAMER, J. H. & PARRILLO, J. E. 1989. Bacterial 
lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4. 
Journal of Clinical Investigation, 83, 970. 
DOHERTY, N., POUBELLE, P., BORGEAT, P., BEAVER, T., WESTRICH, G. & SCHRADER, N. 
1985. Intraperitoneal injection of zymosan in mice induces pain, inflammation and the 
synthesis of peptidoleukotrienes and prostaglandin E< sub> 2</sub>. Prostaglandins, 30, 769-
789. 
DOWLATI, Y., HERRMANN, N., SWARDFAGER, W., LIU, H., SHAM, L., REIM, E. K. & LANCTÔT, K. 
L. 2010. A meta-analysis of cytokines in major depression. Biological psychiatry, 67, 446-457. 
DUIVIS, H. E., DE JONGE, P., PENNINX, B. W., NA, B. Y., COHEN, B. E. & WHOOLEY, M. A. 2014. 
Depressive symptoms, health behaviors, and subsequent inflammation in patients with 
coronary heart disease: prospective findings from the heart and soul study. 
DUIVIS, H. E., VOGELZANGS, N., KUPPER, N., DE JONGE, P. & PENNINX, B. W. 2013. Differential 
association of somatic and cognitive symptoms of depression and anxiety with inflammation: 
findings from the Netherlands Study of Depression and Anxiety (NESDA). 
Psychoneuroendocrinology, 38, 1573-1585. 
DURING, M. J., LIU, X., HUANG, W., MAGEE, D., SLATER, A., MCMURPHY, T., WANG, C. & CAO, 
L. 2015. Adipose VEGF links the white-to-brown fat switch with environmental, genetic, and 
pharmacological stimuli in male mice. Endocrinology, 156, 2059-2073. 
DUTTA, S. & SENGUPTA, P. 2016. Men and mice: relating their ages. Life sciences, 152, 244-248. 
EASH, K. J., MEANS, J. M., WHITE, D. W. & LINK, D. C. 2009. CXCR4 is a key regulator of neutrophil 
release from the bone marrow under basal and stress granulopoiesis conditions. Blood, 113, 
4711-4719. 
EDWARDS, E. A. & DEAN, L. M. 1977. Effects of crowding of mice on humoral antibody formation and 
protection to lethal antigenic challenge. Psychosomatic Medicine, 39, 19-24. 
EHRCHEN, J. M., SUNDERKÖTTER, C., FOELL, D., VOGL, T. & ROTH, J. 2009. The endogenous 
Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, 
autoimmunity, and cancer. Journal of leukocyte biology, 86, 557-566. 
EMELYANOV, V. V. 2001. Rickettsiaceae, rickettsia-like endosymbionts, and the origin of 
mitochondria. Bioscience reports, 21, 1-17. 
EMING, S. A., MARTIN, P. & TOMIC-CANIC, M. 2014. Wound repair and regeneration: mechanisms, 
signaling, and translation. Science translational medicine, 6, 265sr6-265sr6. 
ENGLER, H., BAILEY, M. T., ENGLER, A. & SHERIDAN, J. F. 2004. Effects of repeated social stress 
on leukocyte distribution in bone marrow, peripheral blood and spleen. Journal of 
neuroimmunology, 148, 106-115. 
EPEL, E. S., BLACKBURN, E. H., LIN, J., DHABHAR, F. S., ADLER, N. E., MORROW, J. D. & 
CAWTHON, R. M. 2004. Accelerated telomere shortening in response to life stress. 
Proceedings of the National Academy of Sciences of the United States of America, 101, 
17312-17315. 
EPELMAN, S., LAVINE, K. J. & RANDOLPH, G. J. 2014. Origin and functions of tissue macrophages. 
Immunity, 41, 21-35. 
ERNST, K., TUCHSCHERER, M., KANITZ, E., PUPPE, B. & MANTEUFFEL, G. 2006. Effects of 
attention and rewarded activity on immune parameters and wound healing in pigs. Physiology 
& behavior, 89, 448-456. 
FADOK, V. A., BRATTON, D. L., KONOWAL, A., FREED, P. W., WESTCOTT, J. Y. & HENSON, P. 
M. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory 
cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and 
PAF. Journal of Clinical Investigation, 101, 890. 
FARES, R. P., BELMEGUENAI, A., SANCHEZ, P. E., KOUCHI, H. Y., BODENNEC, J., MORALES, 
A., GEORGES, B., BONNET, C., BOUVARD, S. & SLOVITER, R. S. 2013. Standardized 
environmental enrichment supports enhanced brain plasticity in healthy rats and prevents 
cognitive impairment in epileptic rats. PLoS One, 8, e53888. 
FAURSCHOU, M. & BORREGAARD, N. 2003. Neutrophil granules and secretory vesicles in 
inflammation. Microbes and Infection, 5, 1317-1327. 
FEDOSOV, D. A. & GOMPPER, G. 2014. White blood cell margination in microcirculation. Soft matter, 
10, 2961-2970. 
FERENBACH, D. & HUGHES, J. 2008. Macrophages and dendritic cells: what is the difference? 
Kidney international, 74, 5-7. 
FISCHER, C. P. 2006. Interleukin-6 in acute exercise and training: what is the biological relevance. 
Exerc immunol rev, 12, 41. 
211 
 
FITCHETT, A. E., COLLINS, S. A., MASON, H., BARNARD, C. J. & CASSADAY, H. J. 2005. Urinary 
corticosterone measures: effects of strain and social rank in BKW and CD-1 mice. Behavioural 
processes, 70, 168-176. 
FLESHNER, M., LAUDENSLAGER, M. L., SIMONS, L. & MAIER, S. 1989. Reduced serum antibodies 
associated with social defeat in rats. Physiology & behavior, 45, 1183-1187. 
FORSYTHE, P. & BIENENSTOCK, J. 2010. Immunomodulation by commensal and probiotic bacteria. 
Immunological investigations, 39, 429-448. 
FORTES, C., FARCHI, S., FORASTIERE, F., AGABITI, N., PACIFICI, R., ZUCCARO, P., PERUCCI, 
C. A. & EBRAHIM, S. 2002. Depressive symptoms lead to impaired cellular immune response. 
Psychotherapy and psychosomatics, 72, 253-260. 
FORTUNATI, E., KAZEMIER, K., GRUTTERS, J., KOENDERMAN, L. & VAN DEN BOSCH, V. J. 
2009. Human neutrophils switch to an activated phenotype after homing to the lung 
irrespective of inflammatory disease. Clinical & Experimental Immunology, 155, 559-566. 
FRAGIADAKIS, G. K., GAUDILLIÈRE, B., GANIO, E. A., AGHAEEPOUR, N., TINGLE, M., NOLAN, G. 
P. & ANGST, M. S. 2015. Patient-specific immune states before surgery are strong correlates 
of surgical recovery. The Journal of the American Society of Anesthesiologists, 123, 1241-
1255. 
FRANCESCHI, C., CAPRI, M., MONTI, D., GIUNTA, S., OLIVIERI, F., SEVINI, F., PANOURGIA, M. 
P., INVIDIA, L., CELANI, L. & SCURTI, M. 2007. Inflammaging and anti-inflammaging: a 
systemic perspective on aging and longevity emerged from studies in humans. Mechanisms of 
ageing and development, 128, 92-105. 
FRANCESCHI, C., OLIVIERI, F., MARCHEGIANI, F., CARDELLI, M., CAVALLONE, L., CAPRI, M., 
SALVIOLI, S., VALENSIN, S., DE BENEDICTIS, G. & DI IORIO, A. 2005. Genes involved in 
immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a 
major role in the genetics of human longevity: the lesson of centenarians. Mechanisms of 
ageing and development, 126, 351-361. 
FRANCESCONE, R. A., SCULLY, S., FAIBISH, M., TAYLOR, S. L., OH, D., MORAL, L., YAN, W., 
BENTLEY, B. & SHAO, R. 2011. Role of YKL-40 in the angiogenesis, radioresistance, and 
progression of glioblastoma. Journal of Biological Chemistry, 286, 15332-15343. 
FRANKLIN, G. M., NELSON, L. M., HEATON, R. K., BURKS, J. S. & THOMPSON, D. S. 1988. Stress 
and its relationship to acute exacerbations in multiple sclerosis. Neurorehabilitation and Neural 
Repair, 2, 7-11. 
FRENCH, S. S., MOORE, M. C. & DEMAS, G. E. 2009. Ecological immunology: The organism in 
context. Integr Comp Biol, 49, 246-53. 
FRY, R. W., MORTON, A. R., CRAWFORD, G. & KEAST, D. 1992. Cell numbers and in vitro 
responses of leucocytes and lymphocyte subpopulations following maximal exercise and 
interval training sessions of different intensities. European journal of applied physiology and 
occupational physiology, 64, 218-227. 
FUCHS, T. A., ABED, U., GOOSMANN, C., HURWITZ, R., SCHULZE, I., WAHN, V., WEINRAUCH, 
Y., BRINKMANN, V. & ZYCHLINSKY, A. 2007. Novel cell death program leads to neutrophil 
extracellular traps. The Journal of cell biology, 176, 231-241. 
FUERTIG, R., AZZINNARI, D., BERGAMINI, G., CATHOMAS, F., SIGRIST, H., SEIFRITZ, E., 
VAVASSORI, S., LUIPPOLD, A., HENGERER, B. & CECI, A. 2015. Mouse chronic social 
stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects 
are reversed by inhibition of indoleamine 2, 3-dioxygenase. Brain, behavior, and immunity. 
FUNG, T. T., MCCULLOUGH, M. L., NEWBY, P., MANSON, J. E., MEIGS, J. B., RIFAI, N., WILLETT, 
W. C. & HU, F. B. 2005. Diet-quality scores and plasma concentrations of markers of 
inflammation and endothelial dysfunction. The American journal of clinical nutrition, 82, 163-
173. 
GALLO, I., RATTAZZI, L., PIRAS, G., GOBBETTI, T., PANZA, E., PERRETTI, M., DALLEY, J. W. & 
D'ACQUISTO, F. 2014. Formyl Peptide Receptor as a Novel Therapeutic Target for Anxiety-
Related Disorders. PloS one, 9, e114626. 
GARDNER, H., BROBERG, A., POZZI, A., LAATO, M. & HEINO, J. 1999. Absence of integrin 
alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal 
and wounded dermis. Journal of Cell Science, 112, 263-272. 
GARVY, B., KING, L., TELFORD, W., MORFORD, L. & FRAKER, P. 1993. Chronic elevation of 
plasma corticosterone causes reductions in the number of cycling cells of the B lineage in 
murine bone marrow and induces apoptosis. Immunology, 80, 587. 
GASTARDELO, T. S., DAMAZO, A. S., DALLI, J., FLOWER, R. J., PERRETTI, M. & OLIANI, S. M. 
2009. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating 
neutrophils during acute inflammation. The American journal of pathology, 174, 177-183. 
GEISSMANN, F., JUNG, S. & LITTMAN, D. R. 2003. Blood monocytes consist of two principal subsets 
with distinct migratory properties. Immunity, 19, 71-82. 
212 
 
GEISSMANN, F., MANZ, M. G., JUNG, S., SIEWEKE, M. H., MERAD, M. & LEY, K. 2010. 
Development of monocytes, macrophages, and dendritic cells. Science, 327, 656-661. 
GERSZTEN, R. E., GARCIA-ZEPEDA, E. A., LIM, Y.-C., YOSHIDA, M., DING, H. A., GIMBRONE, M. 
A., LUSTER, A. D., LUSCINSKAS, F. W. & ROSENZWEIG, A. 1999. MCP-1 and IL-8 trigger 
firm adhesion of monocytes to vascular endothelium under flow conditions. Nature, 398, 718-
723. 
GETTING, S. J., FLOWER, R. J. & PERRETTI, M. 1997. Inhibition of neutrophil and monocyte 
recruitment by endogenous and exogenous lipocortin 1. British journal of pharmacology, 120, 
1075-1082. 
GIACCONI, R., CIPRIANO, C., ALBANESE, F., BOCCOLI, G., SABA, V., OLIVIERI, F., 
FRANCESCHI, C. & MOCCHEGIANI, E. 2004. The− 174G/C polymorphism of IL-6 is useful to 
screen old subjects at risk for atherosclerosis or to reach successful ageing. Experimental 
gerontology, 39, 621-628. 
GINHOUX, F. & JUNG, S. 2014. Monocytes and macrophages: developmental pathways and tissue 
homeostasis. Nature Reviews Immunology, 14, 392-404. 
GIRALDO, E., GARCIA, J., HINCHADO, M. & ORTEGA, E. 2009. Exercise intensity-dependent 
changes in the inflammatory response in sedentary women: role of neuroendocrine 
parameters in the neutrophil phagocytic process and the pro-/anti-inflammatory cytokine 
balance. Neuroimmunomodulation, 16, 237-244. 
GLASER, R. & KIECOLT-GLASER, J. K. 2005. Stress-induced immune dysfunction: implications for 
health. Nature Reviews Immunology, 5, 243-251. 
GLEESON, M., BISHOP, N., OLIVEIRA, M., MCCAULEY, T., TAULER, P. & MUHAMAD, A. S. 2012. 
Respiratory infection risk in athletes: association with antigen‐stimulated IL‐10 production 
and salivary IgA secretion. Scandinavian Journal of Medicine & Science in Sports, 22, 410-
417. 
GLEESON, M., BISHOP, N. C., STENSEL, D. J., LINDLEY, M. R., MASTANA, S. S. & NIMMO, M. A. 
2011. The anti-inflammatory effects of exercise: mechanisms and implications for the 
prevention and treatment of disease. Nature Reviews Immunology, 11, 607-615. 
GODBOUT, J., CHEN, J., ABRAHAM, J., RICHWINE, A., BERG, B., KELLEY, K. & JOHNSON, R. 
2005. Exaggerated neuroinflammation and sickness behavior in aged mice following activation 
of the peripheral innate immune system. The FASEB journal, 19, 1329-1331. 
GÓMEZ-GAVIRO, M. V., DOMı́NGUEZ-JIMÉNEZ, C., CARRETERO, J. M., SABANDO, P., 
GONZÁLEZ-ALVARO, I., SÁNCHEZ-MADRID, F. & Dı́AZ-GONZÁLEZ, F. 2000. Down-
regulation of L-selectin expression in neutrophils by nonsteroidal anti-inflammatory drugs: role 
of intracellular ATP concentration. Blood, 96, 3592-3600. 
GOMEZ, C. R., BOEHMER, E. D. & KOVACS, E. J. 2005. The aging innate immune system. Current 
opinion in immunology, 17, 457-462. 
GONG, S., MIAO, Y.-L., JIAO, G.-Z., SUN, M.-J., LI, H., LIN, J., LUO, M.-J. & TAN, J.-H. 2015. 
Dynamics and correlation of serum cortisol and corticosterone under different physiological or 
stressful conditions in mice. PloS one, 10, e0117503. 
GOSHEN, I., AVITAL, A., KREISEL, T., LICHT, T., SEGAL, M. & YIRMIYA, R. 2009. Environmental 
enrichment restores memory functioning in mice with impaired IL-1 signaling via reinstatement 
of long-term potentiation and spine size enlargement. The Journal of Neuroscience, 29, 3395-
3403. 
GRIFFIN, A. C., LO, W. D., WOLNY, A. C. & WHITACRE, C. C. 1993. Suppression of experimental 
autoimmune encephalomyelitis by restraint stress: sex differences. Journal of 
neuroimmunology, 44, 103-116. 
GRIPPO, A. J., IHM, E., WARDWELL, J., MCNEAL, N., SCOTTI, M.-A. L., MOENK, D. A., 
CHANDLER, D. L., LAROCCA, M. A. & PREIHS, K. 2014. The effects of environmental 
enrichment on depressive-and anxiety-relevant behaviors in socially isolated prairie voles. 
Psychosomatic medicine, 76, 277. 
GUDE, D. R., ALVAREZ, S. E., PAUGH, S. W., MITRA, P., YU, J., GRIFFITHS, R., BARBOUR, S. E., 
MILSTIEN, S. & SPIEGEL, S. 2008. Apoptosis induces expression of sphingosine kinase 1 to 
release sphingosine-1-phosphate as a “come-and-get-me” signal. The FASEB Journal, 22, 
2629-2638. 
GUILARTE, T. R., TOSCANO, C. D., MCGLOTHAN, J. L. & WEAVER, S. A. 2003. Environmental 
enrichment reverses cognitive and molecular deficits induced by developmental lead 
exposure. Annals of neurology, 53, 50-56. 
GUILLIAMS, M., GINHOUX, F., JAKUBZICK, C., NAIK, S. H., ONAI, N., SCHRAML, B. U., SEGURA, 
E., TUSSIWAND, R. & YONA, S. 2014. Dendritic cells, monocytes and macrophages: a 
unified nomenclature based on ontogeny. Nature Reviews. Immunology, 14, 571. 
213 
 
GURFEIN, B. T., STAMM, A. W., BACCHETTI, P., DALLMAN, M. F., NADKARNI, N. A., MILUSH, J. 
M., TOUMA, C., PALME, R., DI BORGO, C. P. & FROMENTIN, G. 2012a. The calm mouse: 
an animal model of stress reduction. Molecular Medicine, 18, 606. 
GURFEIN, B. T., STAMM, A. W., BACCHETTI, P., DALLMAN, M. F., NADKARNI, N. A., MILUSH, J. 
M., TOUMA, C., PALME, R., DI BORGO, C. P., FROMENTIN, G. & OTHERS 2012b. The 
calm mouse: an animal model of stress reduction. Molecular Medicine, 18, 606. 
HAKANSSON, A. & MOLIN, G. 2011. Gut microbiota and inflammation. Nutrients, 3, 637-682. 
HALL, J. A., PICTON, R. A., FINNERAN, P. S., BIRD, K. E., SKINNER, M. M., JEWELL, D. E. & 
ZICKER, S. 2006. Dietary antioxidants and behavioral enrichment enhance neutrophil 
phagocytosis in geriatric Beagles. Veterinary immunology and immunopathology, 113, 224-
233. 
HASHIMOTO, D., CHOW, A., NOIZAT, C., TEO, P., BEASLEY, M. B., LEBOEUF, M., BECKER, C. 
D., SEE, P., PRICE, J. & LUCAS, D. 2013. Tissue-resident macrophages self-maintain locally 
throughout adult life with minimal contribution from circulating monocytes. Immunity, 38, 792-
804. 
HASLETT, C. 1992. Resolution of acute inflammation and the role of apoptosis in the tissue fate of 
granulocytes. Clinical science (London, England: 1979), 83, 639-648. 
HAYASHI, A., OHNISHI, H., OKAZAWA, H., NAKAZAWA, S., IKEDA, H., MOTEGI, S.-I., AOKI, N., 
KIMURA, S., MIKUNI, M. & MATOZAKI, T. 2004. Positive regulation of phagocytosis by 
SIRPβ and its signaling mechanism in macrophages. Journal of Biological Chemistry, 279, 
29450-29460. 
HAYASHI, T. & MURAKAMI, K. 2009. The effects of laughter on post-prandial glucose levels and 
gene expression in type 2 diabetic patients. Life Sci, 85, 185-7. 
HAYASHI, T., TSUJII, S., IBURI, T., TAMANAHA, T., YAMAGAMI, K., ISHIBASHI, R., HORI, M., 
SAKAMOTO, S., ISHII, H. & MURAKAMI, K. 2007. Laughter up-regulates the genes related to 
NK cell activity in diabetes. Biomed Res, 28, 281-5. 
HE, C. H., LEE, C. G., CRUZ, C. S. D., LEE, C.-M., ZHOU, Y., AHANGARI, F., MA, B., HERZOG, E. 
L., ROSENBERG, S. A. & LI, Y. 2013. Chitinase 3-like 1 regulates cellular and tissue 
responses via IL-13 receptor α2. Cell reports, 4, 830-841. 
HE, K., LIU, K., DAVIGLUS, M. L., JENNY, N. S., MAYER-DAVIS, E., JIANG, R., STEFFEN, L., 
SISCOVICK, D., TSAI, M. & HERRINGTON, D. 2009. Associations of dietary long-chain n-3 
polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation 
(from the Multi-Ethnic Study of Atherosclerosis [MESA]). The American journal of cardiology, 
103, 1238-1243. 
HEADLAND, S. E. & NORLING, L. V. The resolution of inflammation: Principles and challenges.  
Seminars in immunology, 2015. Elsevier, 149-160. 
HEIDLAND, A., KLASSEN, A., RUTKOWSKI, P. & BAHNER, U. 2006. The contribution of Rudolf 
Virchow to the concept of inflammation: what is still of importance? Journal of nephrology, 19, 
S102. 
HEIDT, T., SAGER, H. B., COURTIES, G., DUTTA, P., IWAMOTO, Y., ZALTSMAN, A., VON ZUR 
MUHLEN, C., BODE, C., FRICCHIONE, G. L. & DENNINGER, J. 2014. Chronic variable 
stress activates hematopoietic stem cells. Nature medicine, 20, 754-758. 
HICKLIN, D. J. & ELLIS, L. M. 2005. Role of the vascular endothelial growth factor pathway in tumor 
growth and angiogenesis. Journal of clinical oncology, 23, 1011-1027. 
HINZ, B. 2007. Formation and function of the myofibroblast during tissue repair. Journal of 
Investigative Dermatology, 127, 526-537. 
HOBBS, M., WEIGLE, W., NOONAN, D., TORBETT, B., MCEVILLY, R., KOCH, R., CARDENAS, G. & 
ERNST, D. 1993. Patterns of cytokine gene expression by CD4+ T cells from young and old 
mice. The Journal of Immunology, 150, 3602-3614. 
HOLLENBERG, S. M., BROUSSARD, M., OSMAN, J. & PARRILLO, J. E. 2000. Increased 
microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide 
synthase. Circulation research, 86, 774-778. 
HOLT, E. M., STEFFEN, L. M., MORAN, A., BASU, S., STEINBERGER, J., ROSS, J. A., HONG, C.-
P. & SINAIKO, A. R. 2009. Fruit and vegetable consumption and its relation to markers of 
inflammation and oxidative stress in adolescents. Journal of the American Dietetic 
Association, 109, 414-421. 
HORII-HAYASHI, N., YOSHIKAWA, M., MATSUSUE, Y., ISHIZAKA, S., NISHI, M. & WANAKA, A. 
2011. Environmental stimulation changes tissue-type plasminogen activator activity in the 
adult mouse hippocampus. Neurochemistry international, 58, 1-4. 
HOSOI, T., YAMAWAKI, Y., KIMURA, H. & OZAWA, K. 2016. Immobilization stress-induced anorexia 
is mediated independent of MyD88. NeuroReport, 27, 974-977. 
214 
 
HOTCHKISS, R., TINSLEY, K., SWANSON, P., CHANG, K., COBB, J., BUCHMAN, T., 
KORSMEYER, S. & KARL, I. 1999. Prevention of lymphocyte cell death in sepsis improves 
survival in mice. Proceedings of the National Academy of Sciences, 96, 14541-14546. 
HOTCHKISS, R. S. & NICHOLSON, D. W. 2006. Apoptosis and caspases regulate death and 
inflammation in sepsis. Nature Reviews Immunology, 6, 813-822. 
HOWE, L. R. 2007. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and 
breast cancer. Breast Cancer Research, 9, 1. 
HUA, L. & RECKLIES, A. D. 2004. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits 
cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-
alpha. Biochemical Journal, 380, 651-659. 
HUBER-LANG, M., BARRATT-DUE, A., PISCHKE, S. E., SANDANGER, Ø., NILSSON, P. H., NUNN, 
M. A., DENK, S., GAUS, W., ESPEVIK, T. & MOLLNES, T. E. 2014. Double blockade of CD14 
and complement C5 abolishes the cytokine storm and improves morbidity and survival in 
polymicrobial sepsis in mice. The Journal of Immunology, 192, 5324-5331. 
HUBRECHT, R., HURST, J., MORTON, D., PETERS, A., RAYMOND, R., SALES, G., SHERWIN, C. 
& WEST, C. 1993. Refining rodent husbandry: the mouse. Laboratory Animals, 27, 301-329. 
HUGO, H. J., SAUNDERS, C., RAMSAY, R. & THOMPSON, E. 2015. New insights on COX-2 in 
chronic inflammation driving breast cancer growth and Metastasis. Journal of mammary gland 
biology and neoplasia, 20, 109-119. 
HUTCHINSON, E., AVERY, A. & VANDEWOUDE, S. 2005. Environmental enrichment for laboratory 
rodents. ILAR journal, 46, 148-161. 
HUTCHINSON, E. K., AVERY, A. C. & VANDEWOUDE, S. 2012. Environmental enrichment during 
rearing alters corticosterone levels, thymocyte numbers, and aggression in female BALB/c 
mice. Journal of the American Association for Laboratory Animal Science: JAALAS, 51, 18. 
HÜTTENRAUCH, M., SALINAS, G. & WIRTHS, O. 2016. Effects of Long-Term Environmental 
Enrichment on Anxiety, Memory, Hippocampal Plasticity and Overall Brain Gene Expression 
in C57BL6 Mice. Frontiers in Molecular Neuroscience, 9. 
HYNES, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25. 
INAOKA, T., BILBE, G., ISHIBASHI, O., TEZUKA, K.-I., KUMEGAWA, M. & KOKUBO, T. 1995. 
Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly 
expressed in bone. Biochemical and biophysical research communications, 206, 89-96. 
IRWIN, M., PATTERSON, T., SMITH, T. L., CALDWELL, C., BROWN, S. A., GILLIN, J. C. & GRANT, 
I. 1990. Reduction of immune function in life stress and depression. Biological psychiatry, 27, 
22-30. 
IRWIN, M. R., OLMSTEAD, R., BREEN, E. C., WITARAMA, T., CARRILLO, C., SADEGHI, N., 
AREVALO, J. M., MA, J., NICASSIO, P. & BOOTZIN, R. 2015. Cognitive behavioral therapy 
and tai chi reverse cellular and genomic markers of inflammation in late-life insomnia: a 
randomized controlled trial. Biological psychiatry, 78, 721-729. 
ISOLAURI, E., RAUTANEN, T., JUNTUNEN, M., SILLANAUKEE, P. & KOIVULA, T. 1991. A human 
Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea 
in children. Pediatrics, 88, 90-97. 
ITALIANI, P. & BORASCHI, D. 2015. From monocytes to M1/M2 macrophages: phenotypical vs. 
functional differentiation. M1/M2 Macrophages: The Arginine Fork in the Road to Health and 
Disease, 47. 
ITO, M., YANG, Z., ANDL, T., CUI, C., KIM, N., MILLAR, S. E. & COTSARELIS, G. 2007. Wnt-
dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature, 447, 
316-320. 
JAIN, V., BAITHARU, I., PRASAD, D. & ILAVAZHAGAN, G. 2013. Enriched environment prevents 
hypobaric hypoxia induced memory impairment and neurodegeneration: role of 
BDNF/PI3K/GSK3beta pathway coupled with CREB activation. PLoS One, 8, e62235. 
JAMES, S. 1997. Passion and action: The emotions in seventeenth-century philosophy. 
JANKOWSKY, J. L., MELNIKOVA, T., FADALE, D. J., XU, G. M., SLUNT, H. H., GONZALES, V., 
YOUNKIN, L. H., YOUNKIN, S. G., BORCHELT, D. R. & SAVONENKO, A. V. 2005. 
Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's 
disease. The Journal of Neuroscience, 25, 5217-5224. 
JENEROWICZ, D., SILNY, W., DANCZAK-PAZDROWSKA, A., POLANSKA, A., OSMOLA-
MANKOWSKA, A. & OLEK-HRAB, K. 2012. Environmental factors and allergic diseases. 
Annals of agricultural and environmental medicine, 19. 
JEONG, J. Y., LEE, D. H. & KANG, S. S. 2013. Effects of chronic restraint stress on body weight, food 
intake, and hypothalamic gene expressions in mice. Endocrinology and metabolism, 28, 288-
296. 
JIA, G.-Q., GONZALO, J. A., LLOYD, C., KREMER, L., LU, L., MARTINEZ-A, C., WERSHIL, B. & 
GUTIERREZ-RAMOS, J. C. 1996. Distinct expression and function of the novel mouse 
215 
 
chemokine monocyte chemotactic protein-5 in lung allergic inflammation. The Journal of 
experimental medicine, 184, 1939-1951. 
JIA, T., SERBINA, N. V., BRANDL, K., ZHONG, M. X., LEINER, I. M., CHARO, I. F. & PAMER, E. G. 
2008. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory 
monocytes during Listeria monocytogenes infection. The Journal of Immunology, 180, 6846-
6853. 
JIANG, C. G., MORROW-TESCH, J. L., BELLER, D. I., LEVY, E. M. & BLACK, P. H. 1990. 
Immunosuppression in mice induced by cold water stress. Brain, behavior, and immunity, 4, 
278-291. 
JOHANNSEN, N. M., PRIEST, E. L., DIXIT, V. D., EARNEST, C. P., BLAIR, S. N. & CHURCH, T. S. 
2008. Association of white blood cell subfraction concentration with fitness and fatness. British 
journal of sports medicine. 
JOHANSEN, J. S. 2006. Studies on serum YKL-40 as a biomarker in diseases with inflammation, 
tissue remodelling, fibroses and cancer. Dan Med Bull, 53, 172-209. 
JUNGER, W. G., HOYT, D. B., LIU, F. C., LOOMIS, W. H. & COIMBRA, R. 1996. Immunosuppression 
after endotoxin shock: the result of multiple anti-inflammatory factors. Journal of Trauma and 
Acute Care Surgery, 40, 702-709. 
JURGENS, H. A. & JOHNSON, R. W. 2012. Environmental enrichment attenuates hippocampal 
neuroinflammation and improves cognitive function during influenza infection. Brain, behavior, 
and immunity, 26, 1006-1016. 
KAMBA, A., LEE, I.-A. & MIZOGUCHI, E. 2013. Potential association between TLR4 and chitinase 3-
like 1 (CHI3L1/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and 
colitis-associated cancer. Current molecular medicine, 13, 1110-1121. 
KANEIDER, N. C., EGGER, P., DJANANI, A. M. & WIEDERMANN, C. J. 2003. Leukocyte motility in 
response to neuropeptides is heparan sulfate proteoglycan dependent. Peptides, 24, 695-700. 
KANT, G. J., LEU, J. R., ANDERSON, S. M. & MOUGEY, E. H. 1987. Effects of chronic stress on 
plasma corticosterone, ACTH and prolactin. Physiology & behavior, 40, 775-779. 
KARSENTY, G. & PARK, R.-W. 1995. Regulation of type I collagen genes expression. International 
reviews of immunology, 12, 177-185. 
KAUFMAN, J. C., HARRIS, T. J., HIGGINS, J. & MAISEL, A. S. 1994. Exercise-induced enhancement 
of immune function in the rat. Circulation, 90, 525-532. 
KAUFMANN, A., SALENTIN, R., GEMSA, D. & SPRENGER, H. 2001. Increase of CCR1 and CCR5 
expression and enhanced functional response to MIP-1α during differentiation of human 
monocytes to macrophages. Journal of leukocyte biology, 69, 248-252. 
KAWAI, T. & AKIRA, S. 2010. The role of pattern-recognition receptors in innate immunity: update on 
Toll-like receptors. Nature immunology, 11, 373-384. 
KELISHADI, R., MIRGHAFFARI, N., POURSAFA, P. & GIDDING, S. S. 2009. Lifestyle and 
environmental factors associated with inflammation, oxidative stress and insulin resistance in 
children. Atherosclerosis, 203, 311-319. 
KELLEY, K., GREENFIELD, R., EVERMANN, J., PARISH, S. & PERRYMAN, L. 1982. Delayed-type 
hypersensitivity, contact sensitivity, and phytohemagglutinin skin-test responses of heat-and 
cold-stressed calves. American journal of veterinary research, 43, 775-779. 
KELLY-SCUMPIA, K. M., SCUMPIA, P. O., DELANO, M. J., WEINSTEIN, J. S., CUENCA, A. G., 
WYNN, J. L. & MOLDAWER, L. L. 2010. Type I interferon signaling in hematopoietic cells is 
required for survival in mouse polymicrobial sepsis by regulating CXCL10. The Journal of 
experimental medicine, 207, 319-326. 
KEMPERMANN, G., KUHN, H. G. & GAGE, F. H. 1997. More hippocampal neurons in adult mice 
living in an enriched environment. Nature, 386, 493-495. 
KERKHOFF, C., KLEMPT, M. & SORG, C. 1998. Novel insights into structure and function of MRP8 
(S100A8) and MRP14 (S100A9). Biochimica et Biophysica Acta (BBA) - Molecular Cell 
Research, 1448, 200-211. 
KIGERL, K. A., MCGAUGHY, V. M. & POPOVICH, P. G. 2006. Comparative analysis of lesion 
development and intraspinal inflammation in four strains of mice following spinal contusion 
injury. Journal of Comparative Neurology, 494, 578-594. 
KIM, B.-J. & JONES, H. P. 2010. Epinephrine-primed murine bone marrow-derived dendritic cells 
facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells. Brain, behavior, and 
immunity, 24, 1126-1136. 
KIM, C., YANG, H., FUKUSHIMA, Y., SAW, P. E., LEE, J., PARK, J.-S., PARK, I., JUNG, J., 
KATAOKA, H. & LEE, D. 2014. Vascular RhoJ is an effective and selective target for tumor 
angiogenesis and vascular disruption. Cancer cell, 25, 102-117. 
KIM, H.-J., ALONZO, E. S., DOROTHEE, G., POLLARD, J. W. & SANT'ANGELO, D. B. 2010. 
Selective depletion of eosinophils or neutrophils in mice impacts the efficiency of apoptotic cell 
clearance in the thymus. PloS one, 5, e11439. 
216 
 
KIMBRELL, D. A. & BEUTLER, B. 2001. The evolution and genetics of innate immunity. Nature 
Reviews Genetics, 2, 256-267. 
KJØLLER, L. 2002. The urokinase plasminogen activator receptor in the regulation of the actin 
cytoskeleton and cell motility. Biological chemistry, 383, 5-19. 
KLEBANOFF, S. J. 2005. Myeloperoxidase: friend and foe. Journal of leukocyte biology, 77, 598-625. 
KLEESSEN, B., KROESEN, A., BUHR, H. & BLAUT, M. 2002. Mucosal and invading bacteria in 
patients with inflammatory bowel disease compared with controls. Scandinavian journal of 
gastroenterology, 37, 1034-1041. 
KLOPFLEISCH, R. 2016. Macrophage reaction against biomaterials in the mouse model–Phenotypes, 
functions and markers. Acta Biomaterialia. 
KOLACZKOWSKA, E., BARTECZKO, M., PLYTYCZ, B. & ARNOLD, B. 2008. Role of lymphocytes in 
the course of murine zymosan-induced peritonitis. Inflammation Research, 57, 272-278. 
KONIKOFF, M. R. & DENSON, L. A. 2006. Role of fecal calprotectin as a biomarker of intestinal 
inflammation in inflammatory bowel disease. Inflammatory bowel diseases, 12, 524-534. 
KORNBLIT, B., HELLEMANN, D., MUNTHE-FOG, L., BONDE, J., STRØM, J. J., MADSEN, H. O., 
JOHANSEN, J. S. & GARRED, P. 2013. Plasma YKL-40 and CHI3L1 in systemic 
inflammation and sepsis—Experience from two prospective cohorts. Immunobiology, 218, 
1227-1234. 
KOVESDI, E., GYORGY, A. B., KWON, S.-K. C., WINGO, D. L., KAMNAKSH, A., LONG, J. B., 
KASPER, C. E. & AGOSTON, D. V. 2011. The effect of enriched environment on the outcome 
of traumatic brain injury; a behavioral, proteomics, and histological study. Frontiers in 
neuroscience, 5, 42. 
KRUSCHINSKI, C., SKRIPULETZ, T., BEDOUI, S., RABER, K., STRAUB, R. H., HOFFMANN, T., 
GROTE, K., JACOBS, R., STEPHAN, M. & PABST, R. 2008. Postnatal life events affect the 
severity of asthmatic airway inflammation in the adult rat. The Journal of Immunology, 180, 
3919-3925. 
KUMAR, V., ABBAS, A. K., FAUSTO, N. & MITCHELL, R. N. 2012. Robbins basic pathology, Elsevier 
Health Sciences. 
KUNDU, G. C. & PATIL, D. 2006. MMP2 (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 
72kDa type IV collagenase). 
KZHYSHKOWSKA, J., MAMIDI, S., GRATCHEV, A., KREMMER, E., SCHMUTTERMAIER, C., 
KRUSELL, L., HAUS, G., UTIKAL, J., SCHLEDZEWSKI, K. & SCHOLTZE, J. 2006. Novel 
stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated 
macrophages and secreted via lysosomal pathway. Blood, 107, 3221-3228. 
LACY, P., DENKERS, E. & GARG, A. D. 2015. Neutrophil-derived cytokines: facts beyond expression. 
Secretion of Cytokines and Chemokines by Innate Immune Cells, 38. 
LAMBETH, J. D. 2004. NOX enzymes and the biology of reactive oxygen. Nature Reviews 
Immunology, 4, 181-189. 
LANCASTER, G. I., KHAN, Q., DRYSDALE, P., WALLACE, F., JEUKENDRUP, A. E., DRAYSON, M. 
T. & GLEESON, M. 2005. The physiological regulation of toll‐like receptor expression and 
function in humans. The Journal of physiology, 563, 945-955. 
LAUBER, K., BOHN, E., KRÖBER, S. M., XIAO, Y.-J., BLUMENTHAL, S. G., LINDEMANN, R. K., 
MARINI, P., WIEDIG, C., ZOBYWALSKI, A. & BAKSH, S. 2003. Apoptotic cells induce 
migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell, 113, 
717-730. 
LAVIOLA, G., REA, M., MORLEY‐FLETCHER, S., DI CARLO, S., BACOSI, A., DE SIMONE, R., 
BERTINI, M. & PACIFICI, R. 2004. Beneficial effects of enriched environment on adolescent 
rats from stressed pregnancies. European Journal of Neuroscience, 20, 1655-1664. 
LE FEVRE, M., KOLT, G. S. & MATHENY, J. 2006. Eustress, distress and their interpretation in 
primary and secondary occupational stress management interventions: which way first? 
Journal of Managerial Psychology, 21, 547-565. 
LE FEVRE, M., MATHENY, J. & KOLT, G. S. 2003. Eustress, distress, and interpretation in 
occupational stress. Journal of Managerial psychology, 18, 726-744. 
LECH, M., GRÖBMAYR, R., WEIDENBUSCH, M. & ANDERS, H.-J. 2012. Tissues use resident 
dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon 
tissue injury: the immunoregulatory role of changing tissue environments. Mediators of 
inflammation, 2012. 
LEE, C. G., DA SILVA, C. A., CRUZ, C. S. D., AHANGARI, F., MA, B., KANG, M.-J., HE, C.-H., 
TAKYAR, S. & ELIAS, J. A. 2011. Role of chitin and chitinase/chitinase-like proteins in 
inflammation, tissue remodeling, and injury. Annual review of physiology, 73. 
LEE, C. G., DA SILVA, C. A., LEE, J.-Y., HARTL, D. & ELIAS, J. A. 2008. Chitin regulation of immune 
responses: an old molecule with new roles. Current opinion in immunology, 20, 684-689. 
217 
 
LEE, C. G., HARTL, D., LEE, G. R., KOLLER, B., MATSUURA, H., DA SILVA, C. A., SOHN, M. H., 
COHN, L., HOMER, R. J. & KOZHICH, A. A. 2009. Role of breast regression protein 39 (BRP-
39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis. The Journal 
of experimental medicine, 206, 1149-1166. 
LEGGATE, M., NOWELL, M. A., JONES, S. A. & NIMMO, M. A. 2010. The response of interleukin-6 
and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous 
moderate intensity cycling. Cell stress and Chaperones, 15, 827-833. 
LEHMANN, J., PRYCE, C., BETTSCHEN, D. & FELDON, J. 1999. The maternal separation paradigm 
and adult emotionality and cognition in male and female Wistar rats. Pharmacology 
Biochemistry and Behavior, 64, 705-715. 
LEHRNER, A., DASKALAKIS, N. & YEHUDA, R. 2016. Cortisol and the Hypothalamic–Pituitary–
Adrenal Axis in PTSD. Posttraumatic Stress Disorder: From Neurobiology to Treatment, 265. 
LEY, K., LAUDANNA, C., CYBULSKY, M. I. & NOURSHARGH, S. 2007. Getting to the site of 
inflammation: the leukocyte adhesion cascade updated. Nature Reviews Immunology, 7, 678-
689. 
LI, G., GAN, Y., FAN, Y., WU, Y., LIN, H., SONG, Y., CAI, X., YU, X., PAN, W. & YAO, M. 2015. 
Enriched environment inhibits mouse pancreatic cancer growth and down-regulates the 
expression of mitochondria-related genes in cancer cells. Scientific reports, 5. 
LI, X., THOMPSON, D., KUMAR, B. & DEMARTINO, G. N. 2014. Molecular and cellular roles of PI31 
(PSMF1) protein in regulation of proteasome function. Journal of Biological Chemistry, 289, 
17392-17405. 
LIN, E.-J. D., CHOI, E., LIU, X., MARTIN, A. & DURING, M. J. 2011. Environmental enrichment exerts 
sex-specific effects on emotionality in C57BL/6J mice. Behavioural brain research, 216, 349-
357. 
LIN, Q., WANG, F., YANG, R., ZHENG, X., GAO, H. & ZHANG, P. 2013. Effect of chronic restraint 
stress on human colorectal carcinoma growth in mice. PloS one, 8, e61435. 
LIRA, F. S., ROSA, J. C., PIMENTEL, G. D., SOUZA, H. A., CAPERUTO, E. C., CARNEVALI, L. C., 
SEELAENDER, M., DAMASO, A. R., OYAMA, L. M. & DE MELLO, M. T. 2010. Endotoxin 
levels correlate positively with a sedentary lifestyle and negatively with highly trained subjects. 
Lipids in health and disease, 9, 82. 
LIU, D.-Q., LI, L.-M., GUO, Y.-L., BAI, R., WANG, C., BIAN, Z., ZHANG, C.-Y. & ZEN, K. 2008. Signal 
Regulatory Protein α Negatively Regulates β<sub>2</sub> Integrin-Mediated Monocyte 
Adhesion, Transendothelial Migration and Phagocytosis. PLoS ONE, 3, e3291. 
LIU, X., SHEN, Y., WANG, H., GE, Q., FEI, A. & PAN, S. 2016. Prognostic Significance of Neutrophil-
to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study. Mediators of 
inflammation, 2016. 
LOPEZ-GARCIA, E., SCHULZE, M. B., MEIGS, J. B., MANSON, J. E., RIFAI, N., STAMPFER, M. J., 
WILLETT, W. C. & HU, F. B. 2005. Consumption of trans fatty acids is related to plasma 
biomarkers of inflammation and endothelial dysfunction. The Journal of nutrition, 135, 562-
566. 
LU, Y.-C., YEH, W.-C. & OHASHI, P. S. 2008. LPS/TLR4 signal transduction pathway. Cytokine, 42, 
145-151. 
LUMENG, C. N. & SALTIEL, A. R. 2011. Inflammatory links between obesity and metabolic disease. 
The Journal of clinical investigation, 121, 2111-2117. 
LUVONE, T., CARNUCCIO, R. & DI ROSA, M. 1994. Modulation of granuloma formation by 
endogenous nitric oxide. European journal of pharmacology, 265, 89-92. 
MA, B., BLACKBURN, M. R., LEE, C. G., HOMER, R. J., LIU, W., FLAVELL, R. A., BOYDEN, L., 
LIFTON, R. P., SUN, C.-X. & YOUNG, H. W. 2006. Adenosine metabolism and murine strain–
specific IL-4–induced inflammation, emphysema, and fibrosis. Journal of Clinical Investigation, 
116, 1274. 
MA, J., CHEN, T., MANDELIN, J., CEPONIS, A., MILLER, N., HUKKANEN, M., MA, G. & 
KONTTINEN, Y. 2003. Regulation of macrophage activation. Cellular and Molecular Life 
Sciences CMLS, 60, 2334-2346. 
MA, X.-C., JIANG, D., JIANG, W.-H., WANG, F., JIA, M., WU, J., HASHIMOTO, K., DANG, Y.-H. & 
GAO, C.-G. 2011. Social isolation-induced aggression potentiates anxiety and depressive-like 
behavior in male mice subjected to unpredictable chronic mild stress. PloS one, 6, e20955. 
MA, X., LIN, W. Y., CHEN, Y., STAWICKI, S., MUKHYALA, K., WU, Y., MARTIN, F., BAZAN, J. F. & 
STAROVASNIK, M. A. 2012. Structural basis for the dual recognition of helical cytokines IL-34 
and CSF-1 by CSF-1R. Structure, 20, 676-687. 
MADDOX, J. F., HACHICHA, M., TAKANO, T., PETASIS, N. A., FOKIN, V. V. & SERHAN, C. N. 1997. 
Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 




MAJCHRZYCKI, M., BARTKOWIAK-WIECZOREK, J., WOLSKI, H., DREWS, K., BOGACZ, A., 
CZERNY, B., ZAGRODNIK-UŁAN, E. & SEREMAK-MROZIKIEWICZ, A. 2015. 
Polymorphisms of collagen 1A1 (COL1A1) gene and their relation to bone mineral density in 
postmenopausal women. Ginekologia polska, 86, 907-914. 
MAJOR, B., RATTAZZI, L., BROD, S., PILIPOVIĆ, I., LEPOSAVIĆ, G. & D’ACQUISTO, F. 2015. 
Massage-like stroking boosts the immune system in mice. Scientific reports, 5. 
MALATYNSKA, E. & KNAPP, R. J. 2005. Dominant–submissive behavior as models of mania and 
depression. Neuroscience & Biobehavioral Reviews, 29, 715-737. 
MALINDA, K. M., PONCE, L., KLEINMAN, H. K., SHACKELTON, L. M. & MILLIS, A. J. 1999. Gp38k, 
a protein synthesized by vascular smooth muscle cells, stimulates directional migration of 
human umbilical vein endothelial cells. Experimental cell research, 250, 168-173. 
MANDINOVA, A., SOLDI, R., GRAZIANI, I., BAGALÁ, C., BELLUM, S., LANDRISCINA, M., 
TARANTINI, F., PRUDOVSKY, I. & MACIAG, T. 2003. S100A13 mediates the copper-
dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells. 
Journal of cell science, 116, 2687-2696. 
MARASHI, V., BARNEKOW, A., OSSENDORF, E. & SACHSER, N. 2003. Effects of different forms of 
environmental enrichment on behavioral, endocrinological, and immunological parameters in 
male mice. Hormones and Behavior, 43, 281-292. 
MARASHI, V., BARNEKOW, A. & SACHSER, N. 2004. Effects of environmental enrichment on males 
of a docile inbred strain of mice. Physiology & behavior, 82, 765-776. 
MARTIN, B., JI, S., MAUDSLEY, S. & MATTSON, M. P. 2010. “Control” laboratory rodents are 
metabolically morbid: why it matters. Proceedings of the National Academy of Sciences, 107, 
6127-6133. 
MARTINEZ, F. O. & GORDON, S. 2014. The M1 and M2 paradigm of macrophage activation: time for 
reassessment. F1000Prime Rep, 6, 12703. 
MARUCHA, P. T., KIECOLT-GLASER, J. K. & FAVAGEHI, M. 1998. Mucosal wound healing is 
impaired by examination stress. Psychosomatic Medicine, 60, 362-365. 
MATHERS, C., FAT, D. M. & BOERMA, J. 2008. The global burden of disease: 2004 update, WHO 
Press, 20 Avenue Appia, 1211 Geneva 27, Switzerland, World Health Organization. 
MATOLTSY, A. G. & VIZIAM, C. B. 1970. Further observations on epithelialization of small wounds. 
Journal of Investigative Dermatology, 55, 20-25. 
MATSUKAWA, A., HOGABOAM, C. M., LUKACS, N. W., LINCOLN, P. M., STRIETER, R. M. & 
KUNKEL, S. L. 1999. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects 
mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. The 
Journal of Immunology, 163, 6148-6154. 
MATSUZAKI, T., NAKAJIMA, A., ISHIGAMI, S., TANNO, M. & YOSHINO, S. 2006. Mirthful laughter 
differentially affects serum pro- and anti-inflammatory cytokine levels depending on the level 
of disease activity in patients with rheumatoid arthritis. Rheumatology (Oxford), 45, 182-6. 
MATUR, E., AKYAZI, İ., ERASLAN, E., ERGUL EKIZ, E., ESECELI, H., KETEN, M., METINER, K. & 
AKTARAN BALA, D. 2016. The effects of environmental enrichment and transport stress on 
the weights of lymphoid organs, cell‐mediated immune response, heterophil functions and 
antibody production in laying hens. Animal Science Journal, 87, 284-292. 
MAWDSLEY, J. & RAMPTON, D. 2005. Psychological stress in IBD: new insights into pathogenic and 
therapeutic implications. Gut, 54, 1481-1491. 
MAYADAS, T. N., CULLERE, X. & LOWELL, C. A. 2014. The multifaceted functions of neutrophils. 
Annual review of pathology, 9, 181. 
MCCARTHY, D. & DALE, M. 1988. The leucocytosis of exercise. Sports medicine, 6, 333-363. 
MCDEVITT, H. O. & BENACERRAF, B. 1969. Genetic control of specific immune responses. 
Advances in immunology, 11, 31-74. 
MCLACHLAN, J. L., SLOAN, A. J., SMITH, A. J., LANDINI, G. & COOPER, P. R. 2004. S100 and 
cytokine expression in caries. Infection and immunity, 72, 4102-4108. 
MCQUAID, R. J., AUDET, M.-C., JACOBSON-PICK, S. & ANISMAN, H. 2013. Environmental 
enrichment influences brain cytokine variations elicited by social defeat in mice. 
Psychoneuroendocrinology, 38, 987-996. 
MCQUIBBAN, G. A., GONG, J.-H., TAM, E. M., MCCULLOCH, C. A., CLARK-LEWIS, I. & OVERALL, 
C. M. 2000. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant 
protein-3. Science, 289, 1202-1206. 
MEDZHITOV, R. 2008. Origin and physiological roles of inflammation. Nature, 454, 428-435. 
MELLEN, J. & SEVENICH MACPHEE, M. 2001. Philosophy of environmental enrichment: past, 
present, and future. Zoo Biology, 20, 211-226. 
MENG, X., WEI, G., CHANG, Q., PENG, R., SHI, G., ZHENG, P., HE, F., WANG, W. & MING, L. 
2016. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, 
219 
 
correlates with hepatitis C virus infection. International Journal of Infectious Diseases, 45, 72-
77. 
MICALLEF, M., MUNRO, I. & GARG, M. 2009. An inverse relationship between plasma n-3 fatty acids 
and C-reactive protein in healthy individuals. European journal of clinical nutrition, 63, 1154-
1156. 
MILLS, C. 2012. M1 and M2 macrophages: oracles of health and disease. Critical Reviews™ in 
Immunology, 32. 
MINEUR, Y. S., BELZUNG, C. & CRUSIO, W. E. 2006. Effects of unpredictable chronic mild stress on 
anxiety and depression-like behavior in mice. Behavioural brain research, 175, 43-50. 
MISSLIN, R., KEMPF, E., SCHLEEF, C., GOBAILLE, S., ROPARTZ, P. & MANDEL, P. 1982. 
Responses to novelty in two inbred strains of mice and their F 1 hybrids: Behaviour and brain 
biogenic amines. Behavioural processes, 7, 135-141. 
MITCHISON, T. & CRAMER, L. 1996. Actin-based cell motility and cell locomotion. Cell, 84, 371-379. 
MONROE, L. L., ARMSTRONG, M. G., ZHANG, X., HALL, J. V., OZMENT, T. R., LI, C., WILLIAMS, 
D. L. & HOOVER, D. B. 2016. Zymosan-induced peritonitis: effects on cardiac function, 
temperature regulation, translocation of bacteria and role of dectin-1. Shock. 
MONTERO-MELENDEZ, T., GOBBETTI, T., COORAY, S. N., JONASSEN, T. E. & PERRETTI, M. 
2015. Biased agonism as a novel strategy to harness the proresolving properties of 
melanocortin receptors without eliciting melanogenic effects. The Journal of Immunology, 194, 
3381-3388. 
MORICI, G., ZANGLA, D., SANTORO, A., PELOSI, E., PETRUCCI, E., GIOIA, M., BONANNO, A., 
PROFITA, M., BELLIA, V. & TESTA, U. 2005. Supramaximal exercise mobilizes 
hematopoietic progenitors and reticulocytes in athletes. American Journal of Physiology-
Regulatory, Integrative and Comparative Physiology, 289, R1496-R1503. 
MOSER, M., DE SMEDT, T., SORNASSE, T., TIELEMANS, F., CHENTOUFI, A. A., MURAILLE, E., 
VAN MECHELEN, M., URBAIN, J. & LEO, O. 1995. Glucocorticoids down‐regulate dendritic 
cell function in vitro and in vivo. European journal of immunology, 25, 2818-2824. 
MOSSER, D. M. 2003. The many faces of macrophage activation. Journal of leukocyte biology, 73, 
209-212. 
MOSSER, D. M. & ZHANG, X. 2008. Interleukin‐10: new perspectives on an old cytokine. 
Immunological reviews, 226, 205-218. 
MOZAFFARIAN, D., PISCHON, T., HANKINSON, S. E., RIFAI, N., JOSHIPURA, K., WILLETT, W. C. 
& RIMM, E. B. 2004. Dietary intake of trans fatty acids and systemic inflammation in women. 
The American journal of clinical nutrition, 79, 606-612. 
MUENZER, J. T., DAVIS, C. G., CHANG, K., SCHMIDT, R. E., DUNNE, W. M., COOPERSMITH, C. 
M. & HOTCHKISS, R. S. 2010. Characterization and modulation of the immunosuppressive 
phase of sepsis. Infection and immunity, 78, 1582-1592. 
MULLER, W. 2013. Getting leukocytes to the site of inflammation. Veterinary Pathology Online, 50, 7-
22. 
MURPHY, C. A., LANGRISH, C. L., CHEN, Y., BLUMENSCHEIN, W., MCCLANAHAN, T., 
KASTELEIN, R. A., SEDGWICK, J. D. & CUA, D. J. 2003. Divergent pro-and antiinflammatory 
roles for IL-23 and IL-12 in joint autoimmune inflammation. The Journal of experimental 
medicine, 198, 1951-1957. 
MURPHY, K. M. 2011. Janeway's immunobiology, Garland Science. 
MYGIND, N. D., AXELSSON, A., RUWALD, M. H., DALSGAARD, M., STEFFENSEN, R., IVERSEN, 
K., JOHANSEN, J. S. & KASTRUP, J. 2016. The inflammatory biomarker YKL-40 decreases 
stepwise after exercise stress test. Cardiovascular Endocrinology, 5, 21-27. 
MYLONAS, K. J., NAIR, M. G., PRIETO-LAFUENTE, L., PAAPE, D. & ALLEN, J. E. 2009. 
Alternatively activated macrophages elicited by helminth infection can be reprogrammed to 
enable microbial killing. The Journal of immunology, 182, 3084-3094. 
NAKAMURA, H., KOBAYASHI, S., OHASHI, Y. & ANDO, S. 1999. Age‐changes of brain synapses 
and synaptic plasticity in response to an enriched environment. Journal of neuroscience 
research, 56, 307-315. 
NATOLI, G., GHISLETTI, S. & BAROZZI, I. 2011. The genomic landscapes of inflammation. Genes & 
development, 25, 101-106. 
NC3RS. 2017. Housing and Husbandry of Rodents [Online]. Available: https://www.nc3rs.org.uk/3rs-
resources/housing-and-husbandry/rodents [Accessed Feb 12 2017]. 
NEWBERRY, R. C. 1995. Environmental enrichment: increasing the biological relevance of captive 
environments. Applied Animal Behaviour Science, 44, 229-243. 
NGUYEN, H. B. & SMITH, D. 2007. Sepsis in the 21st century: recent definitions and therapeutic 
advances. The American journal of emergency medicine, 25, 564-571. 
220 
 
NIBBS, R. J. & GRAHAM, G. J. 2013. Immune regulation by atypical chemokine receptors. Nature 
Reviews Immunology, 13, 815-829. 
NICHOLS, B. A., BAINTON, D. F. & FARQUHAR, M. G. 1971. DIFFERENTIATION OF MONOCYTES 
Origin, Nature, and Fate of Their Azurophil Granules. The Journal of cell biology, 50, 498-515. 
NIELSEN, A. R., PLOMGAARD, P., KRABBE, K. S., JOHANSEN, J. S. & PEDERSEN, B. K. 2011. IL-
6, but not TNF-α, increases plasma YKL-40 in human subjects. Cytokine, 55, 152-155. 
NIELSEN, H. & PEDERSEN, B. 1997. Lymphocyte proliferation in response to exercise. European 
journal of applied physiology and occupational physiology, 75, 375-379. 
NIEMAN, D., NEHLSEN-CANNARELLA, S., MARKOFF, P., BALK-LAMBERTON, A., YANG, H., 
CHRITTON, D., LEE, J. & ARABATZIS, K. 1990. The effects of moderate exercise training on 
natural killer cells and acute upper respiratory tract infections. International journal of sports 
medicine, 11, 467-473. 
NIMMO, E. R., PRENDERGAST, J. G., ALDHOUS, M. C., KENNEDY, N. A., HENDERSON, P., 
DRUMMOND, H. E., RAMSAHOYE, B. H., WILSON, D. C., SEMPLE, C. A. & SATSANGI, J. 
2012. Genome‐wide methylation profiling in Crohn's disease identifies altered epigenetic 
regulation of key host defense mechanisms including the Th17 pathway. Inflammatory bowel 
diseases, 18, 889-899. 
NITHIANANTHARAJAH, J. & HANNAN, A. J. 2006. Enriched environments, experience-dependent 
plasticity and disorders of the nervous system. Nature Reviews Neuroscience, 7, 697-709. 
NSWAARRP 2004. Guidelines for the Housing of Rats in Scientific Institutions. 2 ed. New South 
Wales Agriculture Animal Research Review Panel  
NÚNEZ, M. J., MAÑÁ, P., LINARES, D., RIVEIRO, M. A. P., BALBOA, J., SUÁREZ-QUINTANILLA, J., 
MARACCHI, M., MÉNDEZ, M. R., LÓPEZ, J. M. & FREIRE-GARABAL, M. 2002. Music, 
immunity and cancer. Life Sciences, 71, 1047-1057. 
NURDEN, A. T., NURDEN, P., SANCHEZ, M., ANDIA, I. & ANITUA, E. 2007. Platelets and wound 
healing. Frontiers in bioscience: a journal and virtual library, 13, 3532-3548. 
O’MAHONY, L., MCCARTHY, J., KELLY, P., HURLEY, G., LUO, F., CHEN, K., O’SULLIVAN, G. C., 
KIELY, B., COLLINS, J. K. & SHANAHAN, F. 2005. Lactobacillus and bifidobacterium in 
irritable bowel syndrome: symptom responses and relationship to cytokine profiles. 
Gastroenterology, 128, 541-551. 
OKASHAH, A., EL-SAWY, M., BESHAY, B. & ABD EL-RAOUF, A. 2014. Ratio Of Neutrophil To 
Lymphocyte Counts As A Simple Marker For Sepsis And Severe Sepsis In Intensive Care 
Unit. 
OKIMURA, T., OGAWA, M. & TOSHIHIKO, Y. 1986. Stress and immune responses. III. Effect of 
restraint stress on delayed type hypersensitivity (DTH) response, natural killer (NK) activity 
and phagocytosis in mice. The Japanese Journal of Pharmacology, 41, 229-235. 
OLIVEIRA, M. & GLEESON, M. 2010. The influence of prolonged cycling on monocyte Toll-like 
receptor 2 and 4 expression in healthy men. European journal of applied physiology, 109, 251-
257. 
OLSON, A. K., EADIE, B. D., ERNST, C. & CHRISTIE, B. R. 2006. Environmental enrichment and 
voluntary exercise massively increase neurogenesis in the adult hippocampus via dissociable 
pathways. Hippocampus, 16, 250-260. 
OPDENAKKER, G., FROYEN, G., FITEN, P., PROOST, P. & VANDAMME, J. 1993. Human monocyte 
chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other 
chemokines. Biochemical and biophysical research communications, 191, 535-542. 
OPDENAKKER, G., VAN DEN STEEN, P. E., DUBOIS, B., NELISSEN, I., VAN COILLIE, E., 
MASURE, S., PROOST, P. & VAN DAMME, J. 2001. Gelatinase B functions as regulator and 
effector in leukocyte biology. Journal of leukocyte biology, 69, 851-859. 
ORTEGA‐GÓMEZ, A., PERRETTI, M. & SOEHNLEIN, O. 2013. Resolution of inflammation: an 
integrated view. EMBO molecular medicine, 5, 661-674. 
ORTUZAR, N., RICO-BARRIO, I., BENGOETXEA, H., ARGANDOÑA, E. & LAFUENTE, J. 2013. 
VEGF reverts the cognitive impairment induced by a focal traumatic brain injury during the 
development of rats raised under environmental enrichment. Behavioural brain research, 246, 
36-46. 
OSAKA, N., TAKAHASHI, T., MURAKAMI, S., MATSUZAWA, A., NOGUCHI, T., FUJIWARA, T., 
ABURATANI, H., MORIYAMA, K., TAKEDA, K. & ICHIJO, H. 2007. ASK1-dependent 
recruitment and activation of macrophages induce hair growth in skin wounds. The Journal of 
cell biology, 176, 903-909. 
OTSUKA, K., TERASAKI, F., IKEMOTO, M., FUJITA, S., TSUKADA, B., KATASHIMA, T., KANZAKI, 
Y., SOHMIYA, K., KONO, T. & TOKO, H. 2009. Suppression of inflammation in rat 
autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine 
network. European journal of heart failure, 11, 229-237. 
221 
 
PACE, T. W., NEGI, L. T., ADAME, D. D., COLE, S. P., SIVILLI, T. I., BROWN, T. D., ISSA, M. J. & 
RAISON, C. L. 2009. Effect of compassion meditation on neuroendocrine, innate immune and 
behavioral responses to psychosocial stress. Psychoneuroendocrinology, 34, 87-98. 
PADGETT, D. A., MARUCHA, P. T. & SHERIDAN, J. F. 1998. Restraint stress slows cutaneous 
wound healing in mice. Brain, behavior, and immunity, 12, 64-73. 
PANINA-BORDIGNON, P., MAZZEO, D., LUCIA, P., D'AMBROSIO, D., LANG, R., FABBRI, L., SELF, 
C. & SINIGAGLIA, F. 1997. Beta2-agonists prevent Th1 development by selective inhibition of 
interleukin 12. Journal of Clinical Investigation, 100, 1513. 
PAPAYANNOPOULOS, V. & ZYCHLINSKY, A. 2009. NETs: a new strategy for using old weapons. 
Trends in immunology, 30, 513-521. 
PARKER, J. C., SMARR, K. L., BUCKELEW, S. P., STUCKY‐ROPP, R. C., HEWETT, J. E., 
JOHNSON, J. C., WRIGHT, G. E., IRVIN, W. S. & WALKER, S. E. 1995. Effects of stress 
management on clinical outcomes in rheumatoid arthritis. Arthritis & Rheumatism, 38, 1807-
1818. 
PEDERSEN, B. K. 2012. Muscular interleukin-6 and its role as an energy sensor. Medicine and 
science in sports and exercise, 44, 392-396. 
PERRETTI, M., CROXTALL, J. D., WHELLER, S. K., GOULDING, N. J., HANNON, R. & FLOWER, R. 
J. 1996. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their 
transmigration. Nature medicine, 2, 1259-1262. 
PERRETTI, M. & GAVINS, F. N. 2003. Annexin 1: an endogenous anti-inflammatory protein. 
Physiology, 18, 60-64. 
PERRETTI, M., SOLITO, E. & PARENTE, L. 1992. Evidence that endogenous interleukin-1 is involved 
in leukocyte migration in acute experimental inflammation in rats and mice. Agents and 
actions, 35, 71-78. 
PESCE, J. T., RAMALINGAM, T. R., MENTINK-KANE, M. M., WILSON, M. S., EL KASMI, K. C., 
SMITH, A. M., THOMPSON, R. W., CHEEVER, A. W., MURRAY, P. J. & WYNN, T. A. 2009. 
Arginase-1–expressing macrophages suppress Th2 cytokine–driven inflammation and fibrosis. 
PLoS Pathog, 5, e1000371. 
PETERSEN, A. M. W. & PEDERSEN, B. K. 2005. The anti-inflammatory effect of exercise. Journal of 
applied physiology, 98, 1154-1162. 
PHILLIPS, S. A., BARR, V. A., HAFT, D. H., TAYLOR, S. I. & HAFT, C. R. 2001. Identification and 
characterization of SNX15, a novel sorting nexin involved in protein trafficking. Journal of 
Biological Chemistry, 276, 5074-5084. 
PILCHER, B. K., WANG, M., QIN, X. J., PARKS, W. C., SENIOR, R. M. & WELGUS, H. G. 1999. Role 
of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic 
contact hypersensitivity. Annals of the New York Academy of Sciences, 878, 12-24. 
PITSAVOS, C., PANAGIOTAKOS, D. B., PAPAGEORGIOU, C., TSETSEKOU, E., SOLDATOS, C. & 
STEFANADIS, C. 2006. Anxiety in relation to inflammation and coagulation markers, among 
healthy adults: the ATTICA study. Atherosclerosis, 185, 320-326. 
PONTING, C. P. 2008. The functional repertoires of metazoan genomes. Nature Reviews Genetics, 9, 
689-698. 
POWELL, N. D., SLOAN, E. K., BAILEY, M. T., AREVALO, J. M., MILLER, G. E., CHEN, E., KOBOR, 
M. S., READER, B. F., SHERIDAN, J. F. & COLE, S. W. 2013. Social stress up-regulates 
inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of 
myelopoiesis. Proceedings of the National Academy of Sciences, 110, 16574-16579. 
PRUETT, S. B., ENSLEY, D. K. & CRITTENDEN, P. L. 1993. The role of chemical‐induced stress 
responses in immunosuppression: A review of quantitative associations and cause‐effect 
relationships between chemical‐induced stress responses and immunosuppression. Journal 
of Toxicology and Environmental Health, Part A Current Issues, 39, 163-192. 
PUPPE, B., TUCHSCHERER, M. & TUCHSCHERER, A. 1997. The effect of housing conditions and 
social environment immediately after weaning on the agonistic behaviour, 
neutrophil/lymphocyte ratio, and plasma glucose level in pigs. Livestock Production Science, 
48, 157-164. 
QIAN, B.-Z., LI, J., ZHANG, H., KITAMURA, T., ZHANG, J., CAMPION, L. R., KAISER, E. A., 
SNYDER, L. A. & POLLARD, J. W. 2011. CCL2 recruits inflammatory monocytes to facilitate 
breast-tumour metastasis. Nature, 475, 222-225. 
RAISON, C. L. & MILLER, A. H. 2011. Is depression an inflammatory disorder? Current psychiatry 
reports, 13, 467-475. 
RAJAKARIAR, R., LAWRENCE, T., BYSTROM, J., HILLIARD, M., COLVILLE-NASH, P., 
BELLINGAN, G., FITZGERALD, D., YAQOOB, M. M. & GILROY, D. W. 2008. Novel biphasic 
role for lymphocytes revealed during resolving inflammation. Blood, 111, 4184-4192. 
222 
 
RAKITA, R. M., MICHEL, B. R. & ROSEN, H. 1990. Differential inactivation of Escherichia coli 
membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. 
Biochemistry, 29, 1075-1080. 
RAMASWAMY, H. & HEMLER, M. E. 1990. Cloning, primary structure and properties of a novel 
human integrin beta subunit. The EMBO Journal, 9, 1561. 
RAMPON, C., JIANG, C. H., DONG, H., TANG, Y.-P., LOCKHART, D. J., SCHULTZ, P. G., TSIEN, J. 
Z. & HU, Y. 2000a. Effects of environmental enrichment on gene expression in the brain. 
Proceedings of the National Academy of Sciences, 97, 12880-12884. 
RAMPON, C., TANG, Y.-P., GOODHOUSE, J., SHIMIZU, E., KYIN, M. & TSIEN, J. Z. 2000b. 
Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 
NMDAR1-knockout mice. Nature neuroscience, 3, 238-244. 
RAO, T. S., CURRIE, J. L., SHAFFER, A. F. & ISAKSON, P. C. 1994. In vivo characterization of 
zymosan-induced mouse peritoneal inflammation. Journal of Pharmacology and Experimental 
Therapeutics, 269, 917-925. 
RATHER, L. 1971. Disturbance of function (functio laesa): the legendary fifth cardinal sign of 
inflammation, added by Galen to the four cardinal signs of Celsus. Bulletin of the New York 
Academy of Medicine, 47, 303. 
RAVICHANDRAN, K. S. 2011. Beginnings of a good apoptotic meal: the find-me and eat-me signaling 
pathways. Immunity, 35, 445-455. 
RAY, A. & DITTEL, B. N. 2010. Isolation of mouse peritoneal cavity cells. JoVE (Journal of Visualized 
Experiments), e1488-e1488. 
REED, H., WILKINS, L., AUSTIN, S. & GREGORY, N. 1993. The effect of environmental enrichment 
during rearing on fear reactions and depopulation trauma in adult caged hens. Applied Animal 
Behaviour Science, 36, 39-46. 
REHLI, M., NILLER, H.-H., AMMON, C., LANGMANN, S., SCHWARZFISCHER, L., ANDREESEN, R. 
& KRAUSE, S. W. 2003. Transcriptional regulation of CHI3L1, a marker gene for late stages 
of macrophage differentiation. Journal of Biological Chemistry, 278, 44058-44067. 
REHMAN, J., LI, J., PARVATHANENI, L., KARLSSON, G., PANCHAL, V. R., TEMM, C. J., 
MAHENTHIRAN, J. & MARCH, K. L. 2004. Exercise acutely increases circulating endothelial 
progenitor cells and monocyte-/macrophage-derived angiogenic cells. Journal of the American 
College of Cardiology, 43, 2314-2318. 
REICHMANN, F., PAINSIPP, E. & HOLZER, P. 2013. Environmental enrichment and gut inflammation 
modify stress-induced c-Fos expression in the mouse corticolimbic system. PloS one, 8, 
e54811. 
REYES, M., QUINTANILLA, C., BURROWS, R., BLANCO, E., CIFUENTES, M. & GAHAGAN, S. 
2015. Obesity is associated with acute inflammation in a sample of adolescents. Pediatric 
diabetes, 16, 109-116. 
RIBECHINI, E., GREIFENBERG, V., SANDWICK, S. & LUTZ, M. B. 2010. Subsets, expansion and 
activation of myeloid-derived suppressor cells. Medical microbiology and immunology, 199, 
273-281. 
RIEDEMANN, N. C., NEFF, T. A., GUO, R.-F., BERNACKI, K. D., LAUDES, I. J., SARMA, J. V., 
LAMBRIS, J. D. & WARD, P. A. 2003. Protective effects of IL-6 blockade in sepsis are linked 
to reduced C5a receptor expression. The Journal of Immunology, 170, 503-507. 
RIVA, M., KÄLLBERG, E., BJÖRK, P., HANCZ, D., VOGL, T., ROTH, J., IVARS, F. & LEANDERSON, 
T. 2012. Induction of nuclear factor‐κB responses by the S100A9 protein is Toll‐like 
receptor‐4‐dependent. Immunology, 137, 172-182. 
ROBERTS, A. W. 2005. G-CSF: a key regulator of neutrophil production, but that's not all! Growth 
factors, 23, 33-41. 
ROBERTS, J. E. 2000. Light and immunomodulation. Annals of the New York Academy of Sciences, 
917, 435-445. 
ROCA, L., DI PAOLO, S., PETRUZZELLI, V., GRANDALIANO, G., RANIERI, E., SCHENA, F. P. & 
GESUALDO, L. 2007. Dexamethasone modulates interleukin-12 production by inducing 
monocyte chemoattractant protein-1 in human dendritic cells. Immunology and cell biology, 
85, 610-616. 
ROEDERER, M., QUAYE, L., MANGINO, M., BEDDALL, M. H., MAHNKE, Y., CHATTOPADHYAY, 
P., TOSI, I., NAPOLITANO, L., BARBERIO, M. T. & MENNI, C. 2015. The Genetic 
Architecture of the Human Immune System: A Bioresource for Autoimmunity and Disease 
Pathogenesis. Cell. 
ROGERS, M. P., TRENTHAM, D. E., MCCUNE, W. J., GINSBERG, B. I., RENNKE, H. G., REICH, P. 
& DAVID, J. R. 1980. Effect of psychological stress on the induction of arthritis in rats. Arthritis 
& Rheumatism, 23, 1337-1342. 
223 
 
ROPER, J., CRAIGHEAD, M., O’CARROLL, A. M. & LOLAIT, S. 2010. Attenuated Stress Response to 
Acute Restraint and Forced Swimming Stress in Arginine Vasopressin 1b Receptor Subtype 
(Avpr1b) Receptor Knockout Mice and Wild‐Type Mice Treated with a Novel Avpr1b 
Receptor Antagonist. Journal of neuroendocrinology, 22, 1173-1180. 
ROSE, S., MISHARIN, A. & PERLMAN, H. 2012. A novel Ly6C/Ly6G‐based strategy to analyze the 
mouse splenic myeloid compartment. Cytometry Part A, 81, 343-350. 
ROSENKRANZ, M. A., DAVIDSON, R. J., MACCOON, D. G., SHERIDAN, J. F., KALIN, N. H. & 
LUTZ, A. 2013. A comparison of mindfulness-based stress reduction and an active control in 
modulation of neurogenic inflammation. Brain, Behavior, and Immunity, 27, 174-184. 
ROSENNE, E., SORSKI, L., SHAASHUA, L., NEEMAN, E., MATZNER, P., LEVI, B. & BEN-ELIYAHU, 
S. 2014. In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have 
a minor role compared to catecholamines and prostaglandins. Brain, behavior, and immunity, 
37, 207-219. 
RØSETH, A., AADLAND, E., JAHNSEN, J. & RAKNERUD, N. 1997. Assessment of disease activity in 
ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion, 58, 176-
180. 
RŐSZER, T. 2015. Understanding the mysterious M2 macrophage through activation markers and 
effector mechanisms. Mediators of inflammation, 2015. 
ROTH, J. A. 1985. Cortisol as mediator of stress-associated immunosuppression in cattle. Animal 
stress. Springer. 
RUFF, M., SCHIFFMANN, E., TERRANOVA, V. & PERT, C. B. 1985. Neuropeptides are 
chemoattractants for human tumor cells and monocytes: a possible mechanism for 
metastasis. Clinical immunology and immunopathology, 37, 387-396. 
RUIS, M., TE BRAKE, J., BUWALDA, B., DE BOER, S., MEERLO, P., KORTE, S., BLOKHUIS, H. & 
KOOLHAAS, J. 1999. Housing familiar male wildtype rats together reduces the long-term 
adverse behavioural and physiological effects of social defeat. Psychoneuroendocrinology, 24, 
285-300. 
SAAVEDRA, J. M., BAUMAN, N., PERMAN, J., YOLKEN, R. & OUNG, I. 1994. Feeding of 
Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of 
diarrhoea and shedding of rotavirus. The Lancet, 344, 1046-1049. 
SALAS-VIDAL, E., MEIJER, A. H., CHENG, X. & SPAINK, H. P. 2005. Genomic annotation and 
expression analysis of the zebrafish Rho small GTPase family during development and 
bacterial infection. Genomics, 86, 25-37. 
SALE, A., BERARDI, N. & MAFFEI, L. 2009. Enrich the environment to empower the brain. Trends in 
neurosciences, 32, 233-239. 
SCHALLER, M., MILLER, G. E., GERVAIS, W. M., YAGER, S. & CHEN, E. 2010. Mere visual 
perception of other people’s disease symptoms facilitates a more aggressive immune 
response. Psychological Science. 
SCHAUER, C., JANKO, C., MUNOZ, L. E., ZHAO, Y., KIENHÖFER, D., FREY, B., LELL, M., 
MANGER, B., RECH, J. & NASCHBERGER, E. 2014. Aggregated neutrophil extracellular 
traps limit inflammation by degrading cytokines and chemokines. Nature medicine, 20, 511-
517. 
SCHIOPU, A. & COTOI, O. S. 2013. S100A8 and S100A9: DAMPs at the crossroads between innate 
immunity, traditional risk factors, and cardiovascular disease. Mediators of inflammation, 2013. 
SCHMALTZ, H. N., FRIED, L. P., XUE, Q. L., WALSTON, J., LENG, S. X. & SEMBA, R. D. 2005. 
Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in 
community‐dwelling older women. Journal of the American Geriatrics Society, 53, 747-754. 
SCHNEIDER, M. L., MOORE, C. F., SUOMI, S. J. & CHAMPOUX, M. 1991. Laboratory assessment of 
temperament and environmental enrichment in rhesus monkey infants (Macaca mulatta). 
American Journal of Primatology, 25, 137-155. 
SCHWAB, J. M., CHIANG, N., ARITA, M. & SERHAN, C. N. 2007. Resolvin E1 and protectin D1 
activate inflammation-resolution programmes. Nature, 447, 869-874. 
SCHWARTZ, R., LU, Y., VILLINES, D. & SROUSSI, H. Y. 2010. Effect of human immunodeficiency 
virus infection on S100A8/A9 inhibition of peripheral neutrophils oxidative metabolism. 
Biomedicine & Pharmacotherapy, 64, 572-575. 
SCOTLAND, R. S., STABLES, M. J., MADALLI, S., WATSON, P. & GILROY, D. W. 2011. Sex 
differences in resident immune cell phenotype underlie more efficient acute inflammatory 
responses in female mice. Blood, 118, 5918-5927. 
SCOTT, A., KHAN, K., COOK, J. & DURONIO, V. 2004. What is “inflammation”? Are we ready to 
move beyond Celsus? British journal of sports medicine, 38, 248-249. 
224 
 
SEGAL, A. W., DORLING, J. & COADE, S. 1980. Kinetics of fusion of the cytoplasmic granules with 
phagocytic vacuoles in human polymorphonuclear leukocytes. Biochemical and morphological 
studies. The Journal of cell biology, 85, 42-59. 
SEGERSTROM, S. C. & MILLER, G. E. 2004. Psychological stress and the human immune system: a 
meta-analytic study of 30 years of inquiry. Psychological bulletin, 130, 601. 
SEIFFERT, M., BROSSART, P., CANT, C., CELLA, M., COLONNA, M., BRUGGER, W., KANZ, L., 
ULLRICH, A. & BÜHRING, H.-J. 2001. Signal-regulatory protein α (SIRPα) but not SIRPβ is 
involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature 
CD34+ CD38− hematopoietic cells. Blood, 97, 2741-2749. 
SEITZ, O., SCHÜRMANN, C., HERMES, N., MÜLLER, E., PFEILSCHIFTER, J., FRANK, S. & 
GOREN, I. 2011. Wound healing in mice with high-fat diet-or ob gene-induced diabetes-
obesity syndromes: a comparative study. Experimental diabetes research, 2010. 
SERBINA, N. V., JIA, T., HOHL, T. M. & PAMER, E. G. 2008. Monocyte-mediated defense against 
microbial pathogens. Annual review of immunology, 26, 421. 
SERHAN, C. N., CHIANG, N. & VAN DYKE, T. E. 2008. Resolving inflammation: dual anti-
inflammatory and pro-resolution lipid mediators. Nature Reviews Immunology, 8, 349-361. 
SERHAN, C. N. & SAVILL, J. 2005. Resolution of inflammation: the beginning programs the end. 
Nature immunology, 6, 1191-1197. 
SETHI, S., WRONA, C., GRANT, B. J. & MURPHY, T. F. 2004. Strain-specific immune response to 
Haemophilus influenzae in chronic obstructive pulmonary disease. American journal of 
respiratory and critical care medicine, 169, 448-453. 
SHERMAN, V. R., YANG, W. & MEYERS, M. A. 2015. The materials science of collagen. Journal of 
the mechanical behavior of biomedical materials, 52, 22-50. 
SHERWIN, C. 2007a. Validating refinements to laboratory housing: asking the animals. NCR3RS 
(database online). Available from http://www. nc3rs. org. uk/downloaddoc. asp. 
SHERWIN, C. M. 2002. Comfortable quarters for mice in research institutions. Comfortable quarters 
for laboratory animals, 9, 6-17. 
SHERWIN, C. M. 2007b. Validating refinements to laboratory housing: asking the animals. National 
centre for replacement, refinement and reduction of animals in research. 
SHI, C. & PAMER, E. G. 2011. Monocyte recruitment during infection and inflammation. Nature 
Reviews Immunology, 11, 762-774. 
SHI, Z., WAKIL, A. E. & ROCKEY, D. C. 1997. Strain-specific differences in mouse hepatic wound 
healing are mediated by divergent T helper cytokine responses. Proceedings of the National 
Academy of Sciences, 94, 10663-10668. 
SHIMIZU, K., LIBBY, P., ROCHA, V. Z., FOLCO, E. J., SHUBIKI, R., GRABIE, N., JANG, S., 
LICHTMAN, A. H., SHIMIZU, A. & HOGG, N. 2011. Loss of myeloid related protein-8/14 
exacerbates cardiac allograft rejection. Circulation, 124, 2920-2932. 
SHUTT, D., SMITH, A., WALLACE, C., CONNELL, R. & FELL, L. 1988. Effect of Myiasis and Acute 
Restraint Stress on Plasma Levels of Immunoreactive, ß-Endorphin, Adrenocorticotrophin 
(ACTH) and Cortisol in the Sheep. Australian journal of biological sciences, 41, 297-302. 
SIEDLIK, J. A., DECKERT, J. A., CLOPTON, A. W., GIGLIOTTI, N., CHAN, M. A., BENEDICT, S. H., 
HERDA, T. J., GALLAGHER, P. M. & VARDIMAN, J. P. 2015. Immunoendocrine alterations 
following marine corps martial arts training are associated with changes in moral cognitive 
processes. Physiology & behavior. 
SINGH, P. B., BROWN, R. E. & ROSER, B. 1987. MHC antigens in urine as olfactory recognition 
cues. 
SINGHAL, G., JAEHNE, E. J., CORRIGAN, F. & BAUNE, B. T. 2014. Cellular and molecular 
mechanisms of immunomodulation in the brain through environmental enrichment. Frontiers in 
Cellular Neuroscience, 8. 
SINGLETON, K. & WISCHMEYER, P. 2003. Distance of cecum ligated influences mortality, tumor 
necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the 
rat. European surgical research, 35, 486-491. 
SLATER, A. M. & CAO, L. 2015. A protocol for housing mice in an enriched environment. Journal of 
visualized experiments: JoVE. 
SLUYTER, F., GERLAI, R. T. & PIETROPAOLO, S. 2013. Behavioral Genetics of the Mouse. Autism, 
1, 13. 
SMITH, D. F., GALKINA, E., LEY, K. & HUO, Y. 2005. GRO family chemokines are specialized for 
monocyte arrest from flow. American Journal of Physiology-Heart and Circulatory Physiology, 
289, H1976-H1984. 
SMITH, J., MCKENZIE, S., TELFORD, R. & WEIDEMANN, M. 1992. Why does moderate exercise 
enhance, but intense training depress, immunity. Behavior and Immunity, 155-168. 
SMITH, J. A., GRAY, A. B., PYNE, D. B., BAKER, M. S., TELFORD, R. D. & WEIDEMANN, M. J. 
1996. Moderate exercise triggers both priming and activation of neutrophil subpopulations. 
225 
 
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 270, 
R838-R845. 
SMITH, M. M. & HARGADEN, M. 2001. Developing a rodent enrichment program. Lab animal, 30, 36-
41. 
SO, B., KIM, H.-J., KIM, J. & SONG, W. 2014. Exercise-induced myokines in health and metabolic 
diseases. Integrative Medicine Research, 3, 172-179. 
SOEHNLEIN, O., LINDBOM, L. & WEBER, C. 2009. Mechanisms underlying neutrophil-mediated 
monocyte recruitment. Blood, 114, 4613-4623. 
SOFI, F., CESARI, F., ABBATE, R., GENSINI, G. F. & CASINI, A. 2008. Adherence to Mediterranean 
diet and health status: meta-analysis. Bmj, 337. 
SOKOL, H., PIGNEUR, B., WATTERLOT, L., LAKHDARI, O., BERMÚDEZ-HUMARÁN, L. G., 
GRATADOUX, J.-J., BLUGEON, S., BRIDONNEAU, C., FURET, J.-P. & CORTHIER, G. 
2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by 
gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of 
Sciences, 105, 16731-16736. 
SONG, J., WU, C., ZHANG, X. & SOROKIN, L. M. 2013. In Vivo Processing of CXCL5 (LIX) by Matrix 
Metalloproteinase (MMP)-2 and MMP-9 Promotes Early Neutrophil Recruitment in IL-1β–
Induced Peritonitis. The Journal of Immunology, 190, 401-410. 
SOROKIN, L. 2010. The impact of the extracellular matrix on inflammation. Nature Reviews 
Immunology, 10, 712-723. 
SOUZA, L. M., BOONE, T. C., GABRILOVE, J., LAI, P. H., ZSEBO, K. M., MURDOCK, D. C., 
CHAZIN, V. R., BRUSZEWSKI, J., LU, H. & CHEN, K. K. 1986. Recombinant human 
granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science, 
232, 61-65. 
STACKER, S. A., WILLIAMS, S. P., KARNEZIS, T., SHAYAN, R., FOX, S. B. & ACHEN, M. G. 2014. 
Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nature Reviews Cancer, 14, 
159-172. 
STARKIE, R., ANGUS, D., ROLLAND, J., HARGREAVES, M. & FEBBRAIO, M. 2000. Effect of 
prolonged, submaximal exercise and carbohydrate ingestion on monocyte intracellular 
cytokine production in humans. The Journal of physiology, 528, 647-655. 
STARKIE, R., OSTROWSKI, S. R., JAUFFRED, S., FEBBRAIO, M. & PEDERSEN, B. K. 2003. 
Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans. The FASEB 
Journal, 17, 884-886. 
STEFANSKI, V. & ENGLER, H. 1998. Effects of acute and chronic social stress on blood cellular 
immunity in rats. Physiology & behavior, 64, 733-741. 
STEINMÜLLER, M., SRIVASTAVA, M., KUZIEL, W. A., CHRISTMAN, J. W., SEEGER, W., WELTE, 
T., LOHMEYER, J. & MAUS, U. A. 2006. Endotoxin induced peritonitis elicits monocyte 
immigration into the lung: implications on alveolar space inflammatory responsiveness. 
Respiratory research, 7, 1. 
STOUT, R. D., JIANG, C., MATTA, B., TIETZEL, I., WATKINS, S. K. & SUTTLES, J. 2005. 
Macrophages sequentially change their functional phenotype in response to changes in 
microenvironmental influences. The Journal of Immunology, 175, 342-349. 
STRAUCH, A. R. & RUBENSTEIN, P. 1984. A vascular smooth muscle alpha-isoactin biosynthetic 
intermediate in BC3H1 cells. Identification of acetylcysteine at the NH2 terminus. Journal of 
Biological Chemistry, 259, 7224-7229. 
STŘÍŽ, I. & TREBICHAVSKÝ, I. 2004. Calprotectin—a pleiotropic molecule in acute and chronic 
inflammation. Physiol Res, 53, 245-253. 
STROUS, R. D. & SHOENFELD, Y. 2006. To smell the immune system: olfaction, autoimmunity and 
brain involvement. Autoimmunity reviews, 6, 54-60. 
SUGIMOTO, M. A., SOUSA, L. P., PINHO, V., PERRETTI, M. & TEIXEIRA, M. M. 2016. Resolution of 
inflammation: what Controls its Onset? Frontiers in immunology, 7. 
SUN, Y., LU, Y., ENGELAND, C. G., GORDON, S. C. & SROUSSI, H. Y. 2013. The anti-oxidative, 
anti-inflammatory, and protective effect of S100A8 in endotoxemic mice. Molecular 
immunology, 53, 443-449. 
SUZUKI, K., NAKAJI, S., YAMADA, M., TOTSUKA, M., SATO, K. & SUGAWARA, K. 2002. Systemic 
inflammatory response to exhaustive exercise: cytokine kinetics. Exerc Immunol Rev, 8, 6-48. 
SWAIN, S. D., ROHN, T. T. & QUINN, M. T. 2002. Neutrophil priming in host defense: role of oxidants 
as priming agents. Antioxidants and Redox Signaling, 4, 69-83. 
SWAN, M. P. & HICKMAN, D. L. 2014. Evaluation of the neutrophil-lymphocyte ratio as a measure of 
distress in rats. Lab animal, 43, 276. 




TAK, T., TESSELAAR, K., PILLAY, J., BORGHANS, J. A. & KOENDERMAN, L. 2013. What's your 
age again? Determination of human neutrophil half-lives revisited. Journal of leukocyte 
biology, 94, 595-601. 
TAKAHASHI, K. 2001. Development and Differentiation of Macrophages and Related Cells. Journal of 
clinical and experimental hematopathology, 41, 1-31. 
TAKEUCHI, O. & AKIRA, S. 2010. Pattern recognition receptors and inflammation. Cell, 140, 805-820. 
TAM, E. M., MORRISON, C. J., WU, Y. I., STACK, M. S. & OVERALL, C. M. 2004. Membrane 
protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1–matrix 
metalloproteinase substrates. Proceedings of the National Academy of Sciences of the United 
States of America, 101, 6917-6922. 
TAYLOR, P. R., BROWN, G. D., REID, D. M., WILLMENT, J. A., MARTINEZ-POMARES, L., 
GORDON, S. & WONG, S. Y. 2002. The β-glucan receptor, dectin-1, is predominantly 
expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. The 
Journal of immunology, 169, 3876-3882. 
THEILGAARD-MÖNCH, K., KNUDSEN, S., FOLLIN, P. & BORREGAARD, N. 2004. The 
transcriptional activation program of human neutrophils in skin lesions supports their important 
role in wound healing. The Journal of Immunology, 172, 7684-7693. 
THORSBY, E. 1997. Invited anniversary review: HLA associated diseases. Human immunology, 53, 1-
11. 
TIKELLIS, C., THOMAS, M. C., HARCOURT, B. E., COUGHLAN, M. T., PETE, J., BIALKOWSKI, K., 
TAN, A., BIERHAUS, A., COOPER, M. E. & FORBES, J. M. 2008. Cardiac inflammation 
associated with a Western diet is mediated via activation of RAGE by AGEs. American 
Journal of Physiology-Endocrinology and Metabolism, 295, E323-E330. 
TIMMERMAN, K. L., FLYNN, M. G., COEN, P. M., MARKOFSKI, M. M. & PENCE, B. D. 2008. 
Exercise training-induced lowering of inflammatory (CD14+ CD16+) monocytes: a role in the 
anti-inflammatory influence of exercise? Journal of leukocyte biology, 84, 1271-1278. 
TONNESEN, M. G., FENG, X. & CLARK, R. A. Angiogenesis in wound healing.  Journal of 
Investigative Dermatology Symposium Proceedings, 2000. Nature Publishing Group, 40-46. 
TONO-OKA, S., TANASE, S., MIIKE, T. & TANAKA, H. 1996. Transient expression of collagen type 
XIV during muscle development and its reappearance after denervation and degeneration. 
Journal of Histochemistry & Cytochemistry, 44, 907-918. 
TOSCANO, M. G., GANEA, D. & GAMERO, A. M. 2011. Cecal ligation puncture procedure. JoVE 
(Journal of Visualized Experiments), e2860-e2860. 
TOUMA, C., SACHSER, N., MÖSTL, E. & PALME, R. 2003. Effects of sex and time of day on 
metabolism and excretion of corticosterone in urine and feces of mice. General and 
comparative endocrinology, 130, 267-278. 
TRØSTRUP, H., LUNDQUIST, R., CHRISTENSEN, L., JORGENSEN, L., KARLSMARK, T., HAAB, B. 
& ÅGREN, M. 2011. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by 
multiplexed antibody microarray profiling. British Journal of Dermatology, 165, 292-301. 
TRUMAN, L. A., FORD, C. A., PASIKOWSKA, M., POUND, J. D., WILKINSON, S. J., DUMITRIU, I. 
E., MELVILLE, L., MELROSE, L. A., OGDEN, C. A. & NIBBS, R. 2008. CX3CL1/fractalkine is 
released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood, 112, 5026-
5036. 
TSOU, C.-L., PETERS, W., SI, Y., SLAYMAKER, S., ASLANIAN, A. M., WEISBERG, S. P., MACK, M. 
& CHARO, I. F. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone 
marrow and recruitment to inflammatory sites. The Journal of clinical investigation, 117, 902-
909. 
UNDERHILL, D. M. 2003. Macrophage recognition of zymosan particles. Journal of endotoxin 
research, 9, 176-180. 
UNDERHILL, D. M., OZINSKY, A., HAJJAR, A. M., STEVENS, A., WILSON, C. B., BASSETTI, M. & 
ADEREM, A. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and 
discriminates between pathogens. Nature, 401, 811-815. 
VACHHARAJANI, V., RUSSELL, J. M., SCOTT, K. L., CONRAD, S., STOKES, K. Y., TALLAM, L., 
HALL, J. & GRANGER, D. N. 2005. Obesity exacerbates sepsis-induced inflammation and 
microvascular dysfunction in mouse brain. Microcirculation, 12, 183-194. 
VALENZUELA, M. & SACHDEV, P. 2009. Can cognitive exercise prevent the onset of dementia? 
Systematic review of randomized clinical trials with longitudinal follow-up. The American 
Journal of Geriatric Psychiatry, 17, 179-187. 
VALLÈS, A., MARTENS, G. J., DE WEERD, P., POELMANS, G. & ASCHRAFI, A. 2014. MicroRNA-
137 regulates a glucocorticoid receptor-dependent signalling network: implications for the 
etiology of schizophrenia. Journal of psychiatry & neuroscience: JPN, 39, 312. 
227 
 
VAN DE WEERD, H., BAUMANS, V., KOOLHAAS, J. & VAN ZUTPHEN, L. 1994. Strain specific 
behavioural response to environmental enrichment in the mouse. Journal of experimental 
animal science, 36, 117-117. 
VAN DE WEERD, H., VAN LOO, P., VAN ZUTPHEN, L., KOOLHAAS, J. & BAUMANS, V. 1998. 
Strength of preference for nesting material as environmental enrichment for laboratory mice. 
Applied Animal Behaviour Science, 55, 369-382. 
VAN DE WEERD, H. A. & BAUMANS, V. 1995. Environmental enrichment in rodents. Environmental 
Enrichment Information Resources for Laboratory Animals. AWIC Resource Series, 145-9. 
VAN DER MEER, J., NETEA, M. & DINARELLO, C. 2009. Modulation of muramyl dipeptide 
stimulation of cytokine production by blood components. Clinical & Experimental Immunology, 
156, 428-433. 
VAN FURTH, R. & COHN, Z. A. 1968. The origin and kinetics of mononuclear phagocytes. The 
Journal of experimental medicine, 128, 415-435. 
VAN LOO, P. L., DE GROOT, A. C., VAN ZUTPHEN, B. F. & BAUMANS, V. 2001. Do male mice 
prefer or avoid each other's company? Influence of hierarchy, kinship, and familiarity. Journal 
of Applied Animal Welfare Science, 4, 91-103. 
VAN LOO, P. L., VAN DE WEERD, H. A., VAN ZUTPHEN, L. F. & BAUMANS, V. 2004. Preference for 
social contact versus environmental enrichment in male laboratory mice. Laboratory Animals 
38, 178-88. 
VAN OOSTEN, M. J., DOLHAIN, R. J., KOPER, J. W., VAN ROSSUM, E. F., EMONTS, M., HAN, K. 
H., WOUTERS, J. M., HAZES, J. M., LAMBERTS, S. W. & FEELDERS, R. A. 2010. 
Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are 
associated with rheumatoid arthritis. Arthritis research & therapy, 12, 1. 
VAN WOLFSWINKEL, M. E., VLIEGENTHART-JONGBLOED, K., DE MENDONÇA MELO, M., 
WEVER, P. C., MCCALL, M. B., KOELEWIJN, R., VAN HELLEMOND, J. J. & VAN 
GENDEREN, P. J. 2013. Predictive value of lymphocytopenia and the neutrophil-lymphocyte 
count ratio for severe imported malaria. Malaria journal, 12, 1. 
VARGAS-PÉREZ, H., SELLINGS, L., GRIEDER, T. & DÍAZ, J.-L. 2009. Social dominance rank 
influences wheel running behavior in mice. Neuroscience letters, 457, 137-140. 
VERBURG-VAN KEMENADE, B. M., COHEN, N. & CHADZINSKA, M. 2017. Neuroendocrine-immune 
interaction: Evolutionarily conserved mechanisms that maintain allostasis in an ever-changing 
environment. Dev Comp Immunol, 66, 2-23. 
VIEIRA, O. V., BOTELHO, R. J. & GRINSTEIN, S. 2002. Phagosome maturation: aging gracefully. 
Biochemical Journal, 366, 689-704. 
VIEIRA, V. J., VALENTINE, R. J., WILUND, K. R., ANTAO, N., BAYNARD, T. & WOODS, J. A. 2009. 
Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic 
complications in obese mice. American Journal of Physiology-Endocrinology and Metabolism, 
296, E1164-E1171. 
VISWANATHAN, K., DAUGHERTY, C. & DHABHAR, F. S. 2005. Stress as an endogenous adjuvant: 
augmentation of the immunization phase of cell-mediated immunity. International immunology, 
17, 1059-1069. 
VISWANATHAN, K. & DHABHAR, F. S. 2005. Stress-induced enhancement of leukocyte trafficking 
into sites of surgery or immune activation. Proceedings of the National Academy of Sciences 
of the United States of America, 102, 5808-5813. 
VITALO, A. G., GORANTLA, S., FRICCHIONE, J. G., SCICHILONE, J. M., CAMACHO, J., NIEMI, S. 
M., DENNINGER, J. W., BENSON, H., YARMUSH, M. L. & LEVINE, J. B. 2012. 
Environmental enrichment with nesting material accelerates wound healing in isolation-reared 
rats. Behavioural brain research, 226, 606-612. 
VODOVOTZ, Y. 2006. Deciphering the complexity of acute inflammation using mathematical models. 
Immunologic research, 36, 237-245. 
VOGELZANGS, N., BEEKMAN, A., DE JONGE, P. & PENNINX, B. 2013. Anxiety disorders and 
inflammation in a large adult cohort. Translational psychiatry, 3, e249. 
VOGL, T., TENBROCK, K., LUDWIG, S., LEUKERT, N., EHRHARDT, C., VAN ZOELEN, M. A., 
NACKEN, W., FOELL, D., VAN DER POLL, T. & SORG, C. 2007. Mrp8 and Mrp14 are 
endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. 
Nature medicine, 13, 1042-1049. 
VOLCK, B., PRICE, P. A., JOHANSEN, J. S., SØRENSEN, O., BENFIELD, T. L., NIELSEN, H. J., 
CALAFAT, J. & BORREGAARD, N. 1997. YKL-40, a mammalian member of the chitinase 
family, is a matrix protein of specific granules in human neutrophils. Proceedings of the 
Association of American Physicians, 110, 351-360. 
WANG, J., SONG, H., TANG, X., YANG, Y., VIEIRA, V., NIU, Y. & MA, Y. 2012. Effect of exercise 
training intensity on murine T‐regulatory cells and vaccination response. Scandinavian 
journal of medicine & science in sports, 22, 643-652. 
228 
 
WANG, M., MOLIN, G., AHRNÉ, S., ADAWI, D. & JEPPSSON, B. 2007. High proportions of 
proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as 
revealed by cloning and sequencing of 16S rRNA genes. Digestive diseases and sciences, 
52, 620-627. 
WANTHA, S., ALARD, J.-E., MEGENS, R. T., VAN DER DOES, A. M., DÖRING, Y., DRECHSLER, 
M., PHAM, C. T., WANG, M.-W., WANG, J.-M. & GALLO, R. L. 2013. Neutrophil-derived 
cathelicidin promotes adhesion of classical monocytes. Circulation research, 112, 792-801. 
WARD, P. A. & BOSMANN, M. 2012. A historical perspective on sepsis. The American journal of 
pathology, 181, 2-7. 
WEBER, C., WEBER, K. S., KLIER, C., GU, S., WANK, R., HORUK, R. & NELSON, P. J. 2001. 
Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of 
monocytes and TH1-like/CD45RO+ T cells. Blood, 97, 1144-1146. 
WEIGHARDT, H., KAISER-MOORE, S., SCHLAUTKÖTTER, S., ROSSMANN-BLOECK, T., 
SCHLEICHER, U., BOGDAN, C. & HOLZMANN, B. 2006. Type I IFN modulates host defense 
and late hyperinflammation in septic peritonitis. The Journal of Immunology, 177, 5623-5630. 
WEINER 3RD, J., PARIDA, S. K., MAERTZDORF, J., BLACK, G. F., REPSILBER, D., TELAAR, A., 
MOHNEY, R. P., ARNDT-SULLIVAN, C., GANOZA, C. A. & FAÉ, K. C. 2012. Biomarkers of 
inflammation, immunosuppression and stress with active disease are revealed by 
metabolomic profiling of tuberculosis patients. PloS one, 7, e40221. 
WEISSER, S. B., MCLARREN, K. W., KURODA, E. & SLY, L. M. 2013. Generation and 
characterization of murine alternatively activated macrophages. Basic Cell Culture Protocols, 
225-239. 
WELLS, D. L. 2009. Sensory stimulation as environmental enrichment for captive animals: a review. 
Applied Animal Behaviour Science, 118, 1-11. 
WELLS, H. G. & JOHNSTONE, O. 1907. On the route of absorption of bacteria from the peritoneal 
cavity. Journal of Infectious Diseases, 4, 582-594. 
WICHTERMAN, K. A., BAUE, A. E. & CHAUDRY, I. H. 1980. Sepsis and septic shock—a review of 
laboratory models and a proposal. Journal of Surgical Research, 29, 189-201. 
WIKBY, A., NILSSON, B.-O., FORSEY, R., THOMPSON, J., STRINDHALL, J., LÖFGREN, S., 
ERNERUDH, J., PAWELEC, G., FERGUSON, F. & JOHANSSON, B. 2006. The immune risk 
phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish 
NONA immune longitudinal study of very late life functioning. Mechanisms of ageing and 
development, 127, 695-704. 
WILLIAMS, R. 2006. Killing controversy. The Journal of experimental medicine, 203, 2404. 
WILLIAMSON, L. L., CHAO, A. & BILBO, S. D. 2012. Environmental enrichment alters glial antigen 
expression and neuroimmune function in the adult rat hippocampus. Brain, behavior, and 
immunity, 26, 500-510. 
WILSON, C. L., OUELLETTE, A. J., SATCHELL, D. P., AYABE, T., LÓPEZ-BOADO, Y. S., 
STRATMAN, J. L., HULTGREN, S. J., MATRISIAN, L. M. & PARKS, W. C. 1999. Regulation 
of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. 
Science, 286, 113-117. 
WILSON, E., LESZCZYNSKA, K., POULTER, N. S., EDELMANN, F., SALISBURY, V. A., NOY, P. J., 
BACON, A., RAPPOPORT, J. Z., HEATH, J. K. & BICKNELL, R. 2014. RhoJ interacts with the 
GIT–PIX complex and regulates focal adhesion disassembly. Journal of cell science, 127, 
3039-3051. 
WILSON, J. A. & CLARK, J. J. 2004. Obesity: impediment to postsurgical wound healing. Advances in 
skin & wound care, 17, 426-432. 
WINGETT, D., FORCIER, K. & NIELSON, C. P. 1996. Glucocorticoid‐mediated inhibition of RANTES 
expression in human T lymphocytes. FEBS letters, 398, 308-311. 
WOHLEB, E. S., MCKIM, D. B., SHERIDAN, J. F. & GODBOUT, J. P. 2015. Monocyte trafficking to 
the brain with stress and inflammation: a novel axis of immune-to-brain communication that 
influences mood and behavior. Frontiers in Neuroscience, 8, 447. 
WOLFER, D. P., LITVIN, O., MORF, S., NITSCH, R. M., LIPP, H.-P. & WÜRBEL, H. 2004. Laboratory 
animal welfare: cage enrichment and mouse behaviour. Nature, 432, 821-822. 
WOOD, N. I., CARTA, V., MILDE, S., SKILLINGS, E. A., MCALLISTER, C. J., ANG, Y. M., DUGUID, 
A., WIJESURIYA, N., AFZAL, S. M. & FERNANDES, J. X. 2010. Responses to environmental 
enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease. 
PloS one, 5, e9077. 
WRIGHT, R. J., RODRIGUEZ, M. & COHEN, S. 1998. Review of psychosocial stress and asthma: an 
integrated biopsychosocial approach. Thorax, 53, 1066-1074. 
XERRI, C. & ZENNOU-AZOGUI, Y. 2003. Influence of the postlesion environment and chronic 
piracetam treatment on the organization of the somatotopic map in the rat primary 
somatosensory cortex after focal cortical injury. Neuroscience, 118, 161-177. 
229 
 
YADAV, A., SAINI, V. & ARORA, S. 2010. MCP-1: chemoattractant with a role beyond immunity: a 
review. Clinica chimica acta, 411, 1570-1579. 
YARDEN, Y. & SCHLESSINGER, J. 1987. Epidermal growth factor induces rapid, reversible 
aggregation of the purified epidermal growth factor receptor. Biochemistry, 26, 1443-1451. 
YOKOTA, T., ORITANI, K., TAKAHASHI, I., ISHIKAWA, J., MATSUYAMA, A., OUCHI, N., KIHARA, 
S., FUNAHASHI, T., TENNER, A. J. & TOMIYAMA, Y. 2000. Adiponectin, a new member of 
the family of soluble defense collagens, negatively regulates the growth of myelomonocytic 
progenitors and the functions of macrophages. Blood, 96, 1723-1732. 
YOSHIKAWA, H., KUROKAWA, M., OZAKI, N., NARA, K., ATOU, K., TAKADA, E., KAMOCHI, H. & 
SUZUKI, N. 2006. Nicotine inhibits the production of proinflammatory mediators in human 
monocytes by suppression of I‐κB phosphorylation and nuclear factor‐κB transcriptional 
activity through nicotinic acetylcholine receptor α7. Clinical & Experimental Immunology, 146, 
116-123. 
YOUNG, R. 2003. Environmental enrichment for captive animals. Universities Federation for Animal 
Welfare (UFAW) Series. Oxford: Blackwell Publishing. 
YUEDE, C. M., ZIMMERMAN, S. D., DONG, H., KLING, M. J., BERO, A. W., HOLTZMAN, D. M., 
TIMSON, B. F. & CSERNANSKY, J. G. 2009. Effects of voluntary and forced exercise on 
plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of 
Alzheimer's disease. Neurobiology of disease, 35, 426-432. 
ZANNI, F., VESCOVINI, R., BIASINI, C., FAGNONI, F., ZANLARI, L., TELERA, A., DI PEDE, P., 
PASSERI, G., PEDRAZZONI, M. & PASSERI, M. 2003. Marked increase with age of type 1 
cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to 
understand the relationship between inflammation and immunosenescence. Experimental 
gerontology, 38, 981-987. 
ZHANG, L., LEE, I.-C. J., ENRIQUEZ, R. F., LAU, J., VÄHÄTALO, L. H., BALDOCK, P. A., 
SAVONTAUS, E. & HERZOG, H. 2014. Stress-and diet-induced fat gain is controlled by NPY 
in catecholaminergic neurons. Molecular metabolism, 3, 581-591. 
ZHANG, Y., ZHANG, Y., MIAO, J., HANLEY, G., STUART, C., SUN, X., CHEN, T. & YIN, D. 2008. 
Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated 
phosphoinositide 3-kinase signaling. Journal of neuroimmunology, 204, 13-19. 
ZIMMERMAN, G. A., MCINTYRE, T. M., PRESCOTT, S. M. & STAFFORINI, D. M. 2002. The platelet-
activating factor signaling system and its regulators in syndromes of inflammation and 
thrombosis. Critical care medicine, 30, S294-S301. 
ZIV, Y., RON, N., BUTOVSKY, O., LANDA, G., SUDAI, E., GREENBERG, N., COHEN, H., KIPNIS, J. 
& SCHWARTZ, M. 2006. Immune cells contribute to the maintenance of neurogenesis and 
spatial learning abilities in adulthood. Nature neuroscience, 9, 268-275. 
 
